Processing 00000000.tx.1: Regulation of Myosin-Bound Protein Phosphatase by Insulin in Vascular Smooth Muscle Cells: Evaluation of the Role of Rho Kinase and Phosphatidylinositol-3-Kinase-Dependent Signaling Pathways Najma Begum, Noreen Duddy, Oana Sandu, Jennifer Reinzie and Louis Ragolia The Diabetes Research Laboratory (N.B., N.D., O.S., J.R., L.R.) 

Phrase: "Regulation of Myosin-Bound Protein Phosphatase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0851285:Regulation [Governmental or Regulatory Activity]
   753   C1327622:Regulation [Biologic Function]

Phrase: "by Insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "in Vascular Smooth Muscle Cells"
Meta Candidates (Total=23; Excluded=11; Pruned=0; Remaining=12)
   923   C0026844:Muscle, Smooth, Vascular [Tissue]
   923   C1135918:Smooth Muscle Cells [Cell]
   861   C0596981:Muscle Cells [Cell]
   861   C1267092:Muscle, Smooth [Tissue]
   852   C0005773:Blood Cells [Cell]
   844 E C2328697:Hemal cell [Cell]
   812   C0005847:vascular [Body Part, Organ, or Organ Component]
   812   C0007634:Cells [Cell]
   812   C0026845:Muscle [Tissue]
   812   C0205357:Smooth [Qualitative Concept]
   812   C1558950:VASCULAR [Finding]
   812   C1801960:Vascular [Qualitative Concept]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
   756 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   756 E C1511228:VESSEL, BLOOD [Tissue]
   741 E C0442025:Muscular [Spatial Concept]
   712 E C0005767:Blood [Tissue]
   712 E C0005768:blood [Body Substance]
   712 E C0229664:Blood [Body Substance]
   712 E C0392895:Bloods [Population Group]

Phrase: ":"

Phrase: "Evaluation of the Role of Rho Kinase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0220825:Evaluation [Functional Concept]
   748   C1261322:Evaluation [Health Care Activity]

Phrase: "and"

Phrase: "Phosphatidylinositol-3-Kinase-Dependent Signaling Pathways Najma Begum,"

Phrase: "Noreen Duddy,"

Phrase: "Oana Sandu,"

Phrase: "Jennifer Reinzie"

Phrase: "and"

Phrase: "Louis Ragolia"

Phrase: "The Diabetes Research Laboratory"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0022886:research laboratory [Research Activity]
   827   C0022877:Laboratory [Manufactured Object,Organization]
   827   C0035168:research [Research Activity]
   827   C0242481:Research [Research Activity]
   827   C3244292:laboratory [Functional Concept]

Phrase: "(N.B.,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "D."

Phrase: ","

Phrase: "O.S.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439114:O NOS [Intellectual Product]

Phrase: "J.R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "L.R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: ")"
Processing 00000000.tx.2: Winthrop University Hospital Mineola, New York 11501 School of Medicine (N.B., L.R.) 

Phrase: "Winthrop University Hospital Mineola,"

Phrase: "New York 11501 School of Medicine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0036375:School [Manufactured Object,Organization]

Phrase: "(N.B.,"

Phrase: "L.R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: ")"
Processing 00000000.tx.3: State University of New York @ Stony Brook New York, New York 11794  ABSTRACT TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES  In this study, we examined the molecular mechanism of myosin-bound protein phosphatase (MBP) regulation by insulin and evaluated the role of MBP in insulin-mediated vasorelaxation. 

Phrase: "State University of New York @ Stony Brook New York,"

Phrase: "New York 11794  ABSTRACT TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES  In this study,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   819   C2985663:Study Reference [Intellectual Product]
   770   C0557651:Study [Manufactured Object]
   770   C1514811:Reference [Idea or Concept]
   770   C1706462:Reference [Conceptual Entity]
   770   C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the molecular mechanism of myosin-bound protein phosphatase (MBP) regulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0441712:Mechanism [Functional Concept]
   742   C1706376:Mechanism [Manufactured Object]

Phrase: "by insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "evaluated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluated [Functional Concept]

Phrase: "the role of MBP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]

Phrase: "in insulin-mediated vasorelaxation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0042401:Vasorelaxation [Physiologic Function]
Processing 00000000.tx.4: Insulin rapidly stimulated MBP in confluent primary vascular smooth muscle cell (VSMC) cultures. 

Phrase: "Insulin rapidly stimulated MBP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   845   C0067062:myosin phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   818   C0031686:Protein phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   795   C0031678:Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   795   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C1149880:phosphatase [Molecular Function]

Phrase: "in confluent primary vascular smooth muscle cell (VSMC) cultures."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   884   C1449562:Primary Cell Cultures [Laboratory Procedure]
   818   C0007585:Cell Cultures [Laboratory Procedure]
   811   C0200949:blood cultures [Laboratory Procedure]
   795   C0010453:Cultures [Idea or Concept]
   762 E C0220814:culture [Functional Concept]
   762 E C0430400:Culture [Laboratory Procedure]
   762 E C2242979:Culture [Laboratory Procedure]
Processing 00000000.tx.5: In contrast, VSMCs isolated from diabetic and hypertensive rats exhibited impaired MBP activation by insulin. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "VSMCs"
Meta Candidates (Total=23; Excluded=11; Pruned=0; Remaining=12)
   923   C0026844:Muscle, Smooth, Vascular [Tissue]
   923   C1135918:Smooth Muscle Cells [Cell]
   861   C0596981:Muscle Cells [Cell]
   861   C1267092:Muscle, Smooth [Tissue]
   852   C0005773:Blood Cells [Cell]
   844 E C2328697:Hemal cell [Cell]
   812   C0005847:vascular [Body Part, Organ, or Organ Component]
   812   C0007634:Cells [Cell]
   812   C0026845:Muscle [Tissue]
   812   C0205357:Smooth [Qualitative Concept]
   812   C1558950:VASCULAR [Finding]
   812   C1801960:Vascular [Qualitative Concept]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
   756 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   756 E C1511228:VESSEL, BLOOD [Tissue]
   741 E C0442025:Muscular [Spatial Concept]
   712 E C0005767:Blood [Tissue]
   712 E C0005768:blood [Body Substance]
   712 E C0229664:Blood [Body Substance]
   712 E C0392895:Bloods [Population Group]

Phrase: "isolated from diabetic"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0205409:Isolated [Functional Concept]
   790   C0241863:DIABETIC [Finding]
   790   C1548221:Isolated [Idea or Concept]
   756 E C0370215:Isolate [Substance]
   756 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "and"

Phrase: "hypertensive rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]

Phrase: "exhibited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0015272:Exhibit [Intellectual Product]

Phrase: "impaired MBP activation by insulin."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C0599177:protein activation [Genetic Function]
   744   C1879547:Activation [Activity]
Processing 00000000.tx.6: Insulin-mediated MBP activation was accompanied by a rapid time-dependent reduction in the phosphorylation state of the myosin-bound regulatory subunit (MBS) of MBP. 

Phrase: "Insulin-mediated MBP activation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   829   C0599177:protein activation [Genetic Function]
   795   C1879547:Activation [Activity]

Phrase: "was"

Phrase: "accompanied by a rapid time-dependent reduction"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   748   C0040223:Time [Temporal Concept]
   748   C0301630:Reduction [Natural Phenomenon or Process]
   748   C0392756:Reduction [Qualitative Concept]
   748   C0439831:Rapid [Qualitative Concept]
   748   C0441610:Reduction [Therapeutic or Preventive Procedure]
   748   C0851827:Dependent [Qualitative Concept]
   748   C1701901:Dependent [Qualitative Concept]
   748   C3244310:dependent [Functional Concept]
   748   C3541383:Time [Temporal Concept]

Phrase: "in the phosphorylation state"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0031715:Phosphorylation [Molecular Function]
   861   C1158886:Phosphorylation [Molecular Function]
   861   C1301808:State [Geographic Area]
   861   C1442792:State [Functional Concept]
   861   C3148680:State [Geographic Area]

Phrase: "of the myosin-bound regulatory subunit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1711351:Subunit [Quantitative Concept]

Phrase: "(MBS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1711351:Subunit [Quantitative Concept]

Phrase: ")"

Phrase: "of MBP."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   902   C0067062:myosin phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0031686:Protein phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0031678:Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1149880:phosphatase [Molecular Function]
Processing 00000000.tx.7: The decrease observed in MBS phosphorylation was due to insulin-induced inhibition of Rho kinase activity. 

Phrase: "The decrease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "observed in MBS phosphorylation"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   753   C0027096:Myosin [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0031715:Phosphorylation [Molecular Function]
   753   C0332297:bound [Spatial Concept]
   753   C1145667:Bound [Activity]
   753   C1158886:Phosphorylation [Molecular Function]
   753   C1167622:Bound [Molecular Function]
   753   C1441672:Observed [Functional Concept]
   753   C1689898:% bound [Quantitative Concept]
   753   C1711351:Subunit [Quantitative Concept]
   753   C2349209:Bound [Conceptual Entity]

Phrase: "was due to insulin-induced inhibition of Rho kinase activity."
Meta Candidates (Total=24; Excluded=0; Pruned=0; Remaining=24)
   797   C2247121:inhibition of kinase activity [Molecular Function]
   760   C0389995:rho-Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0678226:Due to [Functional Concept]
           due
   760   C1150423:kinase activity [Molecular Function]
   760   C1335631:RHO KINASE [Gene or Genome]
   757   C1145751:insulin activity [Molecular Function]
   739   C0021467:Inhibition [Mental Process]
   739   C0021469:Inhibition [Molecular Function]
   739   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   739   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0043194:WAS [Disease or Syndrome]
   739   C0205177:Activity [Functional Concept]
   739   C0205263:Induced [Functional Concept]
   739   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0439167:% activity [Quantitative Concept]
   739   C0441655:Activity [Activity]
   739   C1421478:WAS [Gene or Genome]
   739   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   739   C1561536:*Activity [Idea or Concept]
   739   C1579433:Insulin [Pharmacologic Substance]
   739   C1628982:% inhibition [Quantitative Concept]
   739   C3146286:Due [Idea or Concept]
   739   C3463820:Inhibition [Activity]
Processing 00000000.tx.8: Insulin also prevented a thrombin-mediated increase in Rho kinase activation and abolished the thrombin-induced increase in MBS phosphorylation and MBP inactivation. 

Phrase: "Insulin also"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "prevented"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "a thrombin-mediated increase in Rho kinase activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0442805:Increase [Functional Concept]

Phrase: "and"

Phrase: "abolished"

Phrase: "the thrombin-induced increase in MBS phosphorylation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0442805:Increase [Functional Concept]

Phrase: "and"

Phrase: "MBP inactivation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0544461:Inactivation [Cell or Molecular Dysfunction]
   708   C0067062:myosin phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.9: These data are consistent with the notion that insulin inactivates Rho kinase and decreases MBS phosphorylation to activate MBP in VSMCs. 

Phrase: "These data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "consistent with the notion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "that insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "inactivates"

Phrase: "Rho kinase"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0389995:rho-Kinase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1335631:RHO KINASE [Gene or Genome]
   861   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "decreases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "MBS phosphorylation to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0031715:Phosphorylation [Molecular Function]
   804   C1158886:Phosphorylation [Molecular Function]

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "MBP in VSMCs."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   827   C0210219:Smooth Muscle Myosin-bound Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   764   C0031686:Protein phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   762   C0026832:Muscle Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   762   C0067062:myosin phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   762   C0522527:Protein bound [Qualitative Concept]
   742   C0031678:Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C1149880:phosphatase [Molecular Function]
   712   C0005832:blood protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.10: Furthermore, treatment with synthetic inhibitors of phosphatidylinositol-3 kinase (PI3kinase), nitric oxide synthase (NOS), and cyclic guanosine monophosphate (cGMP) all blocked insulins effect on MBP activation. 

Phrase: "Furthermore,"

Phrase: "treatment with synthetic inhibitors of phosphatidylinositol-3 kinase (PI3kinase),"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   744   C0039798:treatment [Functional Concept]
   744   C0087111:Treatment [Therapeutic or Preventive Procedure]
   744   C1522326:Treatment [Functional Concept]
   744   C1533734:Treatment [Therapeutic or Preventive Procedure]
   744   C1705169:Treatment [Conceptual Entity]
   744   C3538994:TREATMENT [Research Activity]

Phrase: "nitric oxide synthase (NOS),"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
           synthase
   901   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C0030015:oxide [Inorganic Chemical]
   827   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "and"

Phrase: "cyclic guanosine monophosphate (cGMP)"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0018338:Cyclic guanosine monophosphate [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   901   C0018346:Guanosine Monophosphate [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0018330:Guanosine [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   827   C0439596:Cyclic [Temporal Concept]
   827   C1511572:Cyclic [Temporal Concept]
   755 E C0031084:Cyclicities [Temporal Concept]

Phrase: "all blocked insulins effect on MBP activation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C1280500:Effect [Qualitative Concept]
   739   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.11: We conclude that insulin stimulates MBP via its regulatory subunit, MBS partly by inactivating Rho kinase and stimulating NO/cGMP signaling via PI3-kinase as part of a complex signaling network that controls 20-kDa myosin light chain (MLC20) phosphorylation and VSMC contraction.  

Phrase: "We"

Phrase: "conclude"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0917903:conclude [Biomedical or Dental Material,Organic Chemical]

Phrase: "that insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "stimulates"

Phrase: "MBP via its regulatory subunit,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   815   C1417582:myosin phosphatase regulatory subunit [Gene or Genome]
   770   C0031686:Protein phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   767   C0067062:myosin phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   767   C0522527:Protein bound [Qualitative Concept]
   767   C0599220:Protein Subunit [Amino Acid, Peptide, or Protein]
   767   C0815047:Regulatory Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0031678:Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C1149880:phosphatase [Molecular Function]

Phrase: "MBS partly by inactivating Rho kinase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1711351:Subunit [Quantitative Concept]

Phrase: "and"

Phrase: "stimulating NO/cGMP signaling via PI3-kinase"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   772   C1155501:nitric oxide signaling [Molecular Function]
   738   C0037083:Signaling [Cell Function]
   738   C3537152:signaling [Biologic Function]

Phrase: "as part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449719:Part [Spatial Concept]
  1000   C1709471:Part [Quantitative Concept]

Phrase: "of a complex signaling network"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1513822:Network [Professional or Occupational Group]
   827   C1705739:Network [Manufactured Object]
   827   C1882071:Network [Conceptual Entity]

Phrase: "that"

Phrase: "controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "20-kDa myosin light chain"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   884   C0027108:Myosin Light Chain [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0023693:Light [Natural Phenomenon or Process]
   804   C0027096:Myosin [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0337112:Chain [Manufactured Object]
   804   C1306462:Light [Functional Concept]
   804   C1524075:Chain [Idea or Concept]
   804   C1881376:Light [Qualitative Concept]

Phrase: "(MLC20"

Phrase: ")"

Phrase: "phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031715:Phosphorylation [Molecular Function]
  1000   C1158886:Phosphorylation [Molecular Function]

Phrase: "and"

Phrase: "VSMC contraction."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   933   C2265839:Vascular smooth muscle contraction [Organ or Tissue Function]
   888   C1155937:smooth muscle contraction [Organ or Tissue Function]
   884   C0026820:Muscle Cell Contraction [Physiologic Function]
           Muscle Contraction
   804   C1140999:Contraction [Pathologic Function]
   717   C0026844:Muscle, Smooth, Vascular [Tissue]
   717   C1135918:Smooth muscle cell [Cell]
Processing 00000000.tx.12: INTRODUCTION TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES  It is well known that insulin promotes relaxation and vasodilation and acutely decreases vascular tone (1, 2, 3, 4). 

Phrase: "INTRODUCTION TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "It"

Phrase: "is"

Phrase: "well known"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205170:Well [Qualitative Concept]
   861   C0205309:Known [Qualitative Concept]
   861   C3146287:Well [Manufactured Object]

Phrase: "that insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "promotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "relaxation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035028:Relaxation [Activity]

Phrase: "and"

Phrase: "vasodilation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0042401:Vasodilation [Physiologic Function]
  1000   C0595862:VASODILATION [Pathologic Function]
  1000   C3537065:Vasodilation [Physiologic Function]

Phrase: "and"

Phrase: "acutely"

Phrase: "decreases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "vascular tone"

Phrase: "(1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "4"

Phrase: ")."
Processing 00000000.tx.13: However, the molecular mechanism by which insulin regulates relaxation of vascular smooth muscle cells (VSMCs) is unclear. 

Phrase: "However,"

Phrase: "the molecular mechanism by which insulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0441712:Mechanism [Functional Concept]
   753   C1706376:Mechanism [Manufactured Object]

Phrase: "regulates"

Phrase: "relaxation of vascular smooth muscle cells (VSMCs)"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   938   C2262829:relaxation of vascular smooth muscle [Organism Function]
           vascular smooth muscle relaxation
   858   C2249967:relaxation of smooth muscle [Organ or Tissue Function]
           smooth muscle relaxation
   820   C0026836:relaxation of muscle [Organ or Tissue Function]
           Muscle Relaxation
   783   C0700323:Muscle relaxation [Disease or Syndrome]
   753   C0035028:Relaxation [Activity]

Phrase: "is"

Phrase: "unclear."
Processing 00000000.tx.14: A detailed understanding of how insulin causes vasorelaxation, inhibits VSMC contraction, and decreases vascular tone in normal cells is necessary to explore the pathophysiology of the vascular complications associated with diabetes. 

Phrase: "A detailed understanding of how insulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0162340:Understanding [Mental Process]

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "vasorelaxation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0042401:Vasorelaxation [Physiologic Function]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "VSMC contraction,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   933   C2265839:Vascular smooth muscle contraction [Organ or Tissue Function]
   888   C1155937:smooth muscle contraction [Organ or Tissue Function]
   884   C0026820:Muscle Cell Contraction [Physiologic Function]
           Muscle Contraction
   804   C1140999:Contraction [Pathologic Function]
   717   C0026844:Muscle, Smooth, Vascular [Tissue]
   717   C1135918:Smooth muscle cell [Cell]

Phrase: "and"

Phrase: "decreases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "vascular tone in normal cells"

Phrase: "is"

Phrase: "necessary to"

Phrase: "explore"

Phrase: "the pathophysiology of the vascular complications"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0031847:pathophysiology [Functional Concept]
   753   C0277785:Pathophysiology [Qualitative Concept]

Phrase: "associated with diabetes."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C0011847:Diabetes [Disease or Syndrome]
   790   C0011849:Diabetes [Disease or Syndrome]
   756 E C0750490:Associate [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.15: Smooth muscle contraction and relaxation are largely mediated by the phosphorylation and dephosphorylation of the 20-kDa regulatory myosin light chain (MLC20) at threonine 18 and serine-19 by myosin light chain kinase (MLCK) and a myosin-bound serine/threonine specific protein phosphatase (MBP, Refs. 5, 6). 

Phrase: "Smooth muscle contraction"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1155937:smooth muscle contraction [Organ or Tissue Function]
   901   C0026820:Muscle Contraction [Physiologic Function]
   827   C1140999:Contraction [Pathologic Function]
   734   C1267092:Muscle, Smooth [Tissue]

Phrase: "and"

Phrase: "relaxation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035028:Relaxation [Activity]

Phrase: "are"

Phrase: "largely"

Phrase: "mediated by the phosphorylation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0031715:Phosphorylation [Molecular Function]
   770   C0086597:mediated [Social Behavior]
   770   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   770   C1158886:Phosphorylation [Molecular Function]

Phrase: "and"

Phrase: "dephosphorylation of the 20-kDa regulatory myosin light chain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C1158884:Dephosphorylation [Molecular Function]
   742   C3160734:Dephosphorylation [Molecular Function]

Phrase: "(MLC20"

Phrase: ")"

Phrase: "at threonine 18"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0040005:Threonine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "serine-19 by myosin light chain kinase (MLCK)"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   853   C0027120:Myosin Light Chain Kinase [Amino Acid, Peptide, or Protein,Enzyme]
           Myosin Kinase
   853   C1150543:myosin light-chain kinase [Molecular Function]
   853   C1334539:MYOSIN LIGHT CHAIN KINASE [Gene or Genome]
   814   C0027108:Myosin Light Chain [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   774   C0072402:Serine Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0023693:Light [Natural Phenomenon or Process]
   748   C0027096:Myosin [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0036720:Serine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   748   C0337112:Chain [Manufactured Object]
   748   C1306462:Light [Functional Concept]
   748   C1524075:Chain [Idea or Concept]
   748   C1881376:Light [Qualitative Concept]

Phrase: "and"

Phrase: "a myosin-bound serine/threonine specific protein phosphatase"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   893   C0067062:myosin phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   868   C0031686:Serine-Threonine Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
           Protein phosphatase
   845   C0643572:Threonine Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   795   C0031678:Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   795   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C1149880:phosphatase [Molecular Function]

Phrase: "(MBP,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   902   C0067062:myosin phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0031686:Protein phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0031678:Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1149880:phosphatase [Molecular Function]

Phrase: "Refs. 5,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1425988:REF [Gene or Genome]

Phrase: "6"

Phrase: ")."
Processing 00000000.tx.16: Intracellular calcium levels ([Ca2+]i) are known to modulate the MLCK to MBP activity ratio and ultimately the degree of contractile force because MLCK activity depends on the amount of the Ca2+/calmodulin complex, which itself hinges on [Ca2+]i (7, 8, 9). 

Phrase: "Intracellular calcium levels"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   901   C0201925:calcium levels [Laboratory Procedure]
   901   C0428302:calcium levels [Laboratory or Test Result]
   827   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   827   C0006726:Calcium [Inorganic Chemical]
   827   C0175996:intracellular [Cell Component]
   827   C0178719:Intracellular [Spatial Concept]
   827   C0441889:Levels [Qualitative Concept]
   827   C2936886:Calcium [Pharmacologic Substance]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "("

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]i)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "are"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "modulate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "the MLCK to MBP activity ratio"
Meta Candidates (Total=27; Excluded=1; Pruned=0; Remaining=26)
   820   C1323639:myosin light-chain kinase phosphatase activity [Molecular Function]
           [Myosin light-chain]-phosphatase activity
   814   C1150543:myosin light chain protein kinase activity [Molecular Function]
           myosin light chain kinase activity
           myosin light-chain kinase
           myosin kinase activity
   804   C0067062:Myosin light-chain kinase phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
           Myosin-Light-Chain Phosphatase
           myosin phosphatase
   790   C0027120:Myosin Light Chain Kinase [Amino Acid, Peptide, or Protein,Enzyme]
           Myosin Kinase
   790   C1334539:MYOSIN LIGHT CHAIN KINASE [Gene or Genome]
   770   C0027108:Myosin Light Chain [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   767   C1149936:myosin phosphatase activity [Molecular Function]
   766   C1150527:protein kinase activity [Molecular Function]
   751   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   751   C0670902:LIGHT Protein [Amino Acid, Peptide, or Protein,Immunologic Factor]
   751   C1150423:kinase activity [Molecular Function]
   751   C1517883:Light Activity [Daily or Recreational Activity]
   747 E C2261495:protein phosphokinase activity [Molecular Function]
   736   C0023693:Light [Natural Phenomenon or Process]
   736   C0027096:Myosin [Amino Acid, Peptide, or Protein,Enzyme]
   736   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   736   C0337112:Chain [Manufactured Object]
   736   C1306462:Light [Functional Concept]
   736   C1524075:Chain [Idea or Concept]
   736   C1881376:Light [Qualitative Concept]

Phrase: "and"

Phrase: "ultimately"

Phrase: "the degree of contractile force"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0441889:Degree [Qualitative Concept]
   760   C0449286:Degree [Quantitative Concept]
   760   C0542560:Degree [Intellectual Product]
   760   C1561545:degree [Quantitative Concept]
   760   C2348088:Degree [Quantitative Concept]

Phrase: "because"

Phrase: "MLCK activity"
Meta Candidates (Total=20; Excluded=0; Pruned=0; Remaining=20)
  1000   C1150543:myosin light chain kinase activity [Molecular Function]
           myosin light-chain kinase
           myosin kinase activity
   937   C0027120:Myosin Light Chain Kinase [Amino Acid, Peptide, or Protein,Enzyme]
           Myosin Kinase
   937   C1334539:MYOSIN LIGHT CHAIN KINASE [Gene or Genome]
   884   C0027108:Myosin Light Chain [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   875   C1517883:Light Activity [Daily or Recreational Activity]
   840   C1150423:kinase activity [Molecular Function]
   804   C0023693:Light [Natural Phenomenon or Process]
   804   C0027096:Myosin [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0205177:Activity [Functional Concept]
   804   C0337112:Chain [Manufactured Object]
   804   C0439167:% activity [Quantitative Concept]
   804   C0441655:Activity [Activity]
   804   C1306462:Light [Functional Concept]
   804   C1524075:Chain [Idea or Concept]
   804   C1561536:*Activity [Idea or Concept]
   804   C1881376:Light [Qualitative Concept]

Phrase: "depends on the amount of the Ca2+/calmodulin complex,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   742   C0006772:Calmodulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0439855:Complex [Qualitative Concept]
   742   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   742   C0725813:depend [Medical Device]
   742   C1265611:Amount [Quantitative Concept]
   742   C1366910:Calmodulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "which"

Phrase: "itself hinges on [Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]i (7,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "8,"

Phrase: "9"

Phrase: ")."
Processing 00000000.tx.17: However, recent studies with intact smooth muscle suggest the existence of other mechanisms that regulate contraction independent of changes in [Ca2+]i. 

Phrase: "However,"

Phrase: "recent studies with intact smooth muscle"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   753   C0947630:studies [Laboratory Procedure]
   719 E C0557651:Study [Manufactured Object]
   719 E C2603343:Study [Research Activity]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "the existence of other mechanisms"

Phrase: "that"

Phrase: "regulate"

Phrase: "contraction independent of changes in [Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1140999:Contraction [Pathologic Function]

Phrase: "]i."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.18: One such mechanism by which this can occur is the inhibition of MBP activity (10, 11, 12). 

Phrase: "One"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205447:One [Quantitative Concept]

Phrase: "such mechanism by which"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0441712:Mechanism [Functional Concept]
   770   C1706376:Mechanism [Manufactured Object]

Phrase: "this"

Phrase: "can"

Phrase: "occur"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1709305:Occur [Activity]
  1000   C2745955:OCCUR [Temporal Concept]

Phrase: "is"

Phrase: "the inhibition of MBP activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0021467:Inhibition [Mental Process]
   744   C0021469:Inhibition [Molecular Function]
   744   C1628982:% inhibition [Quantitative Concept]
   744   C3463820:Inhibition [Activity]

Phrase: "(10,"

Phrase: "11,"

Phrase: "12"

Phrase: ")."
Processing 00000000.tx.19: Thus, MLC20 phosphorylation and contractile force can be increased through Ca2+ sensitization, a G-protein-coupled Ca2+ independent process that inhibits MBP (10, 11, 12). 

Phrase: "Thus,"

Phrase: "MLC20 phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031715:Phosphorylation [Molecular Function]
   861   C1158886:Phosphorylation [Molecular Function]

Phrase: "and"

Phrase: "contractile force"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0026820:Contractile [Physiologic Function]
   861   C0441722:Force [Phenomenon or Process]
   861   C0563538:Force [Phenomenon or Process]
   805 E C0729333:Dynamic [Functional Concept]

Phrase: "can"

Phrase: "be"

Phrase: "increased through Ca2+ sensitization,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0205217:Increased [Quantitative Concept]
   770   C0442805:Increased [Functional Concept]
   770   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   770   C1325847:Sensitisation [Mental Process]

Phrase: "a G-protein-coupled Ca2+ independent process"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C1184743:Process [Body Part, Organ, or Organ Component]
   799   C1522240:Process [Phenomenon or Process]

Phrase: "that"

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "MBP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   902   C0067062:myosin phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0031686:Protein phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0031678:Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1149880:phosphatase [Molecular Function]

Phrase: "(10,"

Phrase: "11,"

Phrase: "12"

Phrase: ")."
Processing 00000000.tx.20: MBP holoenzyme consists of three subunits with molecular masses of 110/130 kDa, 38 kDa, and 20 kDa (13). 

Phrase: "MBP holoenzyme"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   708   C0067062:myosin phosphatase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "consists of three subunits"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205449:Three [Quantitative Concept]
   770   C0332529:CONSIST [Qualitative Concept]
   737   C1711351:Subunit [Quantitative Concept]

Phrase: "with molecular masses"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   983   C3152252:Molecular Mass [Quantitative Concept]
           Mass
   827   C0577559:Mass [Finding]
   827   C1306372:*Mass [Quantitative Concept]

Phrase: "of 110/130 kDa,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1532717:kDa [Quantitative Concept]

Phrase: "38 kDa,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1532717:kDa [Quantitative Concept]

Phrase: "and"

Phrase: "20 kDa (13"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1532717:kDa [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.21: The 38-kDa subunit is an isoform of the catalytic subunit of protein phosphatase-1 (PP-1C). 

Phrase: "The 38-kDa subunit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1711351:Subunit [Quantitative Concept]

Phrase: "is"

Phrase: "an isoform of the catalytic subunit of protein phosphatase-1 (PP-1C)."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   757   C0597298:protein isoform [Amino Acid, Peptide, or Protein]
           Isoform
Processing 00000000.tx.22: The two other subunits (110/130 kDa and 20 kDa) are putative regulatory and targeting subunits that bind to myosin and regulate the catalytic activity of the phosphatase (13). 

Phrase: "The two"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205448:Two [Quantitative Concept]

Phrase: "other subunits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1711351:Subunit [Quantitative Concept]

Phrase: "(110/130 kDa"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1532717:kDa [Quantitative Concept]

Phrase: "and"

Phrase: "20 kDa)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1532717:kDa [Quantitative Concept]

Phrase: "are"

Phrase: "putative regulatory"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0220905:regulatory [Regulation or Law]
   861   C1704735:Regulatory [Conceptual Entity]

Phrase: "and"

Phrase: "targeting subunits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1711351:Subunit [Quantitative Concept]

Phrase: "that"

Phrase: "bind to myosin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0027096:Myosin [Amino Acid, Peptide, or Protein,Enzyme]
   790   C1145667:Bind [Activity]
   790   C1167622:bind [Molecular Function]

Phrase: "and"

Phrase: "regulate"

Phrase: "the catalytic activity of the phosphatase"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0243102:catalytic activity [Molecular Function]
   790   C1264638:Catalytic activity [Functional Concept]
   790   C1547012:*Catalytic Activity [Quantitative Concept]
   783   C1149880:phosphatase activity [Molecular Function]
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1561536:*Activity [Idea or Concept]

Phrase: "(13"

Phrase: ")."
Processing 00000000.tx.23: Studies on purified preparations of MBP indicate that phosphorylation of the large 130-kDa regulatory myosin-bound subunit (MBS), by an associated kinase, results in an inhibition of phosphatase activity (14). 

Phrase: "Studies on purified preparations of MBP"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   742   C0947630:studies [Laboratory Procedure]
   708 E C0557651:Study [Manufactured Object]
   708 E C2603343:Study [Research Activity]

Phrase: "indicate"

Phrase: "that phosphorylation of the large 130-kDa regulatory myosin-bound subunit (MBS),"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0031715:Phosphorylation [Molecular Function]
   738   C1158886:Phosphorylation [Molecular Function]

Phrase: "by an associated kinase,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "results in an inhibition of phosphatase activity"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   778   C1149880:phosphatase activity [Molecular Function]
           phosphatase
   748   C0021467:Inhibition [Mental Process]
   748   C0021469:Inhibition [Molecular Function]
   748   C0031678:Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0205177:Activity [Functional Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C1274040:Result [Functional Concept]
   748   C1546471:Result [Idea or Concept]
   748   C1561536:*Activity [Idea or Concept]
   748   C1628982:% inhibition [Quantitative Concept]
   748   C2825142:Result [Finding]
   748   C3463820:Inhibition [Activity]

Phrase: "(14"

Phrase: ")."
Processing 00000000.tx.24: Further studies revealed that an active GTP-bound Rho, a small guanosine triphosphatase, specifically interacts with MBS (15). 

Phrase: "Further studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that"

Phrase: "an active GTP-bound Rho,"

Phrase: "a small guanosine triphosphatase,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0312235:Triphosphatase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "specifically"

Phrase: "interacts with MBS"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0027096:Myosin [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0332297:bound [Spatial Concept]
   760   C1145667:Bound [Activity]
   760   C1167622:Bound [Molecular Function]
   760   C1689898:% bound [Quantitative Concept]
   760   C1711351:Subunit [Quantitative Concept]
   760   C2349209:Bound [Conceptual Entity]

Phrase: "(15"

Phrase: ")."
Processing 00000000.tx.25: The Rho-associated kinase phosphorylates MBS and consequently inactivates MBP (14, 15), resulting in an increase in MLC20 phosphorylation and contraction of smooth muscle. 

Phrase: "The Rho-associated kinase"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0389995:rho-Associated Kinase [Amino Acid, Peptide, or Protein,Enzyme]
           rho-Kinase
   913   C1335631:RHO KINASE [Gene or Genome]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0332281:Associated [Qualitative Concept]
   793 E C0750490:Associate [Idea or Concept]
   793 E C1706221:Associate [Professional or Occupational Group]

Phrase: "phosphorylates"

Phrase: "MBS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1711351:Subunit [Quantitative Concept]

Phrase: "and"

Phrase: "consequently"

Phrase: "inactivates"

Phrase: "MBP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   902   C0067062:myosin phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0031686:Protein phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0031678:Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1149880:phosphatase [Molecular Function]

Phrase: "(14,"

Phrase: "15"

Phrase: ")"

Phrase: ","

Phrase: "resulting in an increase"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   833   C0332294:Resulting in [Functional Concept]
   770   C0442805:Increase [Functional Concept]
   770   C0678226:resulting [Functional Concept]
   737 E C1274040:Result [Functional Concept]
   737 E C1546471:Result [Idea or Concept]
   737 E C2825142:Result [Finding]

Phrase: "in MLC20 phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031715:Phosphorylation [Molecular Function]
   861   C1158886:Phosphorylation [Molecular Function]

Phrase: "and"

Phrase: "contraction of smooth muscle."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   881   C1155937:smooth muscle contraction [Organ or Tissue Function]
   819   C0026820:Muscle Contraction [Physiologic Function]
   770   C1140999:Contraction [Pathologic Function]
Processing 00000000.tx.26: Although these results clearly explain how activated Rho increases Ca2+ sensitivity of both MLC20 phosphorylation and contraction, the pathway that leads from receptor, to G proteins, and then to the ultimate inhibition of the phosphatase is not known. 

Phrase: "Although"

Phrase: "these results clearly"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "explain"

Phrase: "how activated Rho"

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "Ca2+ sensitivity of both MLC20 phosphorylation"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0036667:Sensitivity [Quantitative Concept]
   753   C0312418:Sensitivity [Mental Process]
   753   C0427965:Sensitivity [Finding]
   753   C1511883:Sensitivity [Quantitative Concept]
   753   C1522640:Sensitivity [Qualitative Concept]
   753   C2346484:SENSITIVITY [Phenomenon or Process]
   753   C2349185:Sensitivity [Qualitative Concept]

Phrase: "and"

Phrase: "contraction,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1140999:Contraction [Pathologic Function]

Phrase: "the pathway"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704259:Pathway [Molecular Function]
  1000   C1705987:Pathway [Conceptual Entity]

Phrase: "that"

Phrase: "leads from receptor,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   790   C0181586:leads [Medical Device]
   790   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   790   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   790   C1522538:Lead [Functional Concept]
   790   C2348269:Lead [Element, Ion, or Isotope]
   790   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "to G proteins,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0086376:G-Proteins [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "then to the ultimate inhibition of the phosphatase"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   744   C0021467:Inhibition [Mental Process]
   744   C0021469:Inhibition [Molecular Function]
   744   C0031678:Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C1149880:phosphatase [Molecular Function]
   744   C1628982:% inhibition [Quantitative Concept]
   744   C1883708:Then [Temporal Concept]
   744   C3463820:Inhibition [Activity]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "known."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]
Processing 00000000.tx.27: Arachidonic acid has been suggested as a possible secondary messenger since it dissociates the trimeric structure of the phosphatase leading to its inhibition (5, 16). 

Phrase: "Arachidonic acid"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0003695:Arachidonic Acid [Eicosanoid]
  1000   C2316832:Arachidonic Acid [Laboratory Procedure]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "has"

Phrase: "been"

Phrase: "suggested as a possible secondary messenger"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   753   C0027627:secondary [Neoplastic Process]
   753   C0169911:messenger [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   753   C0175668:Secondary [Temporal Concept]
   753   C0205436:Secondary [Quantitative Concept]
   753   C0332149:Possible [Qualitative Concept]
   753   C0335218:Messenger [Professional or Occupational Group]
   753   C1705910:Possible [Qualitative Concept]
   753   C2362652:Possible [Qualitative Concept]
   719   C1705535:Suggest [Idea or Concept]

Phrase: "since"

Phrase: "it"

Phrase: "dissociates"

Phrase: "the trimeric structure of the phosphatase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0678594:Structure [Spatial Concept]

Phrase: "leading to its inhibition"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   770   C0021467:Inhibition [Mental Process]
   770   C0021469:Inhibition [Molecular Function]
   770   C0332152:Leading [Temporal Concept]
   770   C1522538:Leading [Functional Concept]
   770   C1628982:% inhibition [Quantitative Concept]
   770   C3463820:Inhibition [Activity]
   737 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   737 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   737 E C2348269:Lead [Element, Ion, or Isotope]
   737 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "(5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "16"

Phrase: ")."
Processing 00000000.tx.28: Moreover, arachidonic acid is known to be released in smooth muscle at concentrations and times consistent with a physiological role (16). 

Phrase: "Moreover,"

Phrase: "arachidonic acid"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0003695:Arachidonic Acid [Eicosanoid]
  1000   C2316832:Arachidonic Acid [Laboratory Procedure]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "is"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "released in smooth muscle"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   833   C1267092:Muscle, Smooth [Tissue]
   802   C0185184:Muscle release [Therapeutic or Preventive Procedure]
   770   C0026845:Muscle [Tissue]
   770   C0205357:Smooth [Qualitative Concept]
   770   C0391871:Released [Functional Concept]
   770   C1283071:Released [Functional Concept]
   737 E C0030685:Release [Health Care Activity]
   737 E C0439180:% release [Quantitative Concept]
   737 E C0680255:release [Health Care Activity]
   737 E C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "at concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0086045:Concentrations [Mental Process]
   966 E C1446561:Concentration [Quantitative Concept]
   916 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "and"

Phrase: "times"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0040223:times [Temporal Concept]
  1000   C1632851:Times [Quantitative Concept]
   966 E C3541383:Time [Temporal Concept]
   928 E C0442043:Temporal [Spatial Concept]
   928 E C2362314:Temporal [Temporal Concept]

Phrase: "consistent with a physiological role"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "(16"

Phrase: ")."
Processing 00000000.tx.29: In addition, Ikebe and Brozovich (17) reported that agonist-induced activation of protein kinase C can also increase VSMC contraction via an inhibition of MBP. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "Ikebe"

Phrase: "and"

Phrase: "Brozovich"

Phrase: "(17"

Phrase: ")"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "that agonist-induced activation of protein kinase C"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   822   C3546691:protein kinase C activation [Molecular Function]
   793   C1819041:protein kinase activation [Cell Function]
   767   C0599177:protein activation [Genetic Function]
   744   C1879547:Activation [Activity]

Phrase: "can"

Phrase: "also"

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "VSMC contraction via an inhibition"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   822   C2265839:Vascular smooth muscle contraction [Organ or Tissue Function]
   800   C0026820:Muscle Cell Contraction [Physiologic Function]
           Muscle Contraction
   793   C1155937:smooth muscle contraction [Organ or Tissue Function]
   744   C1140999:Contraction [Pathologic Function]

Phrase: "of MBP."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   902   C0067062:myosin phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0031686:Protein phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0031678:Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1149880:phosphatase [Molecular Function]
Processing 00000000.tx.30: If phosphorylation of MBP does indeed have a regulatory function in VSMC contraction, then an effective dephosphorylation mechanism must exist and should occur within the time frame observed for physiological effects. 

Phrase: "If"

Phrase: "phosphorylation of MBP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   753   C0031715:Phosphorylation [Molecular Function]

Phrase: "does"

Phrase: "indeed"

Phrase: "have"

Phrase: "a regulatory function in VSMC contraction,"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   781   C0026820:Muscle contraction, function [Physiologic Function]
   762   C0007613:Cell Function [Cell Function]
   762   C0231484:Muscle function [Organ or Tissue Function]
   762   C0232337:Vascular function [Clinical Attribute]
   762   C0517929:function muscle [Finding]
   742   C0031843:function [Physiologic Function]
   742   C0542341:Function [Functional Concept]
   742   C0700205:FUNCTION [Classification]
   742   C1705273:Function [Intellectual Product]
   712 E C0005811:blood function [Organ or Tissue Function]

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "an effective dephosphorylation mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0441712:Mechanism [Functional Concept]
   827   C1706376:Mechanism [Manufactured Object]

Phrase: "must"

Phrase: "exist"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2987476:Exist [Conceptual Entity]

Phrase: "and"

Phrase: "should"

Phrase: "occur within the time frame"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   806   C0332168:Time frame [Temporal Concept]
   806   C0872291:Time Frame [Temporal Concept]
   760   C0040223:Time [Temporal Concept]
   760   C0080089:Frame [Nucleotide Sequence]
   760   C0180979:Frame [Medical Device]
   760   C1705858:Frame [Manufactured Object]
   760   C1709305:Occur [Activity]
   760   C2745955:OCCUR [Temporal Concept]
   760   C3541383:Time [Temporal Concept]
   704 E C0442043:Temporal [Spatial Concept]
   704 E C2362314:Temporal [Temporal Concept]

Phrase: "observed for physiological effects."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   833   C1372798:Physiological Effects [Physiologic Function]
   770   C0205463:Physiological [Functional Concept]
   770   C1280500:effects [Qualitative Concept]
   770   C1441672:Observed [Functional Concept]
   737 E C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.31: Given that insulins vasodilatory effects are mediated via nitric oxide (NO) (18), and cGMP inhibits MLC20 phosphorylation (19), it can be hypothesized that insulin may inhibit VSMC contraction by activating MBP via the NO/cGMP signaling pathway. 

Phrase: "Given"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]

Phrase: "that insulins vasodilatory effects"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1280500:effects [Qualitative Concept]
   793 E C2348382:Effect [Qualitative Concept]

Phrase: "are"

Phrase: "mediated via nitric oxide (NO)"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   770   C0030015:oxide [Inorganic Chemical]
   770   C0086597:mediated [Social Behavior]
   770   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   770   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "(18"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "cGMP"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0018338:Cyclic guanosine monophosphate [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   901   C0018346:Guanosine Monophosphate [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0018330:Guanosine [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   827   C0439596:Cyclic [Temporal Concept]
   827   C1511572:Cyclic [Temporal Concept]
   755 E C0031084:Cyclicities [Temporal Concept]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "MLC20 phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031715:Phosphorylation [Molecular Function]
   861   C1158886:Phosphorylation [Molecular Function]

Phrase: "(19"

Phrase: ")"

Phrase: ","

Phrase: "it"

Phrase: "can"

Phrase: "be"

Phrase: "hypothesized"

Phrase: "that insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "may"

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "VSMC contraction by activating MBP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   792   C2265839:Vascular smooth muscle contraction [Organ or Tissue Function]
   775   C0026820:Muscle Cell Contraction [Physiologic Function]
           Muscle Contraction
   772   C1155937:smooth muscle contraction [Organ or Tissue Function]
   738   C1140999:Contraction [Pathologic Function]

Phrase: "via the NO/cGMP signaling pathway."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   907   C1518333:Nitric Oxide Signaling Pathway [Molecular Function]
   900   C1518332:Nitric Oxide Pathway [Molecular Function]
   818   C0037083:signaling pathway [Cell Function]
   818   C0086982:Signaling Pathway [Molecular Function]
   801 E C0037080:Signal Pathway [Molecular Function]
   795   C1704259:Pathway [Molecular Function]
   795   C1705987:Pathway [Conceptual Entity]
   717   C1155501:nitric oxide signaling [Molecular Function]
Processing 00000000.tx.32: Whether or not dephosphorylation of MBS via agonist-induced signal transduction pathways causes activation of MBP remains unknown. 

Phrase: "Whether"

Phrase: "or"

Phrase: "not dephosphorylation of MBS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1158884:Dephosphorylation [Molecular Function]
   753   C3160734:Dephosphorylation [Molecular Function]

Phrase: "via agonist-induced signal transduction pathways"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   884   C0086982:Signal Transduction Pathways [Molecular Function]
   853   C0037080:Signal Pathways [Molecular Function]
   840   C0037083:Signal Transduction [Cell Function]
   804   C1160185:transduction [Organism Function]
   804   C1704259:Pathways [Molecular Function]
   804   C1705987:Pathways [Conceptual Entity]
   804   C1710082:Signal [Phenomenon or Process]

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "activation of MBP remains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C0599177:protein activation [Genetic Function]
   748   C1879547:Activation [Activity]

Phrase: "unknown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439673:Unknown [Qualitative Concept]
Processing 00000000.tx.33: In this study, we examined whether insulin promotes VSMC relaxation via dephosphorylation of MLC20 by activating MBP and studied the mechanism of MBP regulation by insulin. 

Phrase: "In this study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "whether"

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "promotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "VSMC relaxation via dephosphorylation of MLC20"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   829   C2262829:relaxation of vascular smooth muscle [Organism Function]
           vascular smooth muscle relaxation
   804   C2249967:relaxation of smooth muscle [Organ or Tissue Function]
           smooth muscle relaxation
   781   C0026836:relaxation of muscle [Organ or Tissue Function]
           Muscle Relaxation
   762   C0700323:Muscle relaxation [Disease or Syndrome]
   742   C0035028:Relaxation [Activity]

Phrase: "by activating MBP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   875   C0067062:myosin phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   840   C0031686:Protein phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0031678:Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1149880:phosphatase [Molecular Function]

Phrase: "and"

Phrase: "studied"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]

Phrase: "the mechanism of MBP regulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0441712:Mechanism [Functional Concept]
   744   C1706376:Mechanism [Manufactured Object]

Phrase: "by insulin."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.34: The results of this study indicate that insulin rapidly stimulates MBP by decreasing the phosphorylation of the myosin-bound regulatory subunit, MBS. 

Phrase: "The results of this study"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C0683954:results study [Finding]
   726   C1274040:Result [Functional Concept]
   726   C1546471:Result [Idea or Concept]
   726   C2825142:Result [Finding]

Phrase: "indicate"

Phrase: "that insulin rapidly"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "stimulates"

Phrase: "MBP by decreasing"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0031686:Protein phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   783   C0067062:myosin phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   783   C0522527:Protein bound [Qualitative Concept]
   753   C0031678:Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1149880:phosphatase [Molecular Function]

Phrase: "the phosphorylation of the myosin-bound regulatory subunit,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0031715:Phosphorylation [Molecular Function]
   744   C1158886:Phosphorylation [Molecular Function]

Phrase: "MBS."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1711351:Subunit [Quantitative Concept]
Processing 00000000.tx.35: Furthermore, insulin-mediated MBP activation and decreased MBS phosphorylation are accompanied by Rho kinase inhibition and an increase in NO/cGMP signaling. 

Phrase: "Furthermore,"

Phrase: "insulin-mediated MBP activation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   829   C0599177:protein activation [Genetic Function]
   795   C1879547:Activation [Activity]

Phrase: "and"

Phrase: "decreased MBS phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0031715:Phosphorylation [Molecular Function]
   804   C1158886:Phosphorylation [Molecular Function]

Phrase: "are"

Phrase: "accompanied by Rho kinase inhibition"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0389995:rho-Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   806   C1335631:RHO KINASE [Gene or Genome]
   760   C0021467:Inhibition [Mental Process]
   760   C0021469:Inhibition [Molecular Function]
   760   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C1628982:% inhibition [Quantitative Concept]
   760   C3463820:Inhibition [Activity]

Phrase: "and"

Phrase: "an increase in NO/cGMP signaling."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0442805:Increase [Functional Concept]
Processing 00000000.tx.36: Blocking signaling through phosphatidylinositol-3 kinase (PI3-kinase), NO, and cGMP inhibits insulins effects on MBP activation. 

Phrase: "Blocking"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0233660:Blocking [Mental or Behavioral Dysfunction]
  1000   C0332206:Blocking [Functional Concept]
   966 E C0028778:Block [Pathologic Function]
   966 E C1533157:Block [Substance]
   966 E C1706084:Block [Geographic Area]
   966 E C2828370:Block [Quantitative Concept]

Phrase: "signaling through phosphatidylinositol-3 kinase (PI3-kinase),"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0037083:Signaling [Cell Function]
   760   C3537152:signaling [Biologic Function]

Phrase: "NO,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C0030015:oxide [Inorganic Chemical]
   861   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "and"

Phrase: "cGMP"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0018338:Cyclic guanosine monophosphate [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   901   C0018346:Guanosine Monophosphate [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0018330:Guanosine [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   827   C0439596:Cyclic [Temporal Concept]
   827   C1511572:Cyclic [Temporal Concept]
   755 E C0031084:Cyclicities [Temporal Concept]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "insulins effects on MBP activation."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C1280500:effects [Qualitative Concept]
   711 E C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.37: Activation of MBP seems to be coordinated with inhibition of VSMC contraction due to decreased MLC20 phosphorylation.  

Phrase: "Activation of MBP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0599177:protein activation [Genetic Function]
   753   C1879547:Activation [Activity]

Phrase: "seems"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "coordinated with inhibition of VSMC contraction"
Meta Candidates (Total=29; Excluded=2; Pruned=0; Remaining=27)
   827   C2249966:inhibition of smooth muscle contraction [Organism Function]
   810   C2265839:Vascular smooth muscle contraction [Organ or Tissue Function]
   804   C2249836:inhibition of muscle contraction [Organism Function]
   790   C0026820:Muscle Cell Contraction [Physiologic Function]
           Muscle Contraction
   790   C0026844:Muscle, Smooth, Vascular [Tissue]
   790   C1135918:Smooth muscle cell [Cell]
   784   C1155937:smooth muscle contraction [Organ or Tissue Function]
   764   C0596981:Muscle cell [Cell]
   764   C1267092:Muscle, Smooth [Tissue]
   742   C0005847:vascular [Body Part, Organ, or Organ Component]
   742   C0007634:Cell [Cell]
   742   C0021467:Inhibition [Mental Process]
   742   C0021469:Inhibition [Molecular Function]
   742   C0026845:Muscle [Tissue]
   742   C0205357:Smooth [Qualitative Concept]
   742   C0427184:Coordinated [Finding]
   742   C0700114:Coordinated [Functional Concept]
   742   C1140999:Contraction [Pathologic Function]
   742   C1269647:Cell [Cell]
   742   C1558950:VASCULAR [Finding]
   742   C1628982:% inhibition [Quantitative Concept]
   742   C1704653:Cell [Medical Device]
   742   C1801960:Vascular [Qualitative Concept]
   742   C1948049:Cell [Spatial Concept]
   742   C3463820:Inhibition [Activity]
   720   C2328697:Hemal cell [Cell]
   712 E C0005773:Blood cell [Cell]
   708 E C1707511:Coordinate [Spatial Concept]

Phrase: "due to decreased MLC20 phosphorylation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0031715:Phosphorylation [Molecular Function]
   827   C1158886:Phosphorylation [Molecular Function]
Processing 00000000.tx.38: RESULTS TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES  In the initial experiments, cellular protein phosphatase-1 and protein phosphatase 2A (PP-1 and PP-2A) activities were examined in control and insulin-treated VSMCs using [32P]-labeled phosphorylase a as a substrate. 

Phrase: "RESULTS TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES  In the initial experiments,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   760   C0205265:Initial [Temporal Concept]
   760   C0681814:Experiments [Research Activity]
   760   C1279901:Initial [Qualitative Concept]
   760   C1514811:Reference [Idea or Concept]
   760   C1555582:Initial [Idea or Concept]
   760   C1705685:INITIAL [Functional Concept]
   760   C1706462:Reference [Conceptual Entity]
   726 E C1706386:Experiment [Conceptual Entity]

Phrase: "cellular protein phosphatase-1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   923   C1956003:Protein Phosphatase 1 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0031686:Protein phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0031678:Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1149880:phosphatase [Molecular Function]

Phrase: "and"

Phrase: "protein phosphatase 2A"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C1704708:Protein Phosphatase 2A [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C2254340:protein phosphatase 2A [Molecular Function]
   901   C0031686:Protein phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   901   C2261652:phosphatase 2A [Molecular Function]
   827   C0031678:Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1149880:phosphatase [Molecular Function]

Phrase: "(PP-1"

Phrase: "and"

Phrase: "PP-2A"

Phrase: ")"

Phrase: "activities"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0441655:Activities [Activity]
   966 E C0205177:Activity [Functional Concept]
   966 E C0439167:% activity [Quantitative Concept]
   966 E C1561536:*Activity [Idea or Concept]

Phrase: "were"

Phrase: "examined in control"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0243148:control [Qualitative Concept]
   790   C0332128:Examined [Finding]
   790   C1550141:Control [Substance]
   790   C1882979:Control [Conceptual Entity]
   790   C2587213:Control [Functional Concept]
   790   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "insulin-treated VSMCs"
Meta Candidates (Total=21; Excluded=7; Pruned=0; Remaining=14)
   878   C0030281:Insulin Cell [Cell]
   861   C0026844:Muscle, Smooth, Vascular [Tissue]
   861   C1135918:Smooth Muscle Cells [Cell]
   827   C0596981:Muscle Cells [Cell]
   827   C1267092:Muscle, Smooth [Tissue]
   808   C0005773:Blood Cells [Cell]
   799   C0005847:vascular [Body Part, Organ, or Organ Component]
   799   C0007634:Cells [Cell]
   799   C0026845:Muscle [Tissue]
   799   C0205357:Smooth [Qualitative Concept]
   799   C1558950:VASCULAR [Finding]
   799   C1801960:Vascular [Qualitative Concept]
   799 E C2328697:Hemal cell [Cell]
   799   C3282337:Cells [Cell]
   789   C0853230:insulin blood [Laboratory Procedure]
   766 E C1269647:Cell [Cell]
   766 E C1704653:Cell [Medical Device]
   766 E C1948049:Cell [Spatial Concept]
   743 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   743 E C1511228:VESSEL, BLOOD [Tissue]
   727 E C0442025:Muscular [Spatial Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "[32P"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553631:32p [Medical Device]

Phrase: "]-labeled phosphorylase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0017916:Phosphorylase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0917783:Phosphorylase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "a as a substrate."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1710236:Substrate [Manufactured Object]
Processing 00000000.tx.39: PP-1 constitutes 85% of cellular phosphatase activities while the remaining 15% of activity is due to PP-2A (Fig. 1A). 

Phrase: "PP-1"

Phrase: "constitutes"

Phrase: "85% of cellular phosphatase activities"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   790   C1149880:phosphatase activity [Molecular Function]
           phosphatase
   760   C0007634:Cellular [Cell]
   760   C0031678:Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0178539:Cellular [Functional Concept]
   760   C0441655:Activities [Activity]
   726 E C0205177:Activity [Functional Concept]
   726 E C0439167:% activity [Quantitative Concept]
   726 E C1561536:*Activity [Idea or Concept]

Phrase: "while"

Phrase: "the remaining 15% of activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1527428:Remaining [Qualitative Concept]
   760   C1561536:*Activity [Idea or Concept]

Phrase: "is due to PP-2A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0678226:Due to [Functional Concept]
           due
   760   C3146286:Due [Idea or Concept]

Phrase: "(Fig. 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: ")."
Processing 00000000.tx.40: Physiological concentrations of insulin rapidly increase PP-1 activity in a time- and dose-dependent manner (Fig. 1, B and C). 

Phrase: "Physiological concentrations of insulin rapidly"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0086045:Concentrations [Mental Process]
   726 E C1446561:Concentration [Quantitative Concept]

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "PP-1 activity in a time-"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "dose-dependent manner"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1512045:Dose-dependent [Quantitative Concept]

Phrase: "(Fig. 1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "C)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]
Processing 00000000.tx.41: A half-maximal stimulation of PP-1 was observed with 0.1 nM insulin with a maximal effect seen between 10 and 100 nM insulin after 5 min (Fig. 1C). 

Phrase: "A half-maximal stimulation of PP-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   748   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "was"

Phrase: "observed with 0.1 nM insulin"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0312860:NM [Cell Function]
   753   C1441672:Observed [Functional Concept]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]

Phrase: "with a maximal effect"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0205289:Maximal [Qualitative Concept]
   861   C0806909:Maximal [Quantitative Concept]
   861   C1280500:Effect [Qualitative Concept]
   861   C2348382:Effect [Qualitative Concept]
   789 E C1552615:maximum [Quantitative Concept]
   789 E C2826546:MAXIMUM [Quantitative Concept]

Phrase: "seen between 10"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0205397:Seen [Qualitative Concept]
   756 E C0042789:see [Organism Function]
   756 E C1947903:See [Activity]

Phrase: "and"

Phrase: "100 nM insulin after 5 min (Fig. 1C"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C1579433:Insulin [Pharmacologic Substance]

Phrase: ")."
Processing 00000000.tx.42: In contrast to PP-1, insulin treatment caused a decrease in PP-2A activity (Fig. 1A). 

Phrase: "In contrast to PP-1,"

Phrase: "insulin treatment"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0745343:insulin treatment [Therapeutic or Preventive Procedure]
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]

Phrase: "caused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015127:cause [Functional Concept]
   966   C1524003:Cause [Conceptual Entity]

Phrase: "a decrease in PP-2A activity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0392756:Decrease [Qualitative Concept]
   753   C0547047:Decrease [Quantitative Concept]

Phrase: "(Fig. 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: ")."
Processing 00000000.tx.43: View larger version (16K): [in this window] [in a new window]  Figure 1. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(16K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 1."
Processing 00000000.tx.44: Effect of Insulin on Phosphatase Activities in VSMCs A, Cellular distribution and effect of insulin on PP-1 and PP-2A. 

Phrase: "Effect of Insulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1280500:Effect [Qualitative Concept]
   790   C2348382:Effect [Qualitative Concept]

Phrase: "on Phosphatase Activities"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   983   C1149880:phosphatase activity [Molecular Function]
   861   C0441655:Activities [Activity]
   827 E C0205177:Activity [Functional Concept]
   827 E C0439167:% activity [Quantitative Concept]
   827 E C1561536:*Activity [Idea or Concept]

Phrase: "in VSMCs"
Meta Candidates (Total=23; Excluded=11; Pruned=0; Remaining=12)
   923   C0026844:Muscle, Smooth, Vascular [Tissue]
   923   C1135918:Smooth Muscle Cells [Cell]
   861   C0596981:Muscle Cells [Cell]
   861   C1267092:Muscle, Smooth [Tissue]
   852   C0005773:Blood Cells [Cell]
   844 E C2328697:Hemal cell [Cell]
   812   C0005847:vascular [Body Part, Organ, or Organ Component]
   812   C0007634:Cells [Cell]
   812   C0026845:Muscle [Tissue]
   812   C0205357:Smooth [Qualitative Concept]
   812   C1558950:VASCULAR [Finding]
   812   C1801960:Vascular [Qualitative Concept]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
   756 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   756 E C1511228:VESSEL, BLOOD [Tissue]
   741 E C0442025:Muscular [Spatial Concept]
   712 E C0005767:Blood [Tissue]
   712 E C0005768:blood [Body Substance]
   712 E C0229664:Blood [Body Substance]
   712 E C0392895:Bloods [Population Group]

Phrase: "A,"

Phrase: "Cellular distribution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0520511:distribution [Idea or Concept]
   861   C1704711:Distribution [Functional Concept]

Phrase: "and"

Phrase: "effect of insulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1280500:Effect [Qualitative Concept]
   790   C2348382:Effect [Qualitative Concept]

Phrase: "on PP-1"

Phrase: "and"

Phrase: "PP-2A."
Processing 00000000.tx.45: Confluent serum-starved VSMCs were treated with insulin (10 nM) for 10 min and extracted in phosphatase assay buffer. 

Phrase: "Confluent serum-starved VSMCs"
Meta Candidates (Total=19; Excluded=7; Pruned=0; Remaining=12)
   845   C0026844:Muscle, Smooth, Vascular [Tissue]
   845   C1135918:Smooth Muscle Cells [Cell]
   818   C0596981:Muscle Cells [Cell]
   818   C1267092:Muscle, Smooth [Tissue]
   795   C0005773:Blood Cells [Cell]
   795   C0005847:vascular [Body Part, Organ, or Organ Component]
   795   C0007634:Cells [Cell]
   795   C0026845:Muscle [Tissue]
   795   C0205357:Smooth [Qualitative Concept]
   795   C1558950:VASCULAR [Finding]
   795   C1801960:Vascular [Qualitative Concept]
   795   C3282337:Cells [Cell]
   787 E C2328697:Hemal cell [Cell]
   762 E C1269647:Cell [Cell]
   762 E C1704653:Cell [Medical Device]
   762 E C1948049:Cell [Spatial Concept]
   740 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   740 E C1511228:VESSEL, BLOOD [Tissue]
   724 E C0442025:Muscular [Spatial Concept]

Phrase: "were"

Phrase: "treated with insulin"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1522326:Treated [Functional Concept]
   790   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1579433:Insulin [Pharmacologic Substance]
   756 E C1292734:TREAT [Functional Concept]
   734 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   706 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(10 nM) for 10 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0312860:NM [Cell Function]

Phrase: "and"

Phrase: "extracted in phosphatase assay buffer."
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   760   C0005507:Assay [Laboratory Procedure]
   760   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0031678:Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0185115:Extracted [Therapeutic or Preventive Procedure]
   760   C0243073:assay [Qualitative Concept]
   760   C1149880:phosphatase [Molecular Function]
   760   C1510438:Assay [Laboratory Procedure]
   760   C3541890:EXTRACTED [Finding]
   726 E C2828366:Extract [Substance]
Processing 00000000.tx.46: Equal amounts of proteins (1 g) were assayed for phosphatase activities in the presence and absence of 1 nM okadaic acid. 

Phrase: "Equal amounts of proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1265611:amounts [Quantitative Concept]

Phrase: "(1 g)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "were"

Phrase: "assayed for phosphatase activities"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   816   C1149880:phosphatase activity [Molecular Function]
           phosphatase
   770   C0031678:Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0441655:Activities [Activity]
   737   C0005507:Assay [Laboratory Procedure]
   737 E C0205177:Activity [Functional Concept]
   737   C0243073:assay [Qualitative Concept]
   737 E C0439167:% activity [Quantitative Concept]
   737   C1510438:Assay [Laboratory Procedure]
   737 E C1561536:*Activity [Idea or Concept]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "and"

Phrase: "absence of 1 nM okadaic acid."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0332197:absence [Quantitative Concept]
   753   C1689985:Absence [Anatomical Abnormality]
Processing 00000000.tx.47: Results are the mean  SEM of three separate experiments performed in duplicate. 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "the mean  SEM of three separate experiments"

Phrase: "performed in duplicate."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0205173:Duplicate [Functional Concept]
   790   C0884358:Performed [Functional Concept]
   790   C3539942:Duplicate [Intellectual Product]
   756 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.48: B, Kinetics of PP-1 activation by insulin. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Kinetics of PP-1 activation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0022702:Kinetics [Natural Phenomenon or Process]
   760   C0220865:kinetics [Functional Concept]
   760   C2825046:Kinetics [Occupation or Discipline]

Phrase: "by insulin."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.49: VSMCs were exposed to 10 nM insulin for the indicated time points and assayed for PP-1 activity with [32P]-labeled phosphorylase a as a substrate. 

Phrase: "VSMCs"
Meta Candidates (Total=23; Excluded=11; Pruned=0; Remaining=12)
   923   C0026844:Muscle, Smooth, Vascular [Tissue]
   923   C1135918:Smooth Muscle Cells [Cell]
   861   C0596981:Muscle Cells [Cell]
   861   C1267092:Muscle, Smooth [Tissue]
   852   C0005773:Blood Cells [Cell]
   844 E C2328697:Hemal cell [Cell]
   812   C0005847:vascular [Body Part, Organ, or Organ Component]
   812   C0007634:Cells [Cell]
   812   C0026845:Muscle [Tissue]
   812   C0205357:Smooth [Qualitative Concept]
   812   C1558950:VASCULAR [Finding]
   812   C1801960:Vascular [Qualitative Concept]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
   756 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   756 E C1511228:VESSEL, BLOOD [Tissue]
   741 E C0442025:Muscular [Spatial Concept]
   712 E C0005767:Blood [Tissue]
   712 E C0005768:blood [Body Substance]
   712 E C0229664:Blood [Body Substance]
   712 E C0392895:Bloods [Population Group]

Phrase: "were"

Phrase: "exposed to 10 nM insulin"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   806   C0332157:Exposed to [Clinical Attribute]
           Exposed
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0312860:NM [Cell Function]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "for the indicated time points"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   867   C2348792:Time Point [Temporal Concept]
   827   C0040223:Time [Temporal Concept]
   827   C3541383:Time [Temporal Concept]
   793   C1552961:Point [Quantitative Concept]
   793   C2347617:point [Quantitative Concept]
   771 E C0442043:Temporal [Spatial Concept]
   771 E C2362314:Temporal [Temporal Concept]
   743 E C1632851:Times [Quantitative Concept]

Phrase: "and"

Phrase: "assayed for PP-1 activity"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1561536:*Activity [Idea or Concept]
   726   C0005507:Assay [Laboratory Procedure]
   726   C0243073:assay [Qualitative Concept]
   726   C1510438:Assay [Laboratory Procedure]

Phrase: "with"

Phrase: "[32P"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553631:32p [Medical Device]

Phrase: "]-labeled phosphorylase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0017916:Phosphorylase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0917783:Phosphorylase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "a as a substrate."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1710236:Substrate [Manufactured Object]
Processing 00000000.tx.50: Results are the mean  SEM of four separate experiments performed in duplicate. 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "the mean  SEM of four separate experiments"

Phrase: "performed in duplicate."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0205173:Duplicate [Functional Concept]
   790   C0884358:Performed [Functional Concept]
   790   C3539942:Duplicate [Intellectual Product]
   756 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.51: *, P < 0.05 vs. basal levels. 

Phrase: "*,"

Phrase: "P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "vs. basal levels."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.52: C, Dose response of PP-1 activation by insulin: VSMCs were exposed to various concentrations of insulin for 10 min and assayed for PP-1 activity as detailed in Fig. 

Phrase: "C,"

Phrase: "Dose response of PP-1 activation"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0178602:Dose [Quantitative Concept]
   753   C0869039:Dose [Quantitative Concept]
   753   C0871261:Response [Organism Attribute]
   753   C1114758:Dose # [Clinical Attribute]
   753   C1704632:Response [Finding]
   753   C1706817:Response [Intellectual Product]
   753   C2911692:Response [Mental Process]

Phrase: "by insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: ":"

Phrase: "VSMCs"
Meta Candidates (Total=23; Excluded=11; Pruned=0; Remaining=12)
   923   C0026844:Muscle, Smooth, Vascular [Tissue]
   923   C1135918:Smooth Muscle Cells [Cell]
   861   C0596981:Muscle Cells [Cell]
   861   C1267092:Muscle, Smooth [Tissue]
   852   C0005773:Blood Cells [Cell]
   844 E C2328697:Hemal cell [Cell]
   812   C0005847:vascular [Body Part, Organ, or Organ Component]
   812   C0007634:Cells [Cell]
   812   C0026845:Muscle [Tissue]
   812   C0205357:Smooth [Qualitative Concept]
   812   C1558950:VASCULAR [Finding]
   812   C1801960:Vascular [Qualitative Concept]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
   756 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   756 E C1511228:VESSEL, BLOOD [Tissue]
   741 E C0442025:Muscular [Spatial Concept]
   712 E C0005767:Blood [Tissue]
   712 E C0005768:blood [Body Substance]
   712 E C0229664:Blood [Body Substance]
   712 E C0392895:Bloods [Population Group]

Phrase: "were"

Phrase: "exposed to various concentrations of insulin"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   790   C0332157:Exposed to [Clinical Attribute]
           Exposed
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0086045:Concentrations [Mental Process]
   753   C0440102:Various [Indicator, Reagent, or Diagnostic Aid]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]
   719 E C1446561:Concentration [Quantitative Concept]

Phrase: "for 10 min"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456692:/10 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]

Phrase: "and"

Phrase: "assayed for PP-1 activity"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1561536:*Activity [Idea or Concept]
   726   C0005507:Assay [Laboratory Procedure]
   726   C0243073:assay [Qualitative Concept]
   726   C1510438:Assay [Laboratory Procedure]

Phrase: "as"

Phrase: "detailed in Fig."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   790   C1522508:Detailed [Qualitative Concept]
   756 E C1561567:detail [Functional Concept]
Processing 00000000.tx.53: 1B. 

Phrase: "1B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450345:1B [Intellectual Product]
Processing 00000000.tx.54: Results are the mean  SEM of three separate experiments performed in duplicate. 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "the mean  SEM of three separate experiments"

Phrase: "performed in duplicate."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0205173:Duplicate [Functional Concept]
   790   C0884358:Performed [Functional Concept]
   790   C3539942:Duplicate [Intellectual Product]
   756 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.55: *, P < 0.05 vs. basal levels.  

Phrase: "*,"

Phrase: "P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "vs. basal levels."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.56: Insulin Activates MBP in VSMCs Since VSMCs express MBP, we next examined whether the observed effect of insulin on cellular PP-1 activation was due to an increase in MBP activity. 

Phrase: "Insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "Activates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "MBP in VSMCs"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   827   C0210219:Smooth Muscle Myosin-bound Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   764   C0031686:Protein phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   762   C0026832:Muscle Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   762   C0067062:myosin phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   762   C0522527:Protein bound [Qualitative Concept]
   742   C0031678:Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C1149880:phosphatase [Molecular Function]
   712   C0005832:blood protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "Since"

Phrase: "VSMCs"
Meta Candidates (Total=23; Excluded=11; Pruned=0; Remaining=12)
   923   C0026844:Muscle, Smooth, Vascular [Tissue]
   923   C1135918:Smooth Muscle Cells [Cell]
   861   C0596981:Muscle Cells [Cell]
   861   C1267092:Muscle, Smooth [Tissue]
   852   C0005773:Blood Cells [Cell]
   844 E C2328697:Hemal cell [Cell]
   812   C0005847:vascular [Body Part, Organ, or Organ Component]
   812   C0007634:Cells [Cell]
   812   C0026845:Muscle [Tissue]
   812   C0205357:Smooth [Qualitative Concept]
   812   C1558950:VASCULAR [Finding]
   812   C1801960:Vascular [Qualitative Concept]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
   756 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   756 E C1511228:VESSEL, BLOOD [Tissue]
   741 E C0442025:Muscular [Spatial Concept]
   712 E C0005767:Blood [Tissue]
   712 E C0005768:blood [Body Substance]
   712 E C0229664:Blood [Body Substance]
   712 E C0392895:Bloods [Population Group]

Phrase: "express"

Phrase: "MBP,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   902   C0067062:myosin phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0031686:Protein phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0031678:Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1149880:phosphatase [Molecular Function]

Phrase: "we next"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205117:next [Spatial Concept]
  1000   C0332282:Next [Temporal Concept]
  1000   C1883708:Next [Temporal Concept]

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "whether"

Phrase: "the observed effect of insulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "on cellular PP-1 activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1879547:Activation [Activity]

Phrase: "was due to an increase"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0678226:Due to [Functional Concept]
           due
   760   C0043194:WAS [Disease or Syndrome]
   760   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0442805:Increase [Functional Concept]
   760   C1421478:WAS [Gene or Genome]
   760   C3146286:Due [Idea or Concept]

Phrase: "in MBP activity."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   911   C1149936:myosin phosphatase activity [Molecular Function]
   884   C1149927:protein phosphatase activity [Molecular Function]
   853   C1537044:protein activity [Molecular Function]
   840   C1149880:phosphatase activity [Molecular Function]
   804   C0205177:Activity [Functional Concept]
   804   C0439167:% activity [Quantitative Concept]
   804   C0441655:Activity [Activity]
   804   C1561536:*Activity [Idea or Concept]
   708   C0067062:myosin phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.57: Myosin-enriched fractions were prepared by extraction with a high salt buffer followed by sedimentation of myosin by reducing the salt concentration (20). 

Phrase: "Myosin-enriched fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1264633:Fractions [Quantitative Concept]
   793 E C1554103:Fraction [Idea or Concept]

Phrase: "were"

Phrase: "prepared by extraction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0185115:Extraction [Therapeutic or Preventive Procedure]
   790   C0684295:extraction [Laboratory Procedure]
   756   C1521827:Prepare [Functional Concept]

Phrase: "with a high salt buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "followed by sedimentation of myosin"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   806   C0332283:Followed by [Temporal Concept]
           followed
   760   C0027096:Myosin [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0597428:Sedimentation [Laboratory Procedure]
   760   C1384604:Sedimentation [Natural Phenomenon or Process]
   726 E C1719822:Follow [Intellectual Product]

Phrase: "by reducing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reducing [Qualitative Concept]

Phrase: "the salt concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "(20"

Phrase: ")."
Processing 00000000.tx.58: The resulting pellet, containing more than 95% of total myosin, was dissolved in high-salt buffer and MBP activity was measured using [32P]-labeled MLC and [32P]-labeled phosphorylase a as substrates. 

Phrase: "The resulting pellet,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441436:Pellet [Manufactured Object]
   861   C0993610:Pellet [Biomedical or Dental Material]
   861   C1998480:Pellet [Quantitative Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "more than 95% of total myosin,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0027096:Myosin [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0205172:More [Functional Concept]
   753   C0439175:% total [Quantitative Concept]
   753   C0439810:Total [Qualitative Concept]

Phrase: "was"

Phrase: "dissolved in high-salt buffer"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0036140:Salt [Chemical Viewed Structurally]
   760   C0037494:Salt [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   760   C0205250:High [Qualitative Concept]
   760   C0206136:Salt [Food,Inorganic Chemical]
   760   C1299351:High [Qualitative Concept]
   760   C2700149:HIGH [Intellectual Product]
   726   C1549535:Dissolve [Functional Concept]

Phrase: "and"

Phrase: "MBP activity"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   911   C1149936:myosin phosphatase activity [Molecular Function]
   884   C1149927:protein phosphatase activity [Molecular Function]
   853   C1537044:protein activity [Molecular Function]
   840   C1149880:phosphatase activity [Molecular Function]
   804   C0205177:Activity [Functional Concept]
   804   C0439167:% activity [Quantitative Concept]
   804   C0441655:Activity [Activity]
   804   C1561536:*Activity [Idea or Concept]
   708   C0067062:myosin phosphatase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "was"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "[32P"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553631:32p [Medical Device]

Phrase: "]-labeled MLC"

Phrase: "and ["

Phrase: "32P"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553631:32p [Medical Device]

Phrase: "]-labeled phosphorylase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0017916:Phosphorylase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0917783:Phosphorylase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "a as substrates."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1710236:Substrate [Manufactured Object]
Processing 00000000.tx.59: As reported earlier (21), MBP activity constituted 10% of total cellular PP-1 activity, and the myosin-enriched fraction contained only PP-1 and essentially no PP-2A activity (20). 

Phrase: "As"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "earlier"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1279919:Early [Temporal Concept]

Phrase: "(21"

Phrase: ")"

Phrase: ","

Phrase: "MBP activity"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   911   C1149936:myosin phosphatase activity [Molecular Function]
   884   C1149927:protein phosphatase activity [Molecular Function]
   853   C1537044:protein activity [Molecular Function]
   840   C1149880:phosphatase activity [Molecular Function]
   804   C0205177:Activity [Functional Concept]
   804   C0439167:% activity [Quantitative Concept]
   804   C0441655:Activity [Activity]
   804   C1561536:*Activity [Idea or Concept]
   708   C0067062:myosin phosphatase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "constituted"

Phrase: "10% of total cellular PP-1 activity,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   748   C0007634:Cellular [Cell]
   748   C0178539:Cellular [Functional Concept]
   748   C0205177:Activity [Functional Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0439175:% total [Quantitative Concept]
   748   C0439810:Total [Qualitative Concept]
   748   C0441655:Activity [Activity]
   748   C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "the myosin-enriched fraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1264633:Fraction [Quantitative Concept]
   827   C1554103:Fraction [Idea or Concept]

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "only PP-1"

Phrase: "and"

Phrase: "essentially"

Phrase: "no PP-2A activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "(20"

Phrase: ")."
Processing 00000000.tx.60: Treatment with 100 nM insulin for 10 min caused a 80% increase in MBP activity. 

Phrase: "Treatment with 100 nM insulin"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   797   C0745343:insulin treatment [Therapeutic or Preventive Procedure]
   760   C0039798:treatment [Functional Concept]
   760   C0087111:Treatment [Therapeutic or Preventive Procedure]
   760   C1522326:Treatment [Functional Concept]
   760   C1533734:Treatment [Therapeutic or Preventive Procedure]
   760   C1705169:Treatment [Conceptual Entity]
   760   C3538994:TREATMENT [Research Activity]

Phrase: "for 10 min"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456692:/10 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]

Phrase: "caused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015127:cause [Functional Concept]
   966   C1524003:Cause [Conceptual Entity]

Phrase: "a 80% increase in MBP activity."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0442805:Increase [Functional Concept]
Processing 00000000.tx.61: The effect of insulin was sustained for the 20-min incubation period studied (Fig. 2A). 

Phrase: "The effect of insulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "was"

Phrase: "sustained for the 20-min incubation period"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   778   C1320226:Incubation period [Finding]
   748   C0439531:/period [Temporal Concept]
   748   C0443318:Sustained [Functional Concept]
   748   C0702093:/min [Temporal Concept]
   748   C1948053:Period [Temporal Concept]
   714 E C2732140:Sustain [Organic Chemical,Pharmacologic Substance]

Phrase: "studied"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]

Phrase: "(Fig. 2A"

Phrase: ")."
Processing 00000000.tx.62: Dose-response analyses revealed a maximal increase in MBP activity with 10 nM insulin after 10 min incubation (Fig. 2B). 

Phrase: "Dose-response analyses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C0002778:Analysis [Laboratory Procedure]
   793   C0936012:Analysis [Research Activity]
   793   C1524024:analysis [Functional Concept]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "a maximal increase in MBP activity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0442805:Increase [Functional Concept]

Phrase: "with 10 nM insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "after 10 min incubation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0456692:/10 min [Temporal Concept]

Phrase: "(Fig. 2B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450354:2b [Intellectual Product]
   861   C1706096:2B [Research Activity]

Phrase: ")."
Processing 00000000.tx.63: Similar results were obtained using [32P]-labeled phosphorylase a substrate (basal MBP activity = 1.440  0.156 nmol Pi released/mg protein/min; maximal insulin-stimulated MBP activity = 2.4  0.2 nmol Pi released/mg protein/min). 

Phrase: "Similar results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "were"

Phrase: "obtained"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1301820:Obtained [Functional Concept]
   966 E C1706701:Obtain [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "[32P"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553631:32p [Medical Device]

Phrase: "]-labeled phosphorylase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0017916:Phosphorylase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0917783:Phosphorylase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "a substrate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1710236:Substrate [Manufactured Object]

Phrase: "(basal MBP activity"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   885   C1149936:myosin phosphatase activity [Molecular Function]
   861   C1149927:protein phosphatase activity [Molecular Function]
   839   C1537044:protein activity [Molecular Function]
   827   C1149880:phosphatase activity [Molecular Function]
   799   C0205177:Activity [Functional Concept]
   799   C0439167:% activity [Quantitative Concept]
   799   C0441655:Activity [Activity]
   799   C1561536:*Activity [Idea or Concept]

Phrase: "= 1.440  0.156 nmol Pi"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C0429863:PI [Clinical Attribute]
   799   C3537219:PI [Gene or Genome]
   799   C3539772:PI [Intellectual Product]

Phrase: "released"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0391871:Released [Functional Concept]
  1000   C1283071:Released [Functional Concept]
   966 E C0030685:Release [Health Care Activity]
   966 E C0439180:% release [Quantitative Concept]
   966 E C0680255:release [Health Care Activity]
   966 E C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "/mg protein/min"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   913   C0439420:mg/min [Quantitative Concept]
   827   C0702093:/min [Temporal Concept]

Phrase: "; maximal insulin-stimulated MBP activity"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   878   C1145751:insulin activity [Molecular Function]
   855   C1149936:myosin phosphatase activity [Molecular Function]
   835   C1149927:protein phosphatase activity [Molecular Function]
   822   C1537044:protein activity [Molecular Function]
   812   C1149880:phosphatase activity [Molecular Function]
   793   C0205177:Activity [Functional Concept]
   793   C0439167:% activity [Quantitative Concept]
   793   C0441655:Activity [Activity]
   793   C1561536:*Activity [Idea or Concept]

Phrase: "= 2.4  0.2 nmol Pi"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C0429863:PI [Clinical Attribute]
   799   C3537219:PI [Gene or Genome]
   799   C3539772:PI [Intellectual Product]

Phrase: "released"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0391871:Released [Functional Concept]
  1000   C1283071:Released [Functional Concept]
   966 E C0030685:Release [Health Care Activity]
   966 E C0439180:% release [Quantitative Concept]
   966 E C0680255:release [Health Care Activity]
   966 E C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "/mg protein/min)."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   913   C0439420:mg/min [Quantitative Concept]
   827   C0702093:/min [Temporal Concept]
Processing 00000000.tx.64: PP-1 activity in myosin-depleted supernatants was comparable between control and insulin-treated VSMCs (data not shown). 

Phrase: "PP-1 activity in myosin-depleted supernatants"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0205177:Activity [Functional Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "comparable between control"

Phrase: "and"

Phrase: "insulin-treated VSMCs"
Meta Candidates (Total=21; Excluded=7; Pruned=0; Remaining=14)
   878   C0030281:Insulin Cell [Cell]
   861   C0026844:Muscle, Smooth, Vascular [Tissue]
   861   C1135918:Smooth Muscle Cells [Cell]
   827   C0596981:Muscle Cells [Cell]
   827   C1267092:Muscle, Smooth [Tissue]
   808   C0005773:Blood Cells [Cell]
   799   C0005847:vascular [Body Part, Organ, or Organ Component]
   799   C0007634:Cells [Cell]
   799   C0026845:Muscle [Tissue]
   799   C0205357:Smooth [Qualitative Concept]
   799   C1558950:VASCULAR [Finding]
   799   C1801960:Vascular [Qualitative Concept]
   799 E C2328697:Hemal cell [Cell]
   799   C3282337:Cells [Cell]
   789   C0853230:insulin blood [Laboratory Procedure]
   766 E C1269647:Cell [Cell]
   766 E C1704653:Cell [Medical Device]
   766 E C1948049:Cell [Spatial Concept]
   743 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   743 E C1511228:VESSEL, BLOOD [Tissue]
   727 E C0442025:Muscular [Spatial Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.65: Thus the time and dose-dependent increase observed in cellular PP-1 activity in response to insulin in VSMCs shown in Figs. 

Phrase: "Thus"

Phrase: "the time"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0040223:Time [Temporal Concept]
  1000   C3541383:Time [Temporal Concept]
   944 E C0442043:Temporal [Spatial Concept]
   944 E C2362314:Temporal [Temporal Concept]
   916 E C1632851:Times [Quantitative Concept]

Phrase: "and"

Phrase: "dose-dependent increase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0442805:Increase [Functional Concept]
   734   C1512045:Dose-dependent [Quantitative Concept]

Phrase: "observed in cellular PP-1 activity"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0007634:Cellular [Cell]
   753   C0178539:Cellular [Functional Concept]
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1441672:Observed [Functional Concept]
   753   C1561536:*Activity [Idea or Concept]

Phrase: "in response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871261:Response [Organism Attribute]
  1000   C1704632:Response [Finding]
  1000   C1706817:Response [Intellectual Product]
  1000   C2911692:Response [Mental Process]

Phrase: "to insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "in VSMCs"
Meta Candidates (Total=23; Excluded=11; Pruned=0; Remaining=12)
   923   C0026844:Muscle, Smooth, Vascular [Tissue]
   923   C1135918:Smooth Muscle Cells [Cell]
   861   C0596981:Muscle Cells [Cell]
   861   C1267092:Muscle, Smooth [Tissue]
   852   C0005773:Blood Cells [Cell]
   844 E C2328697:Hemal cell [Cell]
   812   C0005847:vascular [Body Part, Organ, or Organ Component]
   812   C0007634:Cells [Cell]
   812   C0026845:Muscle [Tissue]
   812   C0205357:Smooth [Qualitative Concept]
   812   C1558950:VASCULAR [Finding]
   812   C1801960:Vascular [Qualitative Concept]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
   756 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   756 E C1511228:VESSEL, BLOOD [Tissue]
   741 E C0442025:Muscular [Spatial Concept]
   712 E C0005767:Blood [Tissue]
   712 E C0005768:blood [Body Substance]
   712 E C0229664:Blood [Body Substance]
   712 E C0392895:Bloods [Population Group]

Phrase: "shown in Figs."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0349966:Figs [Food]
   756 E C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.66: 1, B and C, was entirely due to an increase in MBP activity seen in Fig. 

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "C,"

Phrase: "was"

Phrase: "entirely due to an increase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0678226:Due to [Functional Concept]
           due
   760   C0442805:Increase [Functional Concept]
   760   C3146286:Due [Idea or Concept]

Phrase: "in MBP activity"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   911   C1149936:myosin phosphatase activity [Molecular Function]
   884   C1149927:protein phosphatase activity [Molecular Function]
   853   C1537044:protein activity [Molecular Function]
   840   C1149880:phosphatase activity [Molecular Function]
   804   C0205177:Activity [Functional Concept]
   804   C0439167:% activity [Quantitative Concept]
   804   C0441655:Activity [Activity]
   804   C1561536:*Activity [Idea or Concept]
   708   C0067062:myosin phosphatase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "seen in Fig."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0205397:Seen [Qualitative Concept]
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756 E C0042789:see [Organism Function]
   756 E C1947903:See [Activity]
Processing 00000000.tx.67: 2, A and B. 

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "A"

Phrase: "and"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.68: View larger version (19K): [in this window] [in a new window]  Figure 2. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(19K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 2."
Processing 00000000.tx.69: Effect of Insulin on MBP Activation A, PP-1 activation by insulin in VSMCs is due to stimulation of MBP activity: VSMCs were treated with 100 nM insulin for the indicated times. 

Phrase: "Effect of Insulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1280500:Effect [Qualitative Concept]
   790   C2348382:Effect [Qualitative Concept]

Phrase: "on MBP Activation A,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   895   C0949646:Myosin A [Amino Acid, Peptide, or Protein,Enzyme]
   858   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]

Phrase: "PP-1 activation by insulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1879547:Activation [Activity]

Phrase: "in VSMCs"
Meta Candidates (Total=23; Excluded=11; Pruned=0; Remaining=12)
   923   C0026844:Muscle, Smooth, Vascular [Tissue]
   923   C1135918:Smooth Muscle Cells [Cell]
   861   C0596981:Muscle Cells [Cell]
   861   C1267092:Muscle, Smooth [Tissue]
   852   C0005773:Blood Cells [Cell]
   844 E C2328697:Hemal cell [Cell]
   812   C0005847:vascular [Body Part, Organ, or Organ Component]
   812   C0007634:Cells [Cell]
   812   C0026845:Muscle [Tissue]
   812   C0205357:Smooth [Qualitative Concept]
   812   C1558950:VASCULAR [Finding]
   812   C1801960:Vascular [Qualitative Concept]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
   756 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   756 E C1511228:VESSEL, BLOOD [Tissue]
   741 E C0442025:Muscular [Spatial Concept]
   712 E C0005767:Blood [Tissue]
   712 E C0005768:blood [Body Substance]
   712 E C0229664:Blood [Body Substance]
   712 E C0392895:Bloods [Population Group]

Phrase: "is due to stimulation of MBP activity"
Meta Candidates (Total=25; Excluded=0; Pruned=0; Remaining=25)
   782   C1149927:protein phosphatase activity [Molecular Function]
   777   C1149936:myosin phosphatase activity [Molecular Function]
   760   C0031686:Protein phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0678226:Due to [Functional Concept]
           due
   760   C1149880:phosphatase activity [Molecular Function]
           phosphatase
   757   C0067062:myosin phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   757   C0522527:Protein bound [Qualitative Concept]
   757   C1537044:protein activity [Molecular Function]
   739   C0027096:Myosin [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0031678:Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0205177:Activity [Functional Concept]
   739   C0332297:bound [Spatial Concept]
   739   C0439167:% activity [Quantitative Concept]
   739   C0441655:Activity [Activity]
   739   C1145667:Bound [Activity]
   739   C1167622:Bound [Molecular Function]
   739   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   739   C1561536:*Activity [Idea or Concept]
   739   C1689898:% bound [Quantitative Concept]
   739   C1948023:Stimulation [Natural Phenomenon or Process]
   739   C2349209:Bound [Conceptual Entity]
   739   C3146286:Due [Idea or Concept]

Phrase: ":"

Phrase: "VSMCs"
Meta Candidates (Total=23; Excluded=11; Pruned=0; Remaining=12)
   923   C0026844:Muscle, Smooth, Vascular [Tissue]
   923   C1135918:Smooth Muscle Cells [Cell]
   861   C0596981:Muscle Cells [Cell]
   861   C1267092:Muscle, Smooth [Tissue]
   852   C0005773:Blood Cells [Cell]
   844 E C2328697:Hemal cell [Cell]
   812   C0005847:vascular [Body Part, Organ, or Organ Component]
   812   C0007634:Cells [Cell]
   812   C0026845:Muscle [Tissue]
   812   C0205357:Smooth [Qualitative Concept]
   812   C1558950:VASCULAR [Finding]
   812   C1801960:Vascular [Qualitative Concept]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
   756 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   756 E C1511228:VESSEL, BLOOD [Tissue]
   741 E C0442025:Muscular [Spatial Concept]
   712 E C0005767:Blood [Tissue]
   712 E C0005768:blood [Body Substance]
   712 E C0229664:Blood [Body Substance]
   712 E C0392895:Bloods [Population Group]

Phrase: "were"

Phrase: "treated with 100 nM insulin"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   806   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0312860:NM [Cell Function]
   760   C1522326:Treated [Functional Concept]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   726 E C1292734:TREAT [Functional Concept]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "for the indicated times."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0040223:times [Temporal Concept]
   861   C1632851:Times [Quantitative Concept]
   827 E C3541383:Time [Temporal Concept]
   789 E C0442043:Temporal [Spatial Concept]
   789 E C2362314:Temporal [Temporal Concept]
Processing 00000000.tx.70: Myosin-enriched fractions were prepared as detailed in the text. 

Phrase: "Myosin-enriched fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1264633:Fractions [Quantitative Concept]
   793 E C1554103:Fraction [Idea or Concept]

Phrase: "were"

Phrase: "prepared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1521827:Prepare [Functional Concept]

Phrase: "as"

Phrase: "detailed in the text."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C1522508:Detailed [Qualitative Concept]
   770   C1527021:Text [Intellectual Product]
   770   C1554111:Text [Idea or Concept]
   770   C1705606:Text [Intellectual Product]
   770   C3541382:Text [Intellectual Product]
   737 E C1561567:detail [Functional Concept]
Processing 00000000.tx.71: Equal amounts of proteins from myosin-enriched fractions were assayed for MBP activity using [32P]labeled MLC as a substrate. 

Phrase: "Equal amounts of proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1265611:amounts [Quantitative Concept]

Phrase: "from myosin-enriched fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1264633:Fractions [Quantitative Concept]
   793 E C1554103:Fraction [Idea or Concept]

Phrase: "were"

Phrase: "assayed for MBP activity"
Meta Candidates (Total=23; Excluded=0; Pruned=0; Remaining=23)
   814   C1149927:protein phosphatase activity [Molecular Function]
   804   C1149936:myosin phosphatase activity [Molecular Function]
   778   C0031686:Protein phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   778   C1149880:phosphatase activity [Molecular Function]
           phosphatase
   774   C0067062:myosin phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   774   C0522527:Protein bound [Qualitative Concept]
   774   C1537044:protein activity [Molecular Function]
   748   C0027096:Myosin [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0031678:Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0205177:Activity [Functional Concept]
   748   C0332297:bound [Spatial Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C1145667:Bound [Activity]
   748   C1167622:Bound [Molecular Function]
   748   C1561536:*Activity [Idea or Concept]
   748   C1689898:% bound [Quantitative Concept]
   748   C2349209:Bound [Conceptual Entity]
   714   C0005507:Assay [Laboratory Procedure]
   714   C0243073:assay [Qualitative Concept]
   714   C1510438:Assay [Laboratory Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "[32P"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553631:32p [Medical Device]

Phrase: "]labeled MLC as a substrate."
Processing 00000000.tx.72: Results are the mean  SEM of three separate experiments performed in duplicate. 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "the mean  SEM of three separate experiments"

Phrase: "performed in duplicate."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0205173:Duplicate [Functional Concept]
   790   C0884358:Performed [Functional Concept]
   790   C3539942:Duplicate [Intellectual Product]
   756 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.73: *, P < 0.05 vs. basal levels. 

Phrase: "*,"

Phrase: "P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "vs. basal levels."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.74: B, Dose-response of MBP activation by insulin: VSMCs were treated with various concentrations of insulin for 10 min. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Dose-response of MBP activation"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   744   C0178602:Dose [Quantitative Concept]
   744   C0869039:Dose [Quantitative Concept]
   744   C0871261:Response [Organism Attribute]
   744   C1114758:Dose # [Clinical Attribute]
   744   C1704632:Response [Finding]
   744   C1706817:Response [Intellectual Product]
   744   C2911692:Response [Mental Process]

Phrase: "by insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: ":"

Phrase: "VSMCs"
Meta Candidates (Total=23; Excluded=11; Pruned=0; Remaining=12)
   923   C0026844:Muscle, Smooth, Vascular [Tissue]
   923   C1135918:Smooth Muscle Cells [Cell]
   861   C0596981:Muscle Cells [Cell]
   861   C1267092:Muscle, Smooth [Tissue]
   852   C0005773:Blood Cells [Cell]
   844 E C2328697:Hemal cell [Cell]
   812   C0005847:vascular [Body Part, Organ, or Organ Component]
   812   C0007634:Cells [Cell]
   812   C0026845:Muscle [Tissue]
   812   C0205357:Smooth [Qualitative Concept]
   812   C1558950:VASCULAR [Finding]
   812   C1801960:Vascular [Qualitative Concept]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
   756 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   756 E C1511228:VESSEL, BLOOD [Tissue]
   741 E C0442025:Muscular [Spatial Concept]
   712 E C0005767:Blood [Tissue]
   712 E C0005768:blood [Body Substance]
   712 E C0229664:Blood [Body Substance]
   712 E C0392895:Bloods [Population Group]

Phrase: "were"

Phrase: "treated with various concentrations of insulin"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   790   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0086045:Concentrations [Mental Process]
   753   C0440102:Various [Indicator, Reagent, or Diagnostic Aid]
   753   C1522326:Treated [Functional Concept]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]
   719 E C1292734:TREAT [Functional Concept]
   719 E C1446561:Concentration [Quantitative Concept]

Phrase: "for 10 min."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456692:/10 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.75: MBP activity was assayed in myosin-enriched fractions. 

Phrase: "MBP activity"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   911   C1149936:myosin phosphatase activity [Molecular Function]
   884   C1149927:protein phosphatase activity [Molecular Function]
   853   C1537044:protein activity [Molecular Function]
   840   C1149880:phosphatase activity [Molecular Function]
   804   C0205177:Activity [Functional Concept]
   804   C0439167:% activity [Quantitative Concept]
   804   C0441655:Activity [Activity]
   804   C1561536:*Activity [Idea or Concept]
   708   C0067062:myosin phosphatase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "was"

Phrase: "assayed in myosin-enriched fractions."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   760   C0027096:Myosin [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0359583:enriched [Food]
   760   C1264633:Fractions [Quantitative Concept]
   726   C0005507:Assay [Laboratory Procedure]
   726   C0243073:assay [Qualitative Concept]
   726   C1510438:Assay [Laboratory Procedure]
   726 E C1554103:Fraction [Idea or Concept]
Processing 00000000.tx.76: Results are the mean of two separate experiments. 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "the mean of two separate experiments."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0444504:Mean [Quantitative Concept]
   753   C2347634:Mean [Quantitative Concept]
   753   C2348143:Mean [Quantitative Concept]
Processing 00000000.tx.77: C, Insulin does not alter the contents of MBS and PP-1C in the myosin-enriched fractions. 

Phrase: "C,"

Phrase: "Insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "alter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "the contents of MBS"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0456205:Contents [Conceptual Entity]
   753   C1552853:contents [Idea or Concept]
   719 E C0423896:Content [Mental Process]

Phrase: "and"

Phrase: "PP-1C in the myosin-enriched fractions."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   800   C1956003:Protein Phosphatase 1 [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0031686:Protein phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   767   C0067062:myosin phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0031678:Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C1149880:phosphatase [Molecular Function]
Processing 00000000.tx.78: VSMCs were treated with insulin (100 nM x 10 min), thrombin (1U/ml x 3 min), insulin + thrombin (100 nM insulin x 10 min followed by 1U/ml thrombin for 3 min). 

Phrase: "VSMCs"
Meta Candidates (Total=23; Excluded=11; Pruned=0; Remaining=12)
   923   C0026844:Muscle, Smooth, Vascular [Tissue]
   923   C1135918:Smooth Muscle Cells [Cell]
   861   C0596981:Muscle Cells [Cell]
   861   C1267092:Muscle, Smooth [Tissue]
   852   C0005773:Blood Cells [Cell]
   844 E C2328697:Hemal cell [Cell]
   812   C0005847:vascular [Body Part, Organ, or Organ Component]
   812   C0007634:Cells [Cell]
   812   C0026845:Muscle [Tissue]
   812   C0205357:Smooth [Qualitative Concept]
   812   C1558950:VASCULAR [Finding]
   812   C1801960:Vascular [Qualitative Concept]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
   756 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   756 E C1511228:VESSEL, BLOOD [Tissue]
   741 E C0442025:Muscular [Spatial Concept]
   712 E C0005767:Blood [Tissue]
   712 E C0005768:blood [Body Substance]
   712 E C0229664:Blood [Body Substance]
   712 E C0392895:Bloods [Population Group]

Phrase: "were"

Phrase: "treated with insulin"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1522326:Treated [Functional Concept]
   790   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1579433:Insulin [Pharmacologic Substance]
   756 E C1292734:TREAT [Functional Concept]
   734 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   706 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(100 nM x 10 min),"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   840   C0456692:/10 min [Temporal Concept]
   804   C0702093:/min [Temporal Concept]

Phrase: "thrombin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040018:Thrombin [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "(1U/ml x 3 min),"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   875   C0439445:mL/min [Quantitative Concept]
   804   C0702093:/min [Temporal Concept]

Phrase: "insulin + thrombin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0040018:Thrombin [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "(100 nM insulin x 10 min"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0456692:/10 min [Temporal Concept]
   799   C0702093:/min [Temporal Concept]

Phrase: "followed by 1U/ml thrombin"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   806   C0332283:Followed by [Temporal Concept]
           followed
   760   C0040018:Thrombin [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   760   C0439526:/mL [Quantitative Concept]
   726 E C1719822:Follow [Intellectual Product]

Phrase: "for 3 min)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.79: Equal amounts of proteins (20 g) from myosin-enriched fractions were separated on a 7.5% SDS polyacrylamide gel. 

Phrase: "Equal amounts of proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1265611:amounts [Quantitative Concept]

Phrase: "(20 g) from myosin-enriched fractions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0439267:g% [Quantitative Concept]

Phrase: "were"

Phrase: "separated on a 7.5% SDS polyacrylamide gel."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0071500:Polyacrylamide Gel [Biomedical or Dental Material,Pharmacologic Substance]
   744   C0017243:Gel [Biomedical or Dental Material]
   744   C0071499:polyacrylamide [Biomedical or Dental Material,Organic Chemical]
   744   C0086972:Separated [Finding]
   744   C0443299:separated [Spatial Concept]
   744   C0687118:Separated [Functional Concept]
   744   C1382104:Gel [Substance]
Processing 00000000.tx.80: The proteins were transferred to PVDF membrane. 

Phrase: "The proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "transferred to PVDF membrane."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   806   C0071710:polyvinylidene fluoride [Organic Chemical]
   760   C0016327:Fluoride [Inorganic Chemical,Pharmacologic Substance]
   760   C0025255:Membrane [Tissue]
   760   C0348011:transferred [Functional Concept]
   760   C0596901:Membrane [Cell Component]
   760   C1706182:Membrane [Manufactured Object]
   726 E C0040671:Transfer [Mental Process]
   726 E C1705822:Transfer [Activity]
Processing 00000000.tx.81: The membrane was cut into two halves across the 50-kDa marker. 

Phrase: "The membrane"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025255:Membrane [Tissue]
  1000   C0596901:Membrane [Cell Component]
  1000   C1706182:Membrane [Manufactured Object]
   928 E C0205287:Membranous [Qualitative Concept]

Phrase: "was"

Phrase: "cut into two"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0000925:Cut [Injury or Poisoning]
   790   C0205448:Two [Quantitative Concept]
   790   C1883724:CUT [Phenomenon or Process]

Phrase: "halves across the 50-kDa marker."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0005516:Marker [Clinical Attribute]
   753   C1532717:kDa [Quantitative Concept]
Processing 00000000.tx.82: Top portion was probed with anti-MBS antibody and the bottom portion was used to analyze PP-1C content. 

Phrase: "Top portion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449719:Portion [Spatial Concept]

Phrase: "was"

Phrase: "probed with anti-MBS antibody"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   774   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   774   C3533097:Myosin Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   748   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   748   C0027096:Myosin [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0332297:bound [Spatial Concept]
   748   C1145667:Bound [Activity]
   748   C1167622:Bound [Molecular Function]
   748   C1689898:% bound [Quantitative Concept]
   748   C1711351:Subunit [Quantitative Concept]
   748   C2349209:Bound [Conceptual Entity]
   714   C0182400:Probe [Medical Device]
   714   C1704681:Probe [Gene or Genome]
   714   C2347609:Probe [Chemical Viewed Functionally]
   714   C3536729:Probe [Manufactured Object]

Phrase: "and"

Phrase: "the bottom portion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449719:Portion [Spatial Concept]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "analyze"

Phrase: "PP-1C content."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0423896:Content [Mental Process]
   812   C0456205:Content [Conceptual Entity]
   756   C1956003:Protein Phosphatase 1 [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.83: A representative autoradiogram is shown. 

Phrase: "A representative autoradiogram"

Phrase: "is"

Phrase: "shown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]
Processing 00000000.tx.84: Similar results were obtained in multiple experiments. 

Phrase: "Similar results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "were"

Phrase: "obtained in multiple experiments."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0439064:Multiple [Quantitative Concept]
   770   C0681814:Experiments [Research Activity]
   770   C1301820:Obtained [Functional Concept]
   737 E C1706386:Experiment [Conceptual Entity]
   737 E C1706701:Obtain [Activity]
Processing 00000000.tx.85: D, Insulin does not increase the association of PP-1C with the MBS. 

Phrase: "D,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "the association of PP-1C"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0004083:Association [Mental Process]
   753   C0439849:Association [Qualitative Concept]
   753   C0596306:Association [Phenomenon or Process]
   753   C0699792:association [Social Behavior]

Phrase: "with the MBS."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1711351:Subunit [Quantitative Concept]
Processing 00000000.tx.86: Equal amounts of proteins from control and insulin-treated VSMC lysates were immunoprecipitated with the anti-MBS antibody as detailed in the text. 

Phrase: "Equal amounts of proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1265611:amounts [Quantitative Concept]

Phrase: "from control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "insulin-treated VSMC lysates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   801   C1881488:Cell Lysate [Physical Object]
           Lysate
   710   C0030281:Insulin Cell [Cell]

Phrase: "were"

Phrase: "immunoprecipitated with the anti-MBS antibody"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   767   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   767   C3533097:Myosin Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   744   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   744   C0027096:Myosin [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0332297:bound [Spatial Concept]
   744   C1145667:Bound [Activity]
   744   C1167622:Bound [Molecular Function]
   744   C1689898:% bound [Quantitative Concept]
   744   C1711351:Subunit [Quantitative Concept]
   744   C2349209:Bound [Conceptual Entity]
   711   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "as"

Phrase: "detailed in the text."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C1522508:Detailed [Qualitative Concept]
   770   C1527021:Text [Intellectual Product]
   770   C1554111:Text [Idea or Concept]
   770   C1705606:Text [Intellectual Product]
   770   C3541382:Text [Intellectual Product]
   737 E C1561567:detail [Functional Concept]
Processing 00000000.tx.87: The immunoprecipitates were separated by SDS-PAGE followed by Western blot analysis as detailed in Fig. 

Phrase: "The immunoprecipitates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "were"

Phrase: "separated by SDS-PAGE"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   770   C0086972:Separated [Finding]
   770   C0443299:separated [Spatial Concept]
   770   C0687118:Separated [Functional Concept]
   770   C1704732:Page [Intellectual Product]

Phrase: "followed by Western blot analysis"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   862   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   806   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   806   C0332283:Followed by [Temporal Concept]
           followed
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]
   760   C1705493:Western [Spatial Concept]
   726 E C1719822:Follow [Intellectual Product]

Phrase: "as"

Phrase: "detailed in Fig."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   790   C1522508:Detailed [Qualitative Concept]
   756 E C1561567:detail [Functional Concept]
Processing 00000000.tx.88: 2C. 

Phrase: "2C."
Processing 00000000.tx.89: A representative autoradiogram is shown.  

Phrase: "A representative autoradiogram"

Phrase: "is"

Phrase: "shown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]
Processing 00000000.tx.90: Western blot analysis indicated that insulin treatment did not alter the contents of either MBS or PP-1C examined in the myosin-enriched fraction (Fig. 2C) as well as the MBS immunoprecipitates (Fig. 2D). 

Phrase: "Western blot analysis"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   901   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]
   827   C1705493:Western [Spatial Concept]

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "that insulin treatment"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0745343:insulin treatment [Therapeutic or Preventive Procedure]
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "alter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "the contents of either MBS"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   748   C0456205:Contents [Conceptual Entity]
   748   C1552853:contents [Idea or Concept]
   714 E C0423896:Content [Mental Process]

Phrase: "or"

Phrase: "PP-1C"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1956003:Protein Phosphatase 1 [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0031686:Protein phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031678:Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1149880:phosphatase [Molecular Function]

Phrase: "examined in the myosin-enriched fraction"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0027096:Myosin [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0332128:Examined [Finding]
   753   C0359583:enriched [Food]
   753   C1264633:Fraction [Quantitative Concept]
   753   C1554103:Fraction [Idea or Concept]

Phrase: "(Fig. 2C"

Phrase: ")"

Phrase: "as well as"

Phrase: "the MBS immunoprecipitates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "(Fig. 2D"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1705052:2D [Spatial Concept]
   861   C2986796:2D [Functional Concept]

Phrase: ")."
Processing 00000000.tx.91: Furthermore, thrombin, which is known to inhibit MBP activity, did not alter the content of PP-1C in the myosin-enriched fraction. 

Phrase: "Furthermore,"

Phrase: "thrombin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040018:Thrombin [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "which"

Phrase: "is"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "MBP activity,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   911   C1149936:myosin phosphatase activity [Molecular Function]
   884   C1149927:protein phosphatase activity [Molecular Function]
   853   C1537044:protein activity [Molecular Function]
   840   C1149880:phosphatase activity [Molecular Function]
   804   C0205177:Activity [Functional Concept]
   804   C0439167:% activity [Quantitative Concept]
   804   C0441655:Activity [Activity]
   804   C1561536:*Activity [Idea or Concept]
   708   C0067062:myosin phosphatase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "alter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "the content of PP-1C"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0423896:Content [Mental Process]
   753   C0456205:Content [Conceptual Entity]

Phrase: "in the myosin-enriched fraction."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1264633:Fraction [Quantitative Concept]
   827   C1554103:Fraction [Idea or Concept]
Processing 00000000.tx.92: This observation suggests that insulin may be activating the enzyme already bound to the MBS. 

Phrase: "This observation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0302523:Observation [Research Activity]
  1000   C0700325:observation [Health Care Activity]
  1000   C1964257:Observation [Diagnostic Procedure]
   928 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "may"

Phrase: "be"

Phrase: "activating"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1879547:activating [Activity]
   966 E C1515877:Activate [Functional Concept]

Phrase: "the enzyme already"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014442:Enzyme [Enzyme,Organic Chemical]
   777 E C0014445:enzymes [Functional Concept]

Phrase: "bound to the MBS."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0027096:Myosin [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0332297:bound [Spatial Concept]
   753   C1145667:Bound [Activity]
   753   C1167622:Bound [Molecular Function]
   753   C1689898:% bound [Quantitative Concept]
   753   C1711351:Subunit [Quantitative Concept]
   753   C2349209:Bound [Conceptual Entity]
Processing 00000000.tx.93: Insulin Decreases the MBS Phosphorylation and Prevents Thrombin-Induced Increase in MBS Phosphorylation Recent studies suggest that the large 110/130 kDa MBS of myosin-associated phosphatase (MBP) gets phosphorylated by agonists that stimulate smooth muscle contraction (14, 15). 

Phrase: "Insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "Decreases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "the MBS Phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0031715:Phosphorylation [Molecular Function]
   812   C1158886:Phosphorylation [Molecular Function]

Phrase: "and"

Phrase: "Prevents"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0309872:PREVENT [Pharmacologic Substance]
  1000   C1292733:Prevents [Functional Concept]

Phrase: "Thrombin-Induced Increase in MBS Phosphorylation Recent studies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0442805:Increase [Functional Concept]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the large 110/130 kDa MBS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C1711351:Subunit [Quantitative Concept]

Phrase: "of myosin-associated phosphatase"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0067062:myosin phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031678:Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1149880:phosphatase [Molecular Function]

Phrase: "(MBP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   902   C0067062:myosin phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0031686:Protein phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0031678:Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1149880:phosphatase [Molecular Function]

Phrase: ")"

Phrase: "gets"

Phrase: "phosphorylated by agonists"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0243192:agonists [Pharmacologic Substance]
   790   C2987634:agonists [Pharmacologic Substance]

Phrase: "that"

Phrase: "stimulate"

Phrase: "smooth muscle contraction"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1155937:smooth muscle contraction [Organ or Tissue Function]
   901   C0026820:Muscle Contraction [Physiologic Function]
   827   C1140999:Contraction [Pathologic Function]
   734   C1267092:Muscle, Smooth [Tissue]

Phrase: "(14,"

Phrase: "15"

Phrase: ")."
Processing 00000000.tx.94: Furthermore, phosphorylation of MBS results in a decrease in MBP activity (14, 15). 

Phrase: "Furthermore,"

Phrase: "phosphorylation of MBS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0031715:Phosphorylation [Molecular Function]
   760   C1158886:Phosphorylation [Molecular Function]

Phrase: "results in a decrease"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0392756:Decrease [Qualitative Concept]
   770   C0547047:Decrease [Quantitative Concept]
   770   C1274040:Result [Functional Concept]
   770   C1546471:Result [Idea or Concept]
   770   C2825142:Result [Finding]

Phrase: "in MBP activity"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   911   C1149936:myosin phosphatase activity [Molecular Function]
   884   C1149927:protein phosphatase activity [Molecular Function]
   853   C1537044:protein activity [Molecular Function]
   840   C1149880:phosphatase activity [Molecular Function]
   804   C0205177:Activity [Functional Concept]
   804   C0439167:% activity [Quantitative Concept]
   804   C0441655:Activity [Activity]
   804   C1561536:*Activity [Idea or Concept]
   708   C0067062:myosin phosphatase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(14,"

Phrase: "15"

Phrase: ")."
Processing 00000000.tx.95: Our observations that insulin rapidly stimulates MBP suggest that insulin may be activating the phosphatase either by altering MBS phosphorylation status and/or activating the catalytic subunit bound to MBS via another mechanism. 

Phrase: "Our observations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0302523:observations [Research Activity]
  1000   C0700325:observations [Health Care Activity]
  1000   C3244290:observations [Functional Concept]
   966 E C1964257:Observation [Diagnostic Procedure]
   916 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "that insulin rapidly"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "stimulates"

Phrase: "MBP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   902   C0067062:myosin phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0031686:Protein phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0031678:Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1149880:phosphatase [Molecular Function]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "may"

Phrase: "be"

Phrase: "activating"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1879547:activating [Activity]
   966 E C1515877:Activate [Functional Concept]

Phrase: "the phosphatase either by altering MBS phosphorylation status"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   757   C0067062:myosin phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0031678:Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   739   C1149880:phosphatase [Molecular Function]

Phrase: "and/or"

Phrase: "activating"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1879547:activating [Activity]
   966 E C1515877:Activate [Functional Concept]

Phrase: "the catalytic subunit"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0600499:Catalytic Subunit [Amino Acid Sequence]
   861   C1711351:Subunit [Quantitative Concept]

Phrase: "bound to MBS"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0027096:Myosin [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0332297:bound [Spatial Concept]
   760   C1145667:Bound [Activity]
   760   C1167622:Bound [Molecular Function]
   760   C1689898:% bound [Quantitative Concept]
   760   C1711351:Subunit [Quantitative Concept]
   760   C2349209:Bound [Conceptual Entity]

Phrase: "via another mechanism."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0441712:Mechanism [Functional Concept]
  1000   C1706376:Mechanism [Manufactured Object]
Processing 00000000.tx.96: Therefore, we examined the effect of insulin on MBS phosphorylation status. 

Phrase: "Therefore,"

Phrase: "we"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the effect of insulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "on MBS phosphorylation status."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0449438:Status [Qualitative Concept]
Processing 00000000.tx.97: As shown in Fig. 

Phrase: "As"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.98: 3A, treatment with 100 nM insulin for 2 min caused a rapid 53% decrease in [32P] incorporation into MBS (Fig. 3A, compare lane 2 vs. lane 1). 

Phrase: "3A,"

Phrase: "treatment with 100 nM insulin"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   797   C0745343:insulin treatment [Therapeutic or Preventive Procedure]
   760   C0039798:treatment [Functional Concept]
   760   C0087111:Treatment [Therapeutic or Preventive Procedure]
   760   C1522326:Treatment [Functional Concept]
   760   C1533734:Treatment [Therapeutic or Preventive Procedure]
   760   C1705169:Treatment [Conceptual Entity]
   760   C3538994:TREATMENT [Research Activity]

Phrase: "for 2 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "caused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015127:cause [Functional Concept]
   966   C1524003:Cause [Conceptual Entity]

Phrase: "a rapid 53% decrease in [32P"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1553631:32p [Medical Device]

Phrase: "] incorporation into MBS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0243126:incorporation [Functional Concept]

Phrase: "(Fig. 3A,"

Phrase: "compare"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compare [Activity]

Phrase: "lane 2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: "vs. lane 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.99: A 72% decrease in MBS phosphorylation was observed after 5 min insulin incubation (Fig. 3A, compare lane 3 vs. lane 1). 

Phrase: "A 72% decrease in MBS phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0392756:Decrease [Qualitative Concept]
   744   C0547047:Decrease [Quantitative Concept]

Phrase: "was"

Phrase: "observed after 5 min insulin incubation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0702093:/min [Temporal Concept]
   753   C1441672:Observed [Functional Concept]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]

Phrase: "(Fig. 3A,"

Phrase: "compare"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compare [Activity]

Phrase: "lane 3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: "vs. lane 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.100: The observed decrease in MBS phosphorylation was sustained for 20 min of insulin treatment (Fig. 3A, compare lane 5 vs. lane 1). 

Phrase: "The observed decrease in MBS phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0392756:Decrease [Qualitative Concept]
   744   C0547047:Decrease [Quantitative Concept]

Phrase: "was"

Phrase: "sustained for 20 min of insulin treatment"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   778   C0745343:insulin treatment [Therapeutic or Preventive Procedure]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0039798:treatment [Functional Concept]
   748   C0087111:Treatment [Therapeutic or Preventive Procedure]
   748   C0443318:Sustained [Functional Concept]
   748   C0702093:/min [Temporal Concept]
   748   C1522326:Treatment [Functional Concept]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1533734:Treatment [Therapeutic or Preventive Procedure]
   748   C1579433:Insulin [Pharmacologic Substance]
   748   C1705169:Treatment [Conceptual Entity]
   748   C3538994:TREATMENT [Research Activity]
   714 E C2732140:Sustain [Organic Chemical,Pharmacologic Substance]

Phrase: "(Fig. 3A,"

Phrase: "compare"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compare [Activity]

Phrase: "lane 5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: "vs. lane 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.101: View larger version (35K): [in this window] [in a new window]  Figure 3. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(35K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 3."
Processing 00000000.tx.102: Effect of Insulin on MBS Phosphorylation A, Insulin decreases the phosphorylation status of MBS. 

Phrase: "Effect of Insulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1280500:Effect [Qualitative Concept]
   790   C2348382:Effect [Qualitative Concept]

Phrase: "on MBS Phosphorylation A,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   897   C0949646:Myosin A [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "Insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "decreases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "the phosphorylation status of MBS."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0449438:Status [Qualitative Concept]
Processing 00000000.tx.103: [32P]-labeled VSMCs were treated with 100 nM insulin for 230 min. 

Phrase: "[32P"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553631:32p [Medical Device]

Phrase: "]-labeled VSMCs"
Meta Candidates (Total=23; Excluded=11; Pruned=0; Remaining=12)
   884   C0026844:Muscle, Smooth, Vascular [Tissue]
   884   C1135918:Smooth Muscle Cells [Cell]
   840   C0596981:Muscle Cells [Cell]
   840   C1267092:Muscle, Smooth [Tissue]
   825   C0005773:Blood Cells [Cell]
   817 E C2328697:Hemal cell [Cell]
   804   C0005847:vascular [Body Part, Organ, or Organ Component]
   804   C0007634:Cells [Cell]
   804   C0026845:Muscle [Tissue]
   804   C0205357:Smooth [Qualitative Concept]
   804   C1558950:VASCULAR [Finding]
   804   C1801960:Vascular [Qualitative Concept]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]
   748 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   748 E C1511228:VESSEL, BLOOD [Tissue]
   733 E C0442025:Muscular [Spatial Concept]
   704 E C0005767:Blood [Tissue]
   704 E C0005768:blood [Body Substance]
   704 E C0229664:Blood [Body Substance]
   704 E C0392895:Bloods [Population Group]

Phrase: "were"

Phrase: "treated with 100 nM insulin"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   806   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0312860:NM [Cell Function]
   760   C1522326:Treated [Functional Concept]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   726 E C1292734:TREAT [Functional Concept]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "for 230 min."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.104: Equal amounts of cell lysate proteins (250 g) were immunoprecipitated with anti-MBS antibody. 

Phrase: "Equal amounts of cell lysate proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1265611:amounts [Quantitative Concept]

Phrase: "(250 g)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "were"

Phrase: "immunoprecipitated with anti-MBS antibody."
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   774   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   774   C3533097:Myosin Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   748   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   748   C0027096:Myosin [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0332297:bound [Spatial Concept]
   748   C1145667:Bound [Activity]
   748   C1167622:Bound [Molecular Function]
   748   C1689898:% bound [Quantitative Concept]
   748   C1711351:Subunit [Quantitative Concept]
   748   C2349209:Bound [Conceptual Entity]
   714   C0301871:Immunoprecipitate [Immunologic Factor]
Processing 00000000.tx.105: The immunoprecipitates were subjected to SDS-PAGE, transferred to PVDF followed by autoradiography. 

Phrase: "The immunoprecipitates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "were"

Phrase: "subjected to SDS-PAGE,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   770   C1704732:Page [Intellectual Product]
   737   C0681850:Subject [Group]
   737   C1550501:{Subject} [Idea or Concept]
   737   C1706203:Subject [Idea or Concept]
   737   C2349001:Subject [Human]
   737   C2697811:Subject [Functional Concept]

Phrase: "transferred to PVDF"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   833   C0071710:polyvinylidene fluoride [Organic Chemical]
   770   C0016327:Fluoride [Inorganic Chemical,Pharmacologic Substance]
   770   C0348011:transferred [Functional Concept]
   737 E C0040671:Transfer [Mental Process]
   737 E C1705822:Transfer [Activity]

Phrase: "followed by autoradiography."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   882   C0332283:Followed by [Temporal Concept]
           followed
   790   C0004400:Autoradiography [Laboratory Procedure]
   756 E C1719822:Follow [Intellectual Product]
Processing 00000000.tx.106: The blot was probed with anti-MBS antibody to estimate the quantity of MBS protein immunoprecipitated. 

Phrase: "The blot"

Phrase: "was"

Phrase: "probed with anti-MBS antibody to"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   767   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   767   C3533097:Myosin Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   744   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   744   C0027096:Myosin [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0332297:bound [Spatial Concept]
   744   C1145667:Bound [Activity]
   744   C1167622:Bound [Molecular Function]
   744   C1689898:% bound [Quantitative Concept]
   744   C1711351:Subunit [Quantitative Concept]
   744   C2349209:Bound [Conceptual Entity]
   711   C0182400:Probe [Medical Device]
   711   C1704681:Probe [Gene or Genome]
   711   C2347609:Probe [Chemical Viewed Functionally]
   711   C3536729:Probe [Manufactured Object]

Phrase: "estimate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750572:Estimate [Quantitative Concept]

Phrase: "the quantity of MBS protein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C1265611:Quantity [Quantitative Concept]
   748   C1554108:Quantity [Intellectual Product]
   748   C1561573:Quantity [Intellectual Product]

Phrase: "immunoprecipitated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0301871:Immunoprecipitate [Immunologic Factor]
Processing 00000000.tx.107: A representative autoradiogram is shown. 

Phrase: "A representative autoradiogram"

Phrase: "is"

Phrase: "shown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]
Processing 00000000.tx.108: Data from multiple experiments were quantitated by densitometric scanning and normalized for variations in proteins by dividing the intensity of 32P signal with that of protein signal. 

Phrase: "Data from multiple experiments"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1511726:Data [Idea or Concept]
   770   C3245479:data [Medical Device]

Phrase: "were"

Phrase: "quantitated by densitometric scanning"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0011321:densitometric scanning [Laboratory Procedure]
   770   C0034606:Scanning [Diagnostic Procedure]
   770   C0441633:Scanning [Diagnostic Procedure]

Phrase: "and"

Phrase: "normalized for variations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205419:variations [Qualitative Concept]
   790   C1882115:Normalized [Research Activity]

Phrase: "in proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "by dividing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332849:dividing [Functional Concept]

Phrase: "the intensity of 32P signal"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C0871362:signal intensity [Quantitative Concept]
   760   C0522510:Intensity [Qualitative Concept]

Phrase: "with that"

Phrase: "of protein signal."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1710082:Signal [Phenomenon or Process]
Processing 00000000.tx.109: The 32P-specific activity of controls was assigned a value of 100, and the insulin effect was calculated relative to control. 

Phrase: "The 32P-specific activity of controls"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0205177:Activity [Functional Concept]
   753   C0205369:Specific [Qualitative Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1552740:specific [Intellectual Product]
   753   C1561536:*Activity [Idea or Concept]
   731   C1706449:Active Control [Research Activity]

Phrase: "was"

Phrase: "assigned"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516050:Assigned [Functional Concept]
  1000   C1552601:assigned [Intellectual Product]

Phrase: "a value of 100,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1522609:Value [Quantitative Concept]

Phrase: "and"

Phrase: "the insulin effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1280500:Effect [Qualitative Concept]
   861   C2348382:Effect [Qualitative Concept]

Phrase: "was"

Phrase: "calculated"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0444686:Calculated [Functional Concept]
  1000   C1441506:Calculated [Activity]
  1000   C1443182:Calculated [Laboratory Procedure]

Phrase: "relative to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0080103:Relative [Family Group]
   861   C0205345:Relative [Qualitative Concept]
   861   C1547039:*Relative [Quantitative Concept]

Phrase: "control."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.110: Results are the mean  SEM of four separate experiments. 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "the mean  SEM of four separate experiments."
Processing 00000000.tx.111: *, P < 0.05 vs. control (0 min). 

Phrase: "*,"

Phrase: "P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "vs. control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "(0 min)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.112: B, Insulin prevents thrombin-mediated increase in MBS phosphorylation. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "prevents"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0309872:PREVENT [Pharmacologic Substance]
  1000   C1292733:Prevents [Functional Concept]

Phrase: "thrombin-mediated increase in MBS phosphorylation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0442805:Increase [Functional Concept]
Processing 00000000.tx.113: [32P]-labeled VSMCs were treated with insulin (100 nM) for 10 min followed by the addition of thrombin (1 U/ml) for 5 min. 

Phrase: "[32P"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553631:32p [Medical Device]

Phrase: "]-labeled VSMCs"
Meta Candidates (Total=23; Excluded=11; Pruned=0; Remaining=12)
   884   C0026844:Muscle, Smooth, Vascular [Tissue]
   884   C1135918:Smooth Muscle Cells [Cell]
   840   C0596981:Muscle Cells [Cell]
   840   C1267092:Muscle, Smooth [Tissue]
   825   C0005773:Blood Cells [Cell]
   817 E C2328697:Hemal cell [Cell]
   804   C0005847:vascular [Body Part, Organ, or Organ Component]
   804   C0007634:Cells [Cell]
   804   C0026845:Muscle [Tissue]
   804   C0205357:Smooth [Qualitative Concept]
   804   C1558950:VASCULAR [Finding]
   804   C1801960:Vascular [Qualitative Concept]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]
   748 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   748 E C1511228:VESSEL, BLOOD [Tissue]
   733 E C0442025:Muscular [Spatial Concept]
   704 E C0005767:Blood [Tissue]
   704 E C0005768:blood [Body Substance]
   704 E C0229664:Blood [Body Substance]
   704 E C0392895:Bloods [Population Group]

Phrase: "were"

Phrase: "treated with insulin"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1522326:Treated [Functional Concept]
   790   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1579433:Insulin [Pharmacologic Substance]
   756 E C1292734:TREAT [Functional Concept]
   734 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   706 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(100 nM) for 10 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0312860:NM [Cell Function]

Phrase: "followed by the addition of thrombin"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0332283:Followed by [Temporal Concept]
           followed
   753   C0040018:Thrombin [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   753   C1883712:Addition [Functional Concept]
   719 E C1719822:Follow [Intellectual Product]

Phrase: "(1 U/ml) for 5 min."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C2736788:1 U/mL [Quantitative Concept]
   790   C0439340:U/ml [Quantitative Concept]
   790   C1880521:U/mL [Quantitative Concept]
   790   C2945590:U/mL [Quantitative Concept]
   783   C0439445:mL/min [Quantitative Concept]
   753   C0439526:/mL [Quantitative Concept]
Processing 00000000.tx.114: MBS immunoprecipitates were subjected to SDS-PAGE and autoradiography. 

Phrase: "MBS immunoprecipitates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "were"

Phrase: "subjected to SDS-PAGE"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   770   C1704732:Page [Intellectual Product]
   737   C0681850:Subject [Group]
   737   C1550501:{Subject} [Idea or Concept]
   737   C1706203:Subject [Idea or Concept]
   737   C2349001:Subject [Human]
   737   C2697811:Subject [Functional Concept]

Phrase: "and"

Phrase: "autoradiography."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0004400:Autoradiography [Laboratory Procedure]
   900 E C2986957:Autoradiograph [Manufactured Object]
Processing 00000000.tx.115: A representative autoradiogram is shown. 

Phrase: "A representative autoradiogram"

Phrase: "is"

Phrase: "shown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]
Processing 00000000.tx.116: Data from two separate experiments were quantitated by densitometric scanning and normalized for variations in proteins by dividing the intensity of 32P signal with that of protein signal. 

Phrase: "Data from two separate experiments"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1511726:Data [Idea or Concept]
   760   C3245479:data [Medical Device]

Phrase: "were"

Phrase: "quantitated by densitometric scanning"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0011321:densitometric scanning [Laboratory Procedure]
   770   C0034606:Scanning [Diagnostic Procedure]
   770   C0441633:Scanning [Diagnostic Procedure]

Phrase: "and"

Phrase: "normalized for variations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205419:variations [Qualitative Concept]
   790   C1882115:Normalized [Research Activity]

Phrase: "in proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "by dividing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332849:dividing [Functional Concept]

Phrase: "the intensity of 32P signal"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C0871362:signal intensity [Quantitative Concept]
   760   C0522510:Intensity [Qualitative Concept]

Phrase: "with that"

Phrase: "of protein signal."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1710082:Signal [Phenomenon or Process]
Processing 00000000.tx.117: The 32P-specific activity of controls was assigned a value of 100, and the insulin and thrombin effect was calculated relative to control. 

Phrase: "The 32P-specific activity of controls"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0205177:Activity [Functional Concept]
   753   C0205369:Specific [Qualitative Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1552740:specific [Intellectual Product]
   753   C1561536:*Activity [Idea or Concept]
   731   C1706449:Active Control [Research Activity]

Phrase: "was"

Phrase: "assigned"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516050:Assigned [Functional Concept]
  1000   C1552601:assigned [Intellectual Product]

Phrase: "a value of 100,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1522609:Value [Quantitative Concept]

Phrase: "and"

Phrase: "the insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "thrombin effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1280500:Effect [Qualitative Concept]
   861   C2348382:Effect [Qualitative Concept]

Phrase: "was"

Phrase: "calculated"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0444686:Calculated [Functional Concept]
  1000   C1441506:Calculated [Activity]
  1000   C1443182:Calculated [Laboratory Procedure]

Phrase: "relative to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0080103:Relative [Family Group]
   861   C0205345:Relative [Qualitative Concept]
   861   C1547039:*Relative [Quantitative Concept]

Phrase: "control."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.118: Results are the mean of two separate experiments. 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "the mean of two separate experiments."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0444504:Mean [Quantitative Concept]
   753   C2347634:Mean [Quantitative Concept]
   753   C2348143:Mean [Quantitative Concept]
Processing 00000000.tx.119: C, Insulin prevents thrombin-mediated inactivation of MBP in WKY. 

Phrase: "C,"

Phrase: "Insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "prevents"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0309872:PREVENT [Pharmacologic Substance]
  1000   C1292733:Prevents [Functional Concept]

Phrase: "thrombin-mediated inactivation of MBP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0544461:Inactivation [Cell or Molecular Dysfunction]

Phrase: "in WKY."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034709:Wistar Kyoto [Mammal]
Processing 00000000.tx.120: VSMCs were treated with and without insulin followed by thrombin as detailed in Fig. 

Phrase: "VSMCs"
Meta Candidates (Total=23; Excluded=11; Pruned=0; Remaining=12)
   923   C0026844:Muscle, Smooth, Vascular [Tissue]
   923   C1135918:Smooth Muscle Cells [Cell]
   861   C0596981:Muscle Cells [Cell]
   861   C1267092:Muscle, Smooth [Tissue]
   852   C0005773:Blood Cells [Cell]
   844 E C2328697:Hemal cell [Cell]
   812   C0005847:vascular [Body Part, Organ, or Organ Component]
   812   C0007634:Cells [Cell]
   812   C0026845:Muscle [Tissue]
   812   C0205357:Smooth [Qualitative Concept]
   812   C1558950:VASCULAR [Finding]
   812   C1801960:Vascular [Qualitative Concept]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
   756 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   756 E C1511228:VESSEL, BLOOD [Tissue]
   741 E C0442025:Muscular [Spatial Concept]
   712 E C0005767:Blood [Tissue]
   712 E C0005768:blood [Body Substance]
   712 E C0229664:Blood [Body Substance]
   712 E C0392895:Bloods [Population Group]

Phrase: "were"

Phrase: "treated with"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   833   C1522326:Treated [Functional Concept]
   799 E C1292734:TREAT [Functional Concept]

Phrase: "and without insulin"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1515981:And [Idea or Concept]
   790   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1579433:Insulin [Pharmacologic Substance]
   734 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   706 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "followed by thrombin"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   882   C0332283:Followed by [Temporal Concept]
           followed
   790   C0040018:Thrombin [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   756 E C1719822:Follow [Intellectual Product]

Phrase: "as"

Phrase: "detailed in Fig."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   790   C1522508:Detailed [Qualitative Concept]
   756 E C1561567:detail [Functional Concept]
Processing 00000000.tx.121: 3B. 

Phrase: "3B."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0450365:3b [Intellectual Product]
  1000   C1706097:3B [Research Activity]
Processing 00000000.tx.122: MBP activity was measured in myosin-enriched pellets using [32P]-labeled MLC as a substrate. 

Phrase: "MBP activity"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   911   C1149936:myosin phosphatase activity [Molecular Function]
   884   C1149927:protein phosphatase activity [Molecular Function]
   853   C1537044:protein activity [Molecular Function]
   840   C1149880:phosphatase activity [Molecular Function]
   804   C0205177:Activity [Functional Concept]
   804   C0439167:% activity [Quantitative Concept]
   804   C0441655:Activity [Activity]
   804   C1561536:*Activity [Idea or Concept]
   708   C0067062:myosin phosphatase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "was"

Phrase: "measured in myosin-enriched pellets"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   760   C0027096:Myosin [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0359583:enriched [Food]
   760   C0444706:Measured [Qualitative Concept]
   760   C0993610:pellets [Biomedical or Dental Material]
   760   C3541902:MEASURED [Diagnostic Procedure]
   726 E C0079809:Measure [Quantitative Concept]
   726 E C0242485:Measure [Functional Concept]
   726 E C0441436:Pellet [Manufactured Object]
   726 E C1998480:Pellet [Quantitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "[32P"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553631:32p [Medical Device]

Phrase: "]-labeled MLC as a substrate."
Processing 00000000.tx.123: Results are the mean  SEM of four independent experiments performed in duplicate. 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "the mean  SEM of four independent experiments"

Phrase: "performed in duplicate."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0205173:Duplicate [Functional Concept]
   790   C0884358:Performed [Functional Concept]
   790   C3539942:Duplicate [Intellectual Product]
   756 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.124: *, P < 0.05 vs. control; 

Phrase: "*,"

Phrase: "P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "vs. control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.125: **, P < 0.05 vs. thrombin.  

Phrase: "*"

Phrase: "*,"

Phrase: "P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "vs. thrombin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040018:Thrombin [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
Processing 00000000.tx.126: Since thrombin inactivates MBP by increasing the phosphorylation status of MBS (22), we next examined whether insulin prevents the thrombin-induced increase in MBS phosphorylation. 

Phrase: "Since"

Phrase: "thrombin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040018:Thrombin [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "inactivates"

Phrase: "MBP by increasing"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0031686:Protein phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   783   C0067062:myosin phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   783   C0522527:Protein bound [Qualitative Concept]
   753   C0031678:Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1149880:phosphatase [Molecular Function]

Phrase: "the phosphorylation status of MBS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0449438:Status [Qualitative Concept]

Phrase: "(22"

Phrase: ")"

Phrase: ","

Phrase: "we next"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205117:next [Spatial Concept]
  1000   C0332282:Next [Temporal Concept]
  1000   C1883708:Next [Temporal Concept]

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "whether"

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "prevents"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0309872:PREVENT [Pharmacologic Substance]
  1000   C1292733:Prevents [Functional Concept]

Phrase: "the thrombin-induced increase in MBS phosphorylation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0442805:Increase [Functional Concept]
Processing 00000000.tx.127: As shown in Fig. 

Phrase: "As"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.128: 3B, thrombin caused a 70% increase in MBS phosphorylation over basal levels (Fig. 3B, compare lane 3 vs. lane 1). 

Phrase: "3B,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0450365:3b [Intellectual Product]
  1000   C1706097:3B [Research Activity]

Phrase: "thrombin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040018:Thrombin [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "caused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015127:cause [Functional Concept]
   966   C1524003:Cause [Conceptual Entity]

Phrase: "a 70% increase in MBS phosphorylation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0442805:Increase [Functional Concept]

Phrase: "over basal levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "(Fig. 3B,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450365:3b [Intellectual Product]
   861   C1706097:3B [Research Activity]

Phrase: "compare"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compare [Activity]

Phrase: "lane 3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: "vs. lane 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.129: Pretreatment with insulin for 10 min prevented the thrombin-induced increase in MBS phosphorylation (Fig. 3B, compare lane 4 vs. lane 3). 

Phrase: "Pretreatment with insulin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1550147:Pretreatment [Substance]
   790   C2709094:pre treatment [Temporal Concept]
   790   C3539075:Pretreatment [Temporal Concept]
   790   C3539076:Pretreatment [Activity]

Phrase: "for 10 min"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456692:/10 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]

Phrase: "prevented"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "the thrombin-induced increase in MBS phosphorylation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0442805:Increase [Functional Concept]

Phrase: "(Fig. 3B,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450365:3b [Intellectual Product]
   861   C1706097:3B [Research Activity]

Phrase: "compare"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compare [Activity]

Phrase: "lane 4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: "vs. lane 3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.130: However, insulin did not reverse the effect of thrombin on MBS phosphorylation when added to cells prestimulated with thrombin (Fig. 3B, compare lane 5 vs. lane 3). 

Phrase: "However,"

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "reverse"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555029:Reverse [Idea or Concept]

Phrase: "the effect of thrombin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "on MBS phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0031715:Phosphorylation [Molecular Function]
   812   C1158886:Phosphorylation [Molecular Function]

Phrase: "when"

Phrase: "added to cells"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   790   C0007634:Cells [Cell]
   790   C1524062:Added [Functional Concept]
   790   C3282337:Cells [Cell]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1883712:Add [Functional Concept]
   756 E C1948049:Cell [Spatial Concept]

Phrase: "prestimulated with thrombin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0040018:Thrombin [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "(Fig. 3B,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450365:3b [Intellectual Product]
   861   C1706097:3B [Research Activity]

Phrase: "compare"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compare [Activity]

Phrase: "lane 5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: "vs. lane 3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.131: Thrombin-induced MBS phosphorylation was accompanied by marked reductions in MBP activity (Fig. 3C). 

Phrase: "Thrombin-induced MBS phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0031715:Phosphorylation [Molecular Function]
   799   C1158886:Phosphorylation [Molecular Function]

Phrase: "was"

Phrase: "accompanied by marked reductions"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0301630:reductions [Natural Phenomenon or Process]
   770   C0441610:reductions [Therapeutic or Preventive Procedure]
   770   C0522501:Marked [Qualitative Concept]
   770   C1706089:Marked [Qualitative Concept]
   737 E C0392756:Reduction [Qualitative Concept]

Phrase: "in MBP activity"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   911   C1149936:myosin phosphatase activity [Molecular Function]
   884   C1149927:protein phosphatase activity [Molecular Function]
   853   C1537044:protein activity [Molecular Function]
   840   C1149880:phosphatase activity [Molecular Function]
   804   C0205177:Activity [Functional Concept]
   804   C0439167:% activity [Quantitative Concept]
   804   C0441655:Activity [Activity]
   804   C1561536:*Activity [Idea or Concept]
   708   C0067062:myosin phosphatase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(Fig. 3C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450366:3c [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.132: Insulin pretreatment prevented thrombin-induced MBP inactivation and restored the activity to levels observed with insulin alone (Fig. 3C). 

Phrase: "Insulin pretreatment"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1550147:Pretreatment [Substance]
   861   C2709094:pre treatment [Temporal Concept]
   861   C3539075:Pretreatment [Temporal Concept]
   861   C3539076:Pretreatment [Activity]

Phrase: "prevented"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "thrombin-induced MBP inactivation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0544461:Inactivation [Cell or Molecular Dysfunction]

Phrase: "and"

Phrase: "restored"

Phrase: "the activity to levels"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   819   C0683317:activity levels [Finding]
   770   C0205177:Activity [Functional Concept]
   770   C0439167:% activity [Quantitative Concept]
   770   C0441655:Activity [Activity]
   770   C1561536:*Activity [Idea or Concept]

Phrase: "observed with insulin"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1441672:Observed [Functional Concept]
   790   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1579433:Insulin [Pharmacologic Substance]
   734 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   706 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "(Fig. 3C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450366:3c [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.133: High Concentrations of Okadaic Acid Inhibit Insulin-Mediated MBS Phosphorylation The above results raise the interesting possibility that insulin may be dephosphorylating MBS via another phosphatase. 

Phrase: "High Concentrations of Okadaic Acid"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0086045:Concentrations [Mental Process]
   726 E C1446561:Concentration [Quantitative Concept]

Phrase: "Inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "Insulin-Mediated MBS Phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0031715:Phosphorylation [Molecular Function]
   799   C1158886:Phosphorylation [Molecular Function]

Phrase: "The above results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "raise"

Phrase: "the interesting possibility"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   789   C0332149:Possible [Qualitative Concept]
   789   C1705910:Possible [Qualitative Concept]
   789   C2362652:Possible [Qualitative Concept]

Phrase: "that insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "may"

Phrase: "be"

Phrase: "dephosphorylating MBS via another phosphatase."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1711351:Subunit [Quantitative Concept]
Processing 00000000.tx.134: To test this possibility, [32P]-labeled VSMCs were pretreated for 30 min with low (10 nM) and high concentrations (1 M) of okadaic acid (OA) to inhibit the cellular pool of PP-2A and PP-1 activities. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]

Phrase: "this possibility,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   928   C0332149:Possible [Qualitative Concept]
   928   C1705910:Possible [Qualitative Concept]
   928   C2362652:Possible [Qualitative Concept]

Phrase: "[32P"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553631:32p [Medical Device]

Phrase: "]-labeled VSMCs"
Meta Candidates (Total=23; Excluded=11; Pruned=0; Remaining=12)
   884   C0026844:Muscle, Smooth, Vascular [Tissue]
   884   C1135918:Smooth Muscle Cells [Cell]
   840   C0596981:Muscle Cells [Cell]
   840   C1267092:Muscle, Smooth [Tissue]
   825   C0005773:Blood Cells [Cell]
   817 E C2328697:Hemal cell [Cell]
   804   C0005847:vascular [Body Part, Organ, or Organ Component]
   804   C0007634:Cells [Cell]
   804   C0026845:Muscle [Tissue]
   804   C0205357:Smooth [Qualitative Concept]
   804   C1558950:VASCULAR [Finding]
   804   C1801960:Vascular [Qualitative Concept]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]
   748 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   748 E C1511228:VESSEL, BLOOD [Tissue]
   733 E C0442025:Muscular [Spatial Concept]
   704 E C0005767:Blood [Tissue]
   704 E C0005768:blood [Body Substance]
   704 E C0229664:Blood [Body Substance]
   704 E C0392895:Bloods [Population Group]

Phrase: "were"

Phrase: "pretreated for 30 min"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0456693:/30 min [Temporal Concept]
   833   C1442458:30 min [Temporal Concept]
   770   C0702093:/min [Temporal Concept]

Phrase: "with low"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205251:low [Qualitative Concept]
  1000   C1299352:Low [Qualitative Concept]
  1000   C1550472:low [Idea or Concept]

Phrase: "(10 nM)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]

Phrase: "and"

Phrase: "high concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "M) of okadaic acid (OA) to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0069389:Ocadaic Acid [Hazardous or Poisonous Substance,Organic Chemical]
   760   C0001128:Acid [Chemical]
   760   C0202406:Acid [Laboratory Procedure]
   760   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441923:M+ [Intellectual Product]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "the cellular pool of PP-2A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0337051:Pool [Geographic Area]
   753   C1509144:pool [Clinical Attribute]
   753   C2349200:Pool [Functional Concept]

Phrase: "and"

Phrase: "PP-1 activities."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0441655:Activities [Activity]
   793 E C0205177:Activity [Functional Concept]
   793 E C0439167:% activity [Quantitative Concept]
   793 E C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.135: These cells were treated with and without insulin and examined for MBS phosphorylation status. 

Phrase: "These cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "treated with"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   833   C1522326:Treated [Functional Concept]
   799 E C1292734:TREAT [Functional Concept]

Phrase: "and without insulin"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1515981:And [Idea or Concept]
   790   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1579433:Insulin [Pharmacologic Substance]
   734 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   706 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "examined for MBS phosphorylation status."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   748   C0027096:Myosin [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0031715:Phosphorylation [Molecular Function]
   748   C0332128:Examined [Finding]
   748   C0332297:bound [Spatial Concept]
   748   C0449438:Status [Qualitative Concept]
   748   C1145667:Bound [Activity]
   748   C1158886:Phosphorylation [Molecular Function]
   748   C1167622:Bound [Molecular Function]
   748   C1689898:% bound [Quantitative Concept]
   748   C1711351:Subunit [Quantitative Concept]
   748   C2349209:Bound [Conceptual Entity]
Processing 00000000.tx.136: Insulin caused a 57% decrease in MBS phosphorylation. 

Phrase: "Insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "caused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015127:cause [Functional Concept]
   966   C1524003:Cause [Conceptual Entity]

Phrase: "a 57% decrease in MBS phosphorylation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0392756:Decrease [Qualitative Concept]
   744   C0547047:Decrease [Quantitative Concept]
Processing 00000000.tx.137: Low concentrations of OA that specifically inhibit PP-2A activity did not prevent insulin-mediated decrease in MBS phosphorylation. 

Phrase: "Low concentrations of OA"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0086045:Concentrations [Mental Process]
   726 E C1446561:Concentration [Quantitative Concept]

Phrase: "that specifically"

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "PP-2A activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "prevent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "insulin-mediated decrease in MBS phosphorylation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0392756:Decrease [Qualitative Concept]
   744   C0547047:Decrease [Quantitative Concept]
Processing 00000000.tx.138: In contrast, OA at a higher concentration of 1 M completely blocked insulins inhibitory effect on MBS phosphorylation and increased MBS phosphorylation by 44% over the basal levels. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "OA at a higher concentration of 1 M completely blocked insulins inhibitory effect"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0069389:Ocadaic Acid [Hazardous or Poisonous Substance,Organic Chemical]
   734   C0001128:Acid [Chemical]
   734   C0202406:Acid [Laboratory Procedure]

Phrase: "on MBS phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0031715:Phosphorylation [Molecular Function]
   812   C1158886:Phosphorylation [Molecular Function]

Phrase: "and"

Phrase: "increased MBS phosphorylation by 44%"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0031715:Phosphorylation [Molecular Function]
   748   C1158886:Phosphorylation [Molecular Function]

Phrase: "over the basal levels."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.139: OA alone did not appreciably alter basal levels of MBS. 

Phrase: "OA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0069389:Ocadaic Acid [Hazardous or Poisonous Substance,Organic Chemical]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "did"

Phrase: "not appreciably"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "alter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "basal levels of MBS."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.140: Insulin Inhibits Rho Kinase Activity Numerous reports (15, 23) suggest that MBS is phosphorylated by Rho kinase, which is activated upon stimulation with agonists such as thrombin or angiotensin II (AII). 

Phrase: "Insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "Inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "Rho Kinase Activity Numerous reports"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   804   C0684224:Reports [Intellectual Product]
   804   C0700287:reports [Health Care Activity]
   771 E C3273238:Report [Intellectual Product]

Phrase: "(15,"

Phrase: "23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")"

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that MBS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1711351:Subunit [Quantitative Concept]

Phrase: "is"

Phrase: "phosphorylated by Rho kinase,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0389995:rho-Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   833   C1335631:RHO KINASE [Gene or Genome]
   770   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "which"

Phrase: "is"

Phrase: "activated upon stimulation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   790   C1879547:Activated [Activity]
   790   C1948023:Stimulation [Natural Phenomenon or Process]
   756 E C1515877:Activate [Functional Concept]

Phrase: "with agonists"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243192:agonists [Pharmacologic Substance]
  1000   C2987634:agonists [Pharmacologic Substance]

Phrase: "such as thrombin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040018:Thrombin [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "or"

Phrase: "angiotensin II (AII)."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003009:Angiotensin 2 [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
Processing 00000000.tx.141: We tested the possibility that insulin may be inhibiting Rho kinase activity and thereby decreasing MBS phosphorylation. 

Phrase: "We"

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "the possibility"

Phrase: "that insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "may"

Phrase: "be"

Phrase: "inhibiting"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C3463820:Inhibiting [Activity]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C0311403:Inhibited [Qualitative Concept]

Phrase: "Rho kinase activity"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C1150423:kinase activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
   734   C0389995:rho-Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   734   C1335631:RHO KINASE [Gene or Genome]

Phrase: "and"

Phrase: "thereby"

Phrase: "decreasing"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0442797:Decreasing [Qualitative Concept]
   966 E C0392756:Decrease [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "MBS phosphorylation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0031715:Phosphorylation [Molecular Function]
   812   C1158886:Phosphorylation [Molecular Function]
Processing 00000000.tx.142: To test this hypothesis, Rho kinase activity was assayed in anti-Rok- immunoprecipitates using MBP as a substrate. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]

Phrase: "this hypothesis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]

Phrase: "Rho kinase activity"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C1150423:kinase activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
   734   C0389995:rho-Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   734   C1335631:RHO KINASE [Gene or Genome]

Phrase: "was"

Phrase: "assayed in anti-Rok- immunoprecipitates"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   726   C0005507:Assay [Laboratory Procedure]
   726   C0243073:assay [Qualitative Concept]
   726   C0301871:Immunoprecipitate [Immunologic Factor]
   726   C1510438:Assay [Laboratory Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "MBP as a substrate."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C0031686:Protein phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   774   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   774   C0067062:myosin phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   774   C0522527:Protein bound [Qualitative Concept]
   748   C0031678:Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C1149880:phosphatase [Molecular Function]
Processing 00000000.tx.143: As shown in Fig. 

Phrase: "As"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.144: 4A, insulin treatment for 10 min caused a 40% decrease in Rho kinase activity when compared with control lysates. 

Phrase: "4A,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0450373:4a [Intellectual Product]
  1000   C1553636:4a [Medical Device]

Phrase: "insulin treatment for 10 min"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0745343:insulin treatment [Therapeutic or Preventive Procedure]
   760   C0039798:treatment [Functional Concept]
   760   C0087111:Treatment [Therapeutic or Preventive Procedure]
   760   C1522326:Treatment [Functional Concept]
   760   C1533734:Treatment [Therapeutic or Preventive Procedure]
   760   C1705169:Treatment [Conceptual Entity]
   760   C3538994:TREATMENT [Research Activity]

Phrase: "caused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015127:cause [Functional Concept]
   966   C1524003:Cause [Conceptual Entity]

Phrase: "a 40% decrease in Rho kinase activity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0392756:Decrease [Qualitative Concept]
   748   C0547047:Decrease [Quantitative Concept]

Phrase: "when"

Phrase: "compared with control lysates."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0243148:control [Qualitative Concept]
   770   C1550141:Control [Substance]
   770   C1707455:Compared [Activity]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]
   737   C1881488:Lysate [Physical Object]
Processing 00000000.tx.145: More importantly, pretreatment with insulin effectively prevented the thrombin-mediated increase in Rho kinase activity (Fig. 4A). 

Phrase: "More importantly,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205172:More [Functional Concept]

Phrase: "pretreatment with insulin effectively"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C1550147:Pretreatment [Substance]
   770   C2709094:pre treatment [Temporal Concept]
   770   C3539075:Pretreatment [Temporal Concept]
   770   C3539076:Pretreatment [Activity]

Phrase: "prevented"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "the thrombin-mediated increase in Rho kinase activity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0442805:Increase [Functional Concept]

Phrase: "(Fig. 4A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450373:4a [Intellectual Product]
   861   C1553636:4a [Medical Device]

Phrase: ")."
Processing 00000000.tx.146: View larger version (19K): [in this window] [in a new window]  Figure 4. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(19K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 4."
Processing 00000000.tx.147: Effect of Insulin on Rho Kinase Activation A, Insulin inhibits Rho kinase activity and prevents thrombin-mediated increase in Rho kinase. 

Phrase: "Effect of Insulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1280500:Effect [Qualitative Concept]
   790   C2348382:Effect [Qualitative Concept]

Phrase: "on Rho Kinase Activation A,"

Phrase: "Insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "Rho kinase activity"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C1150423:kinase activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
   734   C0389995:rho-Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   734   C1335631:RHO KINASE [Gene or Genome]

Phrase: "and"

Phrase: "prevents"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0309872:PREVENT [Pharmacologic Substance]
  1000   C1292733:Prevents [Functional Concept]

Phrase: "thrombin-mediated increase in Rho kinase."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0442805:Increase [Functional Concept]
Processing 00000000.tx.148: VSMCs were treated with insulin (100 nM) for 10 min followed by 1 U/ml of thrombin for 5 min. 

Phrase: "VSMCs"
Meta Candidates (Total=23; Excluded=11; Pruned=0; Remaining=12)
   923   C0026844:Muscle, Smooth, Vascular [Tissue]
   923   C1135918:Smooth Muscle Cells [Cell]
   861   C0596981:Muscle Cells [Cell]
   861   C1267092:Muscle, Smooth [Tissue]
   852   C0005773:Blood Cells [Cell]
   844 E C2328697:Hemal cell [Cell]
   812   C0005847:vascular [Body Part, Organ, or Organ Component]
   812   C0007634:Cells [Cell]
   812   C0026845:Muscle [Tissue]
   812   C0205357:Smooth [Qualitative Concept]
   812   C1558950:VASCULAR [Finding]
   812   C1801960:Vascular [Qualitative Concept]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
   756 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   756 E C1511228:VESSEL, BLOOD [Tissue]
   741 E C0442025:Muscular [Spatial Concept]
   712 E C0005767:Blood [Tissue]
   712 E C0005768:blood [Body Substance]
   712 E C0229664:Blood [Body Substance]
   712 E C0392895:Bloods [Population Group]

Phrase: "were"

Phrase: "treated with insulin"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1522326:Treated [Functional Concept]
   790   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1579433:Insulin [Pharmacologic Substance]
   756 E C1292734:TREAT [Functional Concept]
   734 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   706 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(100 nM) for 10 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0312860:NM [Cell Function]

Phrase: "followed by 1 U/ml of thrombin"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   778   C0332283:Followed by [Temporal Concept]
           followed
   778   C0439340:U/ml [Quantitative Concept]
   778   C1880521:U/mL [Quantitative Concept]
   778   C2945590:U/mL [Quantitative Concept]
   748   C0040018:Thrombin [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   748   C0439526:/mL [Quantitative Concept]
   714 E C1719822:Follow [Intellectual Product]

Phrase: "for 5 min."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.149: Equal amounts of cell lysate proteins (100 g) were immunoprecipitated with anti-Rok- antibody. 

Phrase: "Equal amounts of cell lysate proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1265611:amounts [Quantitative Concept]

Phrase: "(100 g)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "were"

Phrase: "immunoprecipitated with anti-Rok- antibody."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   726   C0301871:Immunoprecipitate [Immunologic Factor]
Processing 00000000.tx.150: Rho kinase activity in the immunoprecipitates was assayed using MBP as a substrate along with -[32P]ATP. 

Phrase: "Rho kinase activity in the immunoprecipitates"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C1150423:kinase activity [Molecular Function]
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "assayed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0005507:Assay [Laboratory Procedure]
   966   C0243073:assay [Qualitative Concept]
   966   C1510438:Assay [Laboratory Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "MBP as a substrate"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C0031686:Protein phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   774   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   774   C0067062:myosin phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   774   C0522527:Protein bound [Qualitative Concept]
   748   C0031678:Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C1149880:phosphatase [Molecular Function]

Phrase: "along with -"

Phrase: "[32P"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553631:32p [Medical Device]

Phrase: "]ATP."
Processing 00000000.tx.151: Results are the mean  SEM of four separate experiments performed. 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "the mean  SEM of four separate experiments"

Phrase: "performed."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.152: *, P < 0.05 vs. control; 

Phrase: "*,"

Phrase: "P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "vs. control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.153: **, P < 0.05 vs. 

Phrase: "*"

Phrase: "*,"

Phrase: "P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "vs."
Processing 00000000.tx.154: control/insulin; 

Phrase: "control/insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.155: ***, P < 0.05 vs. thrombin. 

Phrase: "*"

Phrase: "*"

Phrase: "*,"

Phrase: "P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "vs. thrombin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040018:Thrombin [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
Processing 00000000.tx.156: B, Time course of insulin-mediated inactivation of Rho kinase: VSMCs were treated with 100 nM insulin for 020 min. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Time course of insulin-mediated inactivation of Rho kinase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   764   C0449247:Time course [Temporal Concept]
   742   C0040223:Time [Temporal Concept]
   742   C0750729:Course [Temporal Concept]
   742   C3541383:Time [Temporal Concept]

Phrase: ":"

Phrase: "VSMCs"
Meta Candidates (Total=23; Excluded=11; Pruned=0; Remaining=12)
   923   C0026844:Muscle, Smooth, Vascular [Tissue]
   923   C1135918:Smooth Muscle Cells [Cell]
   861   C0596981:Muscle Cells [Cell]
   861   C1267092:Muscle, Smooth [Tissue]
   852   C0005773:Blood Cells [Cell]
   844 E C2328697:Hemal cell [Cell]
   812   C0005847:vascular [Body Part, Organ, or Organ Component]
   812   C0007634:Cells [Cell]
   812   C0026845:Muscle [Tissue]
   812   C0205357:Smooth [Qualitative Concept]
   812   C1558950:VASCULAR [Finding]
   812   C1801960:Vascular [Qualitative Concept]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
   756 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   756 E C1511228:VESSEL, BLOOD [Tissue]
   741 E C0442025:Muscular [Spatial Concept]
   712 E C0005767:Blood [Tissue]
   712 E C0005768:blood [Body Substance]
   712 E C0229664:Blood [Body Substance]
   712 E C0392895:Bloods [Population Group]

Phrase: "were"

Phrase: "treated with 100 nM insulin"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   806   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0312860:NM [Cell Function]
   760   C1522326:Treated [Functional Concept]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   726 E C1292734:TREAT [Functional Concept]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "for 020 min."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.157: Equal amounts of proteins were immunoprecipitated as detailed in Fig. 

Phrase: "Equal amounts of proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1265611:amounts [Quantitative Concept]

Phrase: "were"

Phrase: "immunoprecipitated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "as"

Phrase: "detailed in Fig."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   790   C1522508:Detailed [Qualitative Concept]
   756 E C1561567:detail [Functional Concept]
Processing 00000000.tx.158: 4A followed by assay of Rho kinase activity. 

Phrase: "4A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0450373:4a [Intellectual Product]
  1000   C1553636:4a [Medical Device]

Phrase: "followed by assay of Rho kinase activity."
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
   778   C0332283:Followed by [Temporal Concept]
           followed
   778   C0389995:rho-Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   778   C1150423:kinase activity [Molecular Function]
   778   C1335631:RHO KINASE [Gene or Genome]
   748   C0005507:Assay [Laboratory Procedure]
   748   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0205177:Activity [Functional Concept]
   748   C0243073:assay [Qualitative Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C1510438:Assay [Laboratory Procedure]
   748   C1561536:*Activity [Idea or Concept]
   714 E C1719822:Follow [Intellectual Product]
Processing 00000000.tx.159: Results are expressed as percent of control activity in the absence of insulin. 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "expressed as percent of control activity"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   783   C0439167:Percent Activity [Quantitative Concept]
           % activity
   753   C0205177:Activity [Functional Concept]
   753   C0243148:control [Qualitative Concept]
   753   C0439165:Percent [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1550141:Control [Substance]
   753   C1561536:*Activity [Idea or Concept]
   753   C1882979:Control [Conceptual Entity]
   753   C2587213:Control [Functional Concept]
   753   C3274648:Control [Qualitative Concept]
   748   C1706449:Active Control [Research Activity]

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "of insulin."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.160: C, Insulin inhibits thrombin-mediated translocation of Rho to membrane fraction. 

Phrase: "C,"

Phrase: "Insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "thrombin-mediated translocation of Rho"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0040715:Translocation [Cell or Molecular Dysfunction]
   760   C2987521:Translocation [Activity]

Phrase: "to membrane fraction."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1264633:Fraction [Quantitative Concept]
   861   C1554103:Fraction [Idea or Concept]
Processing 00000000.tx.161: VSMCs were exposed to insulin and thrombin as detailed in Fig. 

Phrase: "VSMCs"
Meta Candidates (Total=23; Excluded=11; Pruned=0; Remaining=12)
   923   C0026844:Muscle, Smooth, Vascular [Tissue]
   923   C1135918:Smooth Muscle Cells [Cell]
   861   C0596981:Muscle Cells [Cell]
   861   C1267092:Muscle, Smooth [Tissue]
   852   C0005773:Blood Cells [Cell]
   844 E C2328697:Hemal cell [Cell]
   812   C0005847:vascular [Body Part, Organ, or Organ Component]
   812   C0007634:Cells [Cell]
   812   C0026845:Muscle [Tissue]
   812   C0205357:Smooth [Qualitative Concept]
   812   C1558950:VASCULAR [Finding]
   812   C1801960:Vascular [Qualitative Concept]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
   756 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   756 E C1511228:VESSEL, BLOOD [Tissue]
   741 E C0442025:Muscular [Spatial Concept]
   712 E C0005767:Blood [Tissue]
   712 E C0005768:blood [Body Substance]
   712 E C0229664:Blood [Body Substance]
   712 E C0392895:Bloods [Population Group]

Phrase: "were"

Phrase: "exposed to insulin"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   882   C0332157:Exposed to [Clinical Attribute]
           Exposed
   790   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1579433:Insulin [Pharmacologic Substance]
   734 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   706 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "thrombin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040018:Thrombin [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "as"

Phrase: "detailed in Fig."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   790   C1522508:Detailed [Qualitative Concept]
   756 E C1561567:detail [Functional Concept]
Processing 00000000.tx.162: 4A. 

Phrase: "4A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0450373:4a [Intellectual Product]
  1000   C1553636:4a [Medical Device]
Processing 00000000.tx.163: Equal amounts of membrane proteins were subjected to SDS-PAGE followed by Western blot analysis with anti-Rho a antibody, a representative autoradiogram. 

Phrase: "Equal amounts of membrane proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1265611:amounts [Quantitative Concept]

Phrase: "were"

Phrase: "subjected to SDS-PAGE"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   770   C1704732:Page [Intellectual Product]
   737   C0681850:Subject [Group]
   737   C1550501:{Subject} [Idea or Concept]
   737   C1706203:Subject [Idea or Concept]
   737   C2349001:Subject [Human]
   737   C2697811:Subject [Functional Concept]

Phrase: "followed by Western blot analysis"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   862   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   806   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   806   C0332283:Followed by [Temporal Concept]
           followed
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]
   760   C1705493:Western [Spatial Concept]
   726 E C1719822:Follow [Intellectual Product]

Phrase: "with anti-Rho"

Phrase: "a antibody,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
  1000   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "a representative autoradiogram."
Processing 00000000.tx.164: Similar results were obtained in four different experiments.  

Phrase: "Similar results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "were"

Phrase: "obtained in four different experiments."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   760   C0205450:Four [Quantitative Concept]
   760   C0681814:Experiments [Research Activity]
   760   C1301820:Obtained [Functional Concept]
   760   C1705242:Different [Qualitative Concept]
   726 E C1706386:Experiment [Conceptual Entity]
   726 E C1706701:Obtain [Activity]
Processing 00000000.tx.165: The kinetics of Rho kinase inhibition by insulin revealed a rapid 40% decrease in Rho kinase activity after 2 min, which was sustained for the 20-min time period examined (Fig. 4B). 

Phrase: "The kinetics of Rho kinase inhibition"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0022702:Kinetics [Natural Phenomenon or Process]
   753   C0220865:kinetics [Functional Concept]
   753   C2825046:Kinetics [Occupation or Discipline]

Phrase: "by insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "a rapid 40% decrease in Rho kinase activity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0392756:Decrease [Qualitative Concept]
   744   C0547047:Decrease [Quantitative Concept]

Phrase: "after 2 min,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "which"

Phrase: "was"

Phrase: "sustained for the 20-min time period"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   778   C0439582:Time period [Temporal Concept]
   748   C0040223:Time [Temporal Concept]
   748   C0439531:/period [Temporal Concept]
   748   C0443318:Sustained [Functional Concept]
   748   C0702093:/min [Temporal Concept]
   748   C1948053:Period [Temporal Concept]
   748   C3541383:Time [Temporal Concept]
   714 E C2732140:Sustain [Organic Chemical,Pharmacologic Substance]

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "(Fig. 4B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450375:4b [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.166: The kinetics of Rho kinase inhibition upon insulin treatment correlate very well with the decrease observed in MBS phosphorylation in insulin-treated VSMCs. 

Phrase: "The kinetics of Rho kinase inhibition"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0022702:Kinetics [Natural Phenomenon or Process]
   753   C0220865:kinetics [Functional Concept]
   753   C2825046:Kinetics [Occupation or Discipline]

Phrase: "upon insulin treatment"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0745343:insulin treatment [Therapeutic or Preventive Procedure]
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]

Phrase: "correlate"

Phrase: "very well with the decrease"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0205170:Well [Qualitative Concept]
   760   C0392756:Decrease [Qualitative Concept]
   760   C0442824:Very [Qualitative Concept]
   760   C0547047:Decrease [Quantitative Concept]
   760   C3146287:Well [Manufactured Object]

Phrase: "observed in MBS phosphorylation"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   753   C0027096:Myosin [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0031715:Phosphorylation [Molecular Function]
   753   C0332297:bound [Spatial Concept]
   753   C1145667:Bound [Activity]
   753   C1158886:Phosphorylation [Molecular Function]
   753   C1167622:Bound [Molecular Function]
   753   C1441672:Observed [Functional Concept]
   753   C1689898:% bound [Quantitative Concept]
   753   C1711351:Subunit [Quantitative Concept]
   753   C2349209:Bound [Conceptual Entity]

Phrase: "in insulin-treated VSMCs."
Meta Candidates (Total=21; Excluded=7; Pruned=0; Remaining=14)
   878   C0030281:Insulin Cell [Cell]
   861   C0026844:Muscle, Smooth, Vascular [Tissue]
   861   C1135918:Smooth Muscle Cells [Cell]
   827   C0596981:Muscle Cells [Cell]
   827   C1267092:Muscle, Smooth [Tissue]
   808   C0005773:Blood Cells [Cell]
   799   C0005847:vascular [Body Part, Organ, or Organ Component]
   799   C0007634:Cells [Cell]
   799   C0026845:Muscle [Tissue]
   799   C0205357:Smooth [Qualitative Concept]
   799   C1558950:VASCULAR [Finding]
   799   C1801960:Vascular [Qualitative Concept]
   799 E C2328697:Hemal cell [Cell]
   799   C3282337:Cells [Cell]
   789   C0853230:insulin blood [Laboratory Procedure]
   766 E C1269647:Cell [Cell]
   766 E C1704653:Cell [Medical Device]
   766 E C1948049:Cell [Spatial Concept]
   743 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   743 E C1511228:VESSEL, BLOOD [Tissue]
   727 E C0442025:Muscular [Spatial Concept]
Processing 00000000.tx.167: The effect of insulin on Rho kinase inactivation was accompanied by an inhibition of thrombin-mediated translocation of Rho from cytosol to the membrane fraction (Fig. 4C). 

Phrase: "The effect of insulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "on Rho kinase inactivation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0544461:Inactivation [Cell or Molecular Dysfunction]
   734   C0389995:rho-Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   734   C1335631:RHO KINASE [Gene or Genome]

Phrase: "was"

Phrase: "accompanied by an inhibition of thrombin-mediated translocation of Rho"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   739   C0021467:Inhibition [Mental Process]
   739   C0021469:Inhibition [Molecular Function]
   739   C0040018:Thrombin [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   739   C0040715:Translocation [Cell or Molecular Dysfunction]
   739   C0086597:mediated [Social Behavior]
   739   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   739   C1628982:% inhibition [Quantitative Concept]
   739   C2987521:Translocation [Activity]
   739   C3463820:Inhibition [Activity]

Phrase: "from cytosol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1383501:Cytosol [Cell Component]

Phrase: "to the membrane fraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1264633:Fraction [Quantitative Concept]
   861   C1554103:Fraction [Idea or Concept]

Phrase: "(Fig. 4C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450376:4c [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.168: As evident from Fig. 

Phrase: "As evident"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C0332120:Evidence [Functional Concept]

Phrase: "from Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.169: 4C, a considerable amount of Rho was present in the membrane fraction in untreated VSMCs (Fig. 4C, lane 1). 

Phrase: "4C,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]

Phrase: "a considerable amount of Rho"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1265611:Amount [Quantitative Concept]

Phrase: "was"

Phrase: "present in the membrane fraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0150312:Present [Quantitative Concept]
   760   C0449450:Present [Idea or Concept]

Phrase: "in untreated VSMCs"
Meta Candidates (Total=23; Excluded=11; Pruned=0; Remaining=12)
   884   C0026844:Muscle, Smooth, Vascular [Tissue]
   884   C1135918:Smooth Muscle Cells [Cell]
   840   C0596981:Muscle Cells [Cell]
   840   C1267092:Muscle, Smooth [Tissue]
   825   C0005773:Blood Cells [Cell]
   817 E C2328697:Hemal cell [Cell]
   804   C0005847:vascular [Body Part, Organ, or Organ Component]
   804   C0007634:Cells [Cell]
   804   C0026845:Muscle [Tissue]
   804   C0205357:Smooth [Qualitative Concept]
   804   C1558950:VASCULAR [Finding]
   804   C1801960:Vascular [Qualitative Concept]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]
   748 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   748 E C1511228:VESSEL, BLOOD [Tissue]
   733 E C0442025:Muscular [Spatial Concept]
   704 E C0005767:Blood [Tissue]
   704 E C0005768:blood [Body Substance]
   704 E C0229664:Blood [Body Substance]
   704 E C0392895:Bloods [Population Group]

Phrase: "(Fig. 4C,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450376:4c [Intellectual Product]

Phrase: "lane 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.170: Treatment with 100 nM insulin for 10 min decreased thrombin-mediated translocation of Rho to the membrane fraction (Fig. 4C, compare lane 4 vs. lane 3). 

Phrase: "Treatment with 100 nM insulin"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   797   C0745343:insulin treatment [Therapeutic or Preventive Procedure]
   760   C0039798:treatment [Functional Concept]
   760   C0087111:Treatment [Therapeutic or Preventive Procedure]
   760   C1522326:Treatment [Functional Concept]
   760   C1533734:Treatment [Therapeutic or Preventive Procedure]
   760   C1705169:Treatment [Conceptual Entity]
   760   C3538994:TREATMENT [Research Activity]

Phrase: "for 10 min"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456692:/10 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "thrombin-mediated translocation of Rho"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0040715:Translocation [Cell or Molecular Dysfunction]
   760   C2987521:Translocation [Activity]

Phrase: "to the membrane fraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1264633:Fraction [Quantitative Concept]
   861   C1554103:Fraction [Idea or Concept]

Phrase: "(Fig. 4C,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450376:4c [Intellectual Product]

Phrase: "compare"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compare [Activity]

Phrase: "lane 4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: "vs. lane 3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.171: Insulin alone caused a very small change in the amount of Rho in the membrane fraction (Fig. 4C, lane 2). 

Phrase: "Insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "caused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015127:cause [Functional Concept]
   966   C1524003:Cause [Conceptual Entity]

Phrase: "a very small change in the amount of Rho"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C0392747:Change [Functional Concept]
   742   C0443172:change [Quantitative Concept]
   742   C0700321:Small [Quantitative Concept]
   742   C1705241:Change [Quantitative Concept]

Phrase: "in the membrane fraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1264633:Fraction [Quantitative Concept]
   861   C1554103:Fraction [Idea or Concept]

Phrase: "(Fig. 4C,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450376:4c [Intellectual Product]

Phrase: "lane 2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.172: Impact of NOS/cGMP Signaling on Insulin-Mediated Rho Kinase Inactivation and MBP Activation Given that insulins vasodilatory effects are mediated via NO (18), we next examined the contribution of NOS and cGMP signaling pathways in insulin-mediated Rho kinase inactivation as well as MBP stimulation. 

Phrase: "Impact of NOS/cGMP Signaling"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1825598:IMPACT [Gene or Genome]

Phrase: "on Insulin-Mediated Rho Kinase Inactivation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0544461:Inactivation [Cell or Molecular Dysfunction]

Phrase: "and"

Phrase: "MBP Activation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   853   C0599177:protein activation [Genetic Function]
   804   C1879547:Activation [Activity]
   708   C0067062:myosin phosphatase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "Given"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]

Phrase: "that insulins vasodilatory effects"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1280500:effects [Qualitative Concept]
   793 E C2348382:Effect [Qualitative Concept]

Phrase: "are"

Phrase: "mediated via NO"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   770   C0030015:oxide [Inorganic Chemical]
   770   C0086597:mediated [Social Behavior]
   770   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   770   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "(18"

Phrase: ")"

Phrase: ","

Phrase: "we next"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205117:next [Spatial Concept]
  1000   C0332282:Next [Temporal Concept]
  1000   C1883708:Next [Temporal Concept]

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the contribution of NOS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1880177:Contribution [Activity]

Phrase: "and"

Phrase: "cGMP signaling pathways in insulin-mediated Rho kinase inactivation"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   761   C1512804:Insulin Signaling Pathway [Molecular Function]
   761   C2984300:Insulin signaling pathway [Molecular Function]
   754   C0037080:pathways signaling [Molecular Function]
   739 E C0037083:signaling pathway [Cell Function]
   739 E C0086982:Signaling Pathway [Molecular Function]
   738   C1704259:Pathways [Molecular Function]
   738   C1705987:Pathways [Conceptual Entity]
   737   C2984427:Insulin Pathway [Functional Concept]

Phrase: "as well as"

Phrase: "MBP stimulation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   804   C1948023:Stimulation [Natural Phenomenon or Process]
   708   C0067062:myosin phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.173: VSMCs were pretreated with 1 mM NGmonoethyl L-arginine acetate (L-NMMA, a synthetic inhibitor of NOS) and RpcGMP (100 M, a cGMP antagonist) for 30 min followed by treatment with and without 100 nM insulin for 10 min. 

Phrase: "VSMCs"
Meta Candidates (Total=23; Excluded=11; Pruned=0; Remaining=12)
   923   C0026844:Muscle, Smooth, Vascular [Tissue]
   923   C1135918:Smooth Muscle Cells [Cell]
   861   C0596981:Muscle Cells [Cell]
   861   C1267092:Muscle, Smooth [Tissue]
   852   C0005773:Blood Cells [Cell]
   844 E C2328697:Hemal cell [Cell]
   812   C0005847:vascular [Body Part, Organ, or Organ Component]
   812   C0007634:Cells [Cell]
   812   C0026845:Muscle [Tissue]
   812   C0205357:Smooth [Qualitative Concept]
   812   C1558950:VASCULAR [Finding]
   812   C1801960:Vascular [Qualitative Concept]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
   756 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   756 E C1511228:VESSEL, BLOOD [Tissue]
   741 E C0442025:Muscular [Spatial Concept]
   712 E C0005767:Blood [Tissue]
   712 E C0005768:blood [Body Substance]
   712 E C0229664:Blood [Body Substance]
   712 E C0392895:Bloods [Population Group]

Phrase: "were"

Phrase: "pretreated with 1 mM NGmonoethyl L-arginine acetate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C1418486:MM-1 [Gene or Genome]
   744   C0000975:Acetate [Organic Chemical,Pharmacologic Substance]
   744   C0003765:Arginine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "(L-NMMA,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0069477:L-NMMA [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0439394:l's [Quantitative Concept]
   861   C1706495:L- [Intellectual Product]
   861   C3642217:/L [Quantitative Concept]

Phrase: "a synthetic inhibitor of NOS"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   840   C1373060:Nitric Oxide Synthase Inhibitor [Pharmacologic Substance]
   840   C1744692:nitric-oxide synthase inhibitor [Molecular Function]
   748   C1999216:Inhibitor [Qualitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "RpcGMP"

Phrase: "(100 M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "a cGMP antagonist"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0231491:Antagonist [Organ or Tissue Function]
   756   C0018338:Cyclic guanosine monophosphate [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   712 E C0680242:antagonism [Social Behavior]

Phrase: ")"

Phrase: "for 30 min"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0456693:/30 min [Temporal Concept]
  1000   C1442458:30 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]

Phrase: "followed by treatment"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   882   C0332283:Followed by [Temporal Concept]
           followed
   790   C0039798:treatment [Functional Concept]
   790   C0087111:Treatment [Therapeutic or Preventive Procedure]
   790   C1522326:Treatment [Functional Concept]
   790   C1533734:Treatment [Therapeutic or Preventive Procedure]
   790   C1705169:Treatment [Conceptual Entity]
   790   C3538994:TREATMENT [Research Activity]
   756 E C1719822:Follow [Intellectual Product]

Phrase: "with"

Phrase: "and without 100 nM insulin"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0312860:NM [Cell Function]
   760   C1515981:And [Idea or Concept]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "for 10 min."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456692:/10 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.174: Rho kinase activity was measured in the immunoprecipitates, and MBP activity was assayed in myosin-enriched pellets. 

Phrase: "Rho kinase activity"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C1150423:kinase activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
   734   C0389995:rho-Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   734   C1335631:RHO KINASE [Gene or Genome]

Phrase: "was"

Phrase: "measured in the immunoprecipitates,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0444706:Measured [Qualitative Concept]
   770   C3541902:MEASURED [Diagnostic Procedure]
   737 E C0079809:Measure [Quantitative Concept]
   737 E C0242485:Measure [Functional Concept]
   737   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "and"

Phrase: "MBP activity"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   911   C1149936:myosin phosphatase activity [Molecular Function]
   884   C1149927:protein phosphatase activity [Molecular Function]
   853   C1537044:protein activity [Molecular Function]
   840   C1149880:phosphatase activity [Molecular Function]
   804   C0205177:Activity [Functional Concept]
   804   C0439167:% activity [Quantitative Concept]
   804   C0441655:Activity [Activity]
   804   C1561536:*Activity [Idea or Concept]
   708   C0067062:myosin phosphatase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "was"

Phrase: "assayed in myosin-enriched pellets."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   760   C0027096:Myosin [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0359583:enriched [Food]
   760   C0993610:pellets [Biomedical or Dental Material]
   726   C0005507:Assay [Laboratory Procedure]
   726   C0243073:assay [Qualitative Concept]
   726 E C0441436:Pellet [Manufactured Object]
   726   C1510438:Assay [Laboratory Procedure]
   726 E C1998480:Pellet [Quantitative Concept]
Processing 00000000.tx.175: Both L-NMMA and RpcGMP prevented insulins inhibitory effect on Rho kinase and restored Rho kinase activity to control levels [Rho kinase activity (% of control value): control, 100%; 

Phrase: "Both L-NMMA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0069477:L-NMMA [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0439394:l's [Quantitative Concept]
   861   C1706495:L- [Intellectual Product]
   861   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "RpcGMP prevented insulins inhibitory effect on Rho kinase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1280500:Effect [Qualitative Concept]
   744   C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "restored Rho kinase activity to control levels"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   845   C0683317:activity levels [Finding]
   795   C0243148:control [Qualitative Concept]
   795   C0441889:Levels [Qualitative Concept]
   795   C1550141:Control [Substance]
   795   C1882979:Control [Conceptual Entity]
   795   C2587213:Control [Functional Concept]
   795   C3274648:Control [Qualitative Concept]
   794   C1706449:Active Control [Research Activity]
   762 E C0456079:Level [Classification]
   762 E C1547707:Level [Geographic Area]
   762 E C2946261:Level [Pharmacologic Substance]

Phrase: "[Rho kinase activity"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C1150423:kinase activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
   734   C0389995:rho-Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   734   C1335631:RHO KINASE [Gene or Genome]

Phrase: "(%"

Phrase: "of control value"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0243148:control [Qualitative Concept]
   861   C1522609:Value [Quantitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: ")"

Phrase: ":"

Phrase: "control,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "100%"

Phrase: ";"
Processing 00000000.tx.176: insulin, 60  6%; 

Phrase: "insulin,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "60  6%"

Phrase: ";"
Processing 00000000.tx.177: L-NMMA + insulin, 98  6%; 

Phrase: "L-NMMA + insulin,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]
   734   C0069477:L-NMMA [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "98  6%"

Phrase: ";"
Processing 00000000.tx.178: RpcGMP + insulin, 101  10%] and also blocked insulins effect on MBP activation (Fig. 5). 

Phrase: "RpcGMP + insulin,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "101  10%"

Phrase: "]"

Phrase: "and"

Phrase: "also blocked insulins effect on MBP activation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C1280500:Effect [Qualitative Concept]
   739   C2348382:Effect [Qualitative Concept]

Phrase: "(Fig. 5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.179: Furthermore, sodium nitroprusside (SNP), a NO donor, and 8-bromo cGMP, a cGMP agonist, both mimicked insulins effects on MBP activation (Fig. 5) and Rho kinase inactivation. 

Phrase: "Furthermore,"

Phrase: "sodium nitroprusside (SNP),"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0037533:Sodium Nitroprusside [Organic Chemical,Pharmacologic Substance]
   944 E C0591866:Nipride [Inorganic Chemical,Pharmacologic Substance]
   861   C0028193:Nitroprusside [Inorganic Chemical,Pharmacologic Substance]
   861   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   861   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "a NO donor,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0600437:nitric oxide donor [Pharmacologic Substance]
   827   C0013018:Donor [Population Group]
   827   C0040288:Donor [Population Group]
   827   C1527169:Donor NOS [Finding]
   734   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "8-bromo cGMP,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0050057:8-bromocyclic guanosine monophosphate [Nucleic Acid, Nucleoside, or Nucleotide]
   884   C0018338:Cyclic guanosine monophosphate [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   840   C0018346:Guanosine Monophosphate [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0018330:Guanosine [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]

Phrase: "a cGMP agonist,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C2987634:Agonist [Pharmacologic Substance]
   756   C0018338:Cyclic guanosine monophosphate [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "both mimicked insulins effects on MBP activation"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   739   C1280500:effects [Qualitative Concept]
   706 E C2348382:Effect [Qualitative Concept]

Phrase: "(Fig. 5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: "and"

Phrase: "Rho kinase inactivation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0544461:Inactivation [Cell or Molecular Dysfunction]
   734   C0389995:rho-Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   734   C1335631:RHO KINASE [Gene or Genome]
Processing 00000000.tx.180: Combined treatment with insulin and SNP or 8-bromo cGMP did not further increase MBP activation (data not shown). 

Phrase: "Combined treatment with insulin"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C0009429:combined treatment [Therapeutic or Preventive Procedure]
   833   C1704537:Combined Treatment [Therapeutic or Preventive Procedure]
   819   C0745343:insulin treatment [Therapeutic or Preventive Procedure]
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C1522326:Treatment [Functional Concept]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1705169:Treatment [Conceptual Entity]
   770   C3538994:TREATMENT [Research Activity]

Phrase: "and"

Phrase: "SNP"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0037533:Sodium Nitroprusside [Organic Chemical,Pharmacologic Substance]
   944 E C0591866:Nipride [Inorganic Chemical,Pharmacologic Substance]
   861   C0028193:Nitroprusside [Inorganic Chemical,Pharmacologic Substance]
   861   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   861   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "or"

Phrase: "8-bromo cGMP"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0050057:8-bromocyclic guanosine monophosphate [Nucleic Acid, Nucleoside, or Nucleotide]
   884   C0018338:Cyclic guanosine monophosphate [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   840   C0018346:Guanosine Monophosphate [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0018330:Guanosine [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]

Phrase: "did"

Phrase: "not further"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1517331:Further [Spatial Concept]
   861   C1518422:Not [Functional Concept]
   827 E C0205108:far [Spatial Concept]

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "MBP activation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   853   C0599177:protein activation [Genetic Function]
   804   C1879547:Activation [Activity]
   708   C0067062:myosin phosphatase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.181: These results suggest that insulin-induced NOS/cGMP signaling pathway may participate in insulin-mediated Rho kinase inactivation and MBP activation. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that insulin-induced NOS/cGMP signaling pathway"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   894   C1512804:Insulin Signaling Pathway [Molecular Function]
   894   C2984300:Insulin signaling pathway [Molecular Function]
   891   C2984427:Insulin Pathway [Functional Concept]
   875   C1518333:Nitric Oxide Signaling Pathway [Molecular Function]
   872   C1518332:Nitric Oxide Pathway [Molecular Function]
   804   C0037083:signaling pathway [Cell Function]
   804   C0086982:Signaling Pathway [Molecular Function]
   790   C1704259:Pathway [Molecular Function]
   790   C1705987:Pathway [Conceptual Entity]
   787 E C0037080:Signal Pathway [Molecular Function]

Phrase: "may"

Phrase: "participate in insulin-mediated Rho kinase inactivation"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   778   C0389995:rho-Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   778   C1335631:RHO KINASE [Gene or Genome]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0086597:mediated [Social Behavior]
   748   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   748   C0544461:Inactivation [Cell or Molecular Dysfunction]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]

Phrase: "and"

Phrase: "MBP activation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   853   C0599177:protein activation [Genetic Function]
   804   C1879547:Activation [Activity]
   708   C0067062:myosin phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.182: In our earlier studies, we have demonstrated that insulin rapidly induces iNOS protein expression and cGMP generation in VSMCs from WKY while VSMCs isolated from spontaneous hypertensive rats (SHR) exhibit resistance to insulin in terms of iNOS protein induction and cGMP generation (24). 

Phrase: "In our earlier studies,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "have"

Phrase: "demonstrated"

Phrase: "that insulin rapidly"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "iNOS protein expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1171362:protein expression [Genetic Function]
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "cGMP generation in VSMCs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0079411:Generation [Temporal Concept]
   742   C3146294:Generation [Activity]

Phrase: "from WKY"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034709:Wistar Kyoto [Mammal]

Phrase: "while"

Phrase: "VSMCs"
Meta Candidates (Total=23; Excluded=11; Pruned=0; Remaining=12)
   923   C0026844:Muscle, Smooth, Vascular [Tissue]
   923   C1135918:Smooth Muscle Cells [Cell]
   861   C0596981:Muscle Cells [Cell]
   861   C1267092:Muscle, Smooth [Tissue]
   852   C0005773:Blood Cells [Cell]
   844 E C2328697:Hemal cell [Cell]
   812   C0005847:vascular [Body Part, Organ, or Organ Component]
   812   C0007634:Cells [Cell]
   812   C0026845:Muscle [Tissue]
   812   C0205357:Smooth [Qualitative Concept]
   812   C1558950:VASCULAR [Finding]
   812   C1801960:Vascular [Qualitative Concept]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
   756 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   756 E C1511228:VESSEL, BLOOD [Tissue]
   741 E C0442025:Muscular [Spatial Concept]
   712 E C0005767:Blood [Tissue]
   712 E C0005768:blood [Body Substance]
   712 E C0229664:Blood [Body Substance]
   712 E C0392895:Bloods [Population Group]

Phrase: "isolated from spontaneous hypertensive rats (SHR)"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   851   C0034705:spontaneous hypertensive rat [Mammal]
   760   C0034693:rats [Mammal]
   760   C0034721:Rats [Mammal]
   760   C0205359:Spontaneous [Functional Concept]
   760   C0205409:Isolated [Functional Concept]
   760   C0857121:hypertensive [Finding]
   760   C1548221:Isolated [Idea or Concept]
   726 E C0370215:Isolate [Substance]
   726 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "exhibit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "resistance to insulin"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   858   C0021655:Insulin Resistance [Pathologic Function]
   858   C2700570:INSULIN RESISTANCE [Gene or Genome]
   847   C0332325:Resistant to [Functional Concept]
       E   Resistant
   790   C0237834:Resistance [Mental Process]
   790   C1514892:Resistance [Physiologic Function]
   718 E C1550464:resistent [Idea or Concept]
   718 E C2827757:RESISTANT [Laboratory or Test Result]

Phrase: "in terms of iNOS protein induction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205263:Induction [Functional Concept]
   827   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "cGMP generation"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   812   C0079411:Generation [Temporal Concept]
   812   C3146294:Generation [Activity]
   756   C0018338:Cyclic guanosine monophosphate [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   719 E C1414672:Genesis [Gene or Genome]
   719 E C2984892:Genesis [Gene or Genome]

Phrase: "(24"

Phrase: ")."
Processing 00000000.tx.183: View larger version (32K): [in this window] [in a new window]  Figure 5. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(32K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 5."
Processing 00000000.tx.184: Inhibitors of NOS and cGMP Signaling Block Insulin-Mediated MBP Activation Serum-starved VSMCs were treated with L-NMMA (1 mM), RpcGMP (0.1 mM) for 30 min followed by 100 nM insulin for 10 min or treated with 100 nM SNP or 8-bromo cGMP (1 mM) for 10 min. 

Phrase: "Inhibitors of NOS"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   900   C2757030:Nitric Oxide Synthase Inhibitors [Molecular Function]
   883 E C1373060:Nitric Oxide Synthase Inhibitor [Pharmacologic Substance]
   883 E C1744692:nitric-oxide synthase inhibitor [Molecular Function]
   760   C0243077:inhibitors [Chemical Viewed Functionally]
   726 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "and"

Phrase: "cGMP Signaling Block Insulin-Mediated MBP Activation Serum-starved VSMCs"
Meta Candidates (Total=23; Excluded=7; Pruned=0; Remaining=16)
   842   C0030281:Insulin Cell [Cell]
   827   C0026832:protein muscle [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   821   C1326120:activation cells [Cell Function]
   799   C0026844:Muscle, Smooth, Vascular [Tissue]
   799   C1135918:Smooth Muscle Cells [Cell]
   791   C0596981:Muscle Cells [Cell]
   791   C1267092:Muscle, Smooth [Tissue]
   790   C0853230:insulin blood [Laboratory Procedure]
   784   C0005847:vascular [Body Part, Organ, or Organ Component]
   784   C0007634:Cells [Cell]
   784   C0026845:Muscle [Tissue]
   784   C0205357:Smooth [Qualitative Concept]
   784   C1558950:VASCULAR [Finding]
   784   C1801960:Vascular [Qualitative Concept]
   784   C3282337:Cells [Cell]
   753   C0005773:Blood Cells [Cell]
   750 E C1269647:Cell [Cell]
   750 E C1704653:Cell [Medical Device]
   750 E C1948049:Cell [Spatial Concept]
   744 E C2328697:Hemal cell [Cell]
   728 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   728 E C1511228:VESSEL, BLOOD [Tissue]
   712 E C0442025:Muscular [Spatial Concept]

Phrase: "were"

Phrase: "treated with L-NMMA"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   833   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   819   C0069477:NMMA L [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   770   C1522326:Treated [Functional Concept]
   737 E C1292734:TREAT [Functional Concept]

Phrase: "(1 mM"

Phrase: ")"

Phrase: ","

Phrase: "RpcGMP"

Phrase: "(0.1 mM) for 30 min"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C1418486:MM-1 [Gene or Genome]
   783   C3642211:mm/min [Quantitative Concept]

Phrase: "followed by 100 nM insulin"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   806   C0332283:Followed by [Temporal Concept]
           followed
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0312860:NM [Cell Function]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   726 E C1719822:Follow [Intellectual Product]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "for 10 min"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456692:/10 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]

Phrase: "or"

Phrase: "treated with 100 nM SNP"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   790   C0037533:Sodium Nitroprusside [Organic Chemical,Pharmacologic Substance]
   790   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   753   C0028193:Nitroprusside [Inorganic Chemical,Pharmacologic Substance]
   753   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   753   C0312860:NM [Cell Function]
   753   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]
   753   C1522326:Treated [Functional Concept]
   734 E C0591866:Nipride [Inorganic Chemical,Pharmacologic Substance]
   719 E C1292734:TREAT [Functional Concept]

Phrase: "or"

Phrase: "8-bromo cGMP"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0050057:8-bromocyclic guanosine monophosphate [Nucleic Acid, Nucleoside, or Nucleotide]
   884   C0018338:Cyclic guanosine monophosphate [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   840   C0018346:Guanosine Monophosphate [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0018330:Guanosine [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]

Phrase: "(1 mM) for 10 min."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C1418486:MM-1 [Gene or Genome]
   797   C3642211:mm/min [Quantitative Concept]
Processing 00000000.tx.185: MBP activity was measured in myosin-enriched pellets using MLC as a substrate. 

Phrase: "MBP activity"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   911   C1149936:myosin phosphatase activity [Molecular Function]
   884   C1149927:protein phosphatase activity [Molecular Function]
   853   C1537044:protein activity [Molecular Function]
   840   C1149880:phosphatase activity [Molecular Function]
   804   C0205177:Activity [Functional Concept]
   804   C0439167:% activity [Quantitative Concept]
   804   C0441655:Activity [Activity]
   804   C1561536:*Activity [Idea or Concept]
   708   C0067062:myosin phosphatase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "was"

Phrase: "measured in myosin-enriched pellets"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   760   C0027096:Myosin [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0359583:enriched [Food]
   760   C0444706:Measured [Qualitative Concept]
   760   C0993610:pellets [Biomedical or Dental Material]
   760   C3541902:MEASURED [Diagnostic Procedure]
   726 E C0079809:Measure [Quantitative Concept]
   726 E C0242485:Measure [Functional Concept]
   726 E C0441436:Pellet [Manufactured Object]
   726 E C1998480:Pellet [Quantitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "MLC as a substrate."
Processing 00000000.tx.186: Results are the mean  SEM of four independent experiments performed in duplicate. 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "the mean  SEM of four independent experiments"

Phrase: "performed in duplicate."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0205173:Duplicate [Functional Concept]
   790   C0884358:Performed [Functional Concept]
   790   C3539942:Duplicate [Intellectual Product]
   756 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.187: *, P < 0.05 vs. control; 

Phrase: "*,"

Phrase: "P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "vs. control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.188: **, P < 0.05 vs. insulin.  

Phrase: "*"

Phrase: "*,"

Phrase: "P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "vs. insulin."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.189: Effect of Wortmannin on Insulin-Mediated Rho Kinase Inactivation and MBP Activation In an attempt to understand the upstream signaling components that mediate Rho kinase inactivation, iNOS induction, and MBP activation, we blocked PI3-kinase signaling by treatment with 100 nM wortmannin, a synthetic inhibitor of PI3-kinase and examined insulins effect on PI3-kinase activation, Rho kinase inactivation, and MBP activation. 

Phrase: "Effect of Wortmannin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1280500:Effect [Qualitative Concept]
   790   C2348382:Effect [Qualitative Concept]

Phrase: "on Insulin-Mediated Rho Kinase Inactivation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0544461:Inactivation [Cell or Molecular Dysfunction]

Phrase: "and"

Phrase: "MBP Activation In an attempt to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   762   C0599177:protein activation [Genetic Function]
   742   C1879547:Activation [Activity]

Phrase: "understand"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0162340:Understand [Mental Process]

Phrase: "the upstream signaling components"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0449432:Components [Manufactured Object]
   793 E C1705248:Component [Conceptual Entity]

Phrase: "that"

Phrase: "mediate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "Rho kinase inactivation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0544461:Inactivation [Cell or Molecular Dysfunction]
   734   C0389995:rho-Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   734   C1335631:RHO KINASE [Gene or Genome]

Phrase: "iNOS induction,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205263:Induction [Functional Concept]
   861   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "MBP activation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   853   C0599177:protein activation [Genetic Function]
   804   C1879547:Activation [Activity]
   708   C0067062:myosin phosphatase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "we"

Phrase: "blocked"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0028778:Blocked [Pathologic Function]
  1000   C0332206:Blocked [Functional Concept]
  1000   C2983591:BLOCKED [Research Activity]
   966 E C1533157:Block [Substance]
   966 E C1706084:Block [Geographic Area]
   966 E C2828370:Block [Quantitative Concept]

Phrase: "PI3-kinase signaling by treatment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0037083:Signaling [Cell Function]
   753   C3537152:signaling [Biologic Function]

Phrase: "with 100 nM wortmannin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0078517:wortmannin [Biologically Active Substance,Pharmacologic Substance,Steroid]

Phrase: "a synthetic inhibitor of PI3-kinase"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C1519050:Phosphatidylinositol 3-kinase Inhibitor [Pharmacologic Substance]
   774   C1171350:Kinase Inhibitor [Pharmacologic Substance]
   774   C3537023:kinase inhibitor [Molecular Function]
   774   C3537035:kinase inhibitor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   748   C1999216:Inhibitor [Qualitative Concept]

Phrase: "and"

Phrase: "examined insulins effect on PI3-kinase activation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1280500:Effect [Qualitative Concept]
   744   C2348382:Effect [Qualitative Concept]

Phrase: "Rho kinase inactivation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0544461:Inactivation [Cell or Molecular Dysfunction]
   734   C0389995:rho-Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   734   C1335631:RHO KINASE [Gene or Genome]

Phrase: "and"

Phrase: "MBP activation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   853   C0599177:protein activation [Genetic Function]
   804   C1879547:Activation [Activity]
   708   C0067062:myosin phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.190: Pretreatment of VSMCs with 100 nM wortmannin prevented insulins stimulatory effect on IRS-1-associated PI3-kinase activity (Fig. 

Phrase: "Pretreatment of VSMCs"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C1550147:Pretreatment [Substance]
   753   C2709094:pre treatment [Temporal Concept]
   753   C3539075:Pretreatment [Temporal Concept]
   753   C3539076:Pretreatment [Activity]

Phrase: "with 100 nM wortmannin prevented insulins stimulatory effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C1280500:Effect [Qualitative Concept]
   795   C2348382:Effect [Qualitative Concept]

Phrase: "on IRS-1-associated PI3-kinase activity"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   877   C1323803:phosphatidylinositol 3-kinase activity [Molecular Function]
   852   C2260369:phosphatidylinositol kinase activity [Molecular Function]
   818   C1150423:kinase activity [Molecular Function]
   795   C0205177:Activity [Functional Concept]
   795   C0439167:% activity [Quantitative Concept]
   795   C0441655:Activity [Activity]
   795   C1561536:*Activity [Idea or Concept]
   710   C0217461:IRS kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.191: 6A but did not alter insulins inhibitory effect on Rho kinase (Fig. 6B). 

Phrase: "6A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553638:6a [Medical Device]

Phrase: "but"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "alter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "insulins inhibitory effect on Rho kinase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "(Fig. 6B"

Phrase: ")."
Processing 00000000.tx.192: In contrast to its lack of effect on Rho kinase, wortmannin completely prevented insulin-induced MBP activation (Fig. 6C). 

Phrase: "In contrast to its lack"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:lack [Qualitative Concept]

Phrase: "of effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "on Rho kinase,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0389995:rho-Kinase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1335631:RHO KINASE [Gene or Genome]
   861   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "wortmannin completely prevented insulin-induced MBP activation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   813   C0599177:protein activation [Genetic Function]
   790   C1879547:Activation [Activity]

Phrase: "(Fig. 6C"

Phrase: ")."
Processing 00000000.tx.193: In our recent studies we have shown that wortmannin blocks insulins effects on iNOS protein induction and cGMP generation (24). 

Phrase: "In our recent studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that wortmannin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0078517:wortmannin [Biologically Active Substance,Pharmacologic Substance,Steroid]

Phrase: "blocks"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "insulins effects on iNOS protein induction"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C1280500:effects [Qualitative Concept]
   719 E C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "cGMP generation"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   812   C0079411:Generation [Temporal Concept]
   812   C3146294:Generation [Activity]
   756   C0018338:Cyclic guanosine monophosphate [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   719 E C1414672:Genesis [Gene or Genome]
   719 E C2984892:Genesis [Gene or Genome]

Phrase: "(24"

Phrase: ")."
Processing 00000000.tx.194: Pretreatment with rapamycin, a synthetic inhibitor of ribosomal S6 kinase, did not affect insulin-mediated Rho kinase inactivation (data not shown). 

Phrase: "Pretreatment with rapamycin,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1550147:Pretreatment [Substance]
   790   C2709094:pre treatment [Temporal Concept]
   790   C3539075:Pretreatment [Temporal Concept]
   790   C3539076:Pretreatment [Activity]

Phrase: "a synthetic inhibitor of ribosomal S6 kinase,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   774   C1171350:Kinase Inhibitor [Pharmacologic Substance]
   774   C3537023:kinase inhibitor [Molecular Function]
   774   C3537035:kinase inhibitor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   748   C1999216:Inhibitor [Qualitative Concept]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "insulin-mediated Rho kinase inactivation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0544461:Inactivation [Cell or Molecular Dysfunction]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.195: View larger version (22K): [in this window] [in a new window]  Figure 6. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(22K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 6."
Processing 00000000.tx.196: Inhibition of PI3-Kinase Signaling Blocks InsulinMediated MBP Activation without Affecting Rho Kinase Activity A, Wortmannin inhibits PI3-kinase activation by insulin. 

Phrase: "Inhibition of PI3-Kinase Signaling"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0021467:Inhibition [Mental Process]
   760   C0021469:Inhibition [Molecular Function]
   760   C1628982:% inhibition [Quantitative Concept]
   760   C3463820:Inhibition [Activity]

Phrase: "Blocks"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "InsulinMediated MBP Activation without Affecting Rho Kinase Activity A,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   780   C2247782:protein kinase A activation [Cell Function]
   766   C1819041:protein kinase activation [Cell Function]
   751   C0599177:protein activation [Genetic Function]
   736   C1879547:Activation [Activity]

Phrase: "Wortmannin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0078517:wortmannin [Biologically Active Substance,Pharmacologic Substance,Steroid]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "PI3-kinase activation by insulin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1879547:Activation [Activity]
Processing 00000000.tx.197: VSMCs were pretreated with wortmannin (100 nM) for 30 min followed by treatment with and without insulin (100 nM) for 10 min. 

Phrase: "VSMCs"
Meta Candidates (Total=23; Excluded=11; Pruned=0; Remaining=12)
   923   C0026844:Muscle, Smooth, Vascular [Tissue]
   923   C1135918:Smooth Muscle Cells [Cell]
   861   C0596981:Muscle Cells [Cell]
   861   C1267092:Muscle, Smooth [Tissue]
   852   C0005773:Blood Cells [Cell]
   844 E C2328697:Hemal cell [Cell]
   812   C0005847:vascular [Body Part, Organ, or Organ Component]
   812   C0007634:Cells [Cell]
   812   C0026845:Muscle [Tissue]
   812   C0205357:Smooth [Qualitative Concept]
   812   C1558950:VASCULAR [Finding]
   812   C1801960:Vascular [Qualitative Concept]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
   756 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   756 E C1511228:VESSEL, BLOOD [Tissue]
   741 E C0442025:Muscular [Spatial Concept]
   712 E C0005767:Blood [Tissue]
   712 E C0005768:blood [Body Substance]
   712 E C0229664:Blood [Body Substance]
   712 E C0392895:Bloods [Population Group]

Phrase: "were"

Phrase: "pretreated with wortmannin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0078517:wortmannin [Biologically Active Substance,Pharmacologic Substance,Steroid]

Phrase: "(100 nM) for 30 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0312860:NM [Cell Function]

Phrase: "followed by treatment"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   882   C0332283:Followed by [Temporal Concept]
           followed
   790   C0039798:treatment [Functional Concept]
   790   C0087111:Treatment [Therapeutic or Preventive Procedure]
   790   C1522326:Treatment [Functional Concept]
   790   C1533734:Treatment [Therapeutic or Preventive Procedure]
   790   C1705169:Treatment [Conceptual Entity]
   790   C3538994:TREATMENT [Research Activity]
   756 E C1719822:Follow [Intellectual Product]

Phrase: "with"

Phrase: "and without insulin"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1515981:And [Idea or Concept]
   790   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1579433:Insulin [Pharmacologic Substance]
   734 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   706 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(100 nM) for 10 min."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0312860:NM [Cell Function]
Processing 00000000.tx.198: Equal amounts of precleared lysate proteins (100 g) were immunoprecipitated with an antirabbit IRS-1 antibody followed by the assay of PI3-kinase activity in the immunoprecipitates. 

Phrase: "Equal amounts of precleared lysate proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1265611:amounts [Quantitative Concept]

Phrase: "(100 g)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "were"

Phrase: "immunoprecipitated with an antirabbit IRS-1 antibody"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C0123658:IRS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   748   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   714   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "followed by the assay of PI3-kinase activity"
Meta Candidates (Total=18; Excluded=2; Pruned=0; Remaining=16)
   818   C1323803:phosphatidylinositol 3-kinase activity [Molecular Function]
   790   C0044602:Phosphatidylinositol 3-Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   784   C2260369:phosphatidylinositol kinase activity [Molecular Function]
   764   C0332283:Followed by [Temporal Concept]
           followed
   764   C1150423:kinase activity [Molecular Function]
   762 E C2936824:Phosphatidylinositol 3-Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0005507:Assay [Laboratory Procedure]
   742   C0031621:Phosphatidyl Inositol [Biologically Active Substance,Lipid]
   742   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0205177:Activity [Functional Concept]
   742   C0243073:assay [Qualitative Concept]
   742   C0439167:% activity [Quantitative Concept]
   742   C0441655:Activity [Activity]
   742   C1510438:Assay [Laboratory Procedure]
   742   C1561536:*Activity [Idea or Concept]
   742   C2348046:Phosphatidylinositol [Lipid]
   708 E C1719822:Follow [Intellectual Product]

Phrase: "in the immunoprecipitates."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0301871:Immunoprecipitate [Immunologic Factor]
Processing 00000000.tx.199: Top, A representative autoradiogram from TLC performed on PI3-kinase products is shown. 

Phrase: "Top,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704458:Top [Spatial Concept]

Phrase: "A representative autoradiogram from TLC"

Phrase: "performed on PI3-kinase products"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   833   C0044602:Phosphatidylinositol 3-Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   805 E C2936824:Phosphatidylinositol 3-Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0031621:Phosphatidyl Inositol [Biologically Active Substance,Lipid]
   753   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0884358:Performed [Functional Concept]
   753   C1514468:Products [Entity]
   753   C2348046:Phosphatidylinositol [Lipid]
   719 E C1704444:Product [Quantitative Concept]
   719 E C2947996:Perform [Pharmacologic Substance]

Phrase: "is"

Phrase: "shown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]
Processing 00000000.tx.200: Bottom, Phosphatidylinositol phosphate (PIP) spots were scraped and radioactivity was counted. 

Phrase: "Bottom,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511276:Bottom [Spatial Concept]
  1000   C1552825:bottom [Idea or Concept]

Phrase: "Phosphatidylinositol phosphate (PIP) spots"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0015230:spots [Disease or Syndrome]
   827   C0329155:Spot [Fish]
   827   C0848332:Spots [Sign or Symptom]
   827   C1427618:SPOT [Gene or Genome]
   827   C1705203:Spot [Conceptual Entity]
   734   C0071655:phosphatidylinositol phosphate [Biologically Active Substance,Lipid]

Phrase: "were"

Phrase: "scraped"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0184933:scraped [Therapeutic or Preventive Procedure]
  1000   C0444082:scraped [Body Substance]

Phrase: "and"

Phrase: "radioactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034553:Radioactivity [Natural Phenomenon or Process]

Phrase: "was"

Phrase: "counted."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0750480:Count [Activity]
   966   C1705566:Count [Quantitative Concept]
Processing 00000000.tx.201: Results are the mean  SEM of three separate experiments. 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "the mean  SEM of three separate experiments."
Processing 00000000.tx.202: *, P < 0.05 vs. basal, ** P, 0.05 vs. insulin. 

Phrase: "*,"

Phrase: "P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "vs. basal,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205112:Basal [Spatial Concept]

Phrase: "*"

Phrase: "* P,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "0.05"

Phrase: "vs. insulin."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.203: B, Wortmannin does not prevent insulins inhibitory effects on Rho kinase activity. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Wortmannin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0078517:wortmannin [Biologically Active Substance,Pharmacologic Substance,Steroid]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "prevent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "insulins inhibitory effects on Rho kinase activity."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C1280500:effects [Qualitative Concept]
   714 E C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.204: VSMCs were pretreated with wortmannin (100 nM) for 30 min followed by treatment with and without insulin (100 nM) for 10 min. 

Phrase: "VSMCs"
Meta Candidates (Total=23; Excluded=11; Pruned=0; Remaining=12)
   923   C0026844:Muscle, Smooth, Vascular [Tissue]
   923   C1135918:Smooth Muscle Cells [Cell]
   861   C0596981:Muscle Cells [Cell]
   861   C1267092:Muscle, Smooth [Tissue]
   852   C0005773:Blood Cells [Cell]
   844 E C2328697:Hemal cell [Cell]
   812   C0005847:vascular [Body Part, Organ, or Organ Component]
   812   C0007634:Cells [Cell]
   812   C0026845:Muscle [Tissue]
   812   C0205357:Smooth [Qualitative Concept]
   812   C1558950:VASCULAR [Finding]
   812   C1801960:Vascular [Qualitative Concept]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
   756 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   756 E C1511228:VESSEL, BLOOD [Tissue]
   741 E C0442025:Muscular [Spatial Concept]
   712 E C0005767:Blood [Tissue]
   712 E C0005768:blood [Body Substance]
   712 E C0229664:Blood [Body Substance]
   712 E C0392895:Bloods [Population Group]

Phrase: "were"

Phrase: "pretreated with wortmannin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0078517:wortmannin [Biologically Active Substance,Pharmacologic Substance,Steroid]

Phrase: "(100 nM) for 30 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0312860:NM [Cell Function]

Phrase: "followed by treatment"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   882   C0332283:Followed by [Temporal Concept]
           followed
   790   C0039798:treatment [Functional Concept]
   790   C0087111:Treatment [Therapeutic or Preventive Procedure]
   790   C1522326:Treatment [Functional Concept]
   790   C1533734:Treatment [Therapeutic or Preventive Procedure]
   790   C1705169:Treatment [Conceptual Entity]
   790   C3538994:TREATMENT [Research Activity]
   756 E C1719822:Follow [Intellectual Product]

Phrase: "with"

Phrase: "and without insulin"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1515981:And [Idea or Concept]
   790   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1579433:Insulin [Pharmacologic Substance]
   734 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   706 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(100 nM) for 10 min."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0312860:NM [Cell Function]
Processing 00000000.tx.205: Equal amounts of precleared lysate proteins (100 g) were immunoprecipitated with anti-ROK- antibody followed by Rho kinase assay in the immunoprecipitates. 

Phrase: "Equal amounts of precleared lysate proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1265611:amounts [Quantitative Concept]

Phrase: "(100 g)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "were"

Phrase: "immunoprecipitated with anti-ROK- antibody"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   726   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "followed by Rho kinase assay"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   806   C0332283:Followed by [Temporal Concept]
           followed
   806   C0389995:rho-Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   806   C1335631:RHO KINASE [Gene or Genome]
   760   C0005507:Assay [Laboratory Procedure]
   760   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0243073:assay [Qualitative Concept]
   760   C1510438:Assay [Laboratory Procedure]
   726 E C1719822:Follow [Intellectual Product]

Phrase: "in the immunoprecipitates."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0301871:Immunoprecipitate [Immunologic Factor]
Processing 00000000.tx.206: Details are given in Fig. 

Phrase: "Details"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1522508:Details [Qualitative Concept]
   966 E C1561567:detail [Functional Concept]

Phrase: "are"

Phrase: "given in Fig."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   790   C1442162:GIVEN [Conceptual Entity]
   790   C1550718:given [Idea or Concept]
   790   C3244317:given [Intellectual Product]
   756 E C1947971:Give [Functional Concept]
Processing 00000000.tx.207: 4C, Wortmannin inhibits insulins stimulatory effect on MBP activation. 

Phrase: "4C,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]

Phrase: "Wortmannin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0078517:wortmannin [Biologically Active Substance,Pharmacologic Substance,Steroid]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "insulins stimulatory effect on MBP activation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C1280500:Effect [Qualitative Concept]
   742   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.208: Myosin-enriched fractions prepared from control, insulin, wortmannin,  insulin VSMCs were assayed for MBP activity as detailed in Fig. 

Phrase: "Myosin-enriched fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1264633:Fractions [Quantitative Concept]
   793 E C1554103:Fraction [Idea or Concept]

Phrase: "prepared from control,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0243148:control [Qualitative Concept]
   790   C1550141:Control [Substance]
   790   C1882979:Control [Conceptual Entity]
   790   C2587213:Control [Functional Concept]
   790   C3274648:Control [Qualitative Concept]
   756   C1521827:Prepare [Functional Concept]

Phrase: "insulin,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "wortmannin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0078517:wortmannin [Biologically Active Substance,Pharmacologic Substance,Steroid]

Phrase: "insulin VSMCs"
Meta Candidates (Total=25; Excluded=11; Pruned=0; Remaining=14)
   884   C0026844:Muscle, Smooth, Vascular [Tissue]
   884   C1135918:Smooth Muscle Cells [Cell]
   881   C0030281:Insulin Cell [Cell]
   840   C0596981:Muscle Cells [Cell]
   840   C1267092:Muscle, Smooth [Tissue]
   825   C0005773:Blood Cells [Cell]
   817 E C2328697:Hemal cell [Cell]
   804   C0005847:vascular [Body Part, Organ, or Organ Component]
   804   C0007634:Cells [Cell]
   804   C0026845:Muscle [Tissue]
   804   C0205357:Smooth [Qualitative Concept]
   804   C1558950:VASCULAR [Finding]
   804   C1801960:Vascular [Qualitative Concept]
   804   C3282337:Cells [Cell]
   790   C0853230:insulin blood [Laboratory Procedure]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]
   748 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   748 E C1511228:VESSEL, BLOOD [Tissue]
   733 E C0442025:Muscular [Spatial Concept]
   704 E C0005767:Blood [Tissue]
   704 E C0005768:blood [Body Substance]
   704 E C0229664:Blood [Body Substance]
   704 E C0392895:Bloods [Population Group]

Phrase: "were"

Phrase: "assayed for MBP activity"
Meta Candidates (Total=23; Excluded=0; Pruned=0; Remaining=23)
   814   C1149927:protein phosphatase activity [Molecular Function]
   804   C1149936:myosin phosphatase activity [Molecular Function]
   778   C0031686:Protein phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   778   C1149880:phosphatase activity [Molecular Function]
           phosphatase
   774   C0067062:myosin phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   774   C0522527:Protein bound [Qualitative Concept]
   774   C1537044:protein activity [Molecular Function]
   748   C0027096:Myosin [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0031678:Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0205177:Activity [Functional Concept]
   748   C0332297:bound [Spatial Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C1145667:Bound [Activity]
   748   C1167622:Bound [Molecular Function]
   748   C1561536:*Activity [Idea or Concept]
   748   C1689898:% bound [Quantitative Concept]
   748   C2349209:Bound [Conceptual Entity]
   714   C0005507:Assay [Laboratory Procedure]
   714   C0243073:assay [Qualitative Concept]
   714   C1510438:Assay [Laboratory Procedure]

Phrase: "as"

Phrase: "detailed in Fig."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   790   C1522508:Detailed [Qualitative Concept]
   756 E C1561567:detail [Functional Concept]
Processing 00000000.tx.209: 2. 

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.210: Results are the mean  SEM of three separate experiments performed in duplicate. 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "the mean  SEM of three separate experiments"

Phrase: "performed in duplicate."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0205173:Duplicate [Functional Concept]
   790   C0884358:Performed [Functional Concept]
   790   C3539942:Duplicate [Intellectual Product]
   756 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.211: *, P < 0.05 vs. control; 

Phrase: "*,"

Phrase: "P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "vs. control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.212: **, P < 0.05 vs. insulin.  

Phrase: "*"

Phrase: "*,"

Phrase: "P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "vs. insulin."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.213: Insulin Causes Dephosphorylation of MLC20 Several studies indicate that phosphorylation of MLC20 is a major event in the contraction of VSMCs. 

Phrase: "Insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "Causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "Dephosphorylation of MLC20 Several studies"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1158884:Dephosphorylation [Molecular Function]
   760   C3160734:Dephosphorylation [Molecular Function]

Phrase: "indicate"

Phrase: "that phosphorylation of MLC20"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0031715:Phosphorylation [Molecular Function]
   770   C1158886:Phosphorylation [Molecular Function]

Phrase: "is"

Phrase: "a major event in the contraction of VSMCs."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C0441471:Event [Event]
Processing 00000000.tx.214: MLC20 phosphorylation status reflects a balance between the activities of MLCK and MBP. 

Phrase: "MLC20 phosphorylation status"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0449438:Status [Qualitative Concept]

Phrase: "reflects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:reflect [Mental Process]

Phrase: "a balance between the activities of MLCK"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   739   C0014653:Balance [Organism Function]
   739   C0205415:Balance [Functional Concept]
   739   C0560184:Balance [Finding]

Phrase: "and"

Phrase: "MBP."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   902   C0067062:myosin phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0031686:Protein phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0031678:Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1149880:phosphatase [Molecular Function]
Processing 00000000.tx.215: To further examine the physiological consequences of MBP activation by insulin, we analyzed the effect of insulin on MLC20 phosphorylation. 

Phrase: "To further"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1517331:Further [Spatial Concept]
   861   C1883351:To [Qualitative Concept]
   827 E C0205108:far [Spatial Concept]

Phrase: "examine"

Phrase: "the physiological consequences of MBP activation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0686907:Consequence of [Functional Concept]
           consequences

Phrase: "by insulin,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "we"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "the effect of insulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "on MLC20 phosphorylation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031715:Phosphorylation [Molecular Function]
   861   C1158886:Phosphorylation [Molecular Function]
Processing 00000000.tx.216: As shown in Fig. 

Phrase: "As"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.217: 7, insulin activation of MBP in VSMCs was accompanied by a marked reduction in AII-mediated MLC20 phosphorylation examined in cells pretreated with 100 nM insulin for 10 min followed by treatment with AII (100 nM) for 5 min (Fig. 7). 

Phrase: "7,"

Phrase: "insulin activation of MBP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C0599177:protein activation [Genetic Function]
   748   C1879547:Activation [Activity]

Phrase: "in VSMCs"
Meta Candidates (Total=23; Excluded=11; Pruned=0; Remaining=12)
   923   C0026844:Muscle, Smooth, Vascular [Tissue]
   923   C1135918:Smooth Muscle Cells [Cell]
   861   C0596981:Muscle Cells [Cell]
   861   C1267092:Muscle, Smooth [Tissue]
   852   C0005773:Blood Cells [Cell]
   844 E C2328697:Hemal cell [Cell]
   812   C0005847:vascular [Body Part, Organ, or Organ Component]
   812   C0007634:Cells [Cell]
   812   C0026845:Muscle [Tissue]
   812   C0205357:Smooth [Qualitative Concept]
   812   C1558950:VASCULAR [Finding]
   812   C1801960:Vascular [Qualitative Concept]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
   756 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   756 E C1511228:VESSEL, BLOOD [Tissue]
   741 E C0442025:Muscular [Spatial Concept]
   712 E C0005767:Blood [Tissue]
   712 E C0005768:blood [Body Substance]
   712 E C0229664:Blood [Body Substance]
   712 E C0392895:Bloods [Population Group]

Phrase: "was"

Phrase: "accompanied by a marked reduction"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0301630:Reduction [Natural Phenomenon or Process]
   760   C0392756:Reduction [Qualitative Concept]
   760   C0441610:Reduction [Therapeutic or Preventive Procedure]
   760   C0522501:Marked [Qualitative Concept]
   760   C1706089:Marked [Qualitative Concept]

Phrase: "in AII-mediated MLC20 phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0031715:Phosphorylation [Molecular Function]
   804   C1158886:Phosphorylation [Molecular Function]

Phrase: "examined in cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   790   C0007634:Cells [Cell]
   790   C0332128:Examined [Finding]
   790   C3282337:Cells [Cell]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]

Phrase: "pretreated with 100 nM insulin"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0312860:NM [Cell Function]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "for 10 min"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456692:/10 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]

Phrase: "followed by treatment"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   882   C0332283:Followed by [Temporal Concept]
           followed
   790   C0039798:treatment [Functional Concept]
   790   C0087111:Treatment [Therapeutic or Preventive Procedure]
   790   C1522326:Treatment [Functional Concept]
   790   C1533734:Treatment [Therapeutic or Preventive Procedure]
   790   C1705169:Treatment [Conceptual Entity]
   790   C3538994:TREATMENT [Research Activity]
   756 E C1719822:Follow [Intellectual Product]

Phrase: "with AII"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003009:Angiotensin 2 [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "(100 nM) for 5 min (Fig. 7"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0312860:NM [Cell Function]

Phrase: ")."
Processing 00000000.tx.218: View larger version (30K): [in this window] [in a new window]  Figure 7. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(30K"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1413114:30K [Gene or Genome]

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 7."
Processing 00000000.tx.219: Insulin Causes Dephosphorylation of MLC20 VSMCs were treated with and without insulin (10 nM) for 10 min followed by the addition of AII (100 nM) for 5 min followed by glycerol PAGE and immunoblotting with anti-MLC20 antibody. 

Phrase: "Insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "Causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "Dephosphorylation of MLC20 VSMCs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1158884:Dephosphorylation [Molecular Function]
   748   C3160734:Dephosphorylation [Molecular Function]

Phrase: "were"

Phrase: "treated with"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   833   C1522326:Treated [Functional Concept]
   799 E C1292734:TREAT [Functional Concept]

Phrase: "and without insulin"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1515981:And [Idea or Concept]
   790   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1579433:Insulin [Pharmacologic Substance]
   734 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   706 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(10 nM) for 10 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0312860:NM [Cell Function]

Phrase: "followed by the addition of AII"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   778   C0003009:Angiotensin 2 [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   778   C0332283:Followed by [Temporal Concept]
           followed
   748   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   748   C1883712:Addition [Functional Concept]
   714 E C1719822:Follow [Intellectual Product]

Phrase: "(100 nM) for 5 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0312860:NM [Cell Function]

Phrase: "followed by glycerol PAGE"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   833   C0332283:Followed by [Temporal Concept]
           followed
   770   C0017861:Glycerol [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]
   770   C1704732:Page [Intellectual Product]
   737 E C1719822:Follow [Intellectual Product]

Phrase: "and"

Phrase: "immunoblotting with anti-MLC20 antibody."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0020985:Immunoblotting [Laboratory Procedure]
Processing 00000000.tx.220: A representative autoradiogram is shown.  

Phrase: "A representative autoradiogram"

Phrase: "is"

Phrase: "shown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]
Processing 00000000.tx.221: Insulin Inhibits Thrombin-Induced VSMC Contraction We next examined the ability of insulin to inhibit thrombin-induced VSMC contraction. 

Phrase: "Insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "Inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "Thrombin-Induced VSMC Contraction"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   879   C2265839:Vascular smooth muscle contraction [Organ or Tissue Function]
   852   C1155937:smooth muscle contraction [Organ or Tissue Function]
   845   C0026820:Muscle Cell Contraction [Physiologic Function]
           Muscle Contraction
   795   C1140999:Contraction [Pathologic Function]

Phrase: "We next"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205117:next [Spatial Concept]
  1000   C0332282:Next [Temporal Concept]
  1000   C1883708:Next [Temporal Concept]

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the ability of insulin to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0085732:Ability [Organism Attribute]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "thrombin-induced VSMC contraction."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   879   C2265839:Vascular smooth muscle contraction [Organ or Tissue Function]
   852   C1155937:smooth muscle contraction [Organ or Tissue Function]
   845   C0026820:Muscle Cell Contraction [Physiologic Function]
           Muscle Contraction
   795   C1140999:Contraction [Pathologic Function]
Processing 00000000.tx.222: In these experiments VSMCs (2 x 104 cells/cm2) were grown to confluence on collagen-coated polyethylene cell culture inserts in medium containing 0.5% FBS. 

Phrase: "In these experiments VSMCs"
Meta Candidates (Total=23; Excluded=11; Pruned=0; Remaining=12)
   884   C0026844:Muscle, Smooth, Vascular [Tissue]
   884   C1135918:Smooth Muscle Cells [Cell]
   840   C0596981:Muscle Cells [Cell]
   840   C1267092:Muscle, Smooth [Tissue]
   825   C0005773:Blood Cells [Cell]
   817 E C2328697:Hemal cell [Cell]
   804   C0005847:vascular [Body Part, Organ, or Organ Component]
   804   C0007634:Cells [Cell]
   804   C0026845:Muscle [Tissue]
   804   C0205357:Smooth [Qualitative Concept]
   804   C1558950:VASCULAR [Finding]
   804   C1801960:Vascular [Qualitative Concept]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]
   748 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   748 E C1511228:VESSEL, BLOOD [Tissue]
   733 E C0442025:Muscular [Spatial Concept]
   704 E C0005767:Blood [Tissue]
   704 E C0005768:blood [Body Substance]
   704 E C0229664:Blood [Body Substance]
   704 E C0392895:Bloods [Population Group]

Phrase: "(2 x 104 cells/cm2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0439479:cm2 [Quantitative Concept]
   804   C0555206:CM2 [Congenital Abnormality]

Phrase: ")"

Phrase: "were"

Phrase: "grown to confluence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   718   C0205200:Confluent [Qualitative Concept]

Phrase: "on collagen-coated polyethylene cell culture"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   840   C0007585:Cell Culture [Laboratory Procedure]
   804   C0007634:Cell [Cell]
   804   C0010453:Culture [Idea or Concept]
   804   C0220814:culture [Functional Concept]
   804   C0430400:Culture [Laboratory Procedure]
   804   C1269647:Cell [Cell]
   804   C1704653:Cell [Medical Device]
   804   C1948049:Cell [Spatial Concept]
   804   C2242979:Culture [Laboratory Procedure]

Phrase: "inserts"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0441587:Insert [Health Care Activity]
  1000   C0813036:Inserts [Medical Device]
  1000   C1743766:Insert [Medical Device]
  1000   C1883719:Insert [Functional Concept]

Phrase: "in medium containing 0.5% FBS."
Processing 00000000.tx.223: Serum-starved VSMCs were treated with 100 nM insulin for 30 min followed by treatment with and without thrombin (0.5 U/ml) for 15 min. 

Phrase: "Serum-starved VSMCs"
Meta Candidates (Total=19; Excluded=7; Pruned=0; Remaining=12)
   861   C0026844:Muscle, Smooth, Vascular [Tissue]
   861   C1135918:Smooth Muscle Cells [Cell]
   827   C0596981:Muscle Cells [Cell]
   827   C1267092:Muscle, Smooth [Tissue]
   808   C0005773:Blood Cells [Cell]
   799   C0005847:vascular [Body Part, Organ, or Organ Component]
   799   C0007634:Cells [Cell]
   799   C0026845:Muscle [Tissue]
   799   C0205357:Smooth [Qualitative Concept]
   799   C1558950:VASCULAR [Finding]
   799   C1801960:Vascular [Qualitative Concept]
   799 E C2328697:Hemal cell [Cell]
   799   C3282337:Cells [Cell]
   766 E C1269647:Cell [Cell]
   766 E C1704653:Cell [Medical Device]
   766 E C1948049:Cell [Spatial Concept]
   743 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   743 E C1511228:VESSEL, BLOOD [Tissue]
   727 E C0442025:Muscular [Spatial Concept]

Phrase: "were"

Phrase: "treated with 100 nM insulin"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   806   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0312860:NM [Cell Function]
   760   C1522326:Treated [Functional Concept]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   726 E C1292734:TREAT [Functional Concept]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "for 30 min"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0456693:/30 min [Temporal Concept]
  1000   C1442458:30 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]

Phrase: "followed by treatment"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   882   C0332283:Followed by [Temporal Concept]
           followed
   790   C0039798:treatment [Functional Concept]
   790   C0087111:Treatment [Therapeutic or Preventive Procedure]
   790   C1522326:Treatment [Functional Concept]
   790   C1533734:Treatment [Therapeutic or Preventive Procedure]
   790   C1705169:Treatment [Conceptual Entity]
   790   C3538994:TREATMENT [Research Activity]
   756 E C1719822:Follow [Intellectual Product]

Phrase: "with"

Phrase: "and without thrombin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0040018:Thrombin [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   790   C1515981:And [Idea or Concept]

Phrase: "(0.5 U/ml) for 15 min."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C0439340:U/ml [Quantitative Concept]
   778   C1880521:U/mL [Quantitative Concept]
   778   C2945590:U/mL [Quantitative Concept]
   774   C0439445:mL/min [Quantitative Concept]
   748   C0439526:/mL [Quantitative Concept]
Processing 00000000.tx.224: Transvascular diffusion of horseradish peroxidase (HRP) due to contraction-induced increase in cell permeability was determined spectrophotometrically as detailed in Materials and Methods. 

Phrase: "Transvascular diffusion of horseradish peroxidase (HRP)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0012222:Diffusion [Natural Phenomenon or Process]
   760   C1696141:Diffusion [Functional Concept]

Phrase: "due to contraction-induced increase in cell permeability"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   799   C0031164:Permeability [Natural Phenomenon or Process]
   727 E C0205326:Permeable [Functional Concept]

Phrase: "was"

Phrase: "determined"

Phrase: "spectrophotometrically"

Phrase: "as"

Phrase: "detailed in Materials"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0520510:Materials [Substance]
   790   C1522508:Detailed [Qualitative Concept]
   756 E C1561567:detail [Functional Concept]

Phrase: "and"

Phrase: "Methods."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.225: Pretreatment with insulin caused a 60% decrease in thrombin-induced contractions (Fig. 8). 

Phrase: "Pretreatment with insulin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1550147:Pretreatment [Substance]
   790   C2709094:pre treatment [Temporal Concept]
   790   C3539075:Pretreatment [Temporal Concept]
   790   C3539076:Pretreatment [Activity]

Phrase: "caused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015127:cause [Functional Concept]
   966   C1524003:Cause [Conceptual Entity]

Phrase: "a 60% decrease in thrombin-induced contractions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0392756:Decrease [Qualitative Concept]
   748   C0547047:Decrease [Quantitative Concept]

Phrase: "(Fig. 8"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.226: View larger version (14K): [in this window] [in a new window]  Figure 8. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(14K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 8."
Processing 00000000.tx.227: Insulin Inhibits Thrombin-Induced VSMC Contraction Serum-starved VSMCs were treated with and without insulin(100 nM) for 30 min followed by treatment with thrombin (0.5 U/ml x 15). 

Phrase: "Insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "Inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "Thrombin-Induced VSMC Contraction Serum-starved VSMCs"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   866   C1135918:Smooth Muscle Cells [Cell]
   856   C0596981:Muscle Cells [Cell]
   823   C0005773:Blood Cells [Cell]
   786   C0007634:Cells [Cell]
   786   C3282337:Cells [Cell]

Phrase: "were"

Phrase: "treated with"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   833   C1522326:Treated [Functional Concept]
   799 E C1292734:TREAT [Functional Concept]

Phrase: "and without insulin"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1515981:And [Idea or Concept]
   790   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1579433:Insulin [Pharmacologic Substance]
   734 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   706 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(100 nM) for 30 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0312860:NM [Cell Function]

Phrase: "followed by treatment"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   882   C0332283:Followed by [Temporal Concept]
           followed
   790   C0039798:treatment [Functional Concept]
   790   C0087111:Treatment [Therapeutic or Preventive Procedure]
   790   C1522326:Treatment [Functional Concept]
   790   C1533734:Treatment [Therapeutic or Preventive Procedure]
   790   C1705169:Treatment [Conceptual Entity]
   790   C3538994:TREATMENT [Research Activity]
   756 E C1719822:Follow [Intellectual Product]

Phrase: "with thrombin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040018:Thrombin [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "(0.5 U/ml x 15"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0439340:U/ml [Quantitative Concept]
   827   C0444499:0/5 [Quantitative Concept]
   827   C1880521:U/mL [Quantitative Concept]
   827   C2945590:U/mL [Quantitative Concept]
   799   C0439526:/mL [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.228: Cell contraction was measured as detailed in the text. 

Phrase: "Cell contraction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1140999:Contraction [Pathologic Function]

Phrase: "was"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "as"

Phrase: "detailed in the text."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C1522508:Detailed [Qualitative Concept]
   770   C1527021:Text [Intellectual Product]
   770   C1554111:Text [Idea or Concept]
   770   C1705606:Text [Intellectual Product]
   770   C3541382:Text [Intellectual Product]
   737 E C1561567:detail [Functional Concept]
Processing 00000000.tx.229: Results are the mean  SEM of three experiments.  

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "the mean  SEM of three experiments."
Processing 00000000.tx.230: Diabetes and Hypertension Are Accompanied by Marked Reductions in Insulin-Mediated MBP Activation To further understand the importance of MBP in VSMC function, we examined the activity of this enzyme in VSMCs isolated from diabetic GK rats, a model for non-insulin-dependent diabetes mellitus (NIDDM) (25) and spontaneous hypertensive rats. 

Phrase: "Diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "and"

Phrase: "Hypertension"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0020538:Hypertension [Disease or Syndrome]
  1000   C1963138:Hypertension [Finding]

Phrase: "Are"

Phrase: "Accompanied by Marked Reductions"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0301630:reductions [Natural Phenomenon or Process]
   770   C0441610:reductions [Therapeutic or Preventive Procedure]
   770   C0522501:Marked [Qualitative Concept]
   770   C1706089:Marked [Qualitative Concept]
   737 E C0392756:Reduction [Qualitative Concept]

Phrase: "in Insulin-Mediated MBP Activation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   829   C0599177:protein activation [Genetic Function]
   795   C1879547:Activation [Activity]

Phrase: "To further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "understand"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0162340:Understand [Mental Process]

Phrase: "the importance of MBP"

Phrase: "in VSMC function,"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   897   C0232337:Vascular function [Clinical Attribute]
   853   C0231484:Muscle function [Organ or Tissue Function]
   853   C0517929:muscle function [Finding]
   847 E C0005811:blood function [Organ or Tissue Function]
   840   C0007613:Cell Function [Cell Function]
   804   C0031843:function [Physiologic Function]
   804   C0542341:Function [Functional Concept]
   804   C0700205:FUNCTION [Classification]
   804   C1705273:Function [Intellectual Product]
   733 E C0205245:Functional [Functional Concept]
   733 E C2700217:Functional [Conceptual Entity]
   717   C0026844:Muscle, Smooth, Vascular [Tissue]
   717   C1135918:Smooth muscle cell [Cell]

Phrase: "we"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the activity of this enzyme"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   797   C0243102:enzyme activity [Molecular Function]
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1561536:*Activity [Idea or Concept]

Phrase: "in VSMCs"
Meta Candidates (Total=23; Excluded=11; Pruned=0; Remaining=12)
   923   C0026844:Muscle, Smooth, Vascular [Tissue]
   923   C1135918:Smooth Muscle Cells [Cell]
   861   C0596981:Muscle Cells [Cell]
   861   C1267092:Muscle, Smooth [Tissue]
   852   C0005773:Blood Cells [Cell]
   844 E C2328697:Hemal cell [Cell]
   812   C0005847:vascular [Body Part, Organ, or Organ Component]
   812   C0007634:Cells [Cell]
   812   C0026845:Muscle [Tissue]
   812   C0205357:Smooth [Qualitative Concept]
   812   C1558950:VASCULAR [Finding]
   812   C1801960:Vascular [Qualitative Concept]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
   756 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   756 E C1511228:VESSEL, BLOOD [Tissue]
   741 E C0442025:Muscular [Spatial Concept]
   712 E C0005767:Blood [Tissue]
   712 E C0005768:blood [Body Substance]
   712 E C0229664:Blood [Body Substance]
   712 E C0392895:Bloods [Population Group]

Phrase: "isolated from diabetic GK rats,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   760   C0034693:rats [Mammal]
   760   C0034721:Rats [Mammal]
   760   C0205409:Isolated [Functional Concept]
   760   C0241863:DIABETIC [Finding]
   760   C1548221:Isolated [Idea or Concept]
   726 E C0370215:Isolate [Substance]
   726 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "a model for non-insulin-dependent diabetes mellitus (NIDDM)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C3161035:Model [Intellectual Product]
   703   C0011860:Diabetes Mellitus, Non-Insulin-Dependent [Disease or Syndrome]
   703   C2697407:DIABETES MELLITUS, NONINSULIN-DEPENDENT [Gene or Genome]

Phrase: "(25"

Phrase: ")"

Phrase: "and"

Phrase: "spontaneous hypertensive rats."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   988   C0034705:spontaneous hypertensive rat [Mammal]
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]
Processing 00000000.tx.231: As seen in Fig. 

Phrase: "As"

Phrase: "seen in Fig."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0205397:Seen [Qualitative Concept]
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756 E C0042789:see [Organism Function]
   756 E C1947903:See [Activity]
Processing 00000000.tx.232: 9, both diabetes and hypertension resulted in a 3040% decrease in basal MBP activity in VSMCs. 

Phrase: "9,"

Phrase: "both diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "and"

Phrase: "hypertension"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0020538:Hypertension [Disease or Syndrome]
  1000   C1963138:Hypertension [Finding]

Phrase: "resulted in a 3040% decrease"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0392756:Decrease [Qualitative Concept]
   760   C0547047:Decrease [Quantitative Concept]
   726   C1274040:Result [Functional Concept]
   726   C1546471:Result [Idea or Concept]
   726   C2825142:Result [Finding]

Phrase: "in basal MBP activity"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   885   C1149936:myosin phosphatase activity [Molecular Function]
   861   C1149927:protein phosphatase activity [Molecular Function]
   839   C1537044:protein activity [Molecular Function]
   827   C1149880:phosphatase activity [Molecular Function]
   799   C0205177:Activity [Functional Concept]
   799   C0439167:% activity [Quantitative Concept]
   799   C0441655:Activity [Activity]
   799   C1561536:*Activity [Idea or Concept]

Phrase: "in VSMCs."
Meta Candidates (Total=23; Excluded=11; Pruned=0; Remaining=12)
   923   C0026844:Muscle, Smooth, Vascular [Tissue]
   923   C1135918:Smooth Muscle Cells [Cell]
   861   C0596981:Muscle Cells [Cell]
   861   C1267092:Muscle, Smooth [Tissue]
   852   C0005773:Blood Cells [Cell]
   844 E C2328697:Hemal cell [Cell]
   812   C0005847:vascular [Body Part, Organ, or Organ Component]
   812   C0007634:Cells [Cell]
   812   C0026845:Muscle [Tissue]
   812   C0205357:Smooth [Qualitative Concept]
   812   C1558950:VASCULAR [Finding]
   812   C1801960:Vascular [Qualitative Concept]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
   756 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   756 E C1511228:VESSEL, BLOOD [Tissue]
   741 E C0442025:Muscular [Spatial Concept]
   712 E C0005767:Blood [Tissue]
   712 E C0005768:blood [Body Substance]
   712 E C0229664:Blood [Body Substance]
   712 E C0392895:Bloods [Population Group]
Processing 00000000.tx.233: In addition, these VSMCs were resistant to insulin in terms of MBP activation. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "these VSMCs"
Meta Candidates (Total=23; Excluded=11; Pruned=0; Remaining=12)
   923   C0026844:Muscle, Smooth, Vascular [Tissue]
   923   C1135918:Smooth Muscle Cells [Cell]
   861   C0596981:Muscle Cells [Cell]
   861   C1267092:Muscle, Smooth [Tissue]
   852   C0005773:Blood Cells [Cell]
   844 E C2328697:Hemal cell [Cell]
   812   C0005847:vascular [Body Part, Organ, or Organ Component]
   812   C0007634:Cells [Cell]
   812   C0026845:Muscle [Tissue]
   812   C0205357:Smooth [Qualitative Concept]
   812   C1558950:VASCULAR [Finding]
   812   C1801960:Vascular [Qualitative Concept]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
   756 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   756 E C1511228:VESSEL, BLOOD [Tissue]
   741 E C0442025:Muscular [Spatial Concept]
   712 E C0005767:Blood [Tissue]
   712 E C0005768:blood [Body Substance]
   712 E C0229664:Blood [Body Substance]
   712 E C0392895:Bloods [Population Group]

Phrase: "were"

Phrase: "resistant to insulin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   882   C0332325:Resistant to [Functional Concept]
           Resistant
   790   C2827757:RESISTANT [Laboratory or Test Result]

Phrase: "in terms of MBP activation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   853   C0599177:protein activation [Genetic Function]
   804   C1879547:Activation [Activity]
   708   C0067062:myosin phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.234: While 100 nM insulin caused a 60% increase in MBP activity in VSMCs isolated from control (WKY) rats, VSMCs from Type II diabetic GotoKakizaki (GK) rats and SHR exhibited only a 13% increase in MBP activity over the basal values. 

Phrase: "While"

Phrase: "100 nM insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "caused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015127:cause [Functional Concept]
   966   C1524003:Cause [Conceptual Entity]

Phrase: "a 60% increase in MBP activity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0442805:Increase [Functional Concept]

Phrase: "in VSMCs"
Meta Candidates (Total=23; Excluded=11; Pruned=0; Remaining=12)
   923   C0026844:Muscle, Smooth, Vascular [Tissue]
   923   C1135918:Smooth Muscle Cells [Cell]
   861   C0596981:Muscle Cells [Cell]
   861   C1267092:Muscle, Smooth [Tissue]
   852   C0005773:Blood Cells [Cell]
   844 E C2328697:Hemal cell [Cell]
   812   C0005847:vascular [Body Part, Organ, or Organ Component]
   812   C0007634:Cells [Cell]
   812   C0026845:Muscle [Tissue]
   812   C0205357:Smooth [Qualitative Concept]
   812   C1558950:VASCULAR [Finding]
   812   C1801960:Vascular [Qualitative Concept]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
   756 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   756 E C1511228:VESSEL, BLOOD [Tissue]
   741 E C0442025:Muscular [Spatial Concept]
   712 E C0005767:Blood [Tissue]
   712 E C0005768:blood [Body Substance]
   712 E C0229664:Blood [Body Substance]
   712 E C0392895:Bloods [Population Group]

Phrase: "isolated from control"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   790   C0205409:Isolated [Functional Concept]
   790   C0243148:control [Qualitative Concept]
   790   C1548221:Isolated [Idea or Concept]
   790   C1550141:Control [Substance]
   790   C1882979:Control [Conceptual Entity]
   790   C2587213:Control [Functional Concept]
   790   C3274648:Control [Qualitative Concept]
   756 E C0370215:Isolate [Substance]
   756 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "(WKY) rats,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0034709:Rats, Wistar Kyoto [Mammal]
           Wistar Kyoto
   913   C0034716:Rats, Wistar [Mammal]
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]
   827   C2700262:Wistar [Mammal]

Phrase: "VSMCs from Type II diabetic GotoKakizaki (GK) rats"
Meta Candidates (Total=21; Excluded=4; Pruned=0; Remaining=17)
   782   C0026844:Muscle, Smooth, Vascular [Tissue]
   782   C1135918:Smooth Muscle Cells [Cell]
   766   C1519715:Type II Cell [Cell]
   760   C0596981:Muscle Cells [Cell]
   760   C1267092:Muscle, Smooth [Tissue]
   757   C0449475:cells type [Intellectual Product]
   741 E C0007634:Cell Type [Cell]
           Cells
   739   C0005847:vascular [Body Part, Organ, or Organ Component]
   739   C0026845:Muscle [Tissue]
   739   C0205357:Smooth [Qualitative Concept]
   739   C1558950:VASCULAR [Finding]
   739   C1801960:Vascular [Qualitative Concept]
   739   C3282337:Cells [Cell]
   707   C0005773:Blood Cells [Cell]
   707   C0005810:blood type [Classification]
   707   C1383165:Blood Type [Clinical Attribute]
   707   C3274467:Blood Type [Diagnostic Procedure]
   706 E C1269647:Cell [Cell]
   706 E C1704653:Cell [Medical Device]
   706 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "SHR"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   988   C0034705:spontaneous hypertensive rat [Mammal]
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]

Phrase: "exhibited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0015272:Exhibit [Intellectual Product]

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "a 13% increase in MBP activity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0442805:Increase [Functional Concept]

Phrase: "over the basal values."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0042295:Values [Qualitative Concept]
   827 E C1522609:Value [Quantitative Concept]
Processing 00000000.tx.235: View larger version (25K): [in this window] [in a new window]  Figure 9. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(25K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 9."
Processing 00000000.tx.236: Diabetes and Hypertension Are Accompanied by Impaired MBP Activation by Insulin Serum starved VSMCs were treated with and without insulin (100 nM) for 10 min. 

Phrase: "Diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "and"

Phrase: "Hypertension"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0020538:Hypertension [Disease or Syndrome]
  1000   C1963138:Hypertension [Finding]

Phrase: "Are"

Phrase: "Accompanied by Impaired MBP Activation"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
   770   C0031686:Protein phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   767   C0067062:myosin phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   767   C0522527:Protein bound [Qualitative Concept]
   767   C0599177:protein activation [Genetic Function]
   744   C0027096:Myosin [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0031678:Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0221099:Impaired [Functional Concept]
   744   C0332297:bound [Spatial Concept]
           Bounded by
   744   C0684336:Impaired [Pathologic Function]
   744   C1145667:Bound [Activity]
   744   C1149880:phosphatase [Molecular Function]
   744   C1167622:Bound [Molecular Function]
   744   C1689898:% bound [Quantitative Concept]
   744   C1879547:Activation [Activity]
   744   C2349209:Bound [Conceptual Entity]

Phrase: "by Insulin Serum"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0428357:Insulin - serum [Laboratory Procedure]
  1000   C1261415:insulin serum [Laboratory or Test Result]
   861   C0229671:Serum [Body Substance]
   861   C1546774:Serum [Intellectual Product]
   861   C1550100:Serum [Body Substance]

Phrase: "starved"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2348531:Starve [Activity]

Phrase: "VSMCs"
Meta Candidates (Total=23; Excluded=11; Pruned=0; Remaining=12)
   923   C0026844:Muscle, Smooth, Vascular [Tissue]
   923   C1135918:Smooth Muscle Cells [Cell]
   861   C0596981:Muscle Cells [Cell]
   861   C1267092:Muscle, Smooth [Tissue]
   852   C0005773:Blood Cells [Cell]
   844 E C2328697:Hemal cell [Cell]
   812   C0005847:vascular [Body Part, Organ, or Organ Component]
   812   C0007634:Cells [Cell]
   812   C0026845:Muscle [Tissue]
   812   C0205357:Smooth [Qualitative Concept]
   812   C1558950:VASCULAR [Finding]
   812   C1801960:Vascular [Qualitative Concept]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
   756 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   756 E C1511228:VESSEL, BLOOD [Tissue]
   741 E C0442025:Muscular [Spatial Concept]
   712 E C0005767:Blood [Tissue]
   712 E C0005768:blood [Body Substance]
   712 E C0229664:Blood [Body Substance]
   712 E C0392895:Bloods [Population Group]

Phrase: "were"

Phrase: "treated with"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   833   C1522326:Treated [Functional Concept]
   799 E C1292734:TREAT [Functional Concept]

Phrase: "and without insulin"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1515981:And [Idea or Concept]
   790   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1579433:Insulin [Pharmacologic Substance]
   734 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   706 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(100 nM) for 10 min."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0312860:NM [Cell Function]
Processing 00000000.tx.237: Myosin-enriched fractions were assayed for MBP activity using [32P]-labeled MLC as a substrate. 

Phrase: "Myosin-enriched fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1264633:Fractions [Quantitative Concept]
   793 E C1554103:Fraction [Idea or Concept]

Phrase: "were"

Phrase: "assayed for MBP activity"
Meta Candidates (Total=23; Excluded=0; Pruned=0; Remaining=23)
   814   C1149927:protein phosphatase activity [Molecular Function]
   804   C1149936:myosin phosphatase activity [Molecular Function]
   778   C0031686:Protein phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   778   C1149880:phosphatase activity [Molecular Function]
           phosphatase
   774   C0067062:myosin phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   774   C0522527:Protein bound [Qualitative Concept]
   774   C1537044:protein activity [Molecular Function]
   748   C0027096:Myosin [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0031678:Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0205177:Activity [Functional Concept]
   748   C0332297:bound [Spatial Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C1145667:Bound [Activity]
   748   C1167622:Bound [Molecular Function]
   748   C1561536:*Activity [Idea or Concept]
   748   C1689898:% bound [Quantitative Concept]
   748   C2349209:Bound [Conceptual Entity]
   714   C0005507:Assay [Laboratory Procedure]
   714   C0243073:assay [Qualitative Concept]
   714   C1510438:Assay [Laboratory Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "[32P"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553631:32p [Medical Device]

Phrase: "]-labeled MLC as a substrate."
Processing 00000000.tx.238: Results are the mean  SEM of three separate experiments in duplicate. 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "the mean  SEM of three separate experiments"

Phrase: "in duplicate."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205173:Duplicate [Functional Concept]
  1000   C3539942:Duplicate [Intellectual Product]
Processing 00000000.tx.239: *, P < 0.05 vs. control; 

Phrase: "*,"

Phrase: "P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "vs. control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.240: **, P < 0.05 vs. 

Phrase: "*"

Phrase: "*,"

Phrase: "P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "vs."
Processing 00000000.tx.241: WKY control; 

Phrase: "WKY control"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]
   734   C0034709:Wistar Kyoto [Mammal]

Phrase: ";"
Processing 00000000.tx.242: ***, P < 0.05 vs. 

Phrase: "*"

Phrase: "*"

Phrase: "*,"

Phrase: "P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "vs."
Processing 00000000.tx.243: WKY insulin.   

Phrase: "WKY insulin."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]
   734   C0034709:Wistar Kyoto [Mammal]
Processing 00000000.tx.244: DISCUSSION TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES  The results presented in this study clearly indicate that insulin rapidly stimulates MBP in VSMCs isolated from control rats. 

Phrase: "DISCUSSION TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "The results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "presented in this study clearly"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0449450:Presented [Idea or Concept]
   760   C0557651:Study [Manufactured Object]
   760   C2603343:Study [Research Activity]
   726 E C0150312:Present [Quantitative Concept]

Phrase: "indicate"

Phrase: "that insulin rapidly"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "stimulates"

Phrase: "MBP in VSMCs"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   827   C0210219:Smooth Muscle Myosin-bound Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   764   C0031686:Protein phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   762   C0026832:Muscle Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   762   C0067062:myosin phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   762   C0522527:Protein bound [Qualitative Concept]
   742   C0031678:Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C1149880:phosphatase [Molecular Function]
   712   C0005832:blood protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "isolated from control rats."
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   770   C0034693:rats [Mammal]
   770   C0034721:Rats [Mammal]
   770   C0205409:Isolated [Functional Concept]
   770   C0243148:control [Qualitative Concept]
   770   C1548221:Isolated [Idea or Concept]
   770   C1550141:Control [Substance]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]
   737 E C0370215:Isolate [Substance]
   737 E C1875400:ISOLATE [Pharmacologic Substance]
Processing 00000000.tx.245: The kinetics of MBP activation by insulin parallels the time course of the insulin-mediated decrease in MBS phosphorylation as well as Rho kinase activity. 

Phrase: "The kinetics of MBP activation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0022702:Kinetics [Natural Phenomenon or Process]
   744   C0220865:kinetics [Functional Concept]
   744   C2825046:Kinetics [Occupation or Discipline]

Phrase: "by insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "parallels"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2348042:Parallel [Qualitative Concept]
  1000   C2826345:PARALLEL [Research Activity]

Phrase: "the time course of the insulin-mediated decrease"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0449247:Time course [Temporal Concept]
   744   C0040223:Time [Temporal Concept]
   744   C0750729:Course [Temporal Concept]
   744   C3541383:Time [Temporal Concept]

Phrase: "in MBS phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0031715:Phosphorylation [Molecular Function]
   812   C1158886:Phosphorylation [Molecular Function]

Phrase: "as well as"

Phrase: "Rho kinase activity."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C1150423:kinase activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
   734   C0389995:rho-Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   734   C1335631:RHO KINASE [Gene or Genome]
Processing 00000000.tx.246: Thus, insulin appears to stimulate MBP in part by decreasing the phosphorylation of its regulatory subunit, MBS, via Rho kinase inhibition. 

Phrase: "Thus,"

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "stimulate"

Phrase: "MBP in part"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0031686:Protein phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   783   C0067062:myosin phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   783   C0522527:Protein bound [Qualitative Concept]
   753   C0031678:Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1149880:phosphatase [Molecular Function]

Phrase: "by decreasing"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0442797:Decreasing [Qualitative Concept]
   966 E C0392756:Decrease [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "the phosphorylation of its regulatory subunit,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0031715:Phosphorylation [Molecular Function]
   753   C1158886:Phosphorylation [Molecular Function]

Phrase: "MBS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1711351:Subunit [Quantitative Concept]

Phrase: "via Rho kinase inhibition."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   827   C0021467:Inhibition [Mental Process]
   827   C0021469:Inhibition [Molecular Function]
   827   C1628982:% inhibition [Quantitative Concept]
   827   C3463820:Inhibition [Activity]
   755 E C0311403:Inhibited [Qualitative Concept]
   734   C0389995:rho-Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   734   C1335631:RHO KINASE [Gene or Genome]
Processing 00000000.tx.247: Insulin activation of MBP is accompanied by the inhibition of MLC20 phosphorylation as well as the inhibition of VSMC contraction. 

Phrase: "Insulin activation of MBP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C0599177:protein activation [Genetic Function]
   748   C1879547:Activation [Activity]

Phrase: "is"

Phrase: "accompanied by the inhibition of MLC20 phosphorylation"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   804   C1519062:inhibition of phosphorylation [Molecular Function]
           Phosphorylation Inhibition
   748   C0021467:Inhibition [Mental Process]
   748   C0021469:Inhibition [Molecular Function]
   748   C0031715:Phosphorylation [Molecular Function]
   748   C1158886:Phosphorylation [Molecular Function]
   748   C1628982:% inhibition [Quantitative Concept]
   748   C3463820:Inhibition [Activity]

Phrase: "as well as"

Phrase: "the inhibition of VSMC contraction."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   842   C2249966:inhibition of smooth muscle contraction [Organism Function]
   815   C2249836:inhibition of muscle contraction [Organism Function]
   744   C0021467:Inhibition [Mental Process]
   744   C0021469:Inhibition [Molecular Function]
   744   C1628982:% inhibition [Quantitative Concept]
   744   C3463820:Inhibition [Activity]
Processing 00000000.tx.248: Several lines of evidence presented in this study suggest that MBP activation by insulin in VSMCs is mediated by multiple inputs from the Rho kinase and PI3-kinase/NO/cGMP signaling pathways. 

Phrase: "Several lines of evidence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0205132:lines [Spatial Concept]
   737 E C1550648:Line [Substance]
   737 E C1552960:Line [Quantitative Concept]

Phrase: "presented in this study"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0449450:Presented [Idea or Concept]
   770   C0557651:Study [Manufactured Object]
   770   C2603343:Study [Research Activity]
   737 E C0150312:Present [Quantitative Concept]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that MBP activation by insulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C0599177:protein activation [Genetic Function]
   744   C1879547:Activation [Activity]

Phrase: "in VSMCs"
Meta Candidates (Total=23; Excluded=11; Pruned=0; Remaining=12)
   923   C0026844:Muscle, Smooth, Vascular [Tissue]
   923   C1135918:Smooth Muscle Cells [Cell]
   861   C0596981:Muscle Cells [Cell]
   861   C1267092:Muscle, Smooth [Tissue]
   852   C0005773:Blood Cells [Cell]
   844 E C2328697:Hemal cell [Cell]
   812   C0005847:vascular [Body Part, Organ, or Organ Component]
   812   C0007634:Cells [Cell]
   812   C0026845:Muscle [Tissue]
   812   C0205357:Smooth [Qualitative Concept]
   812   C1558950:VASCULAR [Finding]
   812   C1801960:Vascular [Qualitative Concept]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
   756 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   756 E C1511228:VESSEL, BLOOD [Tissue]
   741 E C0442025:Muscular [Spatial Concept]
   712 E C0005767:Blood [Tissue]
   712 E C0005768:blood [Body Substance]
   712 E C0229664:Blood [Body Substance]
   712 E C0392895:Bloods [Population Group]

Phrase: "is"

Phrase: "mediated by multiple inputs"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0086597:mediated [Social Behavior]
   770   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   770   C0439064:Multiple [Quantitative Concept]
   737   C1708517:Input [Conceptual Entity]

Phrase: "from the Rho kinase"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0389995:rho-Kinase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1335631:RHO KINASE [Gene or Genome]
   861   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "PI3-kinase/NO/cGMP signaling pathways."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   853   C1518333:Nitric Oxide Signaling Pathway [Molecular Function]
   844   C1518332:Nitric Oxide Pathway [Molecular Function]
   790   C1704259:Pathways [Molecular Function]
   790   C1705987:Pathways [Conceptual Entity]
   787   C0037080:Signal Pathways [Molecular Function]
   787   C0037083:signaling pathway [Cell Function]
   787   C0086982:Signaling Pathway [Molecular Function]
   705   C0070797:phosphatidylinositol 3-monophosphate [Lipid]
Processing 00000000.tx.249: First, insulin rapidly inactivates Rho kinase, and this inactivation is accompanied by a marked time-dependent reduction in MBS phosphorylation and MBP activation. 

Phrase: "First,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "insulin rapidly"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "inactivates"

Phrase: "Rho kinase,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0389995:rho-Kinase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1335631:RHO KINASE [Gene or Genome]
   861   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "this inactivation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0544461:Inactivation [Cell or Molecular Dysfunction]

Phrase: "is"

Phrase: "accompanied by a marked time-dependent reduction"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   748   C0040223:Time [Temporal Concept]
   748   C0301630:Reduction [Natural Phenomenon or Process]
   748   C0392756:Reduction [Qualitative Concept]
   748   C0441610:Reduction [Therapeutic or Preventive Procedure]
   748   C0522501:Marked [Qualitative Concept]
   748   C0851827:Dependent [Qualitative Concept]
   748   C1701901:Dependent [Qualitative Concept]
   748   C1706089:Marked [Qualitative Concept]
   748   C3244310:dependent [Functional Concept]
   748   C3541383:Time [Temporal Concept]

Phrase: "in MBS phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0031715:Phosphorylation [Molecular Function]
   812   C1158886:Phosphorylation [Molecular Function]

Phrase: "and"

Phrase: "MBP activation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   853   C0599177:protein activation [Genetic Function]
   804   C1879547:Activation [Activity]
   708   C0067062:myosin phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.250: Second, insulin pretreatment prevents thrombin-mediated Rho kinase activation, MBS phosphorylation, and inactivation of MBP and restores MBP enzymatic activity by partially blocking thrombins stimulatory effects on the translocation of Rho to the membrane fraction. 

Phrase: "Second, insulin pretreatment"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C1550147:Pretreatment [Substance]
   827   C2709094:pre treatment [Temporal Concept]
   827   C3539075:Pretreatment [Temporal Concept]
   827   C3539076:Pretreatment [Activity]

Phrase: "prevents"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0309872:PREVENT [Pharmacologic Substance]
  1000   C1292733:Prevents [Functional Concept]

Phrase: "thrombin-mediated Rho kinase activation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1879547:Activation [Activity]

Phrase: "MBS phosphorylation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0031715:Phosphorylation [Molecular Function]
   812   C1158886:Phosphorylation [Molecular Function]

Phrase: "and"

Phrase: "inactivation of MBP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0544461:Inactivation [Cell or Molecular Dysfunction]

Phrase: "and"

Phrase: "restores"

Phrase: "MBP enzymatic activity by partially blocking thrombins stimulatory effects"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   767   C1149927:protein phosphatase activity [Molecular Function]
   766   C1149936:myosin phosphatase activity [Molecular Function]
   753   C2267219:Enzymatic Activity [Molecular Function]
   751   C1149880:phosphatase activity [Molecular Function]
   751   C1537044:protein activity [Molecular Function]
   736   C0205177:Activity [Functional Concept]
   736   C0439167:% activity [Quantitative Concept]
   736   C0441655:Activity [Activity]
   736   C1561536:*Activity [Idea or Concept]
   734   C1149593:thrombin activity [Molecular Function]

Phrase: "on the translocation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040715:Translocation [Cell or Molecular Dysfunction]
  1000   C2987521:Translocation [Activity]

Phrase: "of Rho"

Phrase: "to the membrane fraction."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1264633:Fraction [Quantitative Concept]
   861   C1554103:Fraction [Idea or Concept]
Processing 00000000.tx.251: Support for our observations comes from a recent study by Feng et al. 

Phrase: "Support for our observations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0183683:Support [Medical Device]
   770   C1521721:Support [Conceptual Entity]

Phrase: "comes from a recent study"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0332185:Recent [Temporal Concept]
   760   C0557651:Study [Manufactured Object]
   760   C2603343:Study [Research Activity]

Phrase: "by Feng et al."
Processing 00000000.tx.252: (26). 

Phrase: "(26"

Phrase: ")."
Processing 00000000.tx.253: Using site- and phosphorylation state-specific antibodies, these authors have identified two major inhibitory Rho kinase phosphorylation sites on MBS: Thr695 and Thr850 (26). 

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "site-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205145:Site [Spatial Concept]
  1000   C1515974:Site [Body Location or Region]
  1000   C2825164:Site [Spatial Concept]

Phrase: "and"

Phrase: "phosphorylation state-specific antibodies,"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
  1000   C1257988:Phosphorylation State-Specific Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   844   C0443640:Specific antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   812   C0031715:Phosphorylation [Molecular Function]
   812   C0205369:Specific [Qualitative Concept]
   812   C1158886:Phosphorylation [Molecular Function]
   812   C1301808:State [Geographic Area]
   812   C1442792:State [Functional Concept]
   812   C1552740:specific [Intellectual Product]
   812   C3148680:State [Geographic Area]
   779 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "these authors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0221193:Authors [Professional or Occupational Group]

Phrase: "have"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "two major inhibitory Rho kinase phosphorylation sites on MBS"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   738   C0031715:Phosphorylation [Molecular Function]
   738   C0205145:Sites [Spatial Concept]
   738   C1158886:Phosphorylation [Molecular Function]
   722   C1519063:Phosphorylation Site [Amino Acid Sequence]
   704 E C1515974:Site [Body Location or Region]
   704 E C2825164:Site [Spatial Concept]

Phrase: ":"

Phrase: "Thr695"

Phrase: "and"

Phrase: "Thr850"

Phrase: "(26"

Phrase: ")."
Processing 00000000.tx.254: Direct phosphorylation of recombinant MBS by Rho kinase was accompanied by inhibition of MBP activity. 

Phrase: "Direct phosphorylation of recombinant MBS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0031715:Phosphorylation [Molecular Function]
   748   C1158886:Phosphorylation [Molecular Function]

Phrase: "by Rho kinase"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0389995:rho-Kinase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1335631:RHO KINASE [Gene or Genome]
   861   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "was"

Phrase: "accompanied by inhibition of MBP activity."
Meta Candidates (Total=25; Excluded=0; Pruned=0; Remaining=25)
   790   C1149927:protein phosphatase activity [Molecular Function]
   784   C1149936:myosin phosphatase activity [Molecular Function]
   764   C0031686:Protein phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   764   C1149880:phosphatase activity [Molecular Function]
           phosphatase
   762   C0067062:myosin phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   762   C0522527:Protein bound [Qualitative Concept]
   762   C1537044:protein activity [Molecular Function]
   742   C0021467:Inhibition [Mental Process]
   742   C0021469:Inhibition [Molecular Function]
   742   C0027096:Myosin [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0031678:Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0205177:Activity [Functional Concept]
   742   C0332297:bound [Spatial Concept]
           Bounded by
   742   C0439167:% activity [Quantitative Concept]
   742   C0441655:Activity [Activity]
   742   C1145667:Bound [Activity]
   742   C1167622:Bound [Molecular Function]
   742   C1561536:*Activity [Idea or Concept]
   742   C1628982:% inhibition [Quantitative Concept]
   742   C1689898:% bound [Quantitative Concept]
   742   C2349209:Bound [Conceptual Entity]
   742   C3463820:Inhibition [Activity]
Processing 00000000.tx.255: Furthermore, agonists that cause Rho kinase activation in intact Swis 3T3 cells also induced an increase in Thr695 phosphorylation on MBS, and this effect was blocked by a Rho kinase inhibitor, Y-27632 (26). 

Phrase: "Furthermore,"

Phrase: "agonists"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243192:agonists [Pharmacologic Substance]
  1000   C2987634:agonists [Pharmacologic Substance]

Phrase: "that"

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "Rho kinase activation in intact Swis 3T3 cells also"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   762   C1326120:activation cells [Cell Function]
   742   C1879547:Activation [Activity]

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "an increase in Thr695 phosphorylation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0442805:Increase [Functional Concept]

Phrase: "on MBS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1711351:Subunit [Quantitative Concept]

Phrase: "and"

Phrase: "this effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "was"

Phrase: "blocked by a Rho kinase inhibitor,"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   790   C0389995:rho-Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   790   C1171350:Kinase Inhibitor [Pharmacologic Substance]
   790   C1335631:RHO KINASE [Gene or Genome]
   790   C3537023:kinase inhibitor [Molecular Function]
   790   C3537035:kinase inhibitor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   753   C0028778:Blocked [Pathologic Function]
   753   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0332206:Blocked [Functional Concept]
   753   C1999216:Inhibitor [Qualitative Concept]
   753   C2983591:BLOCKED [Research Activity]
   719 E C1533157:Block [Substance]
   719 E C1706084:Block [Geographic Area]
   719 E C2828370:Block [Quantitative Concept]

Phrase: "Y-27632"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0667301:Y 27632 [Organic Chemical,Pharmacologic Substance]

Phrase: "(26"

Phrase: ")."
Processing 00000000.tx.256: Earlier studies have also shown that treatment of smooth muscle cells with C3 exoenzyme, which ADP ribosylates and inactivates the Rho family members, results in MBP activation because of Rho kinase inhibition (27) supporting the notion that inactivation of RhoA by insulin may cause MBP activation via Rho kinase inhibition. 

Phrase: "Earlier studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "also"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that treatment of smooth muscle cells"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0039798:treatment [Functional Concept]
   753   C0087111:Treatment [Therapeutic or Preventive Procedure]
   753   C1522326:Treatment [Functional Concept]
   753   C1533734:Treatment [Therapeutic or Preventive Procedure]
   753   C1705169:Treatment [Conceptual Entity]
   753   C3538994:TREATMENT [Research Activity]

Phrase: "with C3 exoenzyme,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596543:exoenzyme [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "which"

Phrase: "ADP ribosylates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0523452:ADP [Laboratory Procedure]

Phrase: "and"

Phrase: "inactivates"

Phrase: "the Rho family members,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   901   C0086282:Family Members [Family Group]
   867 E C1611821:Family Member [Intellectual Product]
   827   C0015576:Family [Family Group]
   827   C0680022:members [Population Group]
   827   C1704727:Family [Conceptual Entity]
   793 E C2698041:Member [Professional or Occupational Group]
   755 E C0241888:Familial [Functional Concept]

Phrase: "results in MBP activation"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
   778   C0031686:Protein phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   774   C0067062:myosin phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   774   C0522527:Protein bound [Qualitative Concept]
   774   C0599177:protein activation [Genetic Function]
   748   C0027096:Myosin [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0031678:Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0332297:bound [Spatial Concept]
   748   C1145667:Bound [Activity]
   748   C1149880:phosphatase [Molecular Function]
   748   C1167622:Bound [Molecular Function]
   748   C1274040:Result [Functional Concept]
   748   C1546471:Result [Idea or Concept]
   748   C1689898:% bound [Quantitative Concept]
   748   C1879547:Activation [Activity]
   748   C2349209:Bound [Conceptual Entity]
   748   C2825142:Result [Finding]

Phrase: "because of Rho kinase inhibition"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   827   C0021467:Inhibition [Mental Process]
   827   C0021469:Inhibition [Molecular Function]
   827   C1628982:% inhibition [Quantitative Concept]
   827   C3463820:Inhibition [Activity]
   755 E C0311403:Inhibited [Qualitative Concept]
   734   C0389995:rho-Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   734   C1335631:RHO KINASE [Gene or Genome]

Phrase: "(27"

Phrase: ")"

Phrase: "supporting"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0183683:Support [Medical Device]
   966   C1521721:Support [Conceptual Entity]

Phrase: "the notion"

Phrase: "that inactivation of RhoA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0544461:Inactivation [Cell or Molecular Dysfunction]

Phrase: "by insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "may"

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "MBP activation via Rho kinase inhibition."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   781   C1819041:protein kinase activation [Cell Function]
   762   C0599177:protein activation [Genetic Function]
   742   C1879547:Activation [Activity]
Processing 00000000.tx.257: Unlike the other effects of insulin, which are mediated via the PI3-kinase signaling pathway, insulins effect on Rho kinase inhibition does not appear to involve PI3-kinase as wortmannin, the PI3-kinase inhibitor, did not prevent insulin-mediated Rho kinase inactivation although it completely abolished insulin-mediated PI3-kinase activation. 

Phrase: "Unlike the"

Phrase: "other effects of insulin,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "which"

Phrase: "are"

Phrase: "mediated via the PI3-kinase signaling pathway,"
Meta Candidates (Total=16; Excluded=3; Pruned=0; Remaining=13)
   800   C0044602:Phosphatidylinositol 3-Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   789   C1155591:phosphatidylinositol-mediated signaling [Molecular Function]
   772 E C2936824:Phosphatidylinositol 3-Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0037083:signaling pathway [Cell Function]
           Signaling
   770   C0086982:Signaling Pathway [Molecular Function]
   767 E C0037080:pathway signaling [Molecular Function]
   744   C0031621:Phosphatidyl Inositol [Biologically Active Substance,Lipid]
   744   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0086597:mediated [Social Behavior]
   744   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   744   C1704259:Pathway [Molecular Function]
   744   C1705987:Pathway [Conceptual Entity]
   744   C2348046:Phosphatidylinositol [Lipid]
   744   C3537152:signaling [Biologic Function]
   711 E C1710082:Signal [Phenomenon or Process]

Phrase: "insulins effect on Rho kinase inhibition"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "appear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "involve"

Phrase: "PI3-kinase as wortmannin,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   862   C0044602:Phosphatidylinositol 3-Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   834 E C2936824:Phosphatidylinositol 3-Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "the PI3-kinase inhibitor,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C1519050:Phosphatidylinositol 3-kinase Inhibitor [Pharmacologic Substance]
   861   C1171350:Kinase Inhibitor [Pharmacologic Substance]
   861   C3537023:kinase inhibitor [Molecular Function]
   861   C3537035:kinase inhibitor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   812   C1999216:Inhibitor [Qualitative Concept]
   756   C0044602:Phosphatidylinositol 3-Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   729 E C2936824:Phosphatidylinositol 3-Kinases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "prevent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "insulin-mediated Rho kinase inactivation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0544461:Inactivation [Cell or Molecular Dysfunction]

Phrase: "although"

Phrase: "it completely abolished insulin-mediated PI3-kinase activation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1879547:Activation [Activity]
Processing 00000000.tx.258: Earlier studies by Kureishi et al (28) have also shown that high concentrations of wortmannin (100 M), which inhibit myosin light chain kinase, did not abolish contractions mediated by the constitutively active form of Rho kinase nor its catalytic activity in permeabilized smooth muscle of rabbit portal vein. 

Phrase: "Earlier studies by Kureishi et al (28"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   748   C0947630:studies [Laboratory Procedure]
   714 E C0557651:Study [Manufactured Object]
   714 E C2603343:Study [Research Activity]

Phrase: ")"

Phrase: "have"

Phrase: "also"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that high concentrations of wortmannin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0086045:Concentrations [Mental Process]
   726 E C1446561:Concentration [Quantitative Concept]

Phrase: "(100"

Phrase: "M)"

Phrase: ","

Phrase: "which"

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "myosin light chain kinase,"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
  1000   C0027120:Myosin Light Chain Kinase [Amino Acid, Peptide, or Protein,Enzyme]
           Myosin Kinase
  1000   C1150543:myosin light-chain kinase [Molecular Function]
  1000   C1334539:MYOSIN LIGHT CHAIN KINASE [Gene or Genome]
   923   C0027108:Myosin Light Chain [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0023693:Light [Natural Phenomenon or Process]
   812   C0027096:Myosin [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0337112:Chain [Manufactured Object]
   812   C1306462:Light [Functional Concept]
   812   C1524075:Chain [Idea or Concept]
   812   C1881376:Light [Qualitative Concept]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "abolish"

Phrase: "contractions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1140999:contractions [Pathologic Function]

Phrase: "mediated by the constitutively active form of Rho kinase"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   764   C0389995:rho-Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   764   C1335631:RHO KINASE [Gene or Genome]
   742   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0086597:mediated [Social Behavior]
   742   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   742   C0205177:Active [Functional Concept]
   742   C0348078:Form [Qualitative Concept]
   742   C0376315:Form [Manufactured Object]
   742   C1522492:Form [Functional Concept]

Phrase: "nor"

Phrase: "its catalytic activity in permeabilized smooth muscle of rabbit portal vein."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   756   C0243102:catalytic activity [Molecular Function]
   756   C1264638:Catalytic activity [Functional Concept]
   756   C1547012:*Catalytic Activity [Quantitative Concept]
   738   C0205177:Activity [Functional Concept]
   738   C0439167:% activity [Quantitative Concept]
   738   C0441655:Activity [Activity]
   738   C1561536:*Activity [Idea or Concept]
   718   C0231484:Muscular activity [Organ or Tissue Function]
Processing 00000000.tx.259: However, in our study, inhibition of PI3-kinase with wortmannin effectively blocks insulin-mediated MBP activation by attenuating insulininduced NO and cGMP generation. 

Phrase: "However,"

Phrase: "in our study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "inhibition of PI3-kinase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0021467:Inhibition [Mental Process]
   760   C0021469:Inhibition [Molecular Function]
   760   C1628982:% inhibition [Quantitative Concept]
   760   C3463820:Inhibition [Activity]

Phrase: "with wortmannin effectively"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0078517:wortmannin [Biologically Active Substance,Pharmacologic Substance,Steroid]

Phrase: "blocks"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "insulin-mediated MBP activation by attenuating insulininduced NO"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   751   C0599177:protein activation [Genetic Function]
   736   C1879547:Activation [Activity]

Phrase: "and"

Phrase: "cGMP generation."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   812   C0079411:Generation [Temporal Concept]
   812   C3146294:Generation [Activity]
   756   C0018338:Cyclic guanosine monophosphate [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   719 E C1414672:Genesis [Gene or Genome]
   719 E C2984892:Genesis [Gene or Genome]
Processing 00000000.tx.260: From the inhibitor studies, it appears that the NOS/cGMP signaling pathway may mediate insulins inhibitory effects on Rho kinase inactivation, thereby decreasing MBS phosphorylation as well as MBP activation. 

Phrase: "From the inhibitor studies,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "it"

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "that"

Phrase: "the NOS/cGMP signaling pathway"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   902   C1518333:Nitric Oxide Signaling Pathway [Molecular Function]
   897   C1518332:Nitric Oxide Pathway [Molecular Function]
   812   C0037083:signaling pathway [Cell Function]
   812   C0086982:Signaling Pathway [Molecular Function]
   795 E C0037080:Signal Pathway [Molecular Function]
   793   C1704259:Pathway [Molecular Function]
   793   C1705987:Pathway [Conceptual Entity]
   717   C1155501:nitric oxide signaling [Molecular Function]

Phrase: "may"

Phrase: "mediate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "insulins inhibitory effects on Rho kinase inactivation,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C1280500:effects [Qualitative Concept]
   714 E C2348382:Effect [Qualitative Concept]

Phrase: "thereby"

Phrase: "decreasing"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0442797:Decreasing [Qualitative Concept]
   966 E C0392756:Decrease [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "MBS phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0031715:Phosphorylation [Molecular Function]
   812   C1158886:Phosphorylation [Molecular Function]

Phrase: "as well as"

Phrase: "MBP activation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   853   C0599177:protein activation [Genetic Function]
   804   C1879547:Activation [Activity]
   708   C0067062:myosin phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.261: For example, blocking NOS activity with L-NMMA attenuates the effect of insulin on Rho kinase inhibition. 

Phrase: "For example,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707959:Example [Conceptual Entity]

Phrase: "blocking"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0233660:Blocking [Mental or Behavioral Dysfunction]
  1000   C0332206:Blocking [Functional Concept]
   966 E C0028778:Block [Pathologic Function]
   966 E C1533157:Block [Substance]
   966 E C1706084:Block [Geographic Area]
   966 E C2828370:Block [Quantitative Concept]

Phrase: "NOS activity with L-NMMA"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   853   C1151383:nitric-oxide synthase activity [Molecular Function]
   748   C0205177:Activity [Functional Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C1561536:*Activity [Idea or Concept]

Phrase: "attenuates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0599946:Attenuate [Activity]

Phrase: "the effect of insulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "on Rho kinase inhibition."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   827   C0021467:Inhibition [Mental Process]
   827   C0021469:Inhibition [Molecular Function]
   827   C1628982:% inhibition [Quantitative Concept]
   827   C3463820:Inhibition [Activity]
   755 E C0311403:Inhibited [Qualitative Concept]
   734   C0389995:rho-Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   734   C1335631:RHO KINASE [Gene or Genome]
Processing 00000000.tx.262: Furthermore, treatment with RpcGMP, a cGMP antagonist, prevents insulin-mediated Rho kinase inactivation as well as MBP activation. 

Phrase: "Furthermore,"

Phrase: "treatment with RpcGMP,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0039798:treatment [Functional Concept]
   790   C0087111:Treatment [Therapeutic or Preventive Procedure]
   790   C1522326:Treatment [Functional Concept]
   790   C1533734:Treatment [Therapeutic or Preventive Procedure]
   790   C1705169:Treatment [Conceptual Entity]
   790   C3538994:TREATMENT [Research Activity]

Phrase: "a cGMP antagonist,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0231491:Antagonist [Organ or Tissue Function]
   756   C0018338:Cyclic guanosine monophosphate [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   712 E C0680242:antagonism [Social Behavior]

Phrase: "prevents"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0309872:PREVENT [Pharmacologic Substance]
  1000   C1292733:Prevents [Functional Concept]

Phrase: "insulin-mediated Rho kinase inactivation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0544461:Inactivation [Cell or Molecular Dysfunction]

Phrase: "as well as"

Phrase: "MBP activation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   853   C0599177:protein activation [Genetic Function]
   804   C1879547:Activation [Activity]
   708   C0067062:myosin phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.263: More importantly, treatment with a cGMP agonist, 8-bromo-cGMP, and SNP, a NO donor, mimics the effect of insulin on Rho kinase inactivation, MBS phosphorylation, and MBP activation. 

Phrase: "More importantly,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205172:More [Functional Concept]

Phrase: "treatment with a cGMP agonist,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0039798:treatment [Functional Concept]
   748   C0087111:Treatment [Therapeutic or Preventive Procedure]
   748   C1522326:Treatment [Functional Concept]
   748   C1533734:Treatment [Therapeutic or Preventive Procedure]
   748   C1705169:Treatment [Conceptual Entity]
   748   C3538994:TREATMENT [Research Activity]

Phrase: "8-bromo-cGMP,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0050057:8-bromocyclic guanosine monophosphate [Nucleic Acid, Nucleoside, or Nucleotide]
   884   C0018338:Cyclic guanosine monophosphate [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   840   C0018346:Guanosine Monophosphate [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0018330:Guanosine [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]

Phrase: "and"

Phrase: "SNP,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0037533:Sodium Nitroprusside [Organic Chemical,Pharmacologic Substance]
   944 E C0591866:Nipride [Inorganic Chemical,Pharmacologic Substance]
   861   C0028193:Nitroprusside [Inorganic Chemical,Pharmacologic Substance]
   861   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   861   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "a NO donor,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0600437:nitric oxide donor [Pharmacologic Substance]
   827   C0013018:Donor [Population Group]
   827   C0040288:Donor [Population Group]
   827   C1527169:Donor NOS [Finding]
   734   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]

Phrase: "mimics"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0393040:mimics [Therapeutic or Preventive Procedure]
  1000   C1176299:mimics [Hazardous or Poisonous Substance,Organic Chemical]

Phrase: "the effect of insulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "on Rho kinase inactivation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0544461:Inactivation [Cell or Molecular Dysfunction]
   734   C0389995:rho-Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   734   C1335631:RHO KINASE [Gene or Genome]

Phrase: "MBS phosphorylation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0031715:Phosphorylation [Molecular Function]
   812   C1158886:Phosphorylation [Molecular Function]

Phrase: "and"

Phrase: "MBP activation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   853   C0599177:protein activation [Genetic Function]
   804   C1879547:Activation [Activity]
   708   C0067062:myosin phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.264: It is not clear, at present, why wortmannin failed to block insulins inhibitory effect on Rho kinase. 

Phrase: "It"

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "clear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2963144:Clear [Qualitative Concept]

Phrase: ","

Phrase: "at present,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150312:Present [Quantitative Concept]
  1000   C0449450:Present [Idea or Concept]

Phrase: "why wortmannin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0078517:wortmannin [Biologically Active Substance,Pharmacologic Substance,Steroid]

Phrase: "failed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:Failed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "block"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "insulins inhibitory effect on Rho kinase."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.265: Further studies with transfected VSMCs overexpressing constitutively active and dominant negative mutants of p85PI3-kinase and p110PI3-kinase, NOS, and protein kinase G (PKG) are needed to clearly establish whether insulin inactivates Rho kinase via a signal generated by NOS signaling independent of the PI3-kinase pathway. 

Phrase: "Further studies with transfected VSMCs"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   744   C0947630:studies [Laboratory Procedure]
   711 E C0557651:Study [Manufactured Object]
   711 E C2603343:Study [Research Activity]

Phrase: "overexpressing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1514559:overexpress [Genetic Function]

Phrase: "constitutively active"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205177:Active [Functional Concept]

Phrase: "and"

Phrase: "dominant negative mutants of p85PI3-kinase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   816   C1512032:Dominant-Negative Mutant [Cell or Molecular Dysfunction]
   753   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "and"

Phrase: "p110PI3-kinase,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "NOS,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
           synthase
   901   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C0030015:oxide [Inorganic Chemical]
   827   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "and"

Phrase: "protein kinase G (PKG)"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0010536:Protein Kinase G [Amino Acid, Peptide, or Protein,Enzyme]
   913   C0060916:protein g [Amino Acid, Peptide, or Protein]
   901   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0439267:g% [Quantitative Concept]

Phrase: "are"

Phrase: "needed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027552:Needed [Qualitative Concept]
  1000   C0686904:needed [Functional Concept]

Phrase: "to clearly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1883351:To [Qualitative Concept]

Phrase: "establish"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443211:establish [Qualitative Concept]

Phrase: "whether"

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "inactivates"

Phrase: "Rho kinase via a signal"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0389995:rho-Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   806   C1335631:RHO KINASE [Gene or Genome]
   760   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "generated by NOS"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   862   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
           synthase
   806   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   760   C0030015:oxide [Inorganic Chemical]
   760   C2986642:oxide [Chemical Viewed Functionally]
   760   C3146294:Generated [Activity]

Phrase: "signaling independent of the PI3-kinase pathway."
Meta Candidates (Total=16; Excluded=2; Pruned=0; Remaining=14)
   800   C0044602:Phosphatidylinositol 3-Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   772 E C2936824:Phosphatidylinositol 3-Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0332291:Independent of [Functional Concept]
   767   C0037080:pathway signaling [Molecular Function]
   767   C0037083:signaling pathway [Cell Function]
           Signaling
   767   C0086982:Signaling Pathway [Molecular Function]
   744   C0031621:Phosphatidyl Inositol [Biologically Active Substance,Lipid]
   744   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0085862:Independent [Idea or Concept]
   744   C1299583:Independent [Finding]
   744   C1704259:Pathway [Molecular Function]
   744   C1705987:Pathway [Conceptual Entity]
   744   C2348046:Phosphatidylinositol [Lipid]
   744   C3537152:signaling [Biologic Function]
   711 E C1710082:Signal [Phenomenon or Process]
Processing 00000000.tx.266: Nonetheless, our results, though indirect, suggest a complex cross-talk between two major contraction/relaxation signaling pathways, Rho kinase and NO/cGMP, to mediate insulins stimulatory effect on MBP activation. 

Phrase: "Nonetheless,"

Phrase: "our results,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "though"

Phrase: "indirect,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439852:Indirect [Qualitative Concept]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "a complex cross-talk between two major contraction/relaxation signaling pathways,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   756   C0010357:Crosstalk [Molecular Function]
   756   C2986468:Cross-talk [Cell Function]
   738   C0037817:Talk [Organism Function]
   738   C0234856:talk [Daily or Recreational Activity]
   738   C0600118:talk [Finding]
   738   C2828360:Cross [Conceptual Entity]

Phrase: "Rho kinase"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0389995:rho-Kinase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1335631:RHO KINASE [Gene or Genome]
   861   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "NO/cGMP,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   884   C0018338:Cyclic guanosine monophosphate [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   840   C0018346:Guanosine Monophosphate [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0018330:Guanosine [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   804   C0439596:Cyclic [Temporal Concept]
   804   C1511572:Cyclic [Temporal Concept]
   733 E C0031084:Cyclicities [Temporal Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "mediate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "insulins stimulatory effect on MBP activation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C1280500:Effect [Qualitative Concept]
   742   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.267: Regarding the role of the NO/cGMP in the insulin-mediated MBP activation, studies performed by others (29), as well as our laboratory (24), have shown that insulin stimulates the induction of iNOS protein leading to the generation of NO and causes an elevation in the cGMP levels (24). 

Phrase: "Regarding"

Phrase: "the role of the NO/cGMP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0035820:Role [Social Behavior]
   742   C1705810:Role [Conceptual Entity]

Phrase: "in the insulin-mediated MBP activation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   829   C0599177:protein activation [Genetic Function]
   795   C1879547:Activation [Activity]

Phrase: "studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "performed by others"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   882   C1550369:Performed By [Qualitative Concept]
   790   C0884358:Performed [Functional Concept]
   790   C1955473:Others [Finding]
   756 E C2947996:Perform [Pharmacologic Substance]

Phrase: "(29"

Phrase: ")"

Phrase: ","

Phrase: "as well as"

Phrase: "our laboratory"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0022877:Laboratory [Manufactured Object,Organization]
  1000   C3244292:laboratory [Functional Concept]

Phrase: "(24"

Phrase: ")"

Phrase: ","

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "stimulates"

Phrase: "the induction of iNOS protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205263:Induction [Functional Concept]
   760   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "leading to the generation of NO"
Meta Candidates (Total=12; Excluded=4; Pruned=0; Remaining=8)
   778   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   757   C0064720:lead oxide [Hazardous or Poisonous Substance,Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid]
   748   C0030015:oxide [Inorganic Chemical]
   748   C0079411:Generation [Temporal Concept]
   748   C0332152:Leading [Temporal Concept]
   748   C1522538:Leading [Functional Concept]
   748   C2986642:oxide [Chemical Viewed Functionally]
   748   C3146294:Generation [Activity]
   714 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   714 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   714 E C2348269:Lead [Element, Ion, or Isotope]
   714 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "an elevation in the cGMP levels"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0439775:Elevation [Therapeutic or Preventive Procedure]
   744   C0702240:Elevation [Spatial Concept]

Phrase: "(24"

Phrase: ")."
Processing 00000000.tx.268: Also, it is well known that cGMP signaling pathway inhibits the contraction of smooth muscle by directly activating MBP (30). 

Phrase: "Also,"

Phrase: "it"

Phrase: "is"

Phrase: "well known"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205170:Well [Qualitative Concept]
   861   C0205309:Known [Qualitative Concept]
   861   C3146287:Well [Manufactured Object]

Phrase: "that cGMP signaling pathway"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   840   C0037083:signaling pathway [Cell Function]
   840   C0086982:Signaling Pathway [Molecular Function]
   823 E C0037080:Signal Pathway [Molecular Function]
   804   C1704259:Pathway [Molecular Function]
   804   C1705987:Pathway [Conceptual Entity]
   717   C0018338:Cyclic guanosine monophosphate [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "the contraction of smooth muscle"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   844   C1155937:smooth muscle contraction [Organ or Tissue Function]
   797   C0026820:Muscle Contraction [Physiologic Function]
   760   C1140999:Contraction [Pathologic Function]

Phrase: "by directly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947931:Directly [Qualitative Concept]

Phrase: "activating"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1879547:activating [Activity]
   966 E C1515877:Activate [Functional Concept]

Phrase: "MBP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   902   C0067062:myosin phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0031686:Protein phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0031678:Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1149880:phosphatase [Molecular Function]

Phrase: "(30"

Phrase: ")."
Processing 00000000.tx.269: It is not exactly clear how cGMP activates MBP. 

Phrase: "It"

Phrase: "is"

Phrase: "not exactly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "clear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2963144:Clear [Qualitative Concept]

Phrase: "how cGMP"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   923   C0018338:Cyclic guanosine monophosphate [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0018346:Guanosine Monophosphate [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0018330:Guanosine [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   812   C0439596:Cyclic [Temporal Concept]
   812   C1511572:Cyclic [Temporal Concept]
   741 E C0031084:Cyclicities [Temporal Concept]

Phrase: "activates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "MBP."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   902   C0067062:myosin phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0031686:Protein phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0031678:Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1149880:phosphatase [Molecular Function]
Processing 00000000.tx.270: Our preliminary studies suggest that in addition to its directs effects on MBP, cGMP may be inhibiting Rho kinase, thereby decreasing MBS phosphorylation leading to MBP activation. 

Phrase: "Our preliminary studies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0439611:Preliminary [Temporal Concept]
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that in addition to its"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1883712:Addition [Functional Concept]

Phrase: "directs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439851:Direct [Qualitative Concept]
  1000   C1947931:Direct [Qualitative Concept]

Phrase: "effects on MBP,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C1280500:effects [Qualitative Concept]
   719 E C2348382:Effect [Qualitative Concept]

Phrase: "cGMP"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0018338:Cyclic guanosine monophosphate [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   901   C0018346:Guanosine Monophosphate [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0018330:Guanosine [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   827   C0439596:Cyclic [Temporal Concept]
   827   C1511572:Cyclic [Temporal Concept]
   755 E C0031084:Cyclicities [Temporal Concept]

Phrase: "may"

Phrase: "be"

Phrase: "inhibiting"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C3463820:Inhibiting [Activity]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C0311403:Inhibited [Qualitative Concept]

Phrase: "Rho kinase,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0389995:rho-Kinase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1335631:RHO KINASE [Gene or Genome]
   861   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "thereby"

Phrase: "decreasing"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0442797:Decreasing [Qualitative Concept]
   966 E C0392756:Decrease [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "MBS phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0031715:Phosphorylation [Molecular Function]
   812   C1158886:Phosphorylation [Molecular Function]

Phrase: "leading to MBP activation."
Meta Candidates (Total=20; Excluded=4; Pruned=0; Remaining=16)
   778   C0031686:Protein phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   774   C0067062:myosin phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   774   C0522527:Protein bound [Qualitative Concept]
   774   C0599177:protein activation [Genetic Function]
   748   C0027096:Myosin [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0031678:Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0332152:Leading [Temporal Concept]
   748   C0332297:bound [Spatial Concept]
   748   C1145667:Bound [Activity]
   748   C1149880:phosphatase [Molecular Function]
   748   C1167622:Bound [Molecular Function]
   748   C1522538:Leading [Functional Concept]
   748   C1689898:% bound [Quantitative Concept]
   748   C1879547:Activation [Activity]
   748   C2349209:Bound [Conceptual Entity]
   714 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   714 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   714 E C2348269:Lead [Element, Ion, or Isotope]
   714 E C3275067:LEAD [Therapeutic or Preventive Procedure]
Processing 00000000.tx.271: Studies by Wu et al. 

Phrase: "Studies by Wu et al."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   760   C0947630:studies [Laboratory Procedure]
   726 E C0557651:Study [Manufactured Object]
   726 E C2603343:Study [Research Activity]
Processing 00000000.tx.272: (30) on smooth muscle from rabbit ileum suggest that cGMP-mediated activation of PKG may phosphorylate MBS on a specific site, resulting in MBP activation. 

Phrase: "(30"

Phrase: ")"

Phrase: "on smooth muscle"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1267092:Muscle, Smooth [Tissue]
   861   C0026845:Muscle [Tissue]
   861   C0205357:Smooth [Qualitative Concept]
   789 E C0442025:Muscular [Spatial Concept]

Phrase: "from rabbit ileum"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0020885:ileum [Body Part, Organ, or Organ Component]
   861   C1278923:Ileum [Body Part, Organ, or Organ Component]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that cGMP-mediated activation of PKG"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   777   C1819041:protein kinase activation [Cell Function]
   757   C0599177:protein activation [Genetic Function]
   739   C1879547:Activation [Activity]

Phrase: "may"

Phrase: "phosphorylate"

Phrase: "MBS on a specific site,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1711351:Subunit [Quantitative Concept]

Phrase: "resulting in MBP activation."
Meta Candidates (Total=19; Excluded=3; Pruned=0; Remaining=16)
   778   C0031686:Protein phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   778   C0332294:Resulting in [Functional Concept]
   774   C0067062:myosin phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   774   C0522527:Protein bound [Qualitative Concept]
   774   C0599177:protein activation [Genetic Function]
   748   C0027096:Myosin [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0031678:Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0332297:bound [Spatial Concept]
   748   C0678226:resulting [Functional Concept]
   748   C1145667:Bound [Activity]
   748   C1149880:phosphatase [Molecular Function]
   748   C1167622:Bound [Molecular Function]
   748   C1689898:% bound [Quantitative Concept]
   748   C1879547:Activation [Activity]
   748   C2349209:Bound [Conceptual Entity]
   714 E C1274040:Result [Functional Concept]
   714 E C1546471:Result [Idea or Concept]
   714 E C2825142:Result [Finding]
Processing 00000000.tx.273: However, recent studies by Nakamura et al. 

Phrase: "However,"

Phrase: "recent studies by Nakamura et al."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   753   C0947630:studies [Laboratory Procedure]
   719 E C0557651:Study [Manufactured Object]
   719 E C2603343:Study [Research Activity]
Processing 00000000.tx.274: (31) indicated that phosphorylation of MBS by cGMP-dependent PKG did not affect the phosphatase activity toward MLC20 but phosphorylation of the MBP holoenzyme decreased the binding of MBP to phospholipid. 

Phrase: "(31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")"

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "that phosphorylation of MBS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0031715:Phosphorylation [Molecular Function]
   753   C1158886:Phosphorylation [Molecular Function]

Phrase: "by cGMP-dependent PKG"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   868   C0061991:Guanosine Monophosphate Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0061985:guanosine kinase [Amino Acid, Peptide, or Protein,Enzyme]
   845   C0010536:Protein Kinase G [Amino Acid, Peptide, or Protein,Enzyme]
   829   C0060916:protein g [Amino Acid, Peptide, or Protein]
   818   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   795   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   795   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0439267:g% [Quantitative Concept]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "the phosphatase activity toward MLC20"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C1149880:phosphatase activity [Molecular Function]
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1561536:*Activity [Idea or Concept]

Phrase: "but"

Phrase: "phosphorylation of the MBP holoenzyme"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   744   C0031715:Phosphorylation [Molecular Function]

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "the binding of MBP"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   804   C1149295:protein phosphatase binding [Molecular Function]
   774   C0033618:Protein Binding [Molecular Function]
   774   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   774   C1149266:myosin binding [Molecular Function]
   774   C1149293:phosphatase binding [Molecular Function]
   748   C0243122:binding [Functional Concept]
   748   C1145667:Binding [Activity]
   748   C1167622:Binding [Molecular Function]

Phrase: "to phospholipid."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031676:Phospholipid [Biologically Active Substance,Lipid]
  1000   C0202177:Phospholipid [Laboratory Procedure]
Processing 00000000.tx.275: Thus, phosphorylation of MBS by PKG is not a direct mechanism in activating MBP. 

Phrase: "Thus,"

Phrase: "phosphorylation of MBS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0031715:Phosphorylation [Molecular Function]
   760   C1158886:Phosphorylation [Molecular Function]

Phrase: "by PKG"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0010536:Protein Kinase G [Amino Acid, Peptide, or Protein,Enzyme]
   913   C0060916:protein g [Amino Acid, Peptide, or Protein]
   901   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0439267:g% [Quantitative Concept]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "a direct mechanism in activating MBP."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0441712:Mechanism [Functional Concept]
   742   C1706376:Mechanism [Manufactured Object]
Processing 00000000.tx.276: Our results do not exclude the possibility that decreased MBS phosphorylation and phosphatase activation by insulin may be due to some unknown mechanism other than Rho kinase inhibition. 

Phrase: "Our results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "exclude"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332196:Exclude [Functional Concept]
  1000   C2828389:Exclude [Activity]

Phrase: "the possibility"

Phrase: "that decreased MBS phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0031715:Phosphorylation [Molecular Function]
   804   C1158886:Phosphorylation [Molecular Function]

Phrase: "and"

Phrase: "phosphatase activation by insulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1879547:Activation [Activity]

Phrase: "may"

Phrase: "be due to some unknown mechanism"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0678226:Due to [Functional Concept]
           due
   753   C0439673:Unknown [Qualitative Concept]
   753   C0441712:Mechanism [Functional Concept]
   753   C1706376:Mechanism [Manufactured Object]
   753   C2987476:Be [Conceptual Entity]
   753   C3146286:Due [Idea or Concept]

Phrase: "other than Rho kinase inhibition."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   827   C0021467:Inhibition [Mental Process]
   827   C0021469:Inhibition [Molecular Function]
   827   C1628982:% inhibition [Quantitative Concept]
   827   C3463820:Inhibition [Activity]
   755 E C0311403:Inhibited [Qualitative Concept]
   734   C0389995:rho-Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   734   C1335631:RHO KINASE [Gene or Genome]
Processing 00000000.tx.277: For example, insulin may activate another phosphatase which dephosphorylates MBS causing MBP activation. 

Phrase: "For example,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707959:Example [Conceptual Entity]

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "may"

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "another phosphatase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031678:Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1149880:phosphatase [Molecular Function]

Phrase: "which"

Phrase: "dephosphorylates"

Phrase: "MBS causing MBP activation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   817   C0599177:protein activation [Genetic Function]
   791   C1879547:Activation [Activity]
   712   C0067062:myosin phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.278: This possibility was tested with OA. 

Phrase: "This possibility"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   928   C0332149:Possible [Qualitative Concept]
   928   C1705910:Possible [Qualitative Concept]
   928   C2362652:Possible [Qualitative Concept]

Phrase: "was"

Phrase: "tested with OA."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   833   C0069389:Ocadaic Acid [Hazardous or Poisonous Substance,Organic Chemical]
   770   C0001128:Acid [Chemical]
   770   C0202406:Acid [Laboratory Procedure]
   770   C0392366:tested [Intellectual Product]
   737 E C0022885:Test [Laboratory Procedure]
   737 E C0039593:Test [Functional Concept]
Processing 00000000.tx.279: We observed that higher concentrations of OA completely prevented insulin-mediated MBS dephosphorylation. 

Phrase: "We"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "that higher concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "of OA completely prevented insulin-mediated MBS dephosphorylation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1158884:Dephosphorylation [Molecular Function]
   790   C3160734:Dephosphorylation [Molecular Function]
Processing 00000000.tx.280: Similar results were obtained in an in vitro study on purified preparations of myosin phosphatase reported by Ichikawa et al. 

Phrase: "Similar results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "were"

Phrase: "obtained in an in vitro study"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   820   C0681828:in vitro study [Research Activity]
           study vitro
   783   C0021135:In Vitro [Intellectual Product]
   783   C1533691:in vitro [Qualitative Concept]
           vitro
   783   C2827718:In Vitro [Functional Concept]
   753   C0557651:Study [Manufactured Object]
   753   C1301820:Obtained [Functional Concept]
   753   C2603343:Study [Research Activity]
   719 E C1706701:Obtain [Activity]

Phrase: "on purified preparations"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   953   C0353043:Cleansing preparations [Pharmacologic Substance]
   827   C0455052:Preparation [Health Care Activity]
   827   C1521827:Preparation [Functional Concept]

Phrase: "of myosin phosphatase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0067062:myosin phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0027096:Myosin [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0031678:Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1149880:phosphatase [Molecular Function]

Phrase: "reported by Ichikawa et al."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   806   C1709908:Reported By [Group]
   760   C0684224:Reported [Intellectual Product]
   760   C0700287:Reported [Health Care Activity]
   760   C3496591:Reported [Clinical Attribute]
   726 E C3273238:Report [Intellectual Product]
Processing 00000000.tx.281: (14). 

Phrase: "(14"

Phrase: ")."
Processing 00000000.tx.282: Although these results suggest the involvement of a type 1 phosphatase, we cannot rule out the possibility that MBP holoenzyme itself may be catalyzing the dephosphorylation of its regulatory subunit, MBS. 

Phrase: "Although"

Phrase: "these results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "the involvement of a type 1 phosphatase,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1314939:Involvement [Functional Concept]

Phrase: "we"

Phrase: "cannot"

Phrase: "rule"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0805874:Rule [Idea or Concept]
  1000   C0870077:Rule [Intellectual Product]
  1000   C1446409:rule [Qualitative Concept]

Phrase: "out"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439787:Out [Spatial Concept]
  1000   C0849355:Out [Qualitative Concept]

Phrase: "the possibility"

Phrase: "that MBP holoenzyme"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   708   C0067062:myosin phosphatase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "itself"

Phrase: "may"

Phrase: "be"

Phrase: "catalyzing"

Phrase: "the dephosphorylation of its regulatory subunit,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1158884:Dephosphorylation [Molecular Function]
   753   C3160734:Dephosphorylation [Molecular Function]

Phrase: "MBS."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1711351:Subunit [Quantitative Concept]
Processing 00000000.tx.283: A detailed analysis of the MBS phosphorylation site(s) that are dephosphorylated by insulin is needed. 

Phrase: "A detailed analysis of the MBS phosphorylation site"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   739   C0002778:Analysis [Laboratory Procedure]
   739   C0936012:Analysis [Research Activity]
   739   C1524024:analysis [Functional Concept]

Phrase: "("

Phrase: "s)"

Phrase: "that"

Phrase: "are"

Phrase: "dephosphorylated by insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1579433:Insulin [Pharmacologic Substance]
   734 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   706 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "is"

Phrase: "needed."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027552:Needed [Qualitative Concept]
  1000   C0686904:needed [Functional Concept]
Processing 00000000.tx.284: However, at present, these experiments are not feasible due to the nonavailability of a site-specific phosphoantibody that would react with the phosphothreonine 695 on MBS, which is believed to be involved in inhibition of MBP (27). 

Phrase: "However,"

Phrase: "at present,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150312:Present [Quantitative Concept]
  1000   C0449450:Present [Idea or Concept]

Phrase: "these experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "are"

Phrase: "not feasible due to the nonavailability of a site-specific phosphoantibody"

Phrase: "that"

Phrase: "would"

Phrase: "react with the phosphothreonine 695"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0031724:Phosphothreonine [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]

Phrase: "on MBS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1711351:Subunit [Quantitative Concept]

Phrase: "which"

Phrase: "is"

Phrase: "believed"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "involved in inhibition of MBP"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
   770   C0031686:Protein phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   767   C0067062:myosin phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   767   C0522527:Protein bound [Qualitative Concept]
   744   C0021467:Inhibition [Mental Process]
   744   C0021469:Inhibition [Molecular Function]
   744   C0027096:Myosin [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0031678:Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0332297:bound [Spatial Concept]
   744   C1145667:Bound [Activity]
   744   C1149880:phosphatase [Molecular Function]
   744   C1167622:Bound [Molecular Function]
   744   C1314939:Involved [Functional Concept]
   744   C1628982:% inhibition [Quantitative Concept]
   744   C1689898:% bound [Quantitative Concept]
   744   C2349209:Bound [Conceptual Entity]
   744   C3463820:Inhibition [Activity]

Phrase: "(27"

Phrase: ")."
Processing 00000000.tx.285: In addition to these potential mechanisms for the regulation of MBP activity, recent studies have reported the presence of heat-stable inhibitors of MBP that are activated via phosphorylation by protein kinase C (PKC) and presumably by Rho kinase (32). 

Phrase: "In addition to these potential mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0441712:Mechanisms [Functional Concept]
   827 E C1706376:Mechanism [Manufactured Object]

Phrase: "for the regulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0851285:Regulation [Governmental or Regulatory Activity]
  1000   C1327622:Regulation [Biologic Function]

Phrase: "of MBP activity,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   911   C1149936:myosin phosphatase activity [Molecular Function]
   884   C1149927:protein phosphatase activity [Molecular Function]
   853   C1537044:protein activity [Molecular Function]
   840   C1149880:phosphatase activity [Molecular Function]
   804   C0205177:Activity [Functional Concept]
   804   C0439167:% activity [Quantitative Concept]
   804   C0441655:Activity [Activity]
   804   C1561536:*Activity [Idea or Concept]
   708   C0067062:myosin phosphatase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "recent studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "the presence of heat-stable inhibitors of MBP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "that"

Phrase: "are"

Phrase: "activated via phosphorylation by protein kinase C (PKC)"
Meta Candidates (Total=15; Excluded=2; Pruned=0; Remaining=13)
   814   C0033634:Protein Kinase C [Amino Acid, Peptide, or Protein,Enzyme]
   804 E C1259877:kinase c protein [Amino Acid, Peptide, or Protein,Enzyme]
   800   C0483249:Activated protein C [Amino Acid, Peptide, or Protein,Enzyme]
   778   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   774   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   774   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   774   C1168438:Protein C [Laboratory Procedure]
   774   C1418943:PROTEIN C [Gene or Genome]
   774   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0031715:Phosphorylation [Molecular Function]
   748   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C1879547:Activated [Activity]
   714 E C1515877:Activate [Functional Concept]

Phrase: "and"

Phrase: "presumably by Rho kinase"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0389995:rho-Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   833   C1335631:RHO KINASE [Gene or Genome]
   770   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(32"

Phrase: ")."
Processing 00000000.tx.286: Therefore, it is plausible that inhibition of Rho kinase by insulin will inhibit the heat-stable inhibitors of MBP, resulting in the activation of the phosphatase. 

Phrase: "Therefore,"

Phrase: "it"

Phrase: "is"

Phrase: "plausible"

Phrase: "that inhibition of Rho kinase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0021467:Inhibition [Mental Process]
   760   C0021469:Inhibition [Molecular Function]
   760   C1628982:% inhibition [Quantitative Concept]
   760   C3463820:Inhibition [Activity]

Phrase: "by insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "will"

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "the heat-stable inhibitors of MBP,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   767   C1514560:Protein Phosphatase Inhibitor [Pharmacologic Substance]
   745   C0597217:phosphatase inhibitor [Pharmacologic Substance]
   742   C0243077:inhibitors [Chemical Viewed Functionally]
   708 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "resulting in the activation of the phosphatase."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   778   C0332294:Resulting in [Functional Concept]
   748   C0031678:Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0678226:resulting [Functional Concept]
   748   C1149880:phosphatase [Molecular Function]
   748   C1879547:Activation [Activity]
   714 E C1274040:Result [Functional Concept]
   714 E C1546471:Result [Idea or Concept]
   714 E C2825142:Result [Finding]
Processing 00000000.tx.287: In contrast to WKY, VSMCs isolated from diabetic GK rats and SHR exhibit marked insulin resistance in terms of MBP activation. 

Phrase: "In contrast to WKY,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034709:Wistar Kyoto [Mammal]

Phrase: "VSMCs"
Meta Candidates (Total=23; Excluded=11; Pruned=0; Remaining=12)
   923   C0026844:Muscle, Smooth, Vascular [Tissue]
   923   C1135918:Smooth Muscle Cells [Cell]
   861   C0596981:Muscle Cells [Cell]
   861   C1267092:Muscle, Smooth [Tissue]
   852   C0005773:Blood Cells [Cell]
   844 E C2328697:Hemal cell [Cell]
   812   C0005847:vascular [Body Part, Organ, or Organ Component]
   812   C0007634:Cells [Cell]
   812   C0026845:Muscle [Tissue]
   812   C0205357:Smooth [Qualitative Concept]
   812   C1558950:VASCULAR [Finding]
   812   C1801960:Vascular [Qualitative Concept]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
   756 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   756 E C1511228:VESSEL, BLOOD [Tissue]
   741 E C0442025:Muscular [Spatial Concept]
   712 E C0005767:Blood [Tissue]
   712 E C0005768:blood [Body Substance]
   712 E C0229664:Blood [Body Substance]
   712 E C0392895:Bloods [Population Group]

Phrase: "isolated from diabetic GK rats"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   760   C0034693:rats [Mammal]
   760   C0034721:Rats [Mammal]
   760   C0205409:Isolated [Functional Concept]
   760   C0241863:DIABETIC [Finding]
   760   C1548221:Isolated [Idea or Concept]
   726 E C0370215:Isolate [Substance]
   726 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "and"

Phrase: "SHR"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   988   C0034705:spontaneous hypertensive rat [Mammal]
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]

Phrase: "exhibit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "marked insulin resistance in terms of MBP activation."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   770   C0597296:protein bound insulin [Amino Acid, Peptide, or Protein]
   756   C0021655:Insulin Resistance [Pathologic Function]
   756   C2700570:INSULIN RESISTANCE [Gene or Genome]
   754   C1317461:Insulin.bound [Laboratory or Test Result]
   738   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   738   C0237834:Resistance [Mental Process]
   738   C1514892:Resistance [Physiologic Function]
   738   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   738   C1579433:Insulin [Pharmacologic Substance]
Processing 00000000.tx.288: In our recent studies we have demonstrated that VSMCs from SHR exhibit impaired iNOS induction in response to insulin (24). 

Phrase: "In our recent studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "have"

Phrase: "demonstrated"

Phrase: "that VSMCs from SHR"
Meta Candidates (Total=16; Excluded=4; Pruned=0; Remaining=12)
   790   C0026844:Muscle, Smooth, Vascular [Tissue]
   790   C1135918:Smooth Muscle Cells [Cell]
   764   C0596981:Muscle Cells [Cell]
   764   C1267092:Muscle, Smooth [Tissue]
   742   C0005847:vascular [Body Part, Organ, or Organ Component]
   742   C0007634:Cells [Cell]
   742   C0026845:Muscle [Tissue]
   742   C0205357:Smooth [Qualitative Concept]
   742   C1558950:VASCULAR [Finding]
   742   C1801960:Vascular [Qualitative Concept]
   742   C3282337:Cells [Cell]
   712   C0005773:Blood Cells [Cell]
   708 E C1269647:Cell [Cell]
   708 E C1704653:Cell [Medical Device]
   708 E C1948049:Cell [Spatial Concept]
   703 E C2328697:Hemal cell [Cell]

Phrase: "exhibit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "impaired iNOS induction in response"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205263:Induction [Functional Concept]
   760   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "to insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(24"

Phrase: ")."
Processing 00000000.tx.289: To our knowledge, this is the first in vivo study demonstrating MBP activation by insulin in VSMCs via reductions in the MBS phosphorylation status and its abnormal regulation in the insulin-resistant states associated with hypertension and NIDDM. 

Phrase: "To our knowledge,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0376554:Knowledge [Intellectual Product]

Phrase: "this"

Phrase: "is"

Phrase: "the first in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "demonstrating"

Phrase: "MBP activation by insulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C0599177:protein activation [Genetic Function]
   748   C1879547:Activation [Activity]

Phrase: "in VSMCs"
Meta Candidates (Total=23; Excluded=11; Pruned=0; Remaining=12)
   923   C0026844:Muscle, Smooth, Vascular [Tissue]
   923   C1135918:Smooth Muscle Cells [Cell]
   861   C0596981:Muscle Cells [Cell]
   861   C1267092:Muscle, Smooth [Tissue]
   852   C0005773:Blood Cells [Cell]
   844 E C2328697:Hemal cell [Cell]
   812   C0005847:vascular [Body Part, Organ, or Organ Component]
   812   C0007634:Cells [Cell]
   812   C0026845:Muscle [Tissue]
   812   C0205357:Smooth [Qualitative Concept]
   812   C1558950:VASCULAR [Finding]
   812   C1801960:Vascular [Qualitative Concept]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
   756 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   756 E C1511228:VESSEL, BLOOD [Tissue]
   741 E C0442025:Muscular [Spatial Concept]
   712 E C0005767:Blood [Tissue]
   712 E C0005768:blood [Body Substance]
   712 E C0229664:Blood [Body Substance]
   712 E C0392895:Bloods [Population Group]

Phrase: "via reductions"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0301630:reductions [Natural Phenomenon or Process]
  1000   C0441610:reductions [Therapeutic or Preventive Procedure]
   966 E C0392756:Reduction [Qualitative Concept]

Phrase: "in the MBS phosphorylation status"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0449438:Status [Qualitative Concept]

Phrase: "and"

Phrase: "its abnormal regulation in the insulin-resistant states"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0851285:Regulation [Governmental or Regulatory Activity]
   744   C1327622:Regulation [Biologic Function]

Phrase: "associated with hypertension"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C0020538:Hypertension [Disease or Syndrome]
   790   C1963138:Hypertension [Finding]
   756 E C0750490:Associate [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]

Phrase: "and"

Phrase: "NIDDM."
Meta Candidates (Total=17; Excluded=2; Pruned=0; Remaining=15)
  1000   C0011860:Diabetes Mellitus, Non-Insulin-Dependent [Disease or Syndrome]
           Non-Insulin Dependent Diabetes
  1000   C2697407:DIABETES MELLITUS, NONINSULIN-DEPENDENT [Gene or Genome]
   937   C0011854:Diabetes Mellitus, Insulin-Dependent [Disease or Syndrome]
           Insulin Dependent Diabetes
   840   C0011849:Diabetes Mellitus [Disease or Syndrome]
           Diabetes
   804   C0011847:Diabetes [Disease or Syndrome]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0851827:Dependent [Qualitative Concept]
   804   C1518422:Non [Functional Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1701901:Dependent [Qualitative Concept]
   804   C3244310:dependent [Functional Concept]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.290: Other studies have demonstrated an inhibitory regulation of MBP by a G protein-dependent mechanism (10, 11, 12). 

Phrase: "Other studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "demonstrated"

Phrase: "an inhibitory regulation of MBP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0851285:Regulation [Governmental or Regulatory Activity]
   744   C1327622:Regulation [Biologic Function]

Phrase: "by a G protein-dependent mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0441712:Mechanism [Functional Concept]
   812   C1706376:Mechanism [Manufactured Object]

Phrase: "(10,"

Phrase: "11,"

Phrase: "12"

Phrase: ")."
Processing 00000000.tx.291: Thus, an inhibition of MBP activity by thrombin (22), arachidonic acid (16), PKC (17), and GTPS (10, 11, 12) have been reported. 

Phrase: "Thus,"

Phrase: "an inhibition of MBP activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0021467:Inhibition [Mental Process]
   744   C0021469:Inhibition [Molecular Function]
   744   C1628982:% inhibition [Quantitative Concept]
   744   C3463820:Inhibition [Activity]

Phrase: "by thrombin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040018:Thrombin [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "(22"

Phrase: ")"

Phrase: ","

Phrase: "arachidonic acid"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0003695:Arachidonic Acid [Eicosanoid]
  1000   C2316832:Arachidonic Acid [Laboratory Procedure]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "(16"

Phrase: ")"

Phrase: ","

Phrase: "PKC"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   760   C0031715:Phosphorylation [Molecular Function]

Phrase: "(17"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "GTPS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0018353:GTP [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(10,"

Phrase: "11,"

Phrase: "12"

Phrase: ")"

Phrase: "have"

Phrase: "been"

Phrase: "reported."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]
Processing 00000000.tx.292: This study adds a new dimension to the above observations by demonstrating that insulins stimulatory effect on MBP activation is due, in part, to a reduction in the MBS phosphorylation state in addition to the concomitant activation of the enzyme bound to MBS via cGMP signaling, thereby causing MLC20 dephosphorylation and insulin-mediated vasorelaxation. 

Phrase: "This study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "adds"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883712:Add [Functional Concept]

Phrase: "a new dimension to the above observations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0439534:Dimension [Quantitative Concept]

Phrase: "by"

Phrase: "demonstrating"

Phrase: "that insulins stimulatory effect on MBP activation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C1280500:Effect [Qualitative Concept]
   739   C2348382:Effect [Qualitative Concept]

Phrase: "is"

Phrase: "due,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0678226:due [Functional Concept]
  1000   C3146286:Due [Idea or Concept]

Phrase: "in part,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449719:Part [Spatial Concept]
  1000   C1709471:Part [Quantitative Concept]

Phrase: "to a reduction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0301630:Reduction [Natural Phenomenon or Process]
  1000   C0392756:Reduction [Qualitative Concept]
  1000   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "in the MBS phosphorylation state"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C0031715:Phosphorylation [Molecular Function]
   804   C1158886:Phosphorylation [Molecular Function]
   804   C1301808:State [Geographic Area]
   804   C1442792:State [Functional Concept]
   804   C3148680:State [Geographic Area]

Phrase: "in addition to the concomitant activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1879547:Activation [Activity]

Phrase: "of the enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0014442:Enzyme [Enzyme,Organic Chemical]
   916 E C0014445:enzymes [Functional Concept]

Phrase: "bound to MBS"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0027096:Myosin [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0332297:bound [Spatial Concept]
   760   C1145667:Bound [Activity]
   760   C1167622:Bound [Molecular Function]
   760   C1689898:% bound [Quantitative Concept]
   760   C1711351:Subunit [Quantitative Concept]
   760   C2349209:Bound [Conceptual Entity]

Phrase: "via cGMP signaling,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0037083:Signaling [Cell Function]
   812   C3537152:signaling [Biologic Function]
   756   C0018338:Cyclic guanosine monophosphate [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "thereby"

Phrase: "causing"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0678227:Causing [Functional Concept]
   966 E C0015127:cause [Functional Concept]
   966 E C1524003:Cause [Conceptual Entity]

Phrase: "MLC20 dephosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1158884:Dephosphorylation [Molecular Function]
   861   C3160734:Dephosphorylation [Molecular Function]

Phrase: "and"

Phrase: "insulin-mediated vasorelaxation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0042401:Vasorelaxation [Physiologic Function]
Processing 00000000.tx.293: Therefore, the impaired vasorelaxation observed in patients with diabetes and hypertension may be due to inherent reductions in MBP activity resulting from defective regulation of MBP activation in response to insulin. 

Phrase: "Therefore,"

Phrase: "the impaired vasorelaxation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0042401:Vasorelaxation [Physiologic Function]

Phrase: "observed in patients"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0030705:Patients [Patient or Disabled Group]
   790   C1441672:Observed [Functional Concept]

Phrase: "with diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "and"

Phrase: "hypertension"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0020538:Hypertension [Disease or Syndrome]
  1000   C1963138:Hypertension [Finding]

Phrase: "may"

Phrase: "be due to inherent reductions"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   806   C0678226:Due to [Functional Concept]
           due
   760   C0301630:reductions [Natural Phenomenon or Process]
   760   C0441610:reductions [Therapeutic or Preventive Procedure]
   760   C2987476:Be [Conceptual Entity]
   760   C3146286:Due [Idea or Concept]
   726 E C0392756:Reduction [Qualitative Concept]

Phrase: "in MBP activity"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   911   C1149936:myosin phosphatase activity [Molecular Function]
   884   C1149927:protein phosphatase activity [Molecular Function]
   853   C1537044:protein activity [Molecular Function]
   840   C1149880:phosphatase activity [Molecular Function]
   804   C0205177:Activity [Functional Concept]
   804   C0439167:% activity [Quantitative Concept]
   804   C0441655:Activity [Activity]
   804   C1561536:*Activity [Idea or Concept]
   708   C0067062:myosin phosphatase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "resulting from defective regulation of MBP activation"
Meta Candidates (Total=21; Excluded=3; Pruned=0; Remaining=18)
   760   C0031686:Protein phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   757   C0067062:myosin phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   757   C0522527:Protein bound [Qualitative Concept]
   757   C0599177:protein activation [Genetic Function]
   739   C0027096:Myosin [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0031678:Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0332297:bound [Spatial Concept]
   739   C0332452:Defective [Functional Concept]
   739   C0678226:resulting [Functional Concept]
   739   C0851285:Regulation [Governmental or Regulatory Activity]
   739   C1145667:Bound [Activity]
   739   C1149880:phosphatase [Molecular Function]
   739   C1167622:Bound [Molecular Function]
   739   C1327622:Regulation [Biologic Function]
   739   C1689898:% bound [Quantitative Concept]
   739   C1879547:Activation [Activity]
   739   C2349209:Bound [Conceptual Entity]
   706 E C1274040:Result [Functional Concept]
   706 E C1546471:Result [Idea or Concept]
   706 E C2825142:Result [Finding]

Phrase: "in response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871261:Response [Organism Attribute]
  1000   C1704632:Response [Finding]
  1000   C1706817:Response [Intellectual Product]
  1000   C2911692:Response [Mental Process]

Phrase: "to insulin."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.294: Given the knowledge that PKC levels are elevated in VSMCs isolated from diabetic rat aortas (33) and the fact that PKC can activate Rho and inhibit MBP, it is tempting to speculate that the impaired MBP activation by insulin observed in diabetes and SHR may be due to an elevation in the PKC activity via excessive release of arachidonic acid by phospholipase A2 (23). 

Phrase: "Given"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]

Phrase: "the knowledge"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0376554:Knowledge [Intellectual Product]

Phrase: "that PKC levels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   748   C0031715:Phosphorylation [Molecular Function]

Phrase: "are"

Phrase: "elevated in VSMCs"
Meta Candidates (Total=18; Excluded=4; Pruned=0; Remaining=14)
   833   C0026844:Muscle, Smooth, Vascular [Tissue]
   833   C1135918:Smooth Muscle Cells [Cell]
   790   C0596981:Muscle Cells [Cell]
   790   C1267092:Muscle, Smooth [Tissue]
   753   C0005847:vascular [Body Part, Organ, or Organ Component]
   753   C0007634:Cells [Cell]
   753   C0026845:Muscle [Tissue]
   753   C0205250:Elevated [Qualitative Concept]
   753   C0205357:Smooth [Qualitative Concept]
   753   C1558950:VASCULAR [Finding]
   753   C1801960:Vascular [Qualitative Concept]
   753   C3163633:Elevated [Qualitative Concept]
   753   C3282337:Cells [Cell]
   733   C0005773:Blood Cells [Cell]
   725 E C2328697:Hemal cell [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "isolated from diabetic rat aortas"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   790   C1882561:Rat Aorta [Body Part, Organ, or Organ Component]
   760   C0003483:Aortas [Body Part, Organ, or Organ Component]
   760   C0034693:Rat, NOS [Mammal]
   760   C0034721:Rat [Mammal]
   760   C0205409:Isolated [Functional Concept]
   760   C0241863:DIABETIC [Finding]
   760   C1548221:Isolated [Idea or Concept]
   726 E C0370215:Isolate [Substance]
   726 E C1278934:Aorta [Body Part, Organ, or Organ Component]
   726 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "(33"

Phrase: ")"

Phrase: "and"

Phrase: "the fact"

Phrase: "that PKC"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   753   C0031715:Phosphorylation [Molecular Function]

Phrase: "can"

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "Rho"

Phrase: "and"

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "MBP,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   902   C0067062:myosin phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0031686:Protein phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0031678:Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1149880:phosphatase [Molecular Function]

Phrase: "it"

Phrase: "is"

Phrase: "tempting"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "speculate"

Phrase: "that"

Phrase: "the impaired MBP activation by insulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   762   C0599177:protein activation [Genetic Function]
   742   C1879547:Activation [Activity]

Phrase: "observed in diabetes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0011847:Diabetes [Disease or Syndrome]
   790   C0011849:Diabetes [Disease or Syndrome]
   790   C1441672:Observed [Functional Concept]

Phrase: "and"

Phrase: "SHR"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   988   C0034705:spontaneous hypertensive rat [Mammal]
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]

Phrase: "may"

Phrase: "be due to an elevation"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0678226:Due to [Functional Concept]
           due
   760   C0439775:Elevation [Therapeutic or Preventive Procedure]
   760   C0702240:Elevation [Spatial Concept]
   760   C2987476:Be [Conceptual Entity]
   760   C3146286:Due [Idea or Concept]

Phrase: "in the PKC activity"
Meta Candidates (Total=22; Excluded=1; Pruned=0; Remaining=21)
   861   C1150572:protein kinase C activity [Molecular Function]
   842   C1150527:protein kinase activity [Molecular Function]
   842   C3642159:Protein C Activity [Laboratory Procedure]
   836   C1537044:protein activity [Molecular Function]
   835   C0033634:Protein Kinase C [Amino Acid, Peptide, or Protein,Enzyme]
   823 E C2261495:protein phosphokinase activity [Molecular Function]
   822   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   822   C1150423:kinase activity [Molecular Function]
   822   C1168438:Protein C [Laboratory Procedure]
   822   C1418943:PROTEIN C [Gene or Genome]
   822   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   793   C0031715:Phosphorylation [Molecular Function]
   793   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   793   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   793   C0150312:In [Quantitative Concept]
   793   C0205177:Activity [Functional Concept]
   793   C0332285:In [Spatial Concept]
   793   C0439167:% activity [Quantitative Concept]
   793   C0441655:Activity [Activity]
   793   C1158886:Phosphorylation [Molecular Function]
   793   C1561536:*Activity [Idea or Concept]

Phrase: "via excessive release"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0030685:Release [Health Care Activity]
   861   C0391871:Release [Functional Concept]
   861   C0439180:% release [Quantitative Concept]
   861   C0680255:release [Health Care Activity]
   861   C1283071:Release [Functional Concept]
   861   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "of arachidonic acid"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0003695:Arachidonic Acid [Eicosanoid]
  1000   C2316832:Arachidonic Acid [Laboratory Procedure]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "by phospholipase A2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031667:Phospholipase A2 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1744635:Phospholipase A2 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C3539768:Phospholipase A2 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0031671:Phospholipase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.295: Arachidonic acid could increase Rho kinase activity as well as interact directly with MBS, causing dissociation of the holoenzyme, thereby reducing MBP activity (23). 

Phrase: "Arachidonic acid"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0003695:Arachidonic Acid [Eicosanoid]
  1000   C2316832:Arachidonic Acid [Laboratory Procedure]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "could"

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "Rho kinase activity"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C1150423:kinase activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
   734   C0389995:rho-Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   734   C1335631:RHO KINASE [Gene or Genome]

Phrase: "as well as"

Phrase: "interact"

Phrase: "directly with MBS,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0027096:Myosin [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0332297:bound [Spatial Concept]
   760   C1145667:Bound [Activity]
   760   C1167622:Bound [Molecular Function]
   760   C1689898:% bound [Quantitative Concept]
   760   C1711351:Subunit [Quantitative Concept]
   760   C1947931:Directly [Qualitative Concept]
   760   C2349209:Bound [Conceptual Entity]

Phrase: "causing"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0678227:Causing [Functional Concept]
   966 E C0015127:cause [Functional Concept]
   966 E C1524003:Cause [Conceptual Entity]

Phrase: "dissociation of the holoenzyme,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0086168:Dissociation [Mental or Behavioral Dysfunction]

Phrase: "thereby"

Phrase: "reducing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reducing [Qualitative Concept]

Phrase: "MBP activity"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   911   C1149936:myosin phosphatase activity [Molecular Function]
   884   C1149927:protein phosphatase activity [Molecular Function]
   853   C1537044:protein activity [Molecular Function]
   840   C1149880:phosphatase activity [Molecular Function]
   804   C0205177:Activity [Functional Concept]
   804   C0439167:% activity [Quantitative Concept]
   804   C0441655:Activity [Activity]
   804   C1561536:*Activity [Idea or Concept]
   708   C0067062:myosin phosphatase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.296: Alternatively, arachidonic acid could activate a kinase that phosphorylates MBS and inhibits MBP. 

Phrase: "Alternatively,"

Phrase: "arachidonic acid"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0003695:Arachidonic Acid [Eicosanoid]
  1000   C2316832:Arachidonic Acid [Laboratory Procedure]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "could"

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "a kinase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "that"

Phrase: "phosphorylates"

Phrase: "MBS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1711351:Subunit [Quantitative Concept]

Phrase: "and"

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "MBP."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   902   C0067062:myosin phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0031686:Protein phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0031678:Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1149880:phosphatase [Molecular Function]
Processing 00000000.tx.297: Our results complement the above observations by documenting that MBS is phosphorylated under basal conditions and the enzymatic activity of MBP is low. 

Phrase: "Our results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "complement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0009498:Complement [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "the above observations by documenting"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   797   C0557070:Documenting observations [Health Care Activity]
   760   C0302523:observations [Research Activity]
   760   C0700325:observations [Health Care Activity]
   760   C3244290:observations [Functional Concept]
   726 E C1964257:Observation [Diagnostic Procedure]

Phrase: "that MBS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1711351:Subunit [Quantitative Concept]

Phrase: "is"

Phrase: "phosphorylated under basal conditions"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0205112:Basal [Spatial Concept]
   737   C0012634:condition [Disease or Syndrome]
   737   C0348080:Condition [Qualitative Concept]
   737   C1705253:Condition [Conceptual Entity]

Phrase: "and"

Phrase: "the enzymatic activity of MBP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   793   C1149927:protein phosphatase activity [Molecular Function]
   789   C1149936:myosin phosphatase activity [Molecular Function]
   770   C2267219:Enzymatic Activity [Molecular Function]
   767   C1149880:phosphatase activity [Molecular Function]
   767   C1537044:protein activity [Molecular Function]
   744   C0205177:Activity [Functional Concept]
   744   C0439167:% activity [Quantitative Concept]
   744   C0441655:Activity [Activity]
   744   C1561536:*Activity [Idea or Concept]

Phrase: "is"

Phrase: "low."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205251:low [Qualitative Concept]
  1000   C1299352:Low [Qualitative Concept]
  1000   C1550472:low [Idea or Concept]
Processing 00000000.tx.298: Insulin treatment relieves the inhibition and restores the enzymatic activity of MBP by decreasing MBS phosphorylation. 

Phrase: "Insulin treatment"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0745343:insulin treatment [Therapeutic or Preventive Procedure]
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]

Phrase: "relieves"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1301676:Relieves [Functional Concept]
   916 E C0332303:relieving [Functional Concept]
   916 E C1301771:Relieved [Qualitative Concept]

Phrase: "the inhibition"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0021467:Inhibition [Mental Process]
  1000   C0021469:Inhibition [Molecular Function]
  1000   C1628982:% inhibition [Quantitative Concept]
  1000   C3463820:Inhibition [Activity]
   928 E C0311403:Inhibited [Qualitative Concept]

Phrase: "and"

Phrase: "restores"

Phrase: "the enzymatic activity of MBP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   793   C1149927:protein phosphatase activity [Molecular Function]
   789   C1149936:myosin phosphatase activity [Molecular Function]
   770   C2267219:Enzymatic Activity [Molecular Function]
   767   C1149880:phosphatase activity [Molecular Function]
   767   C1537044:protein activity [Molecular Function]
   744   C0205177:Activity [Functional Concept]
   744   C0439167:% activity [Quantitative Concept]
   744   C0441655:Activity [Activity]
   744   C1561536:*Activity [Idea or Concept]

Phrase: "by decreasing MBS phosphorylation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0031715:Phosphorylation [Molecular Function]
   804   C1158886:Phosphorylation [Molecular Function]
Processing 00000000.tx.299: In summary, the results of this study suggest that insulin utilizes the Rho kinase and NO/cGMP signaling pathways to reduce the phosphorylation of MBS and activate MBP which causes vasorelaxation by the dephosphorylation of MLC20.  

Phrase: "In summary,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1552616:summary [Intellectual Product]
  1000   C1706244:Summary [Intellectual Product]

Phrase: "the results of this study"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C0683954:results study [Finding]
   726   C1274040:Result [Functional Concept]
   726   C1546471:Result [Idea or Concept]
   726   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "utilizes"

Phrase: "the Rho kinase"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0389995:rho-Kinase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1335631:RHO KINASE [Gene or Genome]
   861   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "NO/cGMP signaling pathways to"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   877   C1518333:Nitric Oxide Signaling Pathway [Molecular Function]
   867   C1518332:Nitric Oxide Pathway [Molecular Function]
   795   C0037080:Signal Pathways [Molecular Function]
   795   C0037083:signaling pathway [Cell Function]
   795   C0086982:Signaling Pathway [Molecular Function]
   793   C1704259:Pathways [Molecular Function]
   793   C1705987:Pathways [Conceptual Entity]
   703   C1155501:nitric oxide signaling [Molecular Function]

Phrase: "reduce"

Phrase: "the phosphorylation of MBS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0031715:Phosphorylation [Molecular Function]
   753   C1158886:Phosphorylation [Molecular Function]

Phrase: "and"

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "MBP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   902   C0067062:myosin phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0031686:Protein phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0031678:Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1149880:phosphatase [Molecular Function]

Phrase: "which"

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "vasorelaxation by the dephosphorylation of MLC20."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0042401:Vasorelaxation [Physiologic Function]
Processing 00000000.tx.300: MATERIALS AND METHODS TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES  Cell culture reagents, FBS, phosphorylase kinase, and phosphorylase b were purchased from Life Technologies, Inc. 

Phrase: "MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Cell culture reagents,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0034760:Reagents [Indicator, Reagent, or Diagnostic Aid]
   734   C0007585:Cell Culture [Laboratory Procedure]

Phrase: "FBS,"

Phrase: "phosphorylase kinase,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031713:Phosphorylase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0017916:Phosphorylase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0917783:Phosphorylase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "phosphorylase b"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0031711:Phosphorylase b [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "were"

Phrase: "purchased from Life Technologies,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0039421:technologies [Occupation or Discipline]
   770   C0376558:Life [Idea or Concept]
   770   C0869011:purchased [Activity]

Phrase: "Inc."
Processing 00000000.tx.301: (Gaithersburg, MD). 

Phrase: "(Gaithersburg,"

Phrase: "MD)."
Processing 00000000.tx.302: [-32P]-ATP (specific activity 3000 Ci/mmol) and [32P]orthophosphoric acid were purchased from New England Nuclear Corp. 

Phrase: "[-32P"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553631:32p [Medical Device]

Phrase: "]-ATP"

Phrase: "(specific activity 3000 Ci/mmol)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0439190:MMOLE [Quantitative Concept]

Phrase: "and ["

Phrase: "32P"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553631:32p [Medical Device]

Phrase: "]orthophosphoric acid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0031700:Orthophosphoric acid [Inorganic Chemical,Pharmacologic Substance]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "were"

Phrase: "purchased from New England Nuclear Corp."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0027965:New England [Geographic Area]
   753   C0014282:England [Geographic Area]
   753   C0205314:New [Temporal Concept]
   753   C0521447:Nuclear [Spatial Concept]
   753   C0683758:Corp. [Organization]
   753   C0869011:purchased [Activity]
Processing 00000000.tx.303: (Boston, MA). 

Phrase: "(Boston,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006037:Boston [Geographic Area]

Phrase: "MA"

Phrase: ")."
Processing 00000000.tx.304: 8-bromo-cGMP, L-NMMA, wortmannin, and RpcGMP were purchased from BIOMOL Research Laboratories, Inc. 

Phrase: "8-bromo-cGMP,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0050057:8-bromocyclic guanosine monophosphate [Nucleic Acid, Nucleoside, or Nucleotide]
   884   C0018338:Cyclic guanosine monophosphate [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   840   C0018346:Guanosine Monophosphate [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0018330:Guanosine [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]

Phrase: "L-NMMA,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0069477:L-NMMA [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0439394:l's [Quantitative Concept]
   861   C1706495:L- [Intellectual Product]
   861   C3642217:/L [Quantitative Concept]

Phrase: "wortmannin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0078517:wortmannin [Biologically Active Substance,Pharmacologic Substance,Steroid]

Phrase: "and"

Phrase: "RpcGMP"

Phrase: "were"

Phrase: "purchased from BIOMOL Research Laboratories,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   797   C0022886:laboratories research [Research Activity]
   760   C0022877:Laboratories [Manufactured Object,Organization]
   760   C0035168:research [Research Activity]
   760   C0242481:Research [Research Activity]
   760   C0869011:purchased [Activity]
   760   C1619828:Laboratories [Intellectual Product]
   726 E C3244292:laboratory [Functional Concept]

Phrase: "Inc."
Processing 00000000.tx.305: (Plymouth Meeting, PA). 

Phrase: "(Plymouth Meeting,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0556656:Meeting [Health Care Activity]

Phrase: "PA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3541314:PA [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.306: Okadaic acid was from Moana Bioproducts (Honolulu, Hawaii). 

Phrase: "Okadaic acid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0069389:Ocadaic Acid [Hazardous or Poisonous Substance,Organic Chemical]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "was from Moana Bioproducts"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0043194:WAS [Disease or Syndrome]
   770   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1421478:WAS [Gene or Genome]

Phrase: "(Honolulu,"

Phrase: "Hawaii"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018619:Hawaii [Geographic Area]

Phrase: ")."
Processing 00000000.tx.307: Porcine insulin was a kind gift from the Eli Lilly & Co. 

Phrase: "Porcine insulin"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0724601:Porcine Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C0770206:Porcine insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0039005:porcine [Mammal]
   861   C1135183:Porcine, NOS [Mammal]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "a kind gift from the Eli Lilly & Co."
Processing 00000000.tx.308: (Indianapolis, IN). 

Phrase: "(Indianapolis,"

Phrase: "IN"

Phrase: ")."
Processing 00000000.tx.309: Type-1 Collagenase was from Worthington Biochemical Corp. 

Phrase: "Type-1 Collagenase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0162745:COLLAGENASE [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   734   C0441729:Type 1 [Classification]

Phrase: "was from Worthington Biochemical Corp."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0043194:WAS [Disease or Syndrome]
   760   C0205474:Biochemical [Functional Concept]
   760   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0683758:Corp. [Organization]
   760   C1421478:WAS [Gene or Genome]
Processing 00000000.tx.310: (Freehold, NJ). 

Phrase: "(Freehold,"

Phrase: "NJ"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027971:NJ [Geographic Area]

Phrase: ")."
Processing 00000000.tx.311: SDS-PAGE and Western blot reagents were from Bio-Rad Laboratories, Inc. 

Phrase: "SDS-PAGE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   861   C1704732:Page [Intellectual Product]

Phrase: "and"

Phrase: "Western blot reagents"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0034760:Reagents [Indicator, Reagent, or Diagnostic Aid]
   734   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   734   C0949466:Western Blot [Laboratory Procedure]

Phrase: "were from Bio-Rad Laboratories,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0022877:Laboratories [Manufactured Object,Organization]
   760   C1619828:Laboratories [Intellectual Product]
   726 E C3244292:laboratory [Functional Concept]

Phrase: "Inc."
Processing 00000000.tx.312: (Hercules, CA). 

Phrase: "(Hercules,"

Phrase: "CA)."
Processing 00000000.tx.313: Antibody against the 160-kDa ROK- was purchased from Transduction Laboratories, Inc. 

Phrase: "Antibody against the 160-kDa ROK-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "was"

Phrase: "purchased from Transduction Laboratories,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0022877:Laboratories [Manufactured Object,Organization]
   770   C0869011:purchased [Activity]
   770   C1160185:transduction [Organism Function]
   770   C1619828:Laboratories [Intellectual Product]
   737 E C3244292:laboratory [Functional Concept]

Phrase: "Inc."
Processing 00000000.tx.314: (Lexington, KY). 

Phrase: "(Lexington,"

Phrase: "KY"

Phrase: ")."
Processing 00000000.tx.315: Antibody against the plekstrin homology domain of IRS-1 was obtained from Upstate Biotechnology, Inc. 

Phrase: "Antibody against the plekstrin homology domain of IRS-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   742   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "was"

Phrase: "obtained from Upstate Biotechnology,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0005574:Biotechnology [Biomedical Occupation or Discipline]
   770   C1301820:Obtained [Functional Concept]
   737 E C1706701:Obtain [Activity]

Phrase: "Inc."
Processing 00000000.tx.316: (Lake Placid, NY). 

Phrase: "(Lake Placid, NY"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0027976:NY [Geographic Area]
   827   C1879958:NY [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.317: Monoclonal antibody against Rho A was purchased from Santa Cruz Biotechnology, Inc. 

Phrase: "Monoclonal antibody against Rho A"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   760   C0746619:monoclonal [Finding]

Phrase: "was"

Phrase: "purchased from Santa Cruz Biotechnology,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0005574:Biotechnology [Biomedical Occupation or Discipline]
   760   C0869011:purchased [Activity]

Phrase: "Inc."
Processing 00000000.tx.318: (Santa Cruz, CA). 

Phrase: "(Santa Cruz,"

Phrase: "CA)."
Processing 00000000.tx.319: Myosin light chain (MLC20) antibody, antimouse IgG-Agarose, Protein A-Sepharose CL-4B, protease inhibitors, calmodulin, sodium orthovanadate, angiotensin II, thrombin, and all other reagents were purchased from Sigma (St. Louis, MO). 

Phrase: "Myosin light chain"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0027108:Myosin Light Chain [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0023693:Light [Natural Phenomenon or Process]
   827   C0027096:Myosin [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0337112:Chain [Manufactured Object]
   827   C1306462:Light [Functional Concept]
   827   C1524075:Chain [Idea or Concept]
   827   C1881376:Light [Qualitative Concept]

Phrase: "(MLC20"

Phrase: ")"

Phrase: "antibody,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
  1000   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "antimouse IgG-Agarose,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0036681:Agarose [Carbohydrate]

Phrase: "Protein A-Sepharose CL-4B,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   884   C0074345:Sepharose CL 4B [Carbohydrate]
   853   C0036682:Sepharose 4B [Biomedical or Dental Material,Carbohydrate]
   804   C0450375:4b [Intellectual Product]
   717   C0075172:protein A-sepharose [Carbohydrate]

Phrase: "protease inhibitors,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0033607:Protease Inhibitors [Biologically Active Substance,Pharmacologic Substance]
   966 E C3536890:Protease Inhibitor [Pharmacologic Substance]
   861   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C0243077:inhibitors [Chemical Viewed Functionally]
   861   C1947941:Protease [Enzyme]
   827 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "calmodulin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006772:Calmodulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1366910:Calmodulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "sodium orthovanadate,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0029366:Orthovanadate [Inorganic Chemical]
   861   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   861   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "angiotensin II,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003009:Angiotensin 2 [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "thrombin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040018:Thrombin [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "and"

Phrase: "all other reagents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034760:Reagents [Indicator, Reagent, or Diagnostic Aid]

Phrase: "were"

Phrase: "purchased from Sigma"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0869011:purchased [Activity]
   790   C1719918:Sigma [Intellectual Product]

Phrase: "(St. Louis,"

Phrase: "MO"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538743:MO [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.320: Anti-MBS antibody and MLCK were a kind gift from Dr. 

Phrase: "Anti-MBS antibody"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   897   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   875   C3533097:Myosin Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   804   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "and"

Phrase: "MLCK"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
  1000   C0027120:Myosin Light Chain Kinase [Amino Acid, Peptide, or Protein,Enzyme]
           Myosin Kinase
  1000   C1150543:myosin light-chain kinase [Molecular Function]
  1000   C1334539:MYOSIN LIGHT CHAIN KINASE [Gene or Genome]
   923   C0027108:Myosin Light Chain [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0023693:Light [Natural Phenomenon or Process]
   812   C0027096:Myosin [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0337112:Chain [Manufactured Object]
   812   C1306462:Light [Functional Concept]
   812   C1524075:Chain [Idea or Concept]
   812   C1881376:Light [Qualitative Concept]

Phrase: "were"

Phrase: "a kind gift from Dr."
Processing 00000000.tx.321: Hartshorne (Tucson, AZ). 

Phrase: "Hartshorne"

Phrase: "(Tucson,"

Phrase: "AZ"

Phrase: ")."
Processing 00000000.tx.322: Myosin light chains were prepared from chicken gizzards according to the published protocol (34). 

Phrase: "Myosin light chains"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0027108:Myosin Light Chains [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0023693:Light [Natural Phenomenon or Process]
   827   C0027096:Myosin [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0337112:chains [Manufactured Object]
   827   C1306462:Light [Functional Concept]
   827   C1524075:Chains [Idea or Concept]
   827   C1881376:Light [Qualitative Concept]

Phrase: "were"

Phrase: "prepared from chicken gizzards"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0008051:Chicken [Bird]
   770   C0677521:Chicken [Food]
   770   C1365945:CHICKEN [Food]
   770   C1510668:Gizzards [Body Part, Organ, or Organ Component]
   737   C1521827:Prepare [Functional Concept]

Phrase: "according to the published protocol"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0442711:Protocol [Intellectual Product]
   861   C1507394:Protocol [Intellectual Product]
   861   C1522729:Protocol [Intellectual Product]
   861   C2348563:Protocol [Intellectual Product]

Phrase: "(34"

Phrase: ")."
Processing 00000000.tx.323: Culture of VSMCs and Treatment with Insulin VSMCs in primary culture were obtained by enzymatic digestion of the aortic media of male Wistar Kyoto (WKY) rats with body weights of 200220 g, as described in our recent publications (24, 35). 

Phrase: "Culture of VSMCs"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   799   C0200949:Culture of blood [Laboratory Procedure]
           Blood culture
   783   C0007585:cells culture [Laboratory Procedure]
   753   C0010453:Culture [Idea or Concept]
   753   C0220814:culture [Functional Concept]
   753   C0430400:Culture [Laboratory Procedure]
   753   C2242979:Culture [Laboratory Procedure]
   733   C0554854:Culture - blood [Finding]

Phrase: "and"

Phrase: "Treatment with Insulin VSMCs"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   774   C0745343:insulin treatment [Therapeutic or Preventive Procedure]
   748   C0039798:treatment [Functional Concept]
   748   C0087111:Treatment [Therapeutic or Preventive Procedure]
   748   C1522326:Treatment [Functional Concept]
   748   C1533734:Treatment [Therapeutic or Preventive Procedure]
   748   C1705169:Treatment [Conceptual Entity]
   748   C3538994:TREATMENT [Research Activity]
   724   C0596197:Blood Treatment [Therapeutic or Preventive Procedure]

Phrase: "in primary culture"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0010453:Culture [Idea or Concept]
   861   C0205225:Primary [Qualitative Concept]
   861   C0220814:culture [Functional Concept]
   861   C0430400:Culture [Laboratory Procedure]
   861   C0439631:Primary [Therapeutic or Preventive Procedure]
   861   C2242979:Culture [Laboratory Procedure]

Phrase: "were"

Phrase: "obtained by enzymatic digestion of the aortic media of male Wistar Kyoto (WKY) rats"
Meta Candidates (Total=22; Excluded=4; Pruned=0; Remaining=18)
   766   C0034709:Rats, Wistar Kyoto [Mammal]
           Wistar Kyoto
   749   C0034716:Rats, Wistar [Mammal]
   735   C0003483:Aortic [Body Part, Organ, or Organ Component]
   735   C0009458:Media [Intellectual Product]
   735   C0012238:Digestion [Organism Function]
   735   C0024554:Male [Finding]
   735   C0034693:rats [Mammal]
   735   C0034721:Rats [Mammal]
   735   C0086582:male [Population Group]
   735   C0162867:Media [Tissue]
   735   C1254021:Media [Tissue]
   735   C1301820:Obtained [Functional Concept]
   735   C1706180:Male [Qualitative Concept]
   735   C1706428:Male [Qualitative Concept]
   735   C1706429:Male [Organism Attribute]
   735   C2349986:Digestion [Research Activity]
   735   C2700262:Wistar [Mammal]
   702 E C0439536:Medium [Quantitative Concept]
   702 E C1705217:Medium [Substance]
   702 E C1706701:Obtain [Activity]
   702 E C3244283:medium [Intellectual Product]

Phrase: "with body weights"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
  1000   C0005910:Weights, Body [Organism Attribute]
       E   weight
  1000   C1305866:body weights [Diagnostic Procedure]
       E   weight
   861   C0043100:Weights [Quantitative Concept]
   861   C0242821:body [Human]
   861   C0460148:Body [Anatomical Structure]
   861   C1268086:Body [Anatomical Structure]
   827 E C1705104:Weight [Idea or Concept]
   777 E C1995017:Bodies [Cell Component]

Phrase: "of 200220 g,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "as"

Phrase: "described in our recent publications"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   760   C0034036:Publications [Intellectual Product,Manufactured Object]
   760   C0332185:Recent [Temporal Concept]
   760   C1552738:described [Idea or Concept]
   726 E C0034037:Publication [Occupational Activity]
   726 E C1704324:Publication [Intellectual Product]

Phrase: "(24,"

Phrase: "35"

Phrase: ")."
Processing 00000000.tx.324: Unless otherwise indicated, primary cultures of VSMCs were maintained in -MEM containing 10% FBS, and 1% antibiotic/antimycotic mixture. 

Phrase: "Unless"

Phrase: "otherwise"

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: ","

Phrase: "primary cultures of VSMCs"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   789   C1449562:Primary Cell Cultures [Laboratory Procedure]
   774   C0007585:cells cultures [Laboratory Procedure]
   769   C0200949:Culture of blood [Laboratory Procedure]
           blood cultures
   748   C0010453:Cultures [Idea or Concept]
   748   C0205225:Primary [Qualitative Concept]
   748   C0439631:Primary [Therapeutic or Preventive Procedure]
   714 E C0220814:culture [Functional Concept]
   714 E C0430400:Culture [Laboratory Procedure]
   714 E C2242979:Culture [Laboratory Procedure]
   707 E C0554854:Culture - blood [Finding]

Phrase: "were"

Phrase: "maintained"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1314677:Maintained [Functional Concept]
   966 E C0024501:Maintain [Activity]

Phrase: "in -MEM"

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "10% FBS,"

Phrase: "and"

Phrase: "1% antibiotic/antimycotic mixture."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0439962:Mixture [Substance]
Processing 00000000.tx.325: VSMCs isolated from diabetic Goto-Kakizaki (GK) rats, a model for NIDDM, were maintained in medium containing 20 mM glucose to mimic a hyperglycemic condition. 

Phrase: "VSMCs"
Meta Candidates (Total=23; Excluded=11; Pruned=0; Remaining=12)
   923   C0026844:Muscle, Smooth, Vascular [Tissue]
   923   C1135918:Smooth Muscle Cells [Cell]
   861   C0596981:Muscle Cells [Cell]
   861   C1267092:Muscle, Smooth [Tissue]
   852   C0005773:Blood Cells [Cell]
   844 E C2328697:Hemal cell [Cell]
   812   C0005847:vascular [Body Part, Organ, or Organ Component]
   812   C0007634:Cells [Cell]
   812   C0026845:Muscle [Tissue]
   812   C0205357:Smooth [Qualitative Concept]
   812   C1558950:VASCULAR [Finding]
   812   C1801960:Vascular [Qualitative Concept]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
   756 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   756 E C1511228:VESSEL, BLOOD [Tissue]
   741 E C0442025:Muscular [Spatial Concept]
   712 E C0005767:Blood [Tissue]
   712 E C0005768:blood [Body Substance]
   712 E C0229664:Blood [Body Substance]
   712 E C0392895:Bloods [Population Group]

Phrase: "isolated from diabetic Goto-Kakizaki"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   760   C0205409:Isolated [Functional Concept]
   760   C0241863:DIABETIC [Finding]
   760   C1548221:Isolated [Idea or Concept]
   726 E C0370215:Isolate [Substance]
   726 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "(GK"

Phrase: ")"

Phrase: "rats,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:rats [Mammal]
  1000   C0034721:Rats [Mammal]

Phrase: "a model for NIDDM,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C3161035:Model [Intellectual Product]
   703   C0011860:Diabetes Mellitus, Non-Insulin-Dependent [Disease or Syndrome]
   703   C2697407:DIABETES MELLITUS, NONINSULIN-DEPENDENT [Gene or Genome]

Phrase: "were"

Phrase: "maintained"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1314677:Maintained [Functional Concept]
   966 E C0024501:Maintain [Activity]

Phrase: "in medium containing 20 mM glucose to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "mimic"

Phrase: "a hyperglycemic condition."
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   861   C0012634:condition [Disease or Syndrome]
   861   C0348080:Condition [Qualitative Concept]
   861   C1705253:Condition [Conceptual Entity]
   789 E C0009647:Conditioned [Mental Process]
   789 E C1701901:Conditional [Qualitative Concept]
   789 E C1963686:Conditional [Functional Concept]
   761 E C1519605:Conditionality [Conceptual Entity]
Processing 00000000.tx.326: Subcultures of VSMCs at passage 5 were used in all experiments. 

Phrase: "Subcultures of VSMCs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C0200940:Subculture [Laboratory Procedure]
   719   C0699799:subculture [Population Group]

Phrase: "at passage 5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439799:Passage [Spatial Concept]

Phrase: "were"

Phrase: "used in all experiments."
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   770   C0681814:Experiments [Research Activity]
   770   C1273517:used [Finding]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1706386:Experiment [Conceptual Entity]
   737 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.327: All experiments on MBP activation, MLC20 phosphorylation, and Rho kinase were performed on highly confluent cells (911 days in culture) at identical passages. 

Phrase: "All experiments on MBP activation,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C0681814:Experiments [Research Activity]
   711 E C1706386:Experiment [Conceptual Entity]

Phrase: "MLC20 phosphorylation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031715:Phosphorylation [Molecular Function]
   861   C1158886:Phosphorylation [Molecular Function]

Phrase: "and"

Phrase: "Rho kinase"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0389995:rho-Kinase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1335631:RHO KINASE [Gene or Genome]
   861   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "were"

Phrase: "performed on highly confluent cells"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   760   C0007634:Cells [Cell]
   760   C0205200:Confluent [Qualitative Concept]
   760   C0205250:Highly [Qualitative Concept]
   760   C0884358:Performed [Functional Concept]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]
   726 E C2947996:Perform [Pharmacologic Substance]

Phrase: "(911 days in culture"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0439228:days [Temporal Concept]
   737 E C0332173:/day [Temporal Concept]
   737 E C0439505:/day [Temporal Concept]

Phrase: ")"

Phrase: "at identical passages."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439799:Passage [Spatial Concept]
Processing 00000000.tx.328: Before each experiment, cells were serum starved for 24 h in serum free -MEM containing 5.5 mM glucose and 1% antibiotics. 

Phrase: "Before each experiment,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0681814:Experiment [Research Activity]
  1000   C1706386:Experiment [Conceptual Entity]
   928 E C1517586:Experimental [Qualitative Concept]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "serum"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0229671:Serum [Body Substance]
  1000   C1546774:Serum [Intellectual Product]
  1000   C1550100:Serum [Body Substance]

Phrase: "starved for 24 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   737   C2348531:Starve [Activity]

Phrase: "in serum free -MEM"

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "5.5 mM glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "and"

Phrase: "1% antibiotics."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003232:Antibiotics [Antibiotic]
Processing 00000000.tx.329: The next day, cells were exposed to insulin (0100 nM) for 030 min. 

Phrase: "The next day,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332173:/day [Temporal Concept]
   861   C0439228:day [Temporal Concept]
   861   C0439505:/day [Temporal Concept]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "exposed to insulin"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   882   C0332157:Exposed to [Clinical Attribute]
           Exposed
   790   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1579433:Insulin [Pharmacologic Substance]
   734 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   706 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(0100 nM) for 030 min."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0312860:NM [Cell Function]
Processing 00000000.tx.330: In some experiments, VSMCs were pretreated with various inhibitors for 30 min followed by exposure to insulin as detailed in the figure legends. 

Phrase: "In some experiments,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "VSMCs"
Meta Candidates (Total=23; Excluded=11; Pruned=0; Remaining=12)
   923   C0026844:Muscle, Smooth, Vascular [Tissue]
   923   C1135918:Smooth Muscle Cells [Cell]
   861   C0596981:Muscle Cells [Cell]
   861   C1267092:Muscle, Smooth [Tissue]
   852   C0005773:Blood Cells [Cell]
   844 E C2328697:Hemal cell [Cell]
   812   C0005847:vascular [Body Part, Organ, or Organ Component]
   812   C0007634:Cells [Cell]
   812   C0026845:Muscle [Tissue]
   812   C0205357:Smooth [Qualitative Concept]
   812   C1558950:VASCULAR [Finding]
   812   C1801960:Vascular [Qualitative Concept]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
   756 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   756 E C1511228:VESSEL, BLOOD [Tissue]
   741 E C0442025:Muscular [Spatial Concept]
   712 E C0005767:Blood [Tissue]
   712 E C0005768:blood [Body Substance]
   712 E C0229664:Blood [Body Substance]
   712 E C0392895:Bloods [Population Group]

Phrase: "were"

Phrase: "pretreated with various inhibitors"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0243077:inhibitors [Chemical Viewed Functionally]
   770   C0440102:Various [Indicator, Reagent, or Diagnostic Aid]
   737 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "for 30 min"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0456693:/30 min [Temporal Concept]
  1000   C1442458:30 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]

Phrase: "followed by exposure"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   882   C0332283:Followed by [Temporal Concept]
           followed
   790   C0274281:Exposure, NOS [Injury or Poisoning]
   790   C0332157:Exposure [Clinical Attribute]
   756 E C1719822:Follow [Intellectual Product]

Phrase: "to insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "as"

Phrase: "detailed in the figure legends."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C1522508:Detailed [Qualitative Concept]
   726 E C1561567:detail [Functional Concept]
   726   C2729544:Legend [Pharmacologic Substance]
Processing 00000000.tx.331: Preparation of Myosin-Enriched Fractions Myosin-enriched fractions of VSMCs were prepared by extraction with a high-salt buffer as described previously (20). 

Phrase: "Preparation of Myosin-Enriched Fractions Myosin-enriched fractions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0455052:Preparation [Health Care Activity]
   744   C1521827:Preparation [Functional Concept]

Phrase: "of VSMCs"
Meta Candidates (Total=23; Excluded=11; Pruned=0; Remaining=12)
   923   C0026844:Muscle, Smooth, Vascular [Tissue]
   923   C1135918:Smooth Muscle Cells [Cell]
   861   C0596981:Muscle Cells [Cell]
   861   C1267092:Muscle, Smooth [Tissue]
   852   C0005773:Blood Cells [Cell]
   844 E C2328697:Hemal cell [Cell]
   812   C0005847:vascular [Body Part, Organ, or Organ Component]
   812   C0007634:Cells [Cell]
   812   C0026845:Muscle [Tissue]
   812   C0205357:Smooth [Qualitative Concept]
   812   C1558950:VASCULAR [Finding]
   812   C1801960:Vascular [Qualitative Concept]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
   756 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   756 E C1511228:VESSEL, BLOOD [Tissue]
   741 E C0442025:Muscular [Spatial Concept]
   712 E C0005767:Blood [Tissue]
   712 E C0005768:blood [Body Substance]
   712 E C0229664:Blood [Body Substance]
   712 E C0392895:Bloods [Population Group]

Phrase: "were"

Phrase: "prepared by extraction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0185115:Extraction [Therapeutic or Preventive Procedure]
   790   C0684295:extraction [Laboratory Procedure]
   756   C1521827:Prepare [Functional Concept]

Phrase: "with a high-salt buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(20"

Phrase: ")."
Processing 00000000.tx.332: This fraction contains only PP-1 activity and essentially no PP-2A activity. 

Phrase: "This fraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1264633:Fraction [Quantitative Concept]
  1000   C1554103:Fraction [Idea or Concept]

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "only PP-1 activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "essentially"

Phrase: "no PP-2A activity."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.333: Measurement of Myosin-Bound Phosphatase Activity Phosphatase activity in myosin-enriched fractions was assayed using [32P]-labeled phosphorylase a as well as [32P]-labeled MLC as substrates (21). 

Phrase: "Measurement of Myosin-Bound Phosphatase Activity Phosphatase activity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0242485:Measurement [Functional Concept]

Phrase: "in myosin-enriched fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1264633:Fractions [Quantitative Concept]
   793 E C1554103:Fraction [Idea or Concept]

Phrase: "was"

Phrase: "assayed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0005507:Assay [Laboratory Procedure]
   966   C0243073:assay [Qualitative Concept]
   966   C1510438:Assay [Laboratory Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "[32P"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553631:32p [Medical Device]

Phrase: "]-labeled phosphorylase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0017916:Phosphorylase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0917783:Phosphorylase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "a"

Phrase: "as well as"

Phrase: "[32P"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553631:32p [Medical Device]

Phrase: "]-labeled MLC as substrates"

Phrase: "(21"

Phrase: ")."
Processing 00000000.tx.334: Briefly, equal amounts of proteins (1 g) were diluted with assay buffer (50 mM Tris-HCl, pH 7.5, 0.1 mM EDTA, 28 mM -mercaptoethanol, and 30 mM KCl). 

Phrase: "Briefly,"

Phrase: "equal amounts of proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1265611:amounts [Quantitative Concept]

Phrase: "(1 g)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "were"

Phrase: "diluted with assay buffer"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0005507:Assay [Laboratory Procedure]
   770   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   770   C0243073:assay [Qualitative Concept]
   770   C1510438:Assay [Laboratory Procedure]
   737   C1720119:Dilute [Functional Concept]
   737   C1948037:Dilute [Functional Concept]

Phrase: "(50 mM Tris-HCl,"

Phrase: "pH 7.5,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "0.1 mM EDTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "28 mM -mercaptoethanol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0025402:Mercaptoethanol [Organic Chemical]

Phrase: "and"

Phrase: "30 mM KCl"

Phrase: ")."
Processing 00000000.tx.335: The reaction was initiated by the addition of [32P]-labeled substrates and stopped after 5 min incubation at 30 C by the addition of 20% trichloroacetic acid (TCA). 

Phrase: "The reaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443286:Reaction [Functional Concept]
  1000   C1114821:Reaction [Clinical Attribute]

Phrase: "was"

Phrase: "initiated by the addition of [32P"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C1553631:32p [Medical Device]
   753   C1883712:Addition [Functional Concept]
   719   C1548602:Initiate [Idea or Concept]
   719   C1704686:Initiate [Functional Concept]

Phrase: "]-labeled substrates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1710236:Substrate [Manufactured Object]

Phrase: "and"

Phrase: "stopped after 5 min incubation"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   760   C0702093:/min [Temporal Concept]
   760   C1272691:stopped [Qualitative Concept]
   726 E C1947925:Stop [Activity]
   726 E C2746065:Stop [Temporal Concept]

Phrase: "at 30 C"

Phrase: "by the addition"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "of 20% trichloroacetic acid (TCA)."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0040900:Trichloroacetic Acid [Organic Chemical,Pharmacologic Substance]
   827   C0001128:Acid [Chemical]
   827   C0202406:Acid [Laboratory Procedure]
Processing 00000000.tx.336: The radioactivity released in the TCA supernatants was counted as detailed in our recent publications (36, 37). 

Phrase: "The radioactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034553:Radioactivity [Natural Phenomenon or Process]

Phrase: "released in the TCA supernatants"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   790   C0040900:Trichloroacetic Acid [Organic Chemical,Pharmacologic Substance]
   753   C0001128:Acid [Chemical]
   753   C0202406:Acid [Laboratory Procedure]
   753   C0391871:Released [Functional Concept]
   753   C1283071:Released [Functional Concept]
   719 E C0030685:Release [Health Care Activity]
   719 E C0439180:% release [Quantitative Concept]
   719 E C0680255:release [Health Care Activity]
   719   C1550101:Supernatant [Body Substance]
   719 E C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "counted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0750480:Count [Activity]
   966   C1705566:Count [Quantitative Concept]

Phrase: "as"

Phrase: "detailed in our recent publications"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   760   C0034036:Publications [Intellectual Product,Manufactured Object]
   760   C0332185:Recent [Temporal Concept]
   760   C1522508:Detailed [Qualitative Concept]
   726 E C0034037:Publication [Occupational Activity]
   726 E C1561567:detail [Functional Concept]
   726 E C1704324:Publication [Intellectual Product]

Phrase: "(36,"

Phrase: "37"

Phrase: ")."
Processing 00000000.tx.337: [32P]-labeled phosphorylase a was prepared by incubating [-32P]-ATP with purified phosphorylase kinase and phosphorylase b (38). 

Phrase: "[32P"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553631:32p [Medical Device]

Phrase: "]-labeled phosphorylase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0017916:Phosphorylase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0917783:Phosphorylase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "a"

Phrase: "was"

Phrase: "prepared by incubating"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1439852:incubating [Laboratory Procedure]
   756   C1521827:Prepare [Functional Concept]

Phrase: "[-32P"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553631:32p [Medical Device]

Phrase: "]-ATP with purified phosphorylase kinase"

Phrase: "and"

Phrase: "phosphorylase b (38"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0031711:Phosphorylase b [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0017916:Phosphorylase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0917783:Phosphorylase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ")."
Processing 00000000.tx.338: [32P]-labeled MLC was prepared according to the published protocol (39) by incubating MLC with purified MLCK and 50 M [-32P]ATP. 

Phrase: "[32P"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553631:32p [Medical Device]

Phrase: "]-labeled MLC"

Phrase: "was"

Phrase: "prepared according to the published protocol"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   753   C0034037:Published [Occupational Activity]
   753   C0442711:Protocol [Intellectual Product]
   753   C0680240:according [Social Behavior]
   753   C1507394:Protocol [Intellectual Product]
   753   C1522729:Protocol [Intellectual Product]
   753   C1704324:Published [Intellectual Product]
   753   C2348563:Protocol [Intellectual Product]
   719   C1521827:Prepare [Functional Concept]

Phrase: "(39"

Phrase: ")"

Phrase: "by incubating MLC"

Phrase: "with purified MLCK"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   937   C0027120:Myosin Light Chain Kinase [Amino Acid, Peptide, or Protein,Enzyme]
           Myosin Kinase
   937   C1150543:myosin light-chain kinase [Molecular Function]
   937   C1334539:MYOSIN LIGHT CHAIN KINASE [Gene or Genome]
   884   C0027108:Myosin Light Chain [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0023693:Light [Natural Phenomenon or Process]
   804   C0027096:Myosin [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0337112:Chain [Manufactured Object]
   804   C1306462:Light [Functional Concept]
   804   C1524075:Chain [Idea or Concept]
   804   C1881376:Light [Qualitative Concept]

Phrase: "and"

Phrase: "50"

Phrase: "M [-"

Phrase: "32P"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553631:32p [Medical Device]

Phrase: "]ATP."
Processing 00000000.tx.339: Metabolic Labeling of VSMCs and Measurement of MBS Phosphorylation by Immunoprecipitation and Western Blot Analyses Serum-starved VSMCs labeled with [32P]orthophosphoric acid (0.3 mCi/ml for 4 h) were exposed to various agonists as detailed in the figure legends. 

Phrase: "Metabolic Labeling of VSMCs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C1167624:Labeling [Mental Process]
   748   C1947902:Labeling [Manufactured Object]
   748   C2827499:Labeling [Governmental or Regulatory Activity]

Phrase: "and"

Phrase: "Measurement of MBS Phosphorylation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0242485:Measurement [Functional Concept]

Phrase: "by Immunoprecipitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021069:Immunoprecipitation [Laboratory Procedure]

Phrase: "and"

Phrase: "Western Blot Analyses Serum-starved VSMCs"
Meta Candidates (Total=19; Excluded=7; Pruned=0; Remaining=12)
   827   C0026844:Muscle, Smooth, Vascular [Tissue]
   827   C1135918:Smooth Muscle Cells [Cell]
   807   C0596981:Muscle Cells [Cell]
   807   C1267092:Muscle, Smooth [Tissue]
   791   C0005847:vascular [Body Part, Organ, or Organ Component]
   791   C0007634:Cells [Cell]
   791   C0026845:Muscle [Tissue]
   791   C0205357:Smooth [Qualitative Concept]
   791   C1558950:VASCULAR [Finding]
   791   C1801960:Vascular [Qualitative Concept]
   791   C3282337:Cells [Cell]
   779   C0005773:Blood Cells [Cell]
   771 E C2328697:Hemal cell [Cell]
   758 E C1269647:Cell [Cell]
   758 E C1704653:Cell [Medical Device]
   758 E C1948049:Cell [Spatial Concept]
   735 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   735 E C1511228:VESSEL, BLOOD [Tissue]
   720 E C0442025:Muscular [Spatial Concept]

Phrase: "labeled with"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   833   C1708632:Labeled [Qualitative Concept]
   799 E C0181496:Label [Manufactured Object]
   799 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "[32P"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553631:32p [Medical Device]

Phrase: "]orthophosphoric acid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0031700:Orthophosphoric acid [Inorganic Chemical,Pharmacologic Substance]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "(0.3 mCi/ml for 4 h)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C2348021:mCi/ml [Quantitative Concept]
   774   C0439391:mL/h [Quantitative Concept]
   748   C0439526:/mL [Quantitative Concept]

Phrase: "were"

Phrase: "exposed to various agonists"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0332157:Exposed to [Clinical Attribute]
           Exposed
   770   C0243192:agonists [Pharmacologic Substance]
   770   C0440102:Various [Indicator, Reagent, or Diagnostic Aid]
   770   C2987634:agonists [Pharmacologic Substance]

Phrase: "as"

Phrase: "detailed in the figure legends."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C1522508:Detailed [Qualitative Concept]
   726 E C1561567:detail [Functional Concept]
   726   C2729544:Legend [Pharmacologic Substance]
Processing 00000000.tx.340: The cells were lysed in a buffer containing 50 mM HEPES, pH 7.5, 2 mM EDTA, 1% Triton X-100, 100 mM NaCl, 50 mM -glycerophosphate, 100 mM NaF, 100 mM sodium pyrophosphate, 2 mM sodium orthovanadate, 2 M microcystin, and a cocktail of protease inhibitors (36). 

Phrase: "The cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "lysed in a buffer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   770   C0024348:lysed [Pathologic Function]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "50 mM HEPES,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "pH 7.5,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "2 mM EDTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "1% Triton X-100,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C0146951:Triton X-100 [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   861   C0133689:Triton X [Organic Chemical,Pharmacologic Substance]
   812   C0242759:Triton [Geographic Area]

Phrase: "100 mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C1959973:% NaCl [Quantitative Concept]

Phrase: "50 mM -glycerophosphate,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017881:glycerophosphate [Carbohydrate,Lipid]

Phrase: "100 mM NaF,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0037508:NaF [Biomedical or Dental Material,Inorganic Chemical]
   827   C1366571:NAF [Gene or Genome]
   827   C1705592:NAF [Gene or Genome]

Phrase: "100 mM sodium pyrophosphate,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0074764:sodium pyrophosphate [Inorganic Chemical,Pharmacologic Substance]
   812   C0034320:Pyrophosphate [Inorganic Chemical,Pharmacologic Substance]
   812   C3252566:Pyrophosphate [Inorganic Chemical,Pharmacologic Substance]

Phrase: "2 mM sodium orthovanadate,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0029366:Orthovanadate [Inorganic Chemical]
   812   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   812   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "2 M microcystin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0211296:Microcystin [Hazardous or Poisonous Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "a cocktail of protease inhibitors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0678420:Cocktail [Food]

Phrase: "(36"

Phrase: ")."
Processing 00000000.tx.341: Precleared lysates with equal amounts of proteins were immunoprecipitated with anti-MBS antibody prebound to Protein A Sepharose for 3 h at 4 C followed by separation of the immunoprecipitates by SDS-PAGE and autoradiography. 

Phrase: "Precleared"

Phrase: "lysates with equal amounts of proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C1881488:Lysate [Physical Object]

Phrase: "were"

Phrase: "immunoprecipitated with anti-MBS antibody"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   774   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   774   C3533097:Myosin Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   748   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   748   C0027096:Myosin [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0332297:bound [Spatial Concept]
   748   C1145667:Bound [Activity]
   748   C1167622:Bound [Molecular Function]
   748   C1689898:% bound [Quantitative Concept]
   748   C1711351:Subunit [Quantitative Concept]
   748   C2349209:Bound [Conceptual Entity]
   714   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "prebound to Protein A Sepharose"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   862   C0075172:protein A-sepharose [Carbohydrate]
   806   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0036681:Sepharose [Carbohydrate]

Phrase: "for 3 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0041119:3 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "at 4 C"

Phrase: "followed by separation of the immunoprecipitates"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   790   C0332283:Followed by [Temporal Concept]
           followed
   753   C0036679:Separation [Pathologic Function]
   753   C0237868:Separation [Social Behavior]
   753   C1881713:SEPARATION [Phenomenon or Process]
   719   C0301871:Immunoprecipitate [Immunologic Factor]
   719 E C1719822:Follow [Intellectual Product]

Phrase: "by SDS-PAGE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   861   C1704732:Page [Intellectual Product]

Phrase: "and"

Phrase: "autoradiography."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0004400:Autoradiography [Laboratory Procedure]
   900 E C2986957:Autoradiograph [Manufactured Object]
Processing 00000000.tx.342: The level of MBS phosphorylation was measured by densitometric scanning of the autoradiograms. 

Phrase: "The level of MBS phosphorylation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0441889:Level [Qualitative Concept]
   748   C0456079:Level [Classification]
   748   C1547707:Level [Geographic Area]
   748   C2946261:Level [Pharmacologic Substance]

Phrase: "was"

Phrase: "measured by densitometric scanning of the autoradiograms."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   778   C0011321:densitometric scanning [Laboratory Procedure]
   748   C0034606:Scanning [Diagnostic Procedure]
   748   C0441633:Scanning [Diagnostic Procedure]
   748   C0444706:Measured [Qualitative Concept]
   748   C3541902:MEASURED [Diagnostic Procedure]
   714 E C0079809:Measure [Quantitative Concept]
   714 E C0242485:Measure [Functional Concept]
Processing 00000000.tx.343: To overcome variations in proteins due to immunoprecipitation, the membranes were probed with anti-MBS antibody followed by incubation with HRP-conjugated secondary antibodies and detection by enhanced chemiluminescence (ECL). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "overcome"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2983310:Overcome [Activity]

Phrase: "variations in proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205419:variations [Qualitative Concept]

Phrase: "due to immunoprecipitation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021069:Immunoprecipitation [Laboratory Procedure]

Phrase: "the membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0025255:Membranes [Tissue]
   966 E C0596901:Membrane [Cell Component]
   966 E C1706182:Membrane [Manufactured Object]
   916 E C0205287:Membranous [Qualitative Concept]

Phrase: "were"

Phrase: "probed with anti-MBS antibody"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   774   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   774   C3533097:Myosin Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   748   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   748   C0027096:Myosin [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0332297:bound [Spatial Concept]
   748   C1145667:Bound [Activity]
   748   C1167622:Bound [Molecular Function]
   748   C1689898:% bound [Quantitative Concept]
   748   C1711351:Subunit [Quantitative Concept]
   748   C2349209:Bound [Conceptual Entity]
   714   C0182400:Probe [Medical Device]
   714   C1704681:Probe [Gene or Genome]
   714   C2347609:Probe [Chemical Viewed Functionally]
   714   C3536729:Probe [Manufactured Object]

Phrase: "followed by incubation"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   882   C0332283:Followed by [Temporal Concept]
           followed
   756 E C1719822:Follow [Intellectual Product]

Phrase: "with HRP-conjugated secondary antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   771 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "and"

Phrase: "detection by enhanced chemiluminescence (ECL)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1511790:Detection [Therapeutic or Preventive Procedure]
Processing 00000000.tx.344: The extent of MBS phosphorylation was quantitated by dividing the intensity of radioactive signal with the protein signal. 

Phrase: "The extent of MBS phosphorylation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0439792:Extent [Spatial Concept]

Phrase: "was"

Phrase: "quantitated by dividing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0332849:dividing [Functional Concept]

Phrase: "the intensity of radioactive signal"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C0871362:signal intensity [Quantitative Concept]
   760   C0522510:Intensity [Qualitative Concept]

Phrase: "with the protein signal."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1710082:Signal [Phenomenon or Process]
Processing 00000000.tx.345: Immunoprecipitation and in Vitro Assay of PI3-Kinase Activity in the IRS-1 Immunoprecipitates Equal amounts of precleared lysate proteins (100 g) were immunoprecipitated with rabbit anti-IRS-1 antibody. 

Phrase: "Immunoprecipitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021069:Immunoprecipitation [Laboratory Procedure]

Phrase: "and"

Phrase: "in Vitro Assay of PI3-Kinase Activity"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   814   C1515653:In Vitro Assay [Research Activity]
   778   C0021135:In Vitro [Intellectual Product]
   778   C1533691:in vitro [Qualitative Concept]
           vitro
   778   C2827718:In Vitro [Functional Concept]
   748   C0005507:Assay [Laboratory Procedure]
   748   C0243073:assay [Qualitative Concept]
   748   C1510438:Assay [Laboratory Procedure]

Phrase: "in the IRS-1 Immunoprecipitates Equal amounts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1265611:amounts [Quantitative Concept]

Phrase: "of precleared lysate proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(100 g)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "were"

Phrase: "immunoprecipitated with rabbit anti-IRS-1 antibody."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C0123658:IRS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   774   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   774   C1979003:Rabbit Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   748   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   748   C0034493:Rabbit [Mammal]
   714   C0301871:Immunoprecipitate [Immunologic Factor]
Processing 00000000.tx.346: PI3kinase activity was assayed in the IRS-1 immunoprecipitates as detailed in our recent publication (24). 

Phrase: "PI3kinase activity"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C1323803:phosphatidylinositol 3-kinase activity [Molecular Function]
   923   C2260369:phosphatidylinositol kinase activity [Molecular Function]
   861   C1150423:kinase activity [Molecular Function]
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]
   756   C0044602:Phosphatidylinositol 3-Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   729 E C2936824:Phosphatidylinositol 3-Kinases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "was"

Phrase: "assayed in the IRS-1 immunoprecipitates"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0123658:IRS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   719   C0005507:Assay [Laboratory Procedure]
   719   C0243073:assay [Qualitative Concept]
   719   C0301871:Immunoprecipitate [Immunologic Factor]
   719   C1510438:Assay [Laboratory Procedure]

Phrase: "as"

Phrase: "detailed in our recent publication"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0034036:Publication [Intellectual Product,Manufactured Object]
   760   C0034037:Publication [Occupational Activity]
   760   C0332185:Recent [Temporal Concept]
   760   C1522508:Detailed [Qualitative Concept]
   760   C1704324:Publication [Intellectual Product]
   726 E C1561567:detail [Functional Concept]

Phrase: "(24"

Phrase: ")."
Processing 00000000.tx.347: Immunoprecipitation and in Vitro Assay of Rho Kinase Activity in the Immune Complexes Rho kinase was immunoprecipitated by incubating equal amounts of precleared lysate proteins (100 g) with anti-ROK- antibody (6 g/tube) at 4 C with constant shaking. 

Phrase: "Immunoprecipitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021069:Immunoprecipitation [Laboratory Procedure]

Phrase: "and"

Phrase: "in Vitro Assay of Rho Kinase Activity"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   814   C1515653:In Vitro Assay [Research Activity]
   778   C0021135:In Vitro [Intellectual Product]
   778   C1533691:in vitro [Qualitative Concept]
           vitro
   778   C2827718:In Vitro [Functional Concept]
   748   C0005507:Assay [Laboratory Procedure]
   748   C0243073:assay [Qualitative Concept]
   748   C1510438:Assay [Laboratory Procedure]

Phrase: "in the Immune Complexes Rho kinase"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0389995:rho-Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1335631:RHO KINASE [Gene or Genome]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "was"

Phrase: "immunoprecipitated by incubating equal amounts of precleared lysate proteins"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   742   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0205163:Equal [Qualitative Concept]
   742   C1265611:amounts [Quantitative Concept]
   742   C1439852:incubating [Laboratory Procedure]
   742   C1549782:Equal [Idea or Concept]
   742   C1881488:Lysate [Physical Object]
   708   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "(100 g) with anti-ROK- antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0369247:G Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0439267:g% [Quantitative Concept]

Phrase: "(6 g/tube"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C1522614:G-TUBE [Therapeutic or Preventive Procedure]
   827   C0175730:Tube [Medical Device]
   827   C0439267:g% [Quantitative Concept]
   827   C1547937:Tube NOS [Intellectual Product]
   827   C1561954:tube [Conceptual Entity]
   827   C1704730:TUBE [Medical Device]

Phrase: ")"

Phrase: "at 4 C"

Phrase: "with constant shaking."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0040822:Shaking [Sign or Symptom]
   827 E C1883023:Shake [Activity]
Processing 00000000.tx.348: Kinase activity in the immunoprecipitates was assayed using myosin-enriched fraction as a substrate (40). 

Phrase: "Kinase activity in the immunoprecipitates"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C1150423:kinase activity [Molecular Function]
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "assayed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0005507:Assay [Laboratory Procedure]
   966   C0243073:assay [Qualitative Concept]
   966   C1510438:Assay [Laboratory Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "myosin-enriched fraction as a substrate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1264633:Fraction [Quantitative Concept]
   753   C1554103:Fraction [Idea or Concept]

Phrase: "(40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.349: After incubation at 30 C for 10 min (enzyme concentration was adjusted to ensure first-order kinetics), 25 l aliquots of the reaction mixture were spotted on phosphocellulose paper followed by extensive washing of the paper and 32P incorporation determined by liquid scintillation spectroscopy. 

Phrase: "After incubation"

Phrase: "at 30 C"

Phrase: "for 10 min (enzyme concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0086045:Concentration [Mental Process]
   812   C1446561:Concentration [Quantitative Concept]
   741 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "was"

Phrase: "adjusted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0456081:Adjusted [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "ensure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0218063:Ensure [Food]

Phrase: "first-order kinetics"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0022702:Kinetics [Natural Phenomenon or Process]
   827   C0220865:kinetics [Functional Concept]
   827   C2825046:Kinetics [Occupation or Discipline]
   734   C1373201:First Order [Functional Concept]

Phrase: ")"

Phrase: ","

Phrase: "25 l aliquots of the reaction mixture"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   714   C1510844:Aliquot [Quantitative Concept]

Phrase: "were"

Phrase: "spotted on phosphocellulose paper"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0030351:Paper [Manufactured Object]
   770   C0070824:phosphocellulose [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   770   C1547566:Paper [Idea or Concept]
   737   C0329155:Spot [Fish]
   737   C1427618:SPOT [Gene or Genome]
   737   C1705203:Spot [Conceptual Entity]

Phrase: "followed by extensive washing of the paper"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   778   C0332283:Followed by [Temporal Concept]
           followed
   748   C0030351:Paper [Manufactured Object]
   748   C0205231:Extensive [Qualitative Concept]
   748   C0441648:Washing [Activity]
   748   C1547566:Paper [Idea or Concept]
   714 E C1719822:Follow [Intellectual Product]

Phrase: "and"

Phrase: "32P incorporation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0243126:incorporation [Functional Concept]

Phrase: "determined by liquid scintillation spectroscopy."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0037812:spectroscopy [Laboratory Procedure]
   760   C0302908:Liquid [Substance]
   760   C0678573:scintillation [Natural Phenomenon or Process]
   760   C1304698:Liquid [Finding]
   760   C1546699:Liquid NOS [Intellectual Product]
   760   C1561501:Liquid NOS [Substance]
   760   C2713504:Spectroscopy [Occupation or Discipline]
   760   C2984732:SPECTROSCOPY [Functional Concept]
Processing 00000000.tx.350: Analyses of Agonist-Induced Rho Translocation to the Membrane Fraction Cytosolic and membrane fractions were prepared by differential centrifugation according to previously published protocols (41). 

Phrase: "Analyses of Agonist-Induced Rho Translocation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   767   C1294199:Translocation analysis [Laboratory Procedure]
   719   C0002778:Analysis [Laboratory Procedure]
   719   C0936012:Analysis [Research Activity]
   719   C1524024:analysis [Functional Concept]

Phrase: "to the Membrane Fraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1264633:Fraction [Quantitative Concept]
   861   C1554103:Fraction [Idea or Concept]

Phrase: "Cytosolic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1383501:Cytosolic [Cell Component]

Phrase: "and"

Phrase: "membrane fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1264633:Fractions [Quantitative Concept]
   827 E C1554103:Fraction [Idea or Concept]

Phrase: "were"

Phrase: "prepared by differential centrifugation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0007703:Centrifugation [Laboratory Procedure]
   770   C0443199:Differential [Qualitative Concept]
   770   C1705242:Differential [Qualitative Concept]
   737   C1521827:Prepare [Functional Concept]

Phrase: "according to previously published protocols"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0442711:Protocols [Intellectual Product]
   793 E C1507394:Protocol [Intellectual Product]
   793 E C1522729:Protocol [Intellectual Product]
   793 E C2348563:Protocol [Intellectual Product]

Phrase: "(41"

Phrase: ")."
Processing 00000000.tx.351: Equal amounts of membrane proteins were subjected to SDS-PAGE, transferred to polyvinylidene fluoride (PVDF) membrane, and probed with mouse anti-Rho A antibody followed by incubation with HRP-labeled secondary antibody and subsequent detection with ECL. 

Phrase: "Equal amounts of membrane proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1265611:amounts [Quantitative Concept]

Phrase: "were"

Phrase: "subjected to SDS-PAGE,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   770   C1704732:Page [Intellectual Product]
   737   C0681850:Subject [Group]
   737   C1550501:{Subject} [Idea or Concept]
   737   C1706203:Subject [Idea or Concept]
   737   C2349001:Subject [Human]
   737   C2697811:Subject [Functional Concept]

Phrase: "transferred to polyvinylidene fluoride (PVDF) membrane,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   806   C0071710:polyvinylidene fluoride [Organic Chemical]
   760   C0016327:Fluoride [Inorganic Chemical,Pharmacologic Substance]
   760   C0025255:Membrane [Tissue]
   760   C0348011:transferred [Functional Concept]
   760   C0596901:Membrane [Cell Component]
   760   C1706182:Membrane [Manufactured Object]
   726 E C0040671:Transfer [Mental Process]
   726 E C1705822:Transfer [Activity]

Phrase: "and"

Phrase: "probed with mouse anti-Rho"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0025914:Mouse [Mammal]
   760   C0025929:mouse [Mammal]
   760   C0026809:Mouse [Mammal]
   726   C0182400:Probe [Medical Device]
   726   C1704681:Probe [Gene or Genome]
   726   C2347609:Probe [Chemical Viewed Functionally]
   726   C3536729:Probe [Manufactured Object]

Phrase: "A antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
  1000   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "followed by incubation"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   882   C0332283:Followed by [Temporal Concept]
           followed
   756 E C1719822:Follow [Intellectual Product]

Phrase: "with HRP-labeled secondary antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   888   C0598670:peroxidase labeled antibody [Immunologic Factor]
   804   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   804   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "and"

Phrase: "subsequent detection with ECL."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1511790:Detection [Therapeutic or Preventive Procedure]
Processing 00000000.tx.352: MLC Phosphorylation MLC20 phosphorylation was analyzed by urea, glycerol-PAGE separation of the mono and diphosphorylated forms of MLC20 as detailed earlier (42). 

Phrase: "MLC Phosphorylation MLC20 phosphorylation"

Phrase: "was"

Phrase: "analyzed by urea,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0041942:Urea [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]
   790   C0936012:Analyzed [Research Activity]
   734 E C0728794:Ureaphil [Organic Chemical,Pharmacologic Substance]

Phrase: "glycerol-PAGE separation of the mono"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0036679:Separation [Pathologic Function]
   753   C0237868:Separation [Social Behavior]
   753   C1881713:SEPARATION [Phenomenon or Process]

Phrase: "and"

Phrase: "diphosphorylated forms of MLC20"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0348078:forms [Qualitative Concept]
   770   C0376315:Forms [Manufactured Object]
   737 E C1522492:Form [Functional Concept]

Phrase: "as"

Phrase: "detailed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1522508:Detailed [Qualitative Concept]
   966 E C1561567:detail [Functional Concept]

Phrase: "earlier"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1279919:Early [Temporal Concept]

Phrase: "(42"

Phrase: ")."
Processing 00000000.tx.353: MLC20 was detected by immunoblot analysis with MLC20 antibody (Sigma) followed by treatment with HRP-conjugated secondary antibodies and detection by ECL. 

Phrase: "MLC20"

Phrase: "was"

Phrase: "detected by immunoblot analysis"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0020985:Immunoblot Analysis [Laboratory Procedure]
           Immunoblot
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0442726:Detected [Finding]
   770   C0936012:Analysis [Research Activity]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]
   770   C1524024:analysis [Functional Concept]

Phrase: "with MLC20 antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")"

Phrase: "followed by treatment"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   882   C0332283:Followed by [Temporal Concept]
           followed
   790   C0039798:treatment [Functional Concept]
   790   C0087111:Treatment [Therapeutic or Preventive Procedure]
   790   C1522326:Treatment [Functional Concept]
   790   C1533734:Treatment [Therapeutic or Preventive Procedure]
   790   C1705169:Treatment [Conceptual Entity]
   790   C3538994:TREATMENT [Research Activity]
   756 E C1719822:Follow [Intellectual Product]

Phrase: "with HRP-conjugated secondary antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   771 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "and"

Phrase: "detection by ECL."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1511790:Detection [Therapeutic or Preventive Procedure]
Processing 00000000.tx.354: The autoradiograms were scanned and quantified, and the percent maximal MLC20 phosphorylation was determined by dividing the sum of fast migrating diphosphorylated MLC20 area and the monophosphorylated MLC20 area by the total of phosphorylated and nonphosphorylated areas. 

Phrase: "The autoradiograms"

Phrase: "were"

Phrase: "scanned"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0441633:scanned [Diagnostic Procedure]
   966 E C0034606:Scan [Diagnostic Procedure]
   966 E C2826292:SCAN [Finding]

Phrase: "and"

Phrase: "quantified,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1709793:Quantify [Quantitative Concept]

Phrase: "and"

Phrase: "the percent maximal MLC20 phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0031715:Phosphorylation [Molecular Function]
   812   C1158886:Phosphorylation [Molecular Function]

Phrase: "was"

Phrase: "determined by dividing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0332849:dividing [Functional Concept]

Phrase: "the sum of fast"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1515051:Sum [Quantitative Concept]

Phrase: "migrating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0232902:migrating [Functional Concept]

Phrase: "diphosphorylated MLC20 area"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0017446:Area [Geographic Area]
   827   C0205146:Area [Spatial Concept]

Phrase: "and"

Phrase: "the monophosphorylated MLC20 area by the total of phosphorylated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0017446:Area [Geographic Area]
   742   C0205146:Area [Spatial Concept]

Phrase: "and"

Phrase: "nonphosphorylated areas."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0205146:areas [Spatial Concept]
   827 E C0017446:Area [Geographic Area]
Processing 00000000.tx.355: Measurement of VSMC Contraction VSMC contraction was measured by analyzing the insulin-mediated decrease in thrombin-stimulated transvascular HRP diffusion according to the published protocol (22). 

Phrase: "Measurement of VSMC Contraction VSMC contraction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   736   C0242485:Measurement [Functional Concept]

Phrase: "was"

Phrase: "measured by analyzing"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0444706:Measured [Qualitative Concept]
   790   C3541902:MEASURED [Diagnostic Procedure]
   756 E C0079809:Measure [Quantitative Concept]
   756 E C0242485:Measure [Functional Concept]

Phrase: "the insulin-mediated decrease in thrombin-stimulated transvascular HRP diffusion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0392756:Decrease [Qualitative Concept]
   738   C0547047:Decrease [Quantitative Concept]

Phrase: "according to the published protocol"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0442711:Protocol [Intellectual Product]
   861   C1507394:Protocol [Intellectual Product]
   861   C1522729:Protocol [Intellectual Product]
   861   C2348563:Protocol [Intellectual Product]

Phrase: "(22"

Phrase: ")."
Processing 00000000.tx.356: Briefly, VSMCs plated on collagen-coated polyethylene trephtalate cell culture inserts (3-m pore size, Becton Dickinson and Co.) were treated in quadruplicate with and without insulin (100 nM) for 30 min followed by the addition of 500 l serum free medium containing thrombin (0.5 U/ml). 

Phrase: "Briefly,"

Phrase: "VSMCs"
Meta Candidates (Total=23; Excluded=11; Pruned=0; Remaining=12)
   923   C0026844:Muscle, Smooth, Vascular [Tissue]
   923   C1135918:Smooth Muscle Cells [Cell]
   861   C0596981:Muscle Cells [Cell]
   861   C1267092:Muscle, Smooth [Tissue]
   852   C0005773:Blood Cells [Cell]
   844 E C2328697:Hemal cell [Cell]
   812   C0005847:vascular [Body Part, Organ, or Organ Component]
   812   C0007634:Cells [Cell]
   812   C0026845:Muscle [Tissue]
   812   C0205357:Smooth [Qualitative Concept]
   812   C1558950:VASCULAR [Finding]
   812   C1801960:Vascular [Qualitative Concept]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
   756 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   756 E C1511228:VESSEL, BLOOD [Tissue]
   741 E C0442025:Muscular [Spatial Concept]
   712 E C0005767:Blood [Tissue]
   712 E C0005768:blood [Body Substance]
   712 E C0229664:Blood [Body Substance]
   712 E C0392895:Bloods [Population Group]

Phrase: "plated on collagen-coated polyethylene trephtalate cell culture inserts"
Meta Candidates (Total=27; Excluded=5; Pruned=0; Remaining=22)
   764   C0007585:Cell Culture [Laboratory Procedure]
   745   C0061622:Cell Coat [Cell Component]
   745   C0180454:Culture plate [Medical Device]
   745   C1166718:cell plate [Cell Component]
   742   C0007634:Cell [Cell]
   742   C0009325:Collagen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Biomedical or Dental Material]
   742   C0010453:Culture [Idea or Concept]
   742   C0032487:polyethylene [Biomedical or Dental Material,Organic Chemical]
   742   C0137914:Polyethylene [Biomedical or Dental Material,Organic Chemical]
   742   C0220814:culture [Functional Concept]
   742   C0430400:Culture [Laboratory Procedure]
   742   C0752345:Polyethylene [Biomedical or Dental Material,Organic Chemical]
   742   C0813036:Inserts [Medical Device]
   742   C1167364:collagen [Cell Component]
   742   C1269647:Cell [Cell]
   742   C1522408:Coated [Qualitative Concept]
   742   C1704653:Cell [Medical Device]
   742   C1948049:Cell [Spatial Concept]
   742   C2242979:Culture [Laboratory Procedure]
   708   C0005971:Plate [Medical Device]
   708 E C0441587:Insert [Health Care Activity]
   708 E C0453946:Coat [Manufactured Object]
   708   C1139930:plate [Medical Device]
   708 E C1743766:Insert [Medical Device]
   708 E C1883719:Insert [Functional Concept]
   708 E C2987482:Coat [Body Part, Organ, or Organ Component]
   708   C3537155:Plate [Manufactured Object]

Phrase: "(3-m pore size,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0456389:size [Spatial Concept]
   812   C1325742:Pore [Cell Component]

Phrase: "Becton Dickinson"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331782:Becton Dickinson [Health Care Related Organization]

Phrase: "and"

Phrase: "Co.)"

Phrase: "were"

Phrase: "treated in quadruplicate"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0205175:Quadruplicate [Quantitative Concept]
   790   C0332293:treated [Therapeutic or Preventive Procedure]
   790   C1522326:Treated [Functional Concept]
   756 E C1292734:TREAT [Functional Concept]

Phrase: "with"

Phrase: "and without insulin"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1515981:And [Idea or Concept]
   790   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1579433:Insulin [Pharmacologic Substance]
   734 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   706 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(100 nM) for 30 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0312860:NM [Cell Function]

Phrase: "followed by the addition of 500 l serum free medium containing thrombin"
Meta Candidates (Total=17; Excluded=1; Pruned=0; Remaining=16)
   753   C0332283:Followed by [Temporal Concept]
           followed
   736   C0009458:Medium [Intellectual Product]
   736   C0040018:Thrombin [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   736   C0229671:Serum [Body Substance]
   736   C0332256:Containing [Functional Concept]
   736   C0332296:free [Functional Concept]
   736   C0439536:Medium [Quantitative Concept]
   736   C1546774:Serum [Intellectual Product]
   736   C1550100:Serum [Body Substance]
   736   C1705217:Medium [Substance]
   736   C1880497:Free [Qualitative Concept]
   736   C1883712:Addition [Functional Concept]
   736   C1996904:Free [Qualitative Concept]
   736   C2700400:Containing [Activity]
   736   C3244283:medium [Intellectual Product]
   703 E C1719822:Follow [Intellectual Product]

Phrase: "(0.5 U/ml"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0439340:U/ml [Quantitative Concept]
   861   C1880521:U/mL [Quantitative Concept]
   861   C2945590:U/mL [Quantitative Concept]
   812   C0439526:/mL [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.357: After 15 min, the lower compartment was filled with 500 l serum-free medium and the medium in the upper compartment was replaced with fresh medium containing HRP (0.34 mg/ml). 

Phrase: "After 15 min,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "the lower compartment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1185625:Compartment [Body Space or Junction]
   861   C2986730:Compartment [Spatial Concept]

Phrase: "was"

Phrase: "filled with 500 l serum-free medium"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   748   C0009458:Medium [Intellectual Product]
   748   C0229671:Serum [Body Substance]
   748   C0332296:free [Functional Concept]
   748   C0439536:Medium [Quantitative Concept]
   748   C1546774:Serum [Intellectual Product]
   748   C1550100:Serum [Body Substance]
   748   C1705217:Medium [Substance]
   748   C1708059:Filled [Activity]
   748   C1880497:Free [Qualitative Concept]
   748   C1996904:Free [Qualitative Concept]
   748   C3244283:medium [Intellectual Product]

Phrase: "and"

Phrase: "the medium in the upper compartment"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0009458:Medium [Intellectual Product]
   753   C0439536:Medium [Quantitative Concept]
   753   C1705217:Medium [Substance]
   753   C3244283:medium [Intellectual Product]

Phrase: "was"

Phrase: "replaced with fresh medium containing HRP"
Meta Candidates (Total=18; Excluded=1; Pruned=0; Remaining=17)
   778   C0019941:Horseradish Peroxidase [Amino Acid, Peptide, or Protein,Enzyme,Indicator, Reagent, or Diagnostic Aid]
   748   C0009458:Medium [Intellectual Product]
   748   C0027021:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0031179:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0330510:Horseradish [Food]
   748   C0332256:Containing [Functional Concept]
   748   C0439536:Medium [Quantitative Concept]
   748   C0443224:Fresh [Qualitative Concept]
   748   C0559956:Replaced [Functional Concept]
   748   C0939835:HORSERADISH [Organic Chemical,Pharmacologic Substance]
   748   C1110641:Horseradish [Plant]
   748   C1299987:replaced [Functional Concept]
   748   C1318719:Peroxidase [Indicator, Reagent, or Diagnostic Aid]
   748   C1705217:Medium [Substance]
   748   C2700400:Containing [Activity]
   748   C2827486:Fresh [Body Substance]
   748   C3244283:medium [Intellectual Product]
   714 E C1554078:Replace [Idea or Concept]

Phrase: "(0.34 mg/ml"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439294:mg ml [Quantitative Concept]
   812   C0439526:/mL [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.358: After 1 min, 60 l of medium from the lower compartment were transferred to a tube and mixed with 860 l of reaction buffer containing 50 mM NaH2PO4, 5 mM Guaiacol and freshly made 0.6 mM H2O2. 

Phrase: "After 1 min,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "60 l of medium from the lower compartment"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0009458:Medium [Intellectual Product]
   744   C0439536:Medium [Quantitative Concept]
   744   C1705217:Medium [Substance]
   744   C3244283:medium [Intellectual Product]

Phrase: "were"

Phrase: "transferred to a tube"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   770   C0175730:Tube [Medical Device]
   770   C0348011:transferred [Functional Concept]
   770   C1547937:Tube NOS [Intellectual Product]
   770   C1561954:tube [Conceptual Entity]
   770   C1704730:TUBE [Medical Device]
   737 E C0040671:Transfer [Mental Process]
   737 E C1705822:Transfer [Activity]

Phrase: "and"

Phrase: "mixed with 860 l of reaction buffer"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   748   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   748   C0205430:Mixed [Functional Concept]
   748   C0443286:Reaction [Functional Concept]
   748   C1114821:Reaction [Clinical Attribute]
   748   C3160715:Mixed [Finding]
   714 E C1421951:MIX [Gene or Genome]
   714 E C1720722:Mix [Qualitative Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "50 mM NaH2PO4,"

Phrase: "5 mM Guaiacol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0018304:Guaiacol [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "freshly"

Phrase: "made"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1881534:Make [Functional Concept]

Phrase: "0.6 mM H2O2."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
Processing 00000000.tx.359: The absorbance was measured at 470 nm after 15 min incubation at room temperature. 

Phrase: "The absorbance"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1268822:Absorbance [Clinical Attribute]
  1000   C2825050:Absorbance [Phenomenon or Process]

Phrase: "was"

Phrase: "measured at 470 nm"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0312860:NM [Cell Function]
   770   C0444706:Measured [Qualitative Concept]
   770   C3541902:MEASURED [Diagnostic Procedure]
   737 E C0079809:Measure [Quantitative Concept]
   737 E C0242485:Measure [Functional Concept]

Phrase: "after 15 min incubation"

Phrase: "at room temperature."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]
Processing 00000000.tx.360: Protein Assay Proteins in the cellular extracts and lysates were quantitated by the bicinchoninic acid (43) or by the Bradford technique (44). 

Phrase: "Protein Assay Proteins in the cellular extracts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "lysates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1881488:Lysate [Physical Object]

Phrase: "were"

Phrase: "quantitated by the bicinchoninic acid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0053554:bicinchoninic acid [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   760   C0001128:Acid [Chemical]
   760   C0202406:Acid [Laboratory Procedure]

Phrase: "(43"

Phrase: ")"

Phrase: "or by the Bradford technique"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0449851:Technique [Functional Concept]

Phrase: "(44"

Phrase: ")."
Processing 00000000.tx.361: Statistics The results are presented as means  SEM of four to six independent experiments each performed in triplicate at different times. 

Phrase: "Statistics"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0038215:Statistics [Occupation or Discipline]
  1000   C0600673:Statistics [Intellectual Product]
   966 E C2348149:Statistic [Quantitative Concept]
   966 E C2828391:Statistic [Quantitative Concept]

Phrase: "The results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "presented as means  SEM of four"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   753   C0205450:Four [Quantitative Concept]
   753   C0449450:Presented [Idea or Concept]
   753   C1704970:Means [Conceptual Entity]
   719 E C0150312:Present [Quantitative Concept]
   719 E C0444504:Mean [Quantitative Concept]
   719 E C2347634:Mean [Quantitative Concept]
   719 E C2348143:Mean [Quantitative Concept]

Phrase: "to six independent experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]

Phrase: "each"

Phrase: "performed in triplicate"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0205174:Triplicate [Quantitative Concept]
   790   C0884358:Performed [Functional Concept]
   756 E C2947996:Perform [Pharmacologic Substance]

Phrase: "at different times."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0040223:times [Temporal Concept]
   861   C1632851:Times [Quantitative Concept]
   827 E C3541383:Time [Temporal Concept]
   789 E C0442043:Temporal [Spatial Concept]
   789 E C2362314:Temporal [Temporal Concept]
Processing 00000000.tx.362: Paired Students t test was used to compare the basal vs. insulin-treated preparations. 

Phrase: "Paired Students t test"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   923   C1709451:Paired t-Test [Intellectual Product]
   812   C0022885:Test [Laboratory Procedure]
   812   C0038492:Students [Professional or Occupational Group]
   812   C0039593:Test [Functional Concept]
   812   C0392366:test [Intellectual Product]
   779 E C1551041:student [Idea or Concept]
   779 E C1552573:student [Intellectual Product]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "compare"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compare [Activity]

Phrase: "the basal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205112:Basal [Spatial Concept]

Phrase: "vs. insulin-treated preparations."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0021641:INSULIN PREPARATIONS [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   793   C0455052:Preparation [Health Care Activity]
   793   C1521827:Preparation [Functional Concept]
Processing 00000000.tx.363: Unpaired t test or ANOVA was used to compare the mean values between treatments. 

Phrase: "Unpaired t test"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1710574:Unpaired t-Test [Intellectual Product]
   827   C0022885:Test [Laboratory Procedure]
   827   C0039593:Test [Functional Concept]
   827   C0392366:test [Intellectual Product]

Phrase: "or"

Phrase: "ANOVA"

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "compare"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compare [Activity]

Phrase: "the mean values between treatments."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0042295:Values [Qualitative Concept]
   760   C0444504:Mean [Quantitative Concept]
   760   C2347634:Mean [Quantitative Concept]
   760   C2348143:Mean [Quantitative Concept]
   726 E C1522609:Value [Quantitative Concept]
Processing 00000000.tx.364: A P value of <0.05 was considered statistically significant.  

Phrase: "A P value of <0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1709380:P-Value [Quantitative Concept]
   799   C1522609:Value [Quantitative Concept]

Phrase: "was"

Phrase: "considered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]

Phrase: "statistically significant."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0237881:statistically significant [Quantitative Concept]
           significant
   928 E C1709380:Statistical Significance [Quantitative Concept]
   861   C0038215:Statistically [Occupation or Discipline]
   861   C0750502:Significant [Idea or Concept]
   861   C1546944:Significant [Qualitative Concept]
Processing 00000000.tx.365: ACKNOWLEDGMENTS  We thank Dr. 

Phrase: "ACKNOWLEDGMENTS"

Phrase: "We"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.366: David Hartshorne for helpful suggestions and interpretations of results.  

Phrase: "David Hartshorne for helpful suggestions"

Phrase: "and"

Phrase: "interpretations of results."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0459471:interpretations [Intellectual Product]
   756 E C3173575:Interpretation [Clinical Attribute]
Processing 00000000.tx.367: FOOTNOTES  Address requests for reprints to: Dr. 

Phrase: "FOOTNOTES  Address"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0376649:Address [Intellectual Product]
   861   C1442065:Address [Spatial Concept]

Phrase: "requests for reprints"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   882   C0686900:Request for [Functional Concept]
           request
   790   C1272683:Request [Functional Concept]
   790   C1522634:Request [Intellectual Product]
   756   C3273171:Reprint [Intellectual Product]

Phrase: "to"

Phrase: ":"

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.368: Najma Begum, the Diabetes Research Laboratory, Winthrop University Hospital, 259 First Street, Mineola, New York 11501. 

Phrase: "Najma Begum,"

Phrase: "the Diabetes Research Laboratory,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0022886:research laboratory [Research Activity]
   827   C0022877:Laboratory [Manufactured Object,Organization]
   827   C0035168:research [Research Activity]
   827   C0242481:Research [Research Activity]
   827   C3244292:laboratory [Functional Concept]

Phrase: "Winthrop University Hospital,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   901   C0020028:university hospital [Health Care Related Organization,Manufactured Object]
   827   C0019994:Hospital, NOS [Health Care Related Organization,Manufactured Object]
   827   C0041740:University [Manufactured Object,Organization]
   827   C0331932:Winthrop [Health Care Related Organization]
   827   C1510665:Hospital [Qualitative Concept]
   743 E C1609061:Hospitals [Intellectual Product]

Phrase: "259 First Street,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0442658:Street [Manufactured Object]
   827   C1301826:Street [Finding]

Phrase: "Mineola,"

Phrase: "New York 11501."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0027976:New York [Geographic Area]
   827   C0205314:New [Temporal Concept]
Processing 00000000.tx.369: This work was supported in part by an Established Investigator Award (N.B.), a Grant-in-Aid New York State affiliate (L.R.) from the American Heart Association, a research award from the American Diabetes Association (N.B.) and funds from the medical eduction and research, Winthrop University Hospital. 

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "supported in part"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0449719:Part [Spatial Concept]
   790   C1521721:Supported [Conceptual Entity]
   790   C1709471:Part [Quantitative Concept]
   756 E C0183683:Support [Medical Device]

Phrase: "by an Established Investigator Award"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0004446:Award [Manufactured Object]

Phrase: "(N.B."

Phrase: ")"

Phrase: ","

Phrase: "a Grant-in-Aid New York State affiliate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C1510825:Affiliate [Qualitative Concept]
   795   C1696107:affiliate [Idea or Concept]

Phrase: "(L.R.) from the American Heart Association,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0205090:R- [Spatial Concept]
   748   C0684010:R. [Professional or Occupational Group]
   748   C2603358:R' [Clinical Attribute]

Phrase: "a research award from the American Diabetes Association"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0004446:Award [Manufactured Object]

Phrase: "(N.B.)"

Phrase: "and"

Phrase: "funds from the medical eduction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0016820:Fund [Quantitative Concept]
   760   C0205476:Medical [Functional Concept]

Phrase: "and"

Phrase: "research,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035168:research [Research Activity]
  1000   C0242481:Research [Research Activity]

Phrase: "Winthrop University Hospital."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   901   C0020028:university hospital [Health Care Related Organization,Manufactured Object]
   827   C0019994:Hospital, NOS [Health Care Related Organization,Manufactured Object]
   827   C0041740:University [Manufactured Object,Organization]
   827   C0331932:Winthrop [Health Care Related Organization]
   827   C1510665:Hospital [Qualitative Concept]
   743 E C1609061:Hospitals [Intellectual Product]
Processing 00000000.tx.370: Received for publication February 18, 2000. 

Phrase: "Received for publication February 18,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0034036:Publication [Intellectual Product,Manufactured Object]
   760   C0034037:Publication [Occupational Activity]
   760   C1514756:Received [Qualitative Concept]
   760   C1704324:Publication [Intellectual Product]

Phrase: "2000."
Processing 00000000.tx.371: Revision received April 26, 2000.  

Phrase: "Revision"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439617:Revision [Temporal Concept]
  1000   C0558347:Revision [Therapeutic or Preventive Procedure]
  1000   C1527075:Revision [Therapeutic or Preventive Procedure]

Phrase: "received"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514756:Received [Qualitative Concept]

Phrase: "April 26,"

Phrase: "2000."
Processing 00000000.tx.372: REFERENCES TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES  Sowers JR, Epstein M 1995 Diabetes mellitus, associated hypertension, vascular disease, nephropathy. 

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Sowers JR,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1708595:Jr [Idea or Concept]
   861   C3280986:JR [Disease or Syndrome]

Phrase: "Epstein M 1995 Diabetes mellitus,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   840   C0011849:Diabetes Mellitus [Disease or Syndrome]
           Diabetes
   804   C0011847:Diabetes [Disease or Syndrome]

Phrase: "associated hypertension,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0020538:Hypertension [Disease or Syndrome]
   861   C1963138:Hypertension [Finding]

Phrase: "vascular disease,"
Meta Candidates (Total=17; Excluded=12; Pruned=0; Remaining=5)
  1000   C0042373:Vascular disease [Disease or Syndrome]
   950 E C0018939:Blood disease NOS [Disease or Syndrome]
   950 E C1533163:Blood disease [Disease or Syndrome]
   861   C0005847:vascular [Body Part, Organ, or Organ Component]
   861   C0012634:Disease [Disease or Syndrome]
   861   C1558950:VASCULAR [Finding]
   861   C1801960:Vascular [Qualitative Concept]
   805 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   805 E C1511228:VESSEL, BLOOD [Tissue]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761 E C0005767:Blood [Tissue]
   761 E C0005768:blood [Body Substance]
   761 E C0229664:Blood [Body Substance]
   761 E C0392895:Bloods [Population Group]
   745 E C0333275:Bloody [Qualitative Concept]

Phrase: "nephropathy."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022658:Nephropathy [Disease or Syndrome]
Processing 00000000.tx.373: An update. 

Phrase: "An update."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1519814:Update [Temporal Concept]
Processing 00000000.tx.374: Hypertension 6: 869879 Stout RW 1992 Insulin, atherogenesis. 

Phrase: "Hypertension 6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0020538:Hypertension [Disease or Syndrome]
   861   C1963138:Hypertension [Finding]

Phrase: ":"

Phrase: "869879 Stout RW 1992 Insulin,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "atherogenesis."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1563937:Atherogenesis [Pathologic Function]
Processing 00000000.tx.375: Eur J Epidemiol 8:134135[Medline] Hsueh WA, Law RE 1999 Insulin signaling in the arterial wall. 

Phrase: "Eur J Epidemiol 8"

Phrase: ":"

Phrase: "134135"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Hsueh WA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0043038:WA [Geographic Area]

Phrase: "Law RE 1999 Insulin signaling in the arterial wall."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0037083:Signaling [Cell Function]
   742   C3537152:signaling [Biologic Function]
Processing 00000000.tx.376: Am J Cardiol 84:21J24J[CrossRef] Kahn AM, Seidel CL, Allen JC, ONeil RG, Shelat H, Song T 1993 Insulin reduces contraction, intracellular calcium concentration in vascular smooth muscle. 

Phrase: "Am"

Phrase: "J Cardiol 84"

Phrase: ":"

Phrase: "21J24J"

Phrase: "[CrossRef"

Phrase: "] Kahn"

Phrase: "AM"

Phrase: ","

Phrase: "Seidel CL,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596019:Cl - [Element, Ion, or Isotope]

Phrase: "Allen JC,"

Phrase: "ONeil RG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1412999:RG [Gene or Genome]

Phrase: "Shelat H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Song T 1993 Insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "reduces"

Phrase: "contraction,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1140999:Contraction [Pathologic Function]

Phrase: "intracellular calcium concentration in vascular smooth muscle."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0086045:Concentration [Mental Process]
   748   C1446561:Concentration [Quantitative Concept]
   724   C0427728:Blood concentration [Laboratory or Test Result]
   724   C0699870:blood concentration [Quantitative Concept]
   724   C1313904:Blood concentration [Laboratory Procedure]
Processing 00000000.tx.377: Hypertension 22:735742[Abstract] Somlyo AP, Somlyo AV 1994 Signal transduction, regulation in smooth muscle. 

Phrase: "Hypertension 22"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0020538:Hypertension [Disease or Syndrome]
   861   C1963138:Hypertension [Finding]

Phrase: ":"

Phrase: "735742"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Somlyo AP,"

Phrase: "Somlyo AV 1994 Signal transduction,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   840   C0037083:Signal Transduction [Cell Function]
   804   C1160185:transduction [Organism Function]
   804   C1710082:Signal [Phenomenon or Process]

Phrase: "regulation in smooth muscle."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0851285:Regulation [Governmental or Regulatory Activity]
   770   C1327622:Regulation [Biologic Function]
Processing 00000000.tx.378: Nature 372:231236[CrossRef][Medline] Lee MR, Li L, Kitazawa T 1997 c GMP causes Ca2+ desensitization in vascular smooth muscle cells by activating the myosin light chain phosphatase. 

Phrase: "Nature 372"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: ":"

Phrase: "231236"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Lee MR,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347167:Mr. [Conceptual Entity]

Phrase: "Li L,"

Phrase: "Kitazawa T 1997 c GMP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0018346:GMP [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   804   C1417862:GMP [Gene or Genome]
   804   C3540519:GMP [Gene or Genome]

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "Ca2+ desensitization in vascular smooth muscle cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0178702:Desensitization [Therapeutic or Preventive Procedure]
   748   C1709852:Desensitization [Molecular Function]

Phrase: "by activating"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1879547:activating [Activity]
   966 E C1515877:Activate [Functional Concept]

Phrase: "the myosin light chain phosphatase."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C0067062:Myosin-Light-Chain Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
           myosin phosphatase
   923   C0027108:Myosin Light Chain [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0023693:Light [Natural Phenomenon or Process]
   812   C0027096:Myosin [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0031678:Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0337112:Chain [Manufactured Object]
   812   C1149880:phosphatase [Molecular Function]
   812   C1306462:Light [Functional Concept]
   812   C1524075:Chain [Idea or Concept]
   812   C1881376:Light [Qualitative Concept]
Processing 00000000.tx.379: J Biol Chem 272: 50635068 Kubota Y, Nomura M, Kamm KE, Mumby MC, Stull JT 1992 GTP gamma S-dependent regulation of smooth muscle contractile elements. 

Phrase: "J Biol Chem 272"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "50635068 Kubota Y,"

Phrase: "Nomura M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Kamm KE,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022558:KE [Geographic Area]

Phrase: "Mumby MC,"

Phrase: "Stull JT 1992 GTP gamma S-dependent regulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0851285:Regulation [Governmental or Regulatory Activity]
   793   C1327622:Regulation [Biologic Function]

Phrase: "of smooth muscle contractile elements."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0013879:Elements [Element, Ion, or Isotope]
   812   C0026820:Contractile [Physiologic Function]
   779 E C1705248:Element [Conceptual Entity]
Processing 00000000.tx.380: Am J Physiol 262:C405C410 Mulchay LT, Ichikawa K, Hartshorne DJ, Siegman MJ, Butler TM 1995 Thiophosphorylation of the 130-kDa subunit is associated with a decreased activity of myosin light chain phosphatase in -toxin permeabilized smooth muscle. 

Phrase: "Am"

Phrase: "J Physiol 262"

Phrase: ":"

Phrase: "C405C410 Mulchay LT,"

Phrase: "Ichikawa K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Hartshorne DJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012836:DJ [Geographic Area]

Phrase: "Siegman MJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439254:MJ [Medical Device]

Phrase: "Butler TM 1995 Thiophosphorylation of the 130-kDa subunit"

Phrase: "is"

Phrase: "associated with a decreased activity of myosin light chain phosphatase in -toxin"
Meta Candidates (Total=31; Excluded=3; Pruned=0; Remaining=28)
   804   C1323639:[Myosin light-chain]-phosphatase activity [Molecular Function]
   790   C0067062:Myosin-Light-Chain Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
           myosin phosphatase
   770   C0027108:Myosin Light Chain [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   766   C1149936:myosin phosphatase activity [Molecular Function]
   753   C0086439:Decreased activity [Sign or Symptom]
   753   C0332281:Associated with [Qualitative Concept]
           Associated
   751   C0949646:Myosin A [Amino Acid, Peptide, or Protein,Enzyme]
   751   C1149880:phosphatase activity [Molecular Function]
           phosphatase
   751   C1152935:toxin activity [Molecular Function]
   751   C1517883:Light Activity [Daily or Recreational Activity]
   736   C0023693:Light [Natural Phenomenon or Process]
   736   C0027096:Myosin [Amino Acid, Peptide, or Protein,Enzyme]
   736   C0031678:Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   736   C0040549:Toxin [Biologically Active Substance,Hazardous or Poisonous Substance]
   736   C0205177:Activity [Functional Concept]
   736   C0205216:Decreased [Quantitative Concept]
   736   C0337112:Chain [Manufactured Object]
   736   C0392756:Decreased [Qualitative Concept]
   736   C0439167:% activity [Quantitative Concept]
   736   C0441655:Activity [Activity]
   736   C0442797:decreased [Qualitative Concept]
   736   C1306462:Light [Functional Concept]
   736   C1524075:Chain [Idea or Concept]
   736   C1561536:*Activity [Idea or Concept]
   736   C1881376:Light [Qualitative Concept]
   703 E C0547047:Decrease [Quantitative Concept]
   703 E C0750490:Associate [Idea or Concept]
   703 E C1706221:Associate [Professional or Occupational Group]

Phrase: "permeabilized"

Phrase: "smooth muscle."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1267092:Muscle, Smooth [Tissue]
   861   C0026845:Muscle [Tissue]
   861   C0205357:Smooth [Qualitative Concept]
   789 E C0442025:Muscular [Spatial Concept]
Processing 00000000.tx.381: J Biol Chem 270:1819118194[Abstract/Free FullText] Takuwa Y 1996 Regulation of vascular smooth muscle contraction. 

Phrase: "J Biol Chem 270"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "1819118194"

Phrase: "[Abstract/Free FullText"

Phrase: "] Takuwa Y 1996 Regulation of vascular smooth muscle contraction."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   882   C2256416:regulation of vascular smooth muscle contraction [Organism Function]
   832   C1155934:regulation of smooth muscle contraction [Organ or Tissue Function]
   807   C1155927:regulation of muscle contraction [Organ or Tissue Function]
   742   C0851285:Regulation [Governmental or Regulatory Activity]
   742   C1327622:Regulation [Biologic Function]
Processing 00000000.tx.382: The roles of Ca2+, protein kinase C, myosin light chain phosphatase. 

Phrase: "The roles of Ca2+,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0035820:Roles [Social Behavior]
   737 E C1705810:Role [Conceptual Entity]

Phrase: "protein kinase C,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0033634:Protein Kinase C [Amino Acid, Peptide, or Protein,Enzyme]
   913   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   913   C1168438:Protein C [Laboratory Procedure]
   913   C1418943:PROTEIN C [Gene or Genome]
   913   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "myosin light chain phosphatase."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C0067062:Myosin-Light-Chain Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
           myosin phosphatase
   923   C0027108:Myosin Light Chain [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0023693:Light [Natural Phenomenon or Process]
   812   C0027096:Myosin [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0031678:Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0337112:Chain [Manufactured Object]
   812   C1149880:phosphatase [Molecular Function]
   812   C1306462:Light [Functional Concept]
   812   C1524075:Chain [Idea or Concept]
   812   C1881376:Light [Qualitative Concept]
Processing 00000000.tx.383: Jpn Heart J 37:793813[Medline] Shimizu H, Ito M, Miyahara M, Ichikawa K, Okubo S, Konishi T, Naka M, Tanaka T, Hirano K, Hartshorne DJ, Nakano T 1994 Characterization of the myosin-binding subunit of smooth muscle myosin phosphatase. 

Phrase: "Jpn Heart J 37"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0018787:Heart [Body Part, Organ, or Organ Component]
   812   C0022341:JPN [Geographic Area]
   812   C1281570:Heart [Body Part, Organ, or Organ Component]

Phrase: ":"

Phrase: "793813"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Shimizu H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Ito M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Miyahara M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Ichikawa K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Okubo S,"

Phrase: "Konishi T,"

Phrase: "Naka M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Tanaka T,"

Phrase: "Hirano K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Hartshorne DJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012836:DJ [Geographic Area]

Phrase: "Nakano T 1994 Characterization of the myosin-binding subunit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1880022:Characterization [Activity]

Phrase: "of smooth muscle myosin phosphatase."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0067062:myosin phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0031678:Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C1149880:phosphatase [Molecular Function]
Processing 00000000.tx.384: J Biol Chem 269: 3040730411 Kitazawa T, Masuo M, Somlyo AP 1991 G protein-mediated inhibition of myosin light chain phosphatase in vascular smooth muscle. 

Phrase: "J Biol Chem 269"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "3040730411 Kitazawa T,"

Phrase: "Masuo M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Somlyo AP 1991 G protein-mediated inhibition of myosin light chain phosphatase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   736   C0021467:Inhibition [Mental Process]
   736   C0021469:Inhibition [Molecular Function]
   736   C1628982:% inhibition [Quantitative Concept]
   736   C3463820:Inhibition [Activity]

Phrase: "in vascular smooth muscle."
Meta Candidates (Total=15; Excluded=8; Pruned=0; Remaining=7)
  1000   C0026844:Muscle, Smooth, Vascular [Tissue]
   901   C1267092:Muscle, Smooth [Tissue]
   827   C0005847:vascular [Body Part, Organ, or Organ Component]
   827   C0026845:Muscle [Tissue]
   827   C0205357:Smooth [Qualitative Concept]
   827   C1558950:VASCULAR [Finding]
   827   C1801960:Vascular [Qualitative Concept]
   771 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   771 E C1511228:VESSEL, BLOOD [Tissue]
   755 E C0442025:Muscular [Spatial Concept]
   727 E C0005767:Blood [Tissue]
   727 E C0005768:blood [Body Substance]
   727 E C0229664:Blood [Body Substance]
   727 E C0392895:Bloods [Population Group]
   711 E C0333275:Bloody [Qualitative Concept]
Processing 00000000.tx.385: Proc Natl Acad Sci USA 88: 93079310 Wu X, Somlyo AV, Somlyo AP 1996 Cyclic GMP dependent stimulation reverses G-protein coupled inhibition of smooth muscle myosin light chain phosphatase. 

Phrase: "Proc Natl Acad Sci USA 88"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   799   C0041703:USA [Geographic Area]
   799   C0268596:ACAD [Disease or Syndrome]
   799   C1418943:PROC [Gene or Genome]
   799   C2700624:ACAD [Cell Function]
   799   C3642273:SCI [Professional or Occupational Group]

Phrase: ":"

Phrase: "93079310 Wu X,"

Phrase: "Somlyo AV,"

Phrase: "Somlyo AP 1996 Cyclic GMP dependent stimulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   795   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "reverses"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555029:Reverse [Idea or Concept]

Phrase: "G-protein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0086376:G-Protein [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0439267:g% [Quantitative Concept]

Phrase: "coupled"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1948027:Coupled [Functional Concept]
   966 E C0010222:couple [Family Group]

Phrase: "inhibition of smooth muscle myosin light chain phosphatase."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0021467:Inhibition [Mental Process]
   744   C0021469:Inhibition [Molecular Function]
   744   C1628982:% inhibition [Quantitative Concept]
   744   C3463820:Inhibition [Activity]
Processing 00000000.tx.386: Biochem Biophys Res Commun 220:658663[CrossRef][Medline] Okubo S, Ito M, Takashiba Y, Ichikawa K, Miyahara M, Shimizu H, Konishi T, Shima H, Nagao M, Hartshorne DJ, Nakano T 1994 A regulatory subunit of smooth muscle myosin bound phosphatase. 

Phrase: "Biochem Biophys Res Commun 220"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C2347379:RES [Finding]

Phrase: ":"

Phrase: "658663"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Okubo S,"

Phrase: "Ito M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Takashiba Y,"

Phrase: "Ichikawa K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Miyahara M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Shimizu H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Konishi T,"

Phrase: "Shima H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Nagao M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Hartshorne DJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012836:DJ [Geographic Area]

Phrase: "Nakano T 1994"

Phrase: "A regulatory subunit of smooth muscle myosin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1711351:Subunit [Quantitative Concept]

Phrase: "bound"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0332297:bound [Spatial Concept]
  1000   C1145667:Bound [Activity]
  1000   C1167622:Bound [Molecular Function]
  1000   C1689898:% bound [Quantitative Concept]
  1000   C2349209:Bound [Conceptual Entity]

Phrase: "phosphatase."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031678:Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1149880:phosphatase [Molecular Function]
Processing 00000000.tx.387: Biochem Biophys Res Commun 200: 429434 Ichikawa K, Ito M, Hartshorne DJ 1996 Phosphorylation of the large regulatory subunit of myosin phosphatase and inhibition of phosphatase activity. 

Phrase: "Biochem Biophys Res Commun 200"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C2347379:RES [Finding]

Phrase: ":"

Phrase: "429434 Ichikawa K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   827   C1708601:K' [Quantitative Concept]

Phrase: "Ito M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Hartshorne DJ 1996 Phosphorylation of the large regulatory subunit of myosin phosphatase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   736   C0031715:Phosphorylation [Molecular Function]
   736   C1158886:Phosphorylation [Molecular Function]

Phrase: "and"

Phrase: "inhibition of phosphatase activity."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0021467:Inhibition [Mental Process]
   770   C0021469:Inhibition [Molecular Function]
   770   C1628982:% inhibition [Quantitative Concept]
   770   C3463820:Inhibition [Activity]
Processing 00000000.tx.388: J Biol Chem 271: 47334740 Kimura K, Ito M, Amano M, Ichihara K, Fukata Y, Nakafuku M, Yamamori B, Feng J, Nakano T, Okawa K, Iwamatsu A, Kaibuchi K 1996 Regulation of myosin phosphatase by Rho and Rho-associated kinase (Rho kinase). 

Phrase: "J Biol Chem 271"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "47334740 Kimura K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   827   C1708601:K' [Quantitative Concept]

Phrase: "Ito M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Amano M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Ichihara K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Fukata Y,"

Phrase: "Nakafuku M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Yamamori B,"

Phrase: "Feng J,"

Phrase: "Nakano T,"

Phrase: "Okawa K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Iwamatsu A,"

Phrase: "Kaibuchi K 1996 Regulation of myosin phosphatase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0851285:Regulation [Governmental or Regulatory Activity]
   748   C1327622:Regulation [Biologic Function]

Phrase: "by Rho"

Phrase: "and"

Phrase: "Rho-associated kinase"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0389995:rho-Associated Kinase [Amino Acid, Peptide, or Protein,Enzyme]
           rho-Kinase
   913   C1335631:RHO KINASE [Gene or Genome]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0332281:Associated [Qualitative Concept]
   793 E C0750490:Associate [Idea or Concept]
   793 E C1706221:Associate [Professional or Occupational Group]

Phrase: "(Rho kinase"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0389995:rho-Kinase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1335631:RHO KINASE [Gene or Genome]
   861   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ")."
Processing 00000000.tx.389: Science 273:245248[Abstract] Gong MG, Fuglsang A, Alessi D, Kobayashi S, Cohen P, Somlyo AV, Somlyo AP 1992 Arachidonic acid inhibits myosin light chain phosphatase and sensitizes smooth muscle to calcium. 

Phrase: "Science 273"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: ":"

Phrase: "245248"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Gong MG,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439269:mg% [Quantitative Concept]
   861   C1960952:mg % [Quantitative Concept]
   861   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "Fuglsang"

Phrase: "A,"

Phrase: "Alessi D,"

Phrase: "Kobayashi S,"

Phrase: "Cohen P,"

Phrase: "Somlyo AV,"

Phrase: "Somlyo AP 1992 Arachidonic acid"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   840   C0003695:Arachidonic Acid [Eicosanoid]
   840   C2316832:Arachidonic Acid [Laboratory Procedure]
   804   C0001128:Acid [Chemical]
   804   C0202406:Acid [Laboratory Procedure]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "myosin light chain phosphatase"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C0067062:Myosin-Light-Chain Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
           myosin phosphatase
   923   C0027108:Myosin Light Chain [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0023693:Light [Natural Phenomenon or Process]
   812   C0027096:Myosin [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0031678:Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0337112:Chain [Manufactured Object]
   812   C1149880:phosphatase [Molecular Function]
   812   C1306462:Light [Functional Concept]
   812   C1524075:Chain [Idea or Concept]
   812   C1881376:Light [Qualitative Concept]

Phrase: "and"

Phrase: "sensitizes"

Phrase: "smooth muscle to calcium."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C1267092:Muscle, Smooth [Tissue]
   770   C0026845:Muscle [Tissue]
   770   C0205357:Smooth [Qualitative Concept]
Processing 00000000.tx.390: J Biol Chem 267:2149221498[Abstract/Free FullText] Ikebe M, Brozovich FV 1996 Protein kinase C increases force and slows relaxation in smooth muscle: evidence for regulation of the myosin light chain phosphatase. 

Phrase: "J Biol Chem 267"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "2149221498"

Phrase: "[Abstract/Free FullText"

Phrase: "] Ikebe M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Brozovich FV 1996 Protein kinase C"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   861   C0033634:Protein Kinase C [Amino Acid, Peptide, or Protein,Enzyme]
   839   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   839   C1168438:Protein C [Laboratory Procedure]
   839   C1418943:PROTEIN C [Gene or Genome]
   839   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "force"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0441722:Force [Phenomenon or Process]
  1000   C0563538:Force [Phenomenon or Process]
   944 E C0729333:Dynamic [Functional Concept]

Phrase: "and"

Phrase: "slows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439834:Slow [Qualitative Concept]

Phrase: "relaxation in smooth muscle"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   881   C2249967:smooth muscle relaxation [Organ or Tissue Function]
   819   C0026836:Muscle Relaxation [Organ or Tissue Function]
   819   C0700323:Muscle relaxation [Disease or Syndrome]
   770   C0035028:Relaxation [Activity]

Phrase: ":"

Phrase: "evidence for regulation of the myosin light chain phosphatase."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   762   C0332120:Evidence of [Functional Concept]
           Evidence
Processing 00000000.tx.391: Biochem Biophys Res Commun 225:370376, 1996[CrossRef][Medline] Steinberg HO, Brechtel G, Johnson A, Fineberg N, Baron AD 1994 Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent. 

Phrase: "Biochem Biophys Res Commun 225"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C2347379:RES [Finding]

Phrase: ":"

Phrase: "370376,"

Phrase: "1996"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Steinberg HO,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1832110:HO [Gene or Genome]

Phrase: "Brechtel G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Johnson A,"

Phrase: "Fineberg N,"

Phrase: "Baron AD 1994 Insulin-mediated skeletal muscle vasodilation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C0042401:Vasodilation [Physiologic Function]
   793   C0595862:VASODILATION [Pathologic Function]
   793   C3537065:Vasodilation [Physiologic Function]

Phrase: "is"

Phrase: "nitric oxide"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C0030015:oxide [Inorganic Chemical]
   861   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "dependent."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0851827:Dependent [Qualitative Concept]
  1000   C1701901:Dependent [Qualitative Concept]
  1000   C3244310:dependent [Functional Concept]
Processing 00000000.tx.392: A novel action of insulin to increase nitric oxide release. 

Phrase: "A novel action of insulin to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0441472:Action [Functional Concept]
   753   C3266814:Action [Activity]

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "nitric oxide release."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0030685:Release [Health Care Activity]
   827   C0391871:Release [Functional Concept]
   827   C0439180:% release [Quantitative Concept]
   827   C0680255:release [Health Care Activity]
   827   C1283071:Release [Functional Concept]
   827   C1963578:Release [Therapeutic or Preventive Procedure]
   734   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
Processing 00000000.tx.393: J Clin Invest 94:25112515[Medline] Lee MR, Li L, Kitazawa T 1997 cGMP causes Ca2+ desensitization in vascular smooth muscle cells by activating the myosin light chain phosphatase. 

Phrase: "J"

Phrase: "Clin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]

Phrase: "Invest"

Phrase: "94"

Phrase: ":"

Phrase: "25112515"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Lee MR,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347167:Mr. [Conceptual Entity]

Phrase: "Li L,"

Phrase: "Kitazawa T 1997 cGMP"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   861   C0018338:Cyclic guanosine monophosphate [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0018346:Guanosine Monophosphate [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   799   C0018330:Guanosine [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   799   C0439596:Cyclic [Temporal Concept]
   799   C1511572:Cyclic [Temporal Concept]
   727 E C0031084:Cyclicities [Temporal Concept]

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "Ca2+ desensitization in vascular smooth muscle cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0178702:Desensitization [Therapeutic or Preventive Procedure]
   748   C1709852:Desensitization [Molecular Function]

Phrase: "by activating"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1879547:activating [Activity]
   966 E C1515877:Activate [Functional Concept]

Phrase: "the myosin light chain phosphatase."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C0067062:Myosin-Light-Chain Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
           myosin phosphatase
   923   C0027108:Myosin Light Chain [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0023693:Light [Natural Phenomenon or Process]
   812   C0027096:Myosin [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0031678:Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0337112:Chain [Manufactured Object]
   812   C1149880:phosphatase [Molecular Function]
   812   C1306462:Light [Functional Concept]
   812   C1524075:Chain [Idea or Concept]
   812   C1881376:Light [Qualitative Concept]
Processing 00000000.tx.394: J Biol Chem 272:50635068[Abstract/Free FullText] Verin AD, Patterson CE, Day MA, Garcia JGN 1995 Regulation of endothelial cell gap formation and barrier function by myosin-associated phosphatase activities Am J Physiol 269:L99L108 Shimizu H, Ito M, Miyahara M, Ichikawa K, Okubo S, Konishi T, Naka M, Tanaka, T, Hirano K, Hartshorne DJ, Nakano T 1994 Characterization of the myosin-binding subunit of smooth muscle myosin phosphatase. 

Phrase: "J Biol Chem 272"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "50635068"

Phrase: "[Abstract/Free FullText"

Phrase: "] Verin AD,"

Phrase: "Patterson CE,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2827664:CE [Idea or Concept]

Phrase: "Day MA,"

Phrase: "Garcia JGN 1995 Regulation of endothelial cell gap formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   784   C1157723:regulation of formation [Molecular Function]
   742   C0851285:Regulation [Governmental or Regulatory Activity]
   742   C1327622:Regulation [Biologic Function]

Phrase: "and"

Phrase: "barrier function by myosin-associated phosphatase activities"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   774   C1292719:Associated function [Functional Concept]
   748   C0031843:function [Physiologic Function]
   748   C0542341:Function [Functional Concept]
   748   C0700205:FUNCTION [Classification]
   748   C1705273:Function [Intellectual Product]
   748   C1706912:BARRIER [Medical Device]
   738   C0695584:functional activities [Therapeutic or Preventive Procedure]

Phrase: "Am"

Phrase: "J Physiol 269"

Phrase: ":"

Phrase: "L99L108 Shimizu H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0033727:H+ [Element, Ion, or Isotope]
   827   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441932:H+ [Classification]
   827   C0564385:/h [Quantitative Concept]

Phrase: "Ito M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Miyahara M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Ichikawa K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Okubo S,"

Phrase: "Konishi T,"

Phrase: "Naka M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Tanaka,"

Phrase: "T,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Hirano K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Hartshorne DJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012836:DJ [Geographic Area]

Phrase: "Nakano T 1994 Characterization of the myosin-binding subunit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1880022:Characterization [Activity]

Phrase: "of smooth muscle myosin phosphatase."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0067062:myosin phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0031678:Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C1149880:phosphatase [Molecular Function]
Processing 00000000.tx.395: J Biol Chem 269:3040730411[Abstract/Free FullText] Essler M, Amano M, Kruse HJ, Kaibuchi K, Weber PC, Aepfelbacher M 1998 Thrombin inactivates myosin light chain phosphatase via Rho and its targets Rho kinase in human endothelial cells. 

Phrase: "J Biol Chem 269"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "3040730411"

Phrase: "[Abstract/Free FullText"

Phrase: "] Essler M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Amano M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Kruse HJ,"

Phrase: "Kaibuchi K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Weber PC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540812:PC [Gene or Genome]

Phrase: "Aepfelbacher M 1998 Thrombin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0040018:Thrombin [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "inactivates"

Phrase: "myosin light chain phosphatase via Rho"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   882   C0067062:Myosin-Light-Chain Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
           myosin phosphatase
   833   C0027108:Myosin Light Chain [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0023693:Light [Natural Phenomenon or Process]
   753   C0027096:Myosin [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0031678:Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0337112:Chain [Manufactured Object]
   753   C1149880:phosphatase [Molecular Function]
   753   C1306462:Light [Functional Concept]
   753   C1524075:Chain [Idea or Concept]
   753   C1881376:Light [Qualitative Concept]

Phrase: "and"

Phrase: "its targets Rho kinase in human endothelial cells."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0389995:rho-Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C1335631:RHO KINASE [Gene or Genome]
   744   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.396: J Biol Chem 273:2186721874[Abstract/Free FullText] Hartshorne DJ, Ito M, Erodi F Myosin light chain phosphatase subunit composition, interactions, and regulation. 

Phrase: "J Biol Chem 273"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "2186721874"

Phrase: "[Abstract/Free FullText"

Phrase: "] Hartshorne DJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012836:DJ [Geographic Area]

Phrase: "Ito M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Erodi F Myosin light chain phosphatase subunit composition,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0486616:Composition [Clinical Attribute]
   793   C1555710:composition [Idea or Concept]

Phrase: "interactions,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "regulation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0851285:Regulation [Governmental or Regulatory Activity]
  1000   C1327622:Regulation [Biologic Function]
Processing 00000000.tx.397: J Muscle Res Cell Motility 19:325341 Begum N, Ragolia L, Rienzie J, McCarthy M 1998 Regulation of MKP-1 induction by insulin in vascular smooth muscle cells: evaluation of the role of the nitric oxide signaling pathway and potential defects in hypertension. 

Phrase: "J Muscle Res Cell Motility 19"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   839   C0596981:Muscle cell [Cell]
   827   C0007608:cell motility [Cell Function]
           Motility
   799   C0007634:Cell [Cell]
   799   C0026845:Muscle [Tissue]
   799   C0678835:Motility [Laboratory or Test Result]
   799   C1269647:Cell [Cell]
   799   C1510470:Motility [Organism Function]
   799   C1704653:Cell [Medical Device]
   799   C1948049:Cell [Spatial Concept]
   799   C2347379:RES [Finding]
   727 E C0442025:Muscular [Spatial Concept]
   727 E C1979933:Motile [Finding]

Phrase: ":"

Phrase: "325341 Begum N,"

Phrase: "Ragolia L,"

Phrase: "Rienzie J,"

Phrase: "McCarthy M 1998 Regulation of MKP-1 induction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0851285:Regulation [Governmental or Regulatory Activity]
   744   C1327622:Regulation [Biologic Function]

Phrase: "by insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "in vascular smooth muscle cells"
Meta Candidates (Total=23; Excluded=11; Pruned=0; Remaining=12)
   923   C0026844:Muscle, Smooth, Vascular [Tissue]
   923   C1135918:Smooth Muscle Cells [Cell]
   861   C0596981:Muscle Cells [Cell]
   861   C1267092:Muscle, Smooth [Tissue]
   852   C0005773:Blood Cells [Cell]
   844 E C2328697:Hemal cell [Cell]
   812   C0005847:vascular [Body Part, Organ, or Organ Component]
   812   C0007634:Cells [Cell]
   812   C0026845:Muscle [Tissue]
   812   C0205357:Smooth [Qualitative Concept]
   812   C1558950:VASCULAR [Finding]
   812   C1801960:Vascular [Qualitative Concept]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
   756 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   756 E C1511228:VESSEL, BLOOD [Tissue]
   741 E C0442025:Muscular [Spatial Concept]
   712 E C0005767:Blood [Tissue]
   712 E C0005768:blood [Body Substance]
   712 E C0229664:Blood [Body Substance]
   712 E C0392895:Bloods [Population Group]

Phrase: ":"

Phrase: "evaluation of the role of the nitric oxide signaling pathway"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0220825:Evaluation [Functional Concept]
   739   C1261322:Evaluation [Health Care Activity]

Phrase: "and"

Phrase: "potential defects in hypertension."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0243067:defects [Functional Concept]
   737 E C1457869:Defect [Functional Concept]
   737 E C1861101:DEFECT [Disease or Syndrome]
Processing 00000000.tx.398: J Biol Chem 273, 2516425170 Begum N, Ragolia L 1998 Altered regulation of insulin signaling comonents in adipocytes of insulin-resistant type II diabetic Goto-Kakizaki (GK) rats. 

Phrase: "J Biol Chem 273,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: "2516425170 Begum N,"

Phrase: "Ragolia L 1998 Altered regulation of insulin signaling comonents"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   784   C2756011:regulation of signaling [Biologic Function]
   742   C0851285:Regulation [Governmental or Regulatory Activity]
   742   C1327622:Regulation [Biologic Function]

Phrase: "in adipocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0206131:Adipocytes [Cell]

Phrase: "of insulin-resistant type II diabetic Goto-Kakizaki"

Phrase: "(GK"

Phrase: ")"

Phrase: "rats."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:rats [Mammal]
  1000   C0034721:Rats [Mammal]
Processing 00000000.tx.399: Metabolism 47:5462[Medline] Feng J, Ito M, Ichikawa K, Isaka N, Nishikawa M, Hartshorne DJ, Nakano T 1999 Inhibitory phosphorylation site for Rho-associated kinase on smooth muscle myosin phosphatase. 

Phrase: "Metabolism 47"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0025519:Metabolism [Organism Function]
   861   C0025520:metabolism [Functional Concept]

Phrase: ":"

Phrase: "5462"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Feng J,"

Phrase: "Ito M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Ichikawa K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Isaka N,"

Phrase: "Nishikawa M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Hartshorne DJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012836:DJ [Geographic Area]

Phrase: "Nakano T 1999 Inhibitory phosphorylation site for Rho-associated kinase"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C1519063:Phosphorylation Site [Amino Acid Sequence]
   739   C0031715:Phosphorylation [Molecular Function]
   739   C0205145:Site [Spatial Concept]
   739   C1158886:Phosphorylation [Molecular Function]
   739   C1515974:Site [Body Location or Region]
   739   C2825164:Site [Spatial Concept]

Phrase: "on smooth muscle myosin phosphatase."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0067062:myosin phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0031678:Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C1149880:phosphatase [Molecular Function]
Processing 00000000.tx.400: J Biol Chem 274:3738537390[Abstract/Free FullText] Noda M, Yasuda-Fukazawa C, Moriishi K, Kato T, Okuda T, Kurokawa K, Takuwa Y 1995 Involvement of in GTP S-induced enhancement of phosphorylation of 20 kDa myosin light chain in vascular smooth muscle cells: inhibition of phosphatase activity. 

Phrase: "J Biol Chem 274"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "3738537390"

Phrase: "[Abstract/Free FullText"

Phrase: "] Noda M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Yasuda-Fukazawa C,"

Phrase: "Moriishi K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Kato T,"

Phrase: "Okuda T,"

Phrase: "Kurokawa K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Takuwa Y 1995 Involvement of"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1314939:Involvement [Functional Concept]

Phrase: "in GTP S-induced enhancement"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1627358:Enhancement [Therapeutic or Preventive Procedure]
   812   C2349975:Enhancement [Activity]

Phrase: "of phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031715:Phosphorylation [Molecular Function]
  1000   C1158886:Phosphorylation [Molecular Function]

Phrase: "of 20 kDa myosin light chain"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   884   C0027108:Myosin Light Chain [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0023693:Light [Natural Phenomenon or Process]
   804   C0027096:Myosin [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0337112:Chain [Manufactured Object]
   804   C1306462:Light [Functional Concept]
   804   C1524075:Chain [Idea or Concept]
   804   C1881376:Light [Qualitative Concept]

Phrase: "in vascular smooth muscle cells"
Meta Candidates (Total=23; Excluded=11; Pruned=0; Remaining=12)
   923   C0026844:Muscle, Smooth, Vascular [Tissue]
   923   C1135918:Smooth Muscle Cells [Cell]
   861   C0596981:Muscle Cells [Cell]
   861   C1267092:Muscle, Smooth [Tissue]
   852   C0005773:Blood Cells [Cell]
   844 E C2328697:Hemal cell [Cell]
   812   C0005847:vascular [Body Part, Organ, or Organ Component]
   812   C0007634:Cells [Cell]
   812   C0026845:Muscle [Tissue]
   812   C0205357:Smooth [Qualitative Concept]
   812   C1558950:VASCULAR [Finding]
   812   C1801960:Vascular [Qualitative Concept]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
   756 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   756 E C1511228:VESSEL, BLOOD [Tissue]
   741 E C0442025:Muscular [Spatial Concept]
   712 E C0005767:Blood [Tissue]
   712 E C0005768:blood [Body Substance]
   712 E C0229664:Blood [Body Substance]
   712 E C0392895:Bloods [Population Group]

Phrase: ":"

Phrase: "inhibition of phosphatase activity."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0021467:Inhibition [Mental Process]
   770   C0021469:Inhibition [Molecular Function]
   770   C1628982:% inhibition [Quantitative Concept]
   770   C3463820:Inhibition [Activity]
Processing 00000000.tx.401: FEBS Lett 367:246250[CrossRef][Medline] Kureishi Y, Kobayashi S, Amano M, Kimura K, Kanaide H, Nakano T, Kaibuchi K, Ito M 1997 Rho-associated kinase directly induces smooth muscle contraction through myosin light chain phosphorylation. 

Phrase: "FEBS Lett 367"

Phrase: ":"

Phrase: "246250"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Kureishi Y,"

Phrase: "Kobayashi S,"

Phrase: "Amano M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Kimura K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Kanaide H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Nakano T,"

Phrase: "Kaibuchi K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Ito M 1997 Rho-associated kinase directly"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   845   C0389995:rho-Associated Kinase [Amino Acid, Peptide, or Protein,Enzyme]
           rho-Kinase
   829   C1335631:RHO KINASE [Gene or Genome]
   795   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   795   C0332281:Associated [Qualitative Concept]
   762 E C0750490:Associate [Idea or Concept]
   762 E C1706221:Associate [Professional or Occupational Group]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "smooth muscle contraction through myosin light chain phosphorylation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   800   C1155937:smooth muscle contraction [Organ or Tissue Function]
   770   C0026820:Muscle Contraction [Physiologic Function]
   744   C1140999:Contraction [Pathologic Function]
Processing 00000000.tx.402: J Biol Chem 272: 1225712260, 1997 Zen JG, Quon MJ: Insulin-stimulated production of nitric oxide is inhibited by wortmannin. 

Phrase: "J Biol Chem 272"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "1225712260,"

Phrase: "1997 Zen JG,"

Phrase: "Quon MJ"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439254:MJ [Medical Device]

Phrase: ":"

Phrase: "Insulin-stimulated production of nitric oxide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0033268:production [Occupational Activity]

Phrase: "is"

Phrase: "inhibited by wortmannin."
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   790   C0078517:wortmannin [Biologically Active Substance,Pharmacologic Substance,Steroid]
   790   C0311403:Inhibited [Qualitative Concept]
   718 E C0018790:arrested [Disease or Syndrome]
   718 E C0237477:Arrest [Temporal Concept]
   718 E C0392351:arrest [Governmental or Regulatory Activity]
   718 E C0521111:Retarded [Qualitative Concept]
Processing 00000000.tx.403: Direct measurement in vascular endothelial cells J Clin Invest 98: 894898, 1996 Wu X, Somlyo AV, Somlyo AP 1996 Cyclic GMP-dependent stimulation reverses G-protein-coupled inhibition of smooth muscle myosin light chain phosphate. 

Phrase: "Direct measurement in vascular endothelial cells J"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0242485:Measurement [Functional Concept]

Phrase: "Clin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]

Phrase: "Invest"

Phrase: "98"

Phrase: ":"

Phrase: "894898,"

Phrase: "1996 Wu X,"

Phrase: "Somlyo AV,"

Phrase: "Somlyo AP 1996 Cyclic GMP-dependent stimulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   795   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "reverses"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555029:Reverse [Idea or Concept]

Phrase: "G-protein-coupled inhibition of smooth muscle myosin light chain phosphate."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   738   C0021467:Inhibition [Mental Process]
   738   C0021469:Inhibition [Molecular Function]
   738   C1628982:% inhibition [Quantitative Concept]
   738   C3463820:Inhibition [Activity]
Processing 00000000.tx.404: Biochem Biophys Res Commun 220:658663[CrossRef][Medline] Nakamura M, Ichikawa K, Ito M, Yamamori B, Ohinaka T, Isaka N, Yoshida Y, Fugita S, Nakano T: Effects of the phosphorylation of myosin phosphatase cyclic GMPdependent protein kinase. 

Phrase: "Biochem Biophys Res Commun 220"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C2347379:RES [Finding]

Phrase: ":"

Phrase: "658663"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Nakamura M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Ichikawa K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Ito M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Yamamori B,"

Phrase: "Ohinaka T,"

Phrase: "Isaka N,"

Phrase: "Yoshida Y,"

Phrase: "Fugita S,"

Phrase: "Nakano T"

Phrase: ":"

Phrase: "Effects of the phosphorylation of myosin phosphatase cyclic GMPdependent protein kinase."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   738   C1280500:effects [Qualitative Concept]
   704 E C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.405: Cell Signal 9:671676, 1999 Li L, Eto M, Lee MR, Morita F, Yazawa M, Kitazawa T 1998 Possible involvement of the novel CPI-17 protein in protein kinase C signal transduction of rabbit arterial smooth muscle. 

Phrase: "Cell Signal 9"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0007634:Cell [Cell]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1710082:Signal [Phenomenon or Process]
   827   C1948049:Cell [Spatial Concept]

Phrase: ":"

Phrase: "671676,"

Phrase: "1999 Li L,"

Phrase: "Eto M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Lee MR,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347167:Mr. [Conceptual Entity]

Phrase: "Morita F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Yazawa M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Kitazawa T 1998 Possible involvement of the novel CPI-17 protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C1314939:Involvement [Functional Concept]

Phrase: "in protein kinase C signal transduction"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   840   C0037083:Signal Transduction [Cell Function]
   804   C1160185:transduction [Organism Function]
   804   C1710082:Signal [Phenomenon or Process]
   717   C0033634:Protein Kinase C [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "of rabbit arterial smooth muscle."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C1267092:Muscle, Smooth [Tissue]
   812   C0026845:Muscle [Tissue]
   812   C0205357:Smooth [Qualitative Concept]
   741 E C0442025:Muscular [Spatial Concept]
Processing 00000000.tx.406: J Physiol (Lond) 508:871881[Abstract/Free FullText] Igarashi M, Wakasaki H, Takahara N, Ishii H, Jiang ZY, Yamauchi T, Kuboki K, Meier, M, Rhodes CJ, King GL 1999 Glucose and diabetes activate p 38 mitogen-activated protein kinase via different pathways. 

Phrase: "J Physiol"

Phrase: "(Lond) 508"

Phrase: ":"

Phrase: "871881"

Phrase: "[Abstract/Free FullText"

Phrase: "] Igarashi M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Wakasaki H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Takahara N,"

Phrase: "Ishii H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Jiang ZY,"

Phrase: "Yamauchi T,"

Phrase: "Kuboki K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Meier,"

Phrase: "M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "Rhodes CJ,"

Phrase: "King"

Phrase: "GL 1999 Glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "and"

Phrase: "diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "p 38 mitogen-activated protein kinase via different pathways."
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
   818   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   790   C1979930:Mitogen-activated protein [Amino Acid, Peptide, or Protein]
   784   C0072374:protein kinase P [Amino Acid, Peptide, or Protein,Enzyme]
   764   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   762   C0082731:P-protein [Amino Acid, Peptide, or Protein,Enzyme]
   762   C1151818:P-protein [Molecular Function]
   742   C0018284:Mitogen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0026249:Mitogen [Pharmacologic Substance]
   742   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   742   C1879547:Activated [Activity]
   742   C2603361:P' [Clinical Attribute]
   708 E C1515877:Activate [Functional Concept]
Processing 00000000.tx.407: J Clin Invest 103:185195[Abstract/Free FullText] Perrie WT, Perry SV 1970 An electrophoretic study of the low-molecular-weight components of myosin. 

Phrase: "J"

Phrase: "Clin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]

Phrase: "Invest"

Phrase: "103"

Phrase: ":"

Phrase: "185195"

Phrase: "[Abstract/Free FullText"

Phrase: "] Perrie WT,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2700323:WT [Fish]

Phrase: "Perry SV 1970"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0013754:SV [Geographic Area]
   827   C0560132:Sv [Quantitative Concept]
   827   C1704677:SV [Idea or Concept]

Phrase: "An electrophoretic study of the low-molecular-weight components of myosin."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0557651:Study [Manufactured Object]
   738   C2603343:Study [Research Activity]
Processing 00000000.tx.408: Biochem J 119:3138[Medline] Begum N, Song Y, Rienzie J, Ragolia L 1998 Vascular smooth muscle cell growth and insulin regulation of mitogen-activated protein kinase in hypertension. 

Phrase: "Biochem J 119"

Phrase: ":"

Phrase: "3138"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Begum N,"

Phrase: "Song Y,"

Phrase: "Rienzie J,"

Phrase: "Ragolia L 1998 Vascular smooth muscle cell growth"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0007595:Cell Growth [Cell Function]
   793   C0018270:'growth' NOS [Organism Function]
   793   C0220844:growth [Physiologic Function]
   793   C1621966:Growth [Organ or Tissue Function]
   793   C2911660:Growth [Activity]

Phrase: "and"

Phrase: "insulin regulation of mitogen-activated protein kinase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0851285:Regulation [Governmental or Regulatory Activity]
   748   C1327622:Regulation [Biologic Function]

Phrase: "in hypertension."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0020538:Hypertension [Disease or Syndrome]
  1000   C1963138:Hypertension [Finding]
Processing 00000000.tx.409: Am J Physiol 275:C4249 Srinivasan M, Begum N 1994 Regulation of protein phosphatase 1, 2A activities by insulin during myogenesis in rat skeletal muscle cells in culture. 

Phrase: "Am"

Phrase: "J Physiol 275"

Phrase: ":"

Phrase: "C4249 Srinivasan M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]

Phrase: "Begum N 1994 Regulation of protein phosphatase 1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0851285:Regulation [Governmental or Regulatory Activity]
   744   C1327622:Regulation [Biologic Function]

Phrase: "2A activities by insulin"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   802   C1145751:insulin activity [Molecular Function]
   770   C0441655:Activities [Activity]
   737 E C0205177:Activity [Functional Concept]
   737 E C0439167:% activity [Quantitative Concept]
   737 E C1561536:*Activity [Idea or Concept]

Phrase: "during myogenesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596997:Myogenesis [Organ or Tissue Function]

Phrase: "in rat skeletal muscle cells"
Meta Candidates (Total=14; Excluded=4; Pruned=0; Remaining=10)
   923   C1882854:Rat Skeletal Muscle [Body Part, Organ, or Organ Component]
   890   C1704336:Skeletal muscle cell [Cell]
   861   C0242692:Muscle, Skeletal [Tissue]
   861   C0596981:Muscle Cells [Cell]
   861   C1280260:Skeletal muscle [Body Part, Organ, or Organ Component]
   812   C0007634:Cells [Cell]
   812   C0026845:Muscle [Tissue]
   812   C0037253:skeletal [Body System]
   812   C0521324:Skeletal [Spatial Concept]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
   741 E C0442025:Muscular [Spatial Concept]

Phrase: "in culture."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0010453:Culture [Idea or Concept]
  1000   C0220814:culture [Functional Concept]
  1000   C0430400:Culture [Laboratory Procedure]
  1000   C2242979:Culture [Laboratory Procedure]
Processing 00000000.tx.410: J Biol Chem 269: 1251412520 Cohen P, Klumpp S, Schelling DL 1989 An improved procedure for identifying and quantitating protein phosphatases in mammalian tissues. 

Phrase: "J Biol Chem 269"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "1251412520 Cohen P,"

Phrase: "Klumpp S,"

Phrase: "Schelling DL 1989"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C3642216:/dL [Quantitative Concept]

Phrase: "An improved procedure for identifying"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0184661:Procedure [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   760   C1948041:Procedure [Therapeutic or Preventive Procedure]
   760   C2700391:Procedure [Activity]
   760   C3274430:PROCEDURE [Health Care Activity]
   760   C3538935:Procedure [Idea or Concept]
   760   C3539779:Procedure [Intellectual Product]

Phrase: "and"

Phrase: "quantitating protein phosphatases in mammalian tissues."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0031686:Protein Phosphatases [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0031678:Phosphatases [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   719 E C1149880:phosphatase [Molecular Function]
Processing 00000000.tx.411: FEBS Lett 250:596600[CrossRef][Medline] Cohen P 1983 Protein phosphatases and their regulation. 

Phrase: "FEBS Lett 250"

Phrase: ":"

Phrase: "596600"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Cohen P 1983 Protein phosphatases"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   840   C0031686:Protein Phosphatases [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0031678:Phosphatases [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   771 E C1149880:phosphatase [Molecular Function]

Phrase: "and"

Phrase: "their regulation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0851285:Regulation [Governmental or Regulatory Activity]
  1000   C1327622:Regulation [Biologic Function]
Processing 00000000.tx.412: Methods Enzymol 99: 243250 Ishihara H, Martin BL, Brautigan DL, Karaki H, Ozaki H, Kato Y, Fusetani N, Watanabe S, Hashimoto K, Uemura D, Hartshorne DJ 1989 Calyculin A and okadaic acid: inhibitors of protein phosphatase activity. 

Phrase: "Methods Enzymol 99"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0025663:Methods [Intellectual Product]
   827   C0025664:methods [Intellectual Product]
   827   C0449851:Methods [Functional Concept]
   793 E C0871511:METHOD [Intellectual Product]

Phrase: ":"

Phrase: "243250 Ishihara H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0033727:H+ [Element, Ion, or Isotope]
   827   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441932:H+ [Classification]
   827   C0564385:/h [Quantitative Concept]

Phrase: "Martin BL,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0006413:BL [Neoplastic Process]
   861   C1552663:BL [Idea or Concept]
   861   C2827109:BL [Geographic Area]

Phrase: "Brautigan DL,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3642216:/dL [Quantitative Concept]

Phrase: "Karaki H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Ozaki H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Kato Y,"

Phrase: "Fusetani N,"

Phrase: "Watanabe S,"

Phrase: "Hashimoto K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Uemura D,"

Phrase: "Hartshorne DJ 1989 Calyculin A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   840   C0054549:calyculin A [Organic Chemical,Pharmacologic Substance]
   804   C0597861:calyculin [Pharmacologic Substance]

Phrase: "and"

Phrase: "okadaic acid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0069389:Ocadaic Acid [Hazardous or Poisonous Substance,Organic Chemical]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: ":"

Phrase: "inhibitors of protein phosphatase activity."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   871   C1152577:protein phosphatase inhibitor activity [Molecular Function]
   827   C1514560:Protein Phosphatase Inhibitor [Pharmacologic Substance]
   824   C1152576:phosphatase inhibitor activity [Molecular Function]
   781   C0597217:phosphatase inhibitor [Pharmacologic Substance]
   760   C0243077:inhibitors [Chemical Viewed Functionally]
   726 E C1999216:Inhibitor [Qualitative Concept]
Processing 00000000.tx.413: Biochem Biophys Res Commun 15: 871877 Feng J, Ito M, Kureishi Y, Ichikawa K, Amano M, Isaka N, Okawa K, Iwamatsu A, Kaibuch K, Hartshorne DJ, Nakano T 1999 Rho associated kinase of chicken gizzard smooth muscle. 

Phrase: "Biochem Biophys Res Commun 15"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C2347379:RES [Finding]

Phrase: ":"

Phrase: "871877 Feng J,"

Phrase: "Ito M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Kureishi Y,"

Phrase: "Ichikawa K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Amano M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Isaka N,"

Phrase: "Okawa K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Iwamatsu A,"

Phrase: "Kaibuch K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Hartshorne DJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012836:DJ [Geographic Area]

Phrase: "Nakano T 1999 Rho associated kinase of chicken gizzard smooth muscle."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   775   C0389995:rho-Associated Kinase [Amino Acid, Peptide, or Protein,Enzyme]
           rho-Kinase
   754   C1335631:RHO KINASE [Gene or Genome]
   738   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   738   C0332281:Associated [Qualitative Concept]
   704 E C0750490:Associate [Idea or Concept]
   704 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.414: J Biol Chem 274:37443752[Abstract/Free FullText] Hoshijima M, Sa VP, Wang Y, Chien KR, Brown JH 1998 The low molecular weight GTPase Rho regulates myofibril formation and organization in neonatal rat ventricular myocytes. 

Phrase: "J Biol Chem 274"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "37443752"

Phrase: "[Abstract/Free FullText"

Phrase: "] Hoshijima M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Sa VP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1883540:{VP} [Quantitative Concept]

Phrase: "Wang Y,"

Phrase: "Chien KR,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022773:KR [Geographic Area]

Phrase: "Brown JH 1998"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0268060:JH [Disease or Syndrome]
   827   C0678579:Brown [Natural Phenomenon or Process]
   827   C1415529:JH [Gene or Genome]

Phrase: "The low molecular weight GTPase Rho"

Phrase: "regulates"

Phrase: "myofibril formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0220781:formation [Biologic Function]
   861   C0439634:formation [Spatial Concept]
   861   C1522492:Formation [Functional Concept]

Phrase: "and"

Phrase: "organization in neonatal rat ventricular myocytes."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0029237:Organisation [Physiologic Function]
   753   C0029246:Organization [Organization]
   753   C0220885:organization [Qualitative Concept]
   753   C1300196:Organization [Functional Concept]
   753   C1522486:Organization [Professional or Occupational Group]
Processing 00000000.tx.415: J Biol Chem. 

Phrase: "J Biol Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.416: 273:77257730 Garcia JGN, Davis HW, Patterson CE 1995 Regulation of endothelial cell gap formation and barrier dysfunction: role of myosin light chain phosphorylation. 

Phrase: "273"

Phrase: ":"

Phrase: "77257730 Garcia JGN,"

Phrase: "Davis HW,"

Phrase: "Patterson CE 1995 Regulation of endothelial cell gap formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   784   C1157723:regulation of formation [Molecular Function]
   742   C0851285:Regulation [Governmental or Regulatory Activity]
   742   C1327622:Regulation [Biologic Function]

Phrase: "and"

Phrase: "barrier dysfunction"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0031847:dysfunction [Functional Concept]
   861   C0277785:Dysfunction, NOS [Qualitative Concept]
   805 E C0231174:Malfunction [Functional Concept]
   805 E C1881681:MALFUNCTION [Phenomenon or Process]

Phrase: ":"

Phrase: "role of myosin light chain phosphorylation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.417: J Cell Physiol 163:510522[Medline] Smith PK, Krohn RI, Hermanso GT, Mallia AK, Gartner FH, Provenzano MD, Fujimot EK, Goeke NM, Olson BJ, Klenk DC 1998 Measurement of proteins using bicinchoninic acid. 

Phrase: "J Cell Physiol 163"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0007634:Cell [Cell]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]

Phrase: ":"

Phrase: "510522"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Smith PK,"

Phrase: "Krohn RI,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035487:RI [Geographic Area]

Phrase: "Hermanso GT,"

Phrase: "Mallia AK,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0001905:AK [Geographic Area]
   861   C1412243:AK [Gene or Genome]

Phrase: "Gartner FH,"

Phrase: "Provenzano MD,"

Phrase: "Fujimot EK,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0008415:EK [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "Goeke NM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]

Phrase: "Olson BJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005005:BJ [Geographic Area]

Phrase: "Klenk DC 1998 Measurement of proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C0202202:Protein measurement [Laboratory Procedure]
   753   C0242485:Measurement [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "bicinchoninic acid."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0053554:bicinchoninic acid [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]
Processing 00000000.tx.418: Anal Biochem 150:7685 Bradford MM 1976 A rapid, sensitive method for the quantitation of microgram quantities of proteins utilizing the principle of protein dye binding. 

Phrase: "Anal Biochem 150"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0003461:Anal [Body Part, Organ, or Organ Component]
   827   C2939124:Anal [Spatial Concept]

Phrase: ":"

Phrase: "7685 Bradford MM 1976"

Phrase: "A rapid, sensitive method for the quantitation of microgram quantities of proteins"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   751   C0872257:rapid method [Diagnostic Procedure]
   736   C0025663:Method [Intellectual Product]
   736   C0449851:Method [Functional Concept]
   736   C0871511:METHOD [Intellectual Product]
   734   C1547724:Quantity method [Idea or Concept]

Phrase: "utilizing"

Phrase: "the principle of protein dye binding."
Processing 00000000.tx.419: Anal Biochem 72:248254[CrossRef][Medline]

Phrase: "Anal Biochem 72"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0003461:Anal [Body Part, Organ, or Organ Component]
   827   C2939124:Anal [Spatial Concept]

Phrase: ":"

Phrase: "248254"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

